,Unnamed: 0,Date,Title,Page Type,Country Code,Author,Category Details,Full Text,Gender,Hashtags,Interest,Professions,Total Monthly Visitors,Twitter Author ID,Twitter Channel Role,Twitter Followers,Twitter Following,Twitter Reply Count,Twitter Reply to,Twitter Retweet of,Twitter Retweets,Twitter Likes,Twitter Tweets,Twitter Verified,clean_tw,key_words,key_words_int,key_words_int_x,Document,Topic,Name,CustomName,Representation,KeyBERT,Llama2,MMR,Representative_Docs,Top_n_words,Probability,Representative_document
0,0,2023-10-16 02:28:53.0,@RealTalkMS_jon Yes Judging by the Science revealed at ECTRIMS we need to strat calling MS a virus instead of Autoimmune,twitter,,bam214_bam,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@realtalkms_jon yes judging by the science revealed at ectrims we need to strat calling ms a virus instead of autoimmune,unknown,,,,6000000000,1354700283494821892,,35,48,0,http://twitter.com/RealTalkMS_jon/statuses/1713648689460269565,,0,1,700,False,yes judging by the science revealed at ectrims we need to strat calling ms a virus instead of autoimmune,"['Ectrims', 'science', 'call', 'virus', 'autoimmune']","ectrims,science,call,virus,autoimmune",science call virus autoimmune,science call virus autoimmune,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,1.0,False
1,1,2023-10-15 23:00:29.0,"StimRouter #neuromodulation system shows remarkable improvements in lower urinary tract issues for patients with #MultipleSclerosis based on a recent study presented at #MSMilan2023. @ACTRIMS @ECTRIMS 

Dive into the details: https://t.co/wrJ8e34meO",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",stimrouter #neuromodulation system shows remarkable improvements in lower urinary tract issues for patients with #multiplesclerosis based on a recent study presented at #msmilan2023. @actrims @ectrims dive into the details: https://t.co/wrj8e34meo,,"#neuromodulation, #multiplesclerosis, #msmilan2023",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8630,518,0,,,0,0,33766,False,stimrouter #neuromodulation system shows remarkable improvements in lower urinary tract issues for patients with multiple sclerosis based on a recent study presented at ms milan. dive into the details:,"['stimrouter', 'neuromodulation', 'system', 'lower urinary tract', 'multiple sclerosis', 'study', 'MS Milan']","stimrouter,neuromodulation,system,lower urinary tract,multiple sclerosis,study,ms milan",stimrouter neuromodulation system lower urinary tract study,stimrouter neuromodulation system lower urinary tract study,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.6426271924228243,False
2,2,2023-10-15 21:00:30.0,"New Research Alert! #Satralizumab continues demonstrating long-term efficacy in patients with AQP4-IgG seropositive #NMOSD, according to a recent study presented at #MSMilan2023. @ACTRIMS @ECTRIMS @UniofOxford

Explore more here: https://t.co/pLMfjjWROy",twitter,USA,neurology_live,"{id=20740632, name=Enspryng / satralizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","new research alert! #satralizumab continues demonstrating long-term efficacy in patients with aqp4-igg seropositive #nmosd, according to a recent study presented at #msmilan2023. @actrims @ectrims @uniofoxford explore more here: https://t.co/plmfjjwroy",,"#satralizumab, #nmosd, #msmilan2023",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8629,517,0,,,0,0,33765,False,"new research alert! #satralizumab continues demonstrating long-term efficacy in patients with aqp4-igg seropositive #nmosd, according to a recent study presented at ms milan. explore more here:","['Satralizumab', 'AQP4-IgG', 'NMOSD', 'MS Milan']","satralizumab,aqp4-igg,nmosd,ms milan",satralizumab aqp4-igg,satralizumab aqp4-igg,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,0.4962340442274282,False
3,3,2023-10-15 19:00:45.0,"Discover the exciting cognitive biomarker improvements in mesenchymal #stemcelltherapy for patients with #MS from this recent study presented at #MSMilan2023. Stay on the cutting edge by learning about the latest advances in #MScare. @ECTRIMS 

Read: https://t.co/I5IueX85Ps",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}",discover the exciting cognitive biomarker improvements in mesenchymal #stemcelltherapy for patients with #ms from this recent study presented at #msmilan2023. stay on the cutting edge by learning about the latest advances in #mscare. @ectrims read: https://t.co/i5iuex85ps,,"#stemcelltherapy, #ms, #msmilan2023, #mscare",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8629,517,0,,,0,2,33764,False,discover the exciting cognitive biomarker improvements in mesenchymal #stemcelltherapy for patients with ms from this recent study presented at ms milan. stay on the cutting edge by learning about the latest advances in mscare. read:,"['mesenchymal stem cells', 'multiple sclerosis', 'cognitive biomarker', 'MSC therapy', 'MS Milan', 'cutting-edge research', 'MSCare']","mesenchymal stem cells,multiple sclerosis,cognitive biomarker,msc therapy,ms milan,cutting-edge research,mscare",mesenchymal stem cells cognitive biomarker msc therapy cutting-edge research mscare,mesenchymal stem cells cognitive biomarker msc therapy cutting-edge research mscare,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
4,4,2023-10-15 17:00:56.0,"The optimal dosage for subcutaneous #ocrelizumab was uncovered in findings from the phase 1b Ocarina I trial and was also presented at the recent #MSMilan2023. @ECTRIMS @ACTRIMS @genentech @OCREVUS_USA @HopkinsMedicine

Get the details: https://t.co/AXL0BTa9Ns",twitter,USA,neurology_live,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=19587268, name=SC, displayName=null, parentId=19587266, parentName=Crova generative AI_SML}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",the optimal dosage for subcutaneous #ocrelizumab was uncovered in findings from the phase 1b ocarina i trial and was also presented at the recent #msmilan2023. @ectrims @actrims @genentech @ocrevus_usa @hopkinsmedicine get the details: https://t.co/axl0bta9ns,,"#ocrelizumab, #msmilan2023",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8629,517,0,,,0,0,33763,False,the optimal dosage for subcutaneous #ocrelizumab was uncovered in findings from the phase 1b ocarina i trial and was also presented at the recent ms milan. get the details:,"['ocrelizumab', 'phase 1b', 'ocarina i trial', 'MS Milan']","ocrelizumab,phase 1b,ocarina i trial,ms milan",ocrelizumab phase 1b ocarina i trial,ocrelizumab phase 1b ocarina i trial,5,5_ocrevus_ocrelizumab_trial_chimes,Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.,"['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['ocrevus', 'ocrelizumab', 'ocarina', 'treatment', 'patients', 'msmilan', 'neurology', 'sclerosis', 'trial', 'neurologist']","['Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.', '', '', '', '', '', '', '', '', '']","['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan', 'ocrevus phase 3 trial', 'interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients']",ocrevus - ocrelizumab - trial - chimes - phase - patients - relapsing - decisions - noninferiority - brumvi,0.5486095444424025,False
5,5,2023-10-15 15:25:01.0,We are very proud that 4 neuropharmacists from the UK had posters @ECTRIMS this year. Highlighting the important contribution of #pharmacists to MS care. Well done to @DebzClark Roshni Dattani @joelamathews @RayDorsey7 #MSMilan2023 #neuropharmacy https://t.co/NDmZyWbFWY,twitter,GBR,UKCPANeuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",we are very proud that 4 neuropharmacists from the uk had posters @ectrims this year. highlighting the important contribution of #pharmacists to ms care. well done to @debzclark roshni dattani @joelamathews @raydorsey7 #msmilan2023 #neuropharmacy https://t.co/ndmzywbfwy,,"#pharmacists, #msmilan2023, #neuropharmacy",,,6000000000,3184780972,,439,79,1,,,1,5,1066,False,we are very proud that 4 neuropharmacists from the uk had posters this year. highlighting the important contribution of #pharmacists to ms care. well done to roshni dattani ms milan #neuropharmacy,"['Pharmacists', 'UK', 'posters', 'MS care', 'Roshni Dattani', 'Milan', 'neuropharmacy']","pharmacists,uk,posters,ms care,roshni dattani,milan,neuropharmacy",pharmacists uk posters ms care roshni dattani neuropharmacy,pharmacists uk posters ms care roshni dattani neuropharmacy,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
6,6,2023-10-15 13:01:03.0,"Learn how #ofatumumab holds the line in patients with #MS previously treated with anti-CD20 therapies in a recent study presented at #MSMilan2023. Stay up-to-date with the latest research in #neurology @ECTRIMS @ACTRIMS @ClevelandClinic

Read: https://t.co/6tbt5z1qP8",twitter,USA,neurology_live,"{id=20767265, name=Kesimpta, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740624, name=Kesimpta / ofatumumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",learn how #ofatumumab holds the line in patients with #ms previously treated with anti-cd20 therapies in a recent study presented at #msmilan2023. stay up-to-date with the latest research in #neurology @ectrims @actrims @clevelandclinic read: https://t.co/6tbt5z1qp8,,"#ofatumumab, #ms, #msmilan2023, #neurology",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8628,517,0,,,0,0,33761,False,learn how #ofatumumab holds the line in patients with ms previously treated with anti-cd20 therapies in a recent study presented at ms milan. stay up-to-date with the latest research in #neurology read:,"['Ofatumumab', 'MS', 'anti-CD20', 'neurology']","ofatumumab,ms,anti-cd20,neurology",ofatumumab anti-cd20 neurology,ofatumumab anti-cd20 neurology,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,1.0,False
7,7,2023-10-15 11:25:47.0,"@RachelHorne19 Hopefully, breakthroughs in treatments (for progression, remyelination etc.) in the next few years will mean the end of ECTRIMS. Next year will be the 40th congress!  MS research still seems to be a growth industry - good for Professors, PhD students and pharma profits.",twitter,GBR,charnbrook,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@rachelhorne19 hopefully, breakthroughs in treatments (for progression, remyelination etc.) in the next few years will mean the end of ectrims. next year will be the 40th congress! ms research still seems to be a growth industry - good for professors, phd students and pharma profits.",unknown,,,,6000000000,202330588,,2,2,0,http://twitter.com/RachelHorne19/statuses/1713278832642241019,,0,0,91,False,"hopefully, breakthroughs in treatments (for progression, remyelination etc.) in the next few years will mean the end of ectrims. next year will be the 40th congress! ms research still seems to be a growth industry - good for professors, phd students and pharma profits.","['treatments', 'progression', 'remyelination', 'ectrims', 'congress', 'MS research', 'growth industry', 'professors', 'PhD students', 'pharma profits']","treatments,progression,remyelination,ectrims,congress,ms research,growth industry,professors,phd students,pharma profits",treatments progression remyelination congress ms research growth industry professors phd students pharma profits,treatments progression remyelination congress ms research growth industry professors phd students pharma profits,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.6193189192804264,False
8,8,2023-10-15 10:54:02.0,"The three women presidents of @ectrims !!!
ðŸ‘ðŸ‘ Great !!!
#MSMilan2023 
#multiplesclerosis 
@MarTintore https://t.co/6nSrBr8ZDR",twitter,ESP,C_OrejaGuevara,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",the three women presidents of @ectrims !!! ðŸ‘ðŸ‘ great !!! #msmilan2023 #multiplesclerosis @martintore https://t.co/6nsrbr8zdr,female,"#msmilan2023, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1221603110,,4151,1106,0,,,3,35,23743,False,the three women presidents of !!! great !!! ms milan multiple sclerosis,"['women', 'presidents', 'MS', 'Milan', 'multiple sclerosis']","women,presidents,ms,milan,multiple sclerosis",women presidents,women presidents,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.856571367495942,False
9,9,2023-10-15 10:47:20.0,"Was great to share our work at @ECTRIMSÂ  #MSMilan2023 (P1513, P1639)!!!! @I_GomezEstevez   @loregarcia8 #multiplesclerosis
 #msresearch #esclerosismultiple #somosclinico https://t.co/1MdzNVi2Dj",twitter,ESP,C_OrejaGuevara,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","was great to share our work at @ectrims #msmilan2023 (p1513, p1639)!!!! @i_gomezestevez @loregarcia8 #multiplesclerosis #msresearch #esclerosismultiple #somosclinico https://t.co/1mdznvi2dj",female,"#msmilan2023, #multiplesclerosis, #msresearch, #esclerosismultiple, #somosclinico",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1221603110,,4151,1106,0,,,3,8,23742,False,"was great to share our work at ms milan (p1513, p1639)!!!! multiple sclerosis msresearch #esclerosismultiple #somosclinico","['ms', 'Milan', 'work', 'research', 'clinic']","ms,milan,work,research,clinic",work clinic,work clinic,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
10,10,2023-10-15 00:23:00.0,Cognitive processing speed improved in nearly 50% of people treated with #Zeposia (@bmsnews) for early relapsing #MultipleSclerosis (#RMS) according to an ad hoc interim analysis presented at #MSMilan2023 @ECTRIMS @ACTRIMS. https://t.co/CkduDUVrTf,twitter,,PracticalNeuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",cognitive processing speed improved in nearly 50% of people treated with #zeposia (@bmsnews) for early relapsing #multiplesclerosis (#rms) according to an ad hoc interim analysis presented at #msmilan2023 @ectrims @actrims. https://t.co/ckduduvrtf,,"#zeposia, #multiplesclerosis, #rms, #msmilan2023",,,6000000000,386755226,,15377,154,0,,,0,4,3860,False,cognitive processing speed improved in nearly 50% of people treated with #zeposia () for early relapsing multiple sclerosis (#rms) according to an ad hoc interim analysis presented at ms milan .,"['zeposia', 'rms', 'ms Milan']","zeposia,rms,ms milan",zeposia rms,zeposia rms,12,12_massimo_filippi_freedman_ciccarelli,"Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['massimo', 'zeposia', 'ciccarelli', 'olga', 'sastregarriga', 'filippi', 'prize', 'rachel', 'horne', 'french']","['Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.', '', '', '', '', '', '', '', '', '']","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['prof olga ciccarelli', 'massimo filippi mark freedman who mogad actrims', 'rachel horne prize massimo filippi']",massimo - filippi - freedman - ciccarelli - career - zeposia - olga - rms - sastregarriga - who,1.0,False
11,12,2023-10-14 21:07:00.0,"An international panel of experts in #MultipleSclerosis developed new consensus statements on #SmolderingDisease in #MS, which were presented at #MSMilan2023 @ECTRIMS @ACTRIMS. @sanofi https://t.co/2FdUO1LfD2",twitter,,PracticalNeuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","an international panel of experts in #multiplesclerosis developed new consensus statements on #smolderingdisease in #ms, which were presented at #msmilan2023 @ectrims @actrims. @sanofi https://t.co/2fduo1lfd2",,"#multiplesclerosis, #smolderingdisease, #ms, #msmilan2023",,,6000000000,386755226,,15378,154,0,,,0,4,3859,False,"an international panel of experts in multiple sclerosis developed new consensus statements on #smolderingdisease in ms, which were presented at ms milan .","['multiple sclerosis', 'smoldering disease', 'MS Milan']","multiple sclerosis,smoldering disease,ms milan",smoldering disease,smoldering disease,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
12,14,2023-10-14 20:05:48.0,"Infection with the Epstein-Barr virus may prime the immune system to accidentally attack a brain protein called ANO2, research shows. https://t.co/WkTDiQpxFb",twitter,,james_jamstew,"{id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}","infection with the epstein-barr virus may prime the immune system to accidentally attack a brain protein called ano2, research shows. https://t.co/wktdiqpxfb",male,,,,6000000000,2930969043,,111,243,0,,,0,0,509,False,"infection with the epstein-barr virus may prime the immune system to accidentally attack a brain protein called ano2, research shows.","['Epstein-Barr virus', 'immune system', 'accidentally attack', 'brain protein', 'Ano2']","epstein-barr virus,immune system,accidentally attack,brain protein,ano2",epstein-barr virus immune system accidentally attack brain protein ano2,epstein-barr virus immune system accidentally attack brain protein ano2,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,1.0,True
13,15,2023-10-14 17:35:52.0,"@drBWillekens @Brandon_Beaber @MarTintore @EANeurology @ECTRIMS #CCSVI
Venous Hypertension
>microbleedings
>iron
>inflammation
>free radicals 
>neurodegeneration
#multiplesclerosis

M.S. - Mystery Solved

Mysterious Autoimmunity
= CCSVI Neurodegeneration",twitter,CAN,ms_matko,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@drbwillekens @brandon_beaber @martintore @eaneurology @ectrims #ccsvi venous hypertension >microbleedings >iron >inflammation >free radicals >neurodegeneration #multiplesclerosis m.s. - mystery solved mysterious autoimmunity = ccsvi neurodegeneration,male,"#ccsvi, #multiplesclerosis",Beauty/Health & Fitness,,6000000000,364700032,,696,2708,1,http://twitter.com/ms_matko/statuses/1713246757243769040,,0,0,37769,False,#ccsvi venous hypertension >microbleedings >iron >inflammation >free radicals >neurodegeneration multiple sclerosis m.s. - mystery solved mysterious autoimmunity = ccsvi neurodegeneration,"['ccsvi', 'venous hypertension', 'microbleedings', 'iron', 'inflammation', 'free radicals', 'neurodegeneration', 'multiple sclerosis', 'mystery', 'autoimmunity']","ccsvi,venous hypertension,microbleedings,iron,inflammation,free radicals,neurodegeneration,multiple sclerosis,mystery,autoimmunity",ccsvi venous hypertension microbleedings iron inflammation free radicals neurodegeneration mystery autoimmunity,ccsvi venous hypertension microbleedings iron inflammation free radicals neurodegeneration mystery autoimmunity,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.5823872023957681,False
14,16,2023-10-14 17:33:52.0,@drBWillekens @Brandon_Beaber @MarTintore @EANeurology @ECTRIMS So happens a protocol of treatment for MS and Neurovascular Disease CCSVI Venous Angioplasty to fix mechanical Vascular issue and stem cell therapy to repair neurological damage caused by leaky narrow malfotmed often leaky Veins! #VagusNerve,twitter,CAN,ms_matko,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@drbwillekens @brandon_beaber @martintore @eaneurology @ectrims so happens a protocol of treatment for ms and neurovascular disease ccsvi venous angioplasty to fix mechanical vascular issue and stem cell therapy to repair neurological damage caused by leaky narrow malfotmed often leaky veins! #vagusnerve,male,#vagusnerve,Beauty/Health & Fitness,,6000000000,364700032,,696,2708,1,http://twitter.com/ms_matko/statuses/1713246357706944633,,0,0,37768,False,so happens a protocol of treatment for ms and neurovascular disease ccsvi venous angioplasty to fix mechanical vascular issue and stem cell therapy to repair neurological damage caused by leaky narrow malfotmed often leaky veins! vagus nerve,"['MS', 'treatment', 'protocol', 'CCSVI', 'venous angioplasty', 'stem cell therapy', 'neurovascular disease', 'vagus nerve']","ms,treatment,protocol,ccsvi,venous angioplasty,stem cell therapy,neurovascular disease,vagus nerve",protocol ccsvi venous angioplasty stem cell therapy neurovascular disease vagus nerve,protocol ccsvi venous angioplasty stem cell therapy neurovascular disease vagus nerve,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.5823872023957681,False
15,17,2023-10-14 15:00:01.0,"Thanks for joining us at #MSMilan2023! Stay connected to OCREVUS and learn more about the CHIMES study below.

Please see full Prescribing Information at https://t.co/k33kg31vLt. Intended for US healthcare professionals only.",twitter,USA,OCREVUSHCP_USA,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thanks for joining us at #msmilan2023! stay connected to ocrevus and learn more about the chimes study below. please see full prescribing information at https://t.co/k33kg31vlt. intended for us healthcare professionals only.,,#msmilan2023,,,6000000000,1480658024738009092,,155,0,0,,,0,0,31,False,thanks for joining us at ms milan! stay connected to ocrevus and learn more about the chimes study below. please see full prescribing information at . intended for us healthcare professionals only.,"['ms milan', 'ocrevus', 'chimes study', 'healthcare professionals']","ms milan,ocrevus,chimes study,healthcare professionals",ocrevus chimes study healthcare professionals,ocrevus chimes study healthcare professionals,5,5_ocrevus_ocrelizumab_trial_chimes,Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.,"['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['ocrevus', 'ocrelizumab', 'ocarina', 'treatment', 'patients', 'msmilan', 'neurology', 'sclerosis', 'trial', 'neurologist']","['Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.', '', '', '', '', '', '', '', '', '']","['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan', 'ocrevus phase 3 trial', 'interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients']",ocrevus - ocrelizumab - trial - chimes - phase - patients - relapsing - decisions - noninferiority - brumvi,1.0,False
16,18,2023-10-14 14:23:52.0,"Really proud to provide the most recent advances presented at #ECTRIMS2023 #MSMILAN2023 in the diagnostic work-up of #MS, #NMOSD, and #MOGAD at the second Patientâ€™s Community day https://t.co/tfyotMYsxu",twitter,ITA,paolopreziosa,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","really proud to provide the most recent advances presented at #ectrims2023 #msmilan2023 in the diagnostic work-up of #ms, #nmosd, and #mogad at the second patientâ€™s community day https://t.co/tfyotmysxu",male,"#ectrims2023, #msmilan2023, #ms, #nmosd, #mogad",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1058541278,,397,563,0,,,1,11,722,False,"really proud to provide the most recent advances presented at ec trims ms milan in the diagnostic work-up of ms, #nmosd, and #mogad at the second patients community day","['MS', 'Milan', 'diagnostic', 'work-up', 'advances', 'recent', 'proud', 'provide', 'community']","ms,milan,diagnostic,work-up,advances,recent,proud,provide,community",diagnostic work-up advances recent proud provide,diagnostic work-up advances recent proud provide,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,1.0,False
17,19,2023-10-14 13:08:21.0,"Such a privilege to be here as @MarTintore opens the @ECTRIMS Patient Community Day at #MSMilan2023. Ensuring that information about #MultipleSclerosis research is accurately communicated to the #MS community is something we are passionate about, so itâ€™s fantastic to be involved! https://t.co/aCXjNFRNlw",twitter,AUS,MStranslate,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","such a privilege to be here as @martintore opens the @ectrims patient community day at #msmilan2023. ensuring that information about #multiplesclerosis research is accurately communicated to the #ms community is something we are passionate about, so itâ€™s fantastic to be involved! https://t.co/acxjnfrnlw",,"#msmilan2023, #multiplesclerosis, #ms",,,6000000000,833579503,,4910,4079,0,,,2,17,3608,False,"such a privilege to be here as opens the patient community day at ms milan. ensuring that information about multiple sclerosis research is accurately communicated to the ms community is something we are passionate about, so its fantastic to be involved!","['multiple sclerosis', 'patient', 'community', 'research', 'information', 'passionate', 'involved']","multiple sclerosis,patient,community,research,information,passionate,involved",information passionate involved,information passionate involved,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
18,20,2023-10-14 12:56:09.0,Our team was also present at the #ECTRIMS2023 and we were delighted to disclose our works based on our lines of research to the #MultipleSclerosis community. @ECTRIMS https://t.co/L08LjJOaSl,twitter,ESP,UNIEMTGirona,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",our team was also present at the #ectrims2023 and we were delighted to disclose our works based on our lines of research to the #multiplesclerosis community. @ectrims https://t.co/l08ljjoasl,unknown,"#ectrims2023, #multiplesclerosis",,,6000000000,329846559,,318,274,1,,,3,7,998,False,our team was also present at the ec trims and we were delighted to disclose our works based on our lines of research to the multiple sclerosis community.,"['team', 'ec trims', 'research', 'lines', 'works', 'multiple sclerosis', 'community']","team,ec trims,research,lines,works,multiple sclerosis,community",team lines works,team lines works,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
19,21,2023-10-14 12:33:25.0,ECTRIMS 2023: Treating SPMS with OCH shows promise in small study | #MultipleSclerosis News Today https://t.co/OijA1XwhEk,twitter,GBR,AbiBuddComms,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: treating spms with och shows promise in small study | #multiplesclerosis news today https://t.co/oija1xwhek,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4065,2558,0,,,0,2,25544,False,ectrims 2023: treating spms with och shows promise in small study | multiple sclerosis news today,"['ectrims', 'MS', 'SPMS', 'OCH', 'treatment', 'promise', 'small study', 'Multiple Sclerosis']","ectrims,ms,spms,och,treatment,promise,small study,multiple sclerosis",spms och promise small study,spms och promise small study,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
20,22,2023-10-14 12:33:02.0,ECTRIMS 2023: Early high-efficacy DMTs may help slow MS disability | Slower disability progression found in RRMS patients on early DMTs | #MultipleSclerosis News Today https://t.co/JPH1GBswzq,twitter,GBR,AbiBuddComms,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: early high-efficacy dmts may help slow ms disability | slower disability progression found in rrms patients on early dmts | #multiplesclerosis news today https://t.co/jph1gbswzq,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4065,2558,0,,,1,1,25543,False,ectrims 2023: early high-efficacy dmts may help slow ms disability | slower disability progression found in rrms patients on early dmts | multiple sclerosis news today,"['ectrims', '2023', 'dmts', 'disability', 'ms', 'progression', 'rrms', 'multiple sclerosis']","ectrims,2023,dmts,disability,ms,progression,rrms,multiple sclerosis",2023 dmts disability progression rrms,2023 dmts disability progression rrms,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,True
21,23,2023-10-14 12:32:32.0,ECTRIMS 2023: Personalized Tysabri dosing shows good efficacy | #MultipleSclerosis News Today https://t.co/UhxLo7fcgg,twitter,GBR,AbiBuddComms,"{id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: personalized tysabri dosing shows good efficacy | #multiplesclerosis news today https://t.co/uhxlo7fcgg,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4065,2558,0,,,0,0,25542,False,ectrims 2023: personalized tysabri dosing shows good efficacy | multiple sclerosis news today,"['ectrims', 'Tysabri', 'dosing', 'efficacy', 'multiple sclerosis', 'news']","ectrims,tysabri,dosing,efficacy,multiple sclerosis,news",tysabri dosing efficacy news,tysabri dosing efficacy news,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
22,24,2023-10-14 09:10:05.0,"Don't forget the MSMilan Patient Community Day is happening later today. 

Connect with the MS community online: share your questions, voice your needs and spark conversations.

ðŸ“…Saturday 14 October 2023
âž¡ï¸Register to the event: https://t.co/IKRU9Eg19J

#ECTRIMS4me https://t.co/9Dt6dvE3ZH",twitter,GBR,mssocietyuk,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","don't forget the msmilan patient community day is happening later today. connect with the ms community online: share your questions, voice your needs and spark conversations. ðŸ“…saturday 14 october 2023 âž¡ï¸register to the event: https://t.co/ikru9eg19j #ectrims4me https://t.co/9dt6dve3zh",female,#ectrims4me,,,6000000000,10869022,,55546,4342,0,,,4,16,54561,False,"don't forget the msmilan patient community day is happening later today. connect with the ms community online: share your questions, voice your needs and spark conversations. saturday 14 october 2023 register to the event: ec trims4me","['MS', 'community', 'day', 'patient', 'connect', 'questions', 'needs', 'conversation', 'Saturday', 'October', 'register', 'event', 'EC', 'trims4me']","ms,community,day,patient,connect,questions,needs,conversation,saturday,october,register,event,ec,trims4me",day connect questions needs conversation saturday october register event trims4me,day connect questions needs conversation saturday october register event trims4me,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,True
23,25,2023-10-14 08:56:36.0,Thank you for having us @tarunyaarun at the Women in MS evening dinner @ECTRIMS . Exciting times ahead ðŸ™@NoreenB06207742 @MavisAyer1 https://t.co/S9x7Cbrhjb,twitter,GBR,TheUKMSSNA,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thank you for having us @tarunyaarun at the women in ms evening dinner @ectrims . exciting times ahead ðŸ™@noreenb06207742 @mavisayer1 https://t.co/s9x7cbrhjb,unknown,,Beauty/Health & Fitness,,6000000000,2569726689,,489,537,0,,,1,12,497,False,thank you for having us at the women in ms evening dinner . exciting times ahead,"['thank', 'you', 'having', 'us', 'women', 'ms', 'evening', 'dinner', 'exciting', 'times', 'ahead']","thank,you,having,us,women,ms,evening,dinner,exciting,times,ahead",thank you having us women evening dinner exciting times ahead,thank you having us women evening dinner exciting times ahead,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9955981151322286,False
24,26,2023-10-14 08:48:46.0,"It has been an honour to present our work at #ECTRIMS2023 
@MAGNIMS @imscogs @MScentrum020 #MSMilan2023 #MS https://t.co/2TD50EJWpI",twitter,GBR,elisacolato,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",it has been an honour to present our work at #ectrims2023 @magnims @imscogs @mscentrum020 #msmilan2023 #ms https://t.co/2td50ejwpi,female,"#ectrims2023, #msmilan2023, #ms","Travel, Food & Drinks",,6000000000,2411136657,,102,112,0,,,1,16,28,False,it has been an honour to present our work at ec trims ms milan ms,"['EC', 'TRIms', 'Milan']","ec,trims,milan",,,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9776474658713359,False
25,27,2023-10-14 06:28:55.0,"@MsStacyEllis @mssocietyHCP @mssociety @ECTRIMS @ACTRIMS To cure & to perhaps vaccinate to prevent origin is required; otherwise its all symptom management. Might be longer term relief, but the disease is not cured",twitter,CAN,BurnabyAnn,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@msstacyellis @mssocietyhcp @mssociety @ectrims @actrims to cure & to perhaps vaccinate to prevent origin is required; otherwise its all symptom management. might be longer term relief, but the disease is not cured",unknown,,,,6000000000,36122900,,391,349,1,http://twitter.com/MsStacyEllis/statuses/1713059583311130902,,0,0,13511,False,"to cure & to perhaps vaccinate to prevent origin is required; otherwise its all symptom management. might be longer term relief, but the disease is not cured","['cure', 'vaccinate', 'prevent', 'origin', 'symptom', 'management', 'relief', 'disease']","cure,vaccinate,prevent,origin,symptom,management,relief,disease",cure vaccinate prevent origin symptom management relief disease,cure vaccinate prevent origin symptom management relief disease,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.5329091555360468,False
26,28,2023-10-14 05:10:06.0,"@BurnabyAnn @mssocietyHCP @mssociety @ECTRIMS @ACTRIMS #MS caused by different things in different people, usually by the Epstein-Barr virus. But there are many ways to cure diseases. You donâ€™t even necessarily need to know the cause in order to cure disease. Detox, homeopathy, etc.",twitter,USA,MsStacyEllis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@burnabyann @mssocietyhcp @mssociety @ectrims @actrims #ms caused by different things in different people, usually by the epstein-barr virus. but there are many ways to cure diseases. you donâ€™t even necessarily need to know the cause in order to cure disease. detox, homeopathy, etc.",female,#ms,Beauty/Health & Fitness,"{profession=Health practitioner, jobTitle=Psychotherapist}",6000000000,1179505063150182400,,985,559,1,http://twitter.com/BurnabyAnn/statuses/1712972528917041388,,0,0,31772,False,"ms caused by different things in different people, usually by the epstein-barr virus. but there are many ways to cure diseases. you dont even necessarily need to know the cause in order to cure disease. detox, homeopathy, etc.","['ms', 'Epstein-Barr virus', 'cure', 'disease', 'detox', 'homeopathy']","ms,epstein-barr virus,cure,disease,detox,homeopathy",epstein-barr virus cure disease detox homeopathy,epstein-barr virus cure disease detox homeopathy,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,1.0,False
27,29,2023-10-14 03:02:51.0,@GenentechMed It's truly remarkable to witness the dedication to advancements in multiple sclerosis research and patient care at #MSMilan2023. Bridging science and clinical practice is vital for improving health outcomes.,twitter,USA,MinneBio,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@genentechmed it's truly remarkable to witness the dedication to advancements in multiple sclerosis research and patient care at #msmilan2023. bridging science and clinical practice is vital for improving health outcomes.,unknown,#msmilan2023,Beauty/Health & Fitness,,6000000000,1693294855814844416,,83,958,0,http://twitter.com/GenentechMed/statuses/1712860753055904186,,0,0,761,False,it's truly remarkable to witness the dedication to advancements in multiple sclerosis research and patient care at ms milan. bridging science and clinical practice is vital for improving health outcomes.,"['ms', 'Milan', 'research', 'dedication', 'advancements', 'multiple sclerosis', 'patient care', 'health outcomes', 'science', 'clinical practice']","ms,milan,research,dedication,advancements,multiple sclerosis,patient care,health outcomes,science,clinical practice",dedication advancements patient care health outcomes science clinical practice,dedication advancements patient care health outcomes science clinical practice,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,1.0,True
28,30,2023-10-14 02:05:02.0,"Five of six people with secondary progressive MS treated with OCH in a small clinical trial experienced no disease activity over six months. https://t.co/XhmHjU8kBj 

#ectrims2023 #ms #multiplesclerosis #msresearch #msnews #ECTRIMS #MSMilan2023 https://t.co/z63KJfRy6A",twitter,USA,MSNewsToday,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",five of six people with secondary progressive ms treated with och in a small clinical trial experienced no disease activity over six months. https://t.co/xhmhju8kbj #ectrims2023 #ms #multiplesclerosis #msresearch #msnews #ectrims #msmilan2023 https://t.co/z63kjfry6a,female,"#ectrims2023, #ms, #multiplesclerosis, #msresearch, #msnews, #ectrims, #msmilan2023",,,6000000000,2473350271,,10062,1542,1,,,4,20,28190,False,five of six people with secondary progressive ms treated with och in a small clinical trial experienced no disease activity over six months. ec trims ms multiple sclerosis msresearch msnews ec trims ms milan,"['MS', 'multiple sclerosis', 'OCH', 'clinical trial', 'disease activity', 'EC trims']","ms,multiple sclerosis,och,clinical trial,disease activity,ec trims",och clinical trial disease activity,och clinical trial disease activity,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,0.8365847613701691,False
29,31,2023-10-14 01:25:10.0,"A recent analysis presented at #MSMilan2023 showed significant cognitive and biomarker improvements among patients with progressive multiple sclerosis receiving repeated intrathecal injections of autologous mesenchymal #stemcells.
https://t.co/KqBBfErvj7",twitter,USA,byMattHoffman,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}",a recent analysis presented at #msmilan2023 showed significant cognitive and biomarker improvements among patients with progressive multiple sclerosis receiving repeated intrathecal injections of autologous mesenchymal #stemcells. https://t.co/kqbbfervj7,male,"#msmilan2023, #stemcells",,"{profession=Journalist, jobTitle=Associate Editorial Director}, {profession=Artist, jobTitle=Producer}",6000000000,895689692271828992,,1068,989,0,,,0,0,10033,False,a recent analysis presented at ms milan showed significant cognitive and biomarker improvements among patients with progressive multiple sclerosis receiving repeated intrathecal injections of autologous mesenchymal #stemcells.,"['multiple sclerosis', 'intrathecal injections', 'autologous mesenchymal stem cells']","multiple sclerosis,intrathecal injections,autologous mesenchymal stem cells",intrathecal injections autologous mesenchymal stem cells,intrathecal injections autologous mesenchymal stem cells,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
30,32,2023-10-14 00:53:00.0,"Research from #MSMilan2023 @ECTRIMS @ACTRIMS compared #Uplizna (@HorizonNews @Amgen) as treatment for #NMOSD to 2 other #mABs, showing decreased risk of attack and better results for life years.
https://t.co/byDKNcWwTL",twitter,,PracticalNeuro,"{id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","research from #msmilan2023 @ectrims @actrims compared #uplizna (@horizonnews @amgen) as treatment for #nmosd to 2 other #mabs, showing decreased risk of attack and better results for life years. https://t.co/bydkncwwtl",,"#msmilan2023, #uplizna, #nmosd, #mabs",,,6000000000,386755226,,15373,154,0,,,0,2,3857,False,"research from ms milan compared #uplizna ( ) as treatment for #nmosd to 2 other #mabs, showing decreased risk of attack and better results for life years.","['MS Milan', 'uplizna', 'NMOSD', 'MABs', 'attack', 'risk', 'life years']","ms milan,uplizna,nmosd,mabs,attack,risk,life years",uplizna mabs attack risk life years,uplizna mabs attack risk life years,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,1.0,False
31,33,2023-10-13 23:50:22.0,See you next year in Denmark! @ECTRIMS #MSMilan2023 #MultipleSclerosis #msguncel https://t.co/uoInmACBWT,twitter,,MSguncel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",see you next year in denmark! @ectrims #msmilan2023 #multiplesclerosis #msguncel https://t.co/uoinmacbwt,female,"#msmilan2023, #multiplesclerosis, #msguncel",,,6000000000,1338606356346048512,,1448,61,0,,,0,3,822,False,see you next year in denmark! ms milan multiple sclerosis msguncel,"['Denmark', 'MS', 'Milan']","denmark,ms,milan",denmark,denmark,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
32,34,2023-10-13 23:13:50.0,"@RosaCortese5 @Brandon_Beaber @ECTRIMS My neurologist thinks I may have MOGAD and not PPMS because I do have an odd clinical history.  We are gathering more data etc.
Iâ€™m very stable neurologicallyâ€¦",twitter,USA,sardonicarious,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@rosacortese5 @brandon_beaber @ectrims my neurologist thinks i may have mogad and not ppms because i do have an odd clinical history. we are gathering more data etc. iâ€™m very stable neurologicallyâ€¦,male,,"Science, Technology","{profession=Scientist & Researcher, jobTitle=Scientist}, {profession=Software developer & IT, jobTitle=Software Developer}",6000000000,1032433773059571712,,203,660,0,http://twitter.com/RosaCortese5/statuses/1712769799309136343,,0,0,12444,False,my neurologist thinks i may have mogad and not ppms because i do have an odd clinical history. we are gathering more data etc. im very stable neurologically,"['Mogad', 'PPMS', 'neurologist', 'clinical history', 'data', 'stable', 'neurologically']","mogad,ppms,neurologist,clinical history,data,stable,neurologically",mogad ppms neurologist clinical history stable neurologically,mogad ppms neurologist clinical history stable neurologically,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.7456148739434957,False
33,35,2023-10-13 23:00:31.0,"Enhancing patient well-being with innovative solutions! The StimRouter neuromodulation system shows promise in addressing lower urinary tract issues in #MS. Dive into the data and its implications for your practice. #MSMilan @ECTRIMS @ACTRIMS

Read more: https://t.co/wrJ8e34meO",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",enhancing patient well-being with innovative solutions! the stimrouter neuromodulation system shows promise in addressing lower urinary tract issues in #ms. dive into the data and its implications for your practice. #msmilan @ectrims @actrims read more: https://t.co/wrj8e34meo,,"#ms, #msmilan",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8625,517,0,,,0,0,33758,False,enhancing patient well-being with innovative solutions! the stimrouter neuromodulation system shows promise in addressing lower urinary tract issues in ms. dive into the data and its implications for your practice. msmilan read more:,"['patient', 'well-being', 'innovative', 'solutions', 'stimrouter', 'neuromodulation', 'system', 'lower', 'urinary', 'tract', 'issues', 'MS', 'data', 'implications', 'practice', 'msmilan']","patient,well-being,innovative,solutions,stimrouter,neuromodulation,system,lower,urinary,tract,issues,ms,data,implications,practice,msmilan",well-being innovative solutions stimrouter neuromodulation system lower urinary tract issues implications practice msmilan,well-being innovative solutions stimrouter neuromodulation system lower urinary tract issues implications practice msmilan,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
34,37,2023-10-13 21:36:19.0,"T. Berger: great research on how EBV can cause #MS depending on virus and host genetic predispositions. 
In these cases, the control of molecular mimicry induced by EBV-infected B-cells is ineffective and increases #MS risk by 261 ðŸ˜³!
#MSMilan2023 
Will be published in Cell ðŸ‘ðŸ»ðŸ‘ðŸ» https://t.co/JPCxUUjlzA",twitter,BEL,bart_professor,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","t. berger: great research on how ebv can cause #ms depending on virus and host genetic predispositions. in these cases, the control of molecular mimicry induced by ebv-infected b-cells is ineffective and increases #ms risk by 261 ðŸ˜³! #msmilan2023 will be published in cell ðŸ‘ðŸ»ðŸ‘ðŸ» https://t.co/jpcxuujlza",unknown,"#ms, #ms, #msmilan2023",,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1109554254979743744,,1954,886,1,,,14,49,1893,False,"t. berger: great research on how ebv can cause ms depending on virus and host genetic predispositions. in these cases, the control of molecular mimicry induced by ebv-infected b-cells is ineffective and increases ms risk by 261 ! ms milan will be published in cell","['EBV', 'MS', 'host genetic predispositions', 'molecular mimicry', 'B-cells', 'risk', 'Milan', 'Cell']","ebv,ms,host genetic predispositions,molecular mimicry,b-cells,risk,milan,cell",ebv host genetic predispositions molecular mimicry b-cells risk cell,ebv host genetic predispositions molecular mimicry b-cells risk cell,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.9945721725350324,False
35,38,2023-10-13 21:00:56.0,"The future of #MS care just got more versatile. Learn about the noninferiority of subcutaneous #ocrelizumab compared with IV in relapsing and primary progressive MS. How might this impact your treatment decisions? #MSMilan @ECTRIMS @HopkinsMedicine

Read: https://t.co/6OHhlDIIQY",twitter,USA,neurology_live,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=19587268, name=SC, displayName=null, parentId=19587266, parentName=Crova generative AI_SML}",the future of #ms care just got more versatile. learn about the noninferiority of subcutaneous #ocrelizumab compared with iv in relapsing and primary progressive ms. how might this impact your treatment decisions? #msmilan @ectrims @hopkinsmedicine read: https://t.co/6ohhldiiqy,,"#ms, #ocrelizumab, #msmilan",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8625,517,0,,,0,0,33757,False,the future of ms care just got more versatile. learn about the noninferiority of subcutaneous #ocrelizumab compared with iv in relapsing and primary progressive ms. how might this impact your treatment decisions? msmilan read:,"['ms', 'care', 'versatile', 'noninferiority', 'subcutaneous', 'ocrelizumab', 'IV', 'relapsing', 'primary progressive', 'MS', 'treatment decisions', 'msmilan']","ms,care,versatile,noninferiority,subcutaneous,ocrelizumab,iv,relapsing,primary progressive,ms,treatment decisions,msmilan",care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan,care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan,5,5_ocrevus_ocrelizumab_trial_chimes,Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.,"['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['ocrevus', 'ocrelizumab', 'ocarina', 'treatment', 'patients', 'msmilan', 'neurology', 'sclerosis', 'trial', 'neurologist']","['Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.', '', '', '', '', '', '', '', '', '']","['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan', 'ocrevus phase 3 trial', 'interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients']",ocrevus - ocrelizumab - trial - chimes - phase - patients - relapsing - decisions - noninferiority - brumvi,1.0,True
36,39,2023-10-13 19:58:01.0,"Interim results from the CHIMES trial presented at #MSMilan2023 (@ECTRIMS @ACTRIMS) demonstrated the safety & efficacy of #Ocrevus (@genentech) in treating Relapsing #MultipleSclerosis (#RMS) in Black and Hispanic patients.
https://t.co/P3AyyTLthN",twitter,,PracticalNeuro,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",interim results from the chimes trial presented at #msmilan2023 (@ectrims @actrims) demonstrated the safety & efficacy of #ocrevus (@genentech) in treating relapsing #multiplesclerosis (#rms) in black and hispanic patients. https://t.co/p3ayytlthn,,"#msmilan2023, #ocrevus, #multiplesclerosis, #rms",,,6000000000,386755226,,15374,154,0,,,3,4,3856,False,interim results from the chimes trial presented at ms milan ( ) demonstrated the safety & efficacy of #ocrevus () in treating relapsing multiple sclerosis (#rms) in black and hispanic patients.,"['interim results', 'chimes trial', 'MS Milan', 'Ocrevus', 'relapsing multiple sclerosis', 'black patients', 'Hispanic patients']","interim results,chimes trial,ms milan,ocrevus,relapsing multiple sclerosis,black patients,hispanic patients",interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients,interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients,5,5_ocrevus_ocrelizumab_trial_chimes,Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.,"['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['ocrevus', 'ocrelizumab', 'ocarina', 'treatment', 'patients', 'msmilan', 'neurology', 'sclerosis', 'trial', 'neurologist']","['Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.', '', '', '', '', '', '', '', '', '']","['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan', 'ocrevus phase 3 trial', 'interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients']",ocrevus - ocrelizumab - trial - chimes - phase - patients - relapsing - decisions - noninferiority - brumvi,0.49550013098577067,True
37,40,2023-10-13 19:14:35.0,"Last day !
Should treatments in pediatric MS Â«Â HEETÂ Â»? 
Very interesting results and a nice overview of new treatments in pediatric MS by Pr Chitnis ! #Ectrims https://t.co/Lf1s8eXbMu",twitter,FRA,PrDeiva,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",last day ! should treatments in pediatric ms Â« heet Â»? very interesting results and a nice overview of new treatments in pediatric ms by pr chitnis ! #ectrims https://t.co/lf1s8exbmu,unknown,#ectrims,,,6000000000,1239175635706265601,,31,49,0,,,0,2,36,False,last day ! should treatments in pediatric ms heet ? very interesting results and a nice overview of new treatments in pediatric ms by pr chitnis ! ec trims,"['treatments', 'pediatric', 'MS', 'interesting', 'results', 'overview', 'new', 'Pr Chitnis', 'EC trims']","treatments,pediatric,ms,interesting,results,overview,new,pr chitnis,ec trims",treatments pediatric interesting results overview new pr chitnis,treatments pediatric interesting results overview new pr chitnis,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.20193723231974586,False
38,41,2023-10-13 18:57:10.0,"P1149: Spasticity-Plus Syndrome recently coined for 7 symptoms related to #spasticity due to #MultipleSclerosis. Most frequent SSP triad: spasticity (94.6%), pain (91.9%), spasms (79.7%). IDing SSP can help avoid polypharmacy & improve long-term MS mgmt. #MSMilan2023 @Janigoico",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","p1149: spasticity-plus syndrome recently coined for 7 symptoms related to #spasticity due to #multiplesclerosis. most frequent ssp triad: spasticity (94.6%), pain (91.9%), spasms (79.7%). iding ssp can help avoid polypharmacy & improve long-term ms mgmt. #msmilan2023 @janigoico",,"#spasticity, #multiplesclerosis, #msmilan2023",,,6000000000,1054320667,,901,625,0,,,0,0,4231,False,"p1149: spasticity-plus syndrome recently coined for 7 symptoms related to #spasticity due to multiple sclerosis. most frequent ssp triad: spasticity (94.6%), pain (91.9%), spasms (79.7%). iding ssp can help avoid polypharmacy & improve long-term ms mgmt. ms milan","['spasticity', 'plus syndrome', 'multiple sclerosis', 'SSP', 'spasm', 'polypharmacy', 'MS management']","spasticity,plus syndrome,multiple sclerosis,ssp,spasm,polypharmacy,ms management",spasticity plus syndrome ssp spasm polypharmacy ms management,spasticity plus syndrome ssp spasm polypharmacy ms management,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
39,42,2023-10-13 18:51:22.0,"Was great to share our work at @ECTRIMS  #MSMilan2023 (P1511)! We characterise the degree of lymphopenia with siponimod, and demonstrate that you cannot predict which patients are more likely to experience grade 4 lymphopenia @nikosevangelou3 @DrWBRO https://t.co/9F8h8zueHG",twitter,,ChrisGSG,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","was great to share our work at @ectrims #msmilan2023 (p1511)! we characterise the degree of lymphopenia with siponimod, and demonstrate that you cannot predict which patients are more likely to experience grade 4 lymphopenia @nikosevangelou3 @drwbro https://t.co/9f8h8zuehg",male,#msmilan2023,,,6000000000,2344932985,,108,327,0,,,3,11,69,False,"was great to share our work at ms milan (p1511)! we characterise the degree of lymphopenia with siponimod, and demonstrate that you cannot predict which patients are more likely to experience grade 4 lymphopenia","['work', 'share', 'ms', 'Milan', 'lymphopenia', 'Siponimod', 'patients', 'grade', 'predict', 'likely', 'experience']","work,share,ms,milan,lymphopenia,siponimod,patients,grade,predict,likely,experience",work share lymphopenia siponimod grade predict likely experience,work share lymphopenia siponimod grade predict likely experience,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
40,43,2023-10-13 18:45:00.0,"O165: Clinical trials lack #diversity. Current efforts to advance health equity via MS clinical trial participation=inadequate. Lack of inclusion& representation are obstacle to effectively understand safety, benefits&treatment response across MS pop. @AmezcuaLilyana #MSMilan2023",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","o165: clinical trials lack #diversity. current efforts to advance health equity via ms clinical trial participation=inadequate. lack of inclusion& representation are obstacle to effectively understand safety, benefits&treatment response across ms pop. @amezcualilyana #msmilan2023",,"#diversity, #msmilan2023",,,6000000000,1054320667,,901,625,0,,,0,0,4230,False,"o165: clinical trials lack #diversity. current efforts to advance health equity via ms clinical trial participation=inadequate. lack of inclusion& representation are obstacle to effectively understand safety, benefits&treatment response across ms pop. ms milan","['clinical trials', 'diversity', 'health equity', 'MS', 'multiple sclerosis', 'Milan']","clinical trials,diversity,health equity,ms,multiple sclerosis,milan",clinical trials diversity health equity,clinical trials diversity health equity,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,0.8492618515372913,False
41,44,2023-10-13 18:29:01.0,"Thrilled to make it on to the #ECTRIMS stage at #MSMilan2023 to give Dr Rhonda Voskuhl the inaugural Rachel Horne Prize for Women's Research in MS. 
With @MSDoc_Freedman,  Massimo Filippi & @MarTintore
Thank u @ECTRIMS, @ACTRIMS &, of course, @IntNatlWiMS - who made it happen.",twitter,GBR,RachelHorne19,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","thrilled to make it on to the #ectrims stage at #msmilan2023 to give dr rhonda voskuhl the inaugural rachel horne prize for women's research in ms. with @msdoc_freedman, massimo filippi & @martintore thank u @ectrims, @actrims &, of course, @intnatlwims - who made it happen.",female,"#ectrims, #msmilan2023",,"{profession=Journalist, jobTitle=Journalist}, {profession=Scientist & Researcher, jobTitle=Research Fellow}",6000000000,1284849469704540160,,6207,3465,3,,,9,95,5533,False,"thrilled to make it on to the ec trims stage at ms milan to give dr rhonda voskuhl the inaugural rachel horne prize for women's research in ms. with , massimo filippi & thank u , &, of course, - who made it happen.","['Rachel Horne Prize', 'MS Milan', 'Massimo Filippi']","rachel horne prize,ms milan,massimo filippi",rachel horne prize massimo filippi,rachel horne prize massimo filippi,12,12_massimo_filippi_freedman_ciccarelli,"Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['massimo', 'zeposia', 'ciccarelli', 'olga', 'sastregarriga', 'filippi', 'prize', 'rachel', 'horne', 'french']","['Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.', '', '', '', '', '', '', '', '', '']","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['prof olga ciccarelli', 'massimo filippi mark freedman who mogad actrims', 'rachel horne prize massimo filippi']",massimo - filippi - freedman - ciccarelli - career - zeposia - olga - rms - sastregarriga - who,1.0,True
42,46,2023-10-13 17:46:25.0,"Thank you for this beautiful congress! ðŸ‡®ðŸ‡¹Exciting news, interesting discussions, many dear colleagues from all over the world ðŸŒŽnow we go home motivated and well informed #MultipleSclerosis #NMOSD #MOGAD @ECTRIMS",twitter,DEU,NeuroVisionLab,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","thank you for this beautiful congress! ðŸ‡®ðŸ‡¹exciting news, interesting discussions, many dear colleagues from all over the world ðŸŒŽnow we go home motivated and well informed #multiplesclerosis #nmosd #mogad @ectrims",male,"#multiplesclerosis, #nmosd, #mogad",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1330131970068770821,,269,147,0,,,1,8,153,False,"thank you for this beautiful congress! exciting news, interesting discussions, many dear colleagues from all over the world now we go home motivated and well informed multiple sclerosis #nmosd #mogad","['congress', 'beautiful', 'exciting', 'discussions', 'colleagues', 'motivated', 'informed', 'multiple sclerosis', '#nmosd', '#mogad']","congress,beautiful,exciting,discussions,colleagues,motivated,informed,multiple sclerosis,#nmosd,#mogad",congress beautiful exciting discussions colleagues motivated informed #nmosd #mogad,congress beautiful exciting discussions colleagues motivated informed #nmosd #mogad,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.8498691802259124,False
43,47,2023-10-13 17:40:43.0,So grateful to have met some awesome researchers focused on #femalehealth in #MultipleSclerosis during #MSMilan2023 this year! Itâ€™s so important for #GlobalHealth to also focus on #FemaleBrainHealth! Looking forward to more discoveries to come ðŸ™‹ðŸ»â€â™€ï¸ðŸ§ ðŸ©º Thanks @ECTRIMS for a g8 one! https://t.co/cBNP157ZZS,twitter,DEU,ClaudiaAcadem,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",so grateful to have met some awesome researchers focused on #femalehealth in #multiplesclerosis during #msmilan2023 this year! itâ€™s so important for #globalhealth to also focus on #femalebrainhealth! looking forward to more discoveries to come ðŸ™‹ðŸ»â€â™€ï¸ðŸ§ ðŸ©º thanks @ectrims for a g8 one! https://t.co/cbnp157zzs,female,"#femalehealth, #multiplesclerosis, #msmilan2023, #globalhealth, #femalebrainhealth","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Teacher & Lecturer, jobTitle=Teacher}",6000000000,393547855,,635,738,0,,,0,3,6765,False,so grateful to have met some awesome researchers focused on #femalehealth in multiple sclerosis during ms milan this year! its so important for #globalhealth to also focus on #femalebrainhealth! looking forward to more discoveries to come thanks for a g8 one!,"['#femalehealth', '#globalhealth', '#femalebrainhealth', 'ms', 'Milan', 'researchers', 'discoveries']","#femalehealth,#globalhealth,#femalebrainhealth,ms,milan,researchers,discoveries",#femalehealth #globalhealth #femalebrainhealth researchers discoveries,#femalehealth #globalhealth #femalebrainhealth researchers discoveries,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
44,48,2023-10-13 17:02:12.0,"Precision medicine takes center stage in #MultipleSclerosis care! @NerdyNeuroMDshares her expertise in advancing personalized treatments for patients with #MS. Stay informed about the future of #neurology. ðŸ§¬ðŸ’Š #MSMilan @ECTRIMS @ACTRIMS 

View: https://t.co/oC7c9PBbn5 https://t.co/sxI1pEpElW",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",precision medicine takes center stage in #multiplesclerosis care! @nerdyneuromdshares her expertise in advancing personalized treatments for patients with #ms. stay informed about the future of #neurology. ðŸ§¬ðŸ’Š #msmilan @ectrims @actrims view: https://t.co/oc7c9pbbn5 https://t.co/sxi1pepelw,,"#multiplesclerosis, #ms, #neurology, #msmilan",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8625,517,0,,,0,1,33755,False,precision medicine takes center stage in multiple sclerosis care! her expertise in advancing personalized treatments for patients with ms. stay informed about the future of #neurology. msmilan view:,"['precision medicine', 'multiple sclerosis', 'personalized treatments', 'neurology', 'MS', 'MS Milan']","precision medicine,multiple sclerosis,personalized treatments,neurology,ms,ms milan",precision medicine personalized treatments neurology,precision medicine personalized treatments neurology,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,1.0,False
45,49,2023-10-13 16:39:34.0,"It was such an amazing experience to be able to give a talk at #ECTRIMS2023 and receive amazing feedback. Thanks to all my collaborators, especially @LeredeAnnalaura @UKMSRegister

#MSMilan2023 #Research #MultipleSclerosis
@imperialcollege @ECTRIMS",twitter,,valegiunca,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","it was such an amazing experience to be able to give a talk at #ectrims2023 and receive amazing feedback. thanks to all my collaborators, especially @leredeannalaura @ukmsregister #msmilan2023 #research #multiplesclerosis @imperialcollege @ectrims",female,"#ectrims2023, #msmilan2023, #research, #multiplesclerosis",Science,"{profession=Student, jobTitle=Student}",6000000000,1389587917924864005,,110,167,2,,,1,13,84,False,"it was such an amazing experience to be able to give a talk at ec trims and receive amazing feedback. thanks to all my collaborators, especially ms milan #research multiple sclerosis","['talk', 'experience', 'feedback', 'collaborators', 'research', 'multiple sclerosis']","talk,experience,feedback,collaborators,research,multiple sclerosis",talk experience feedback collaborators,talk experience feedback collaborators,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.8970324624279941,False
46,50,2023-10-13 16:33:28.0,"@MarTintore @ECTRIMS @XMontalban @J_SastreGarriga @GeoArrambide @TheSumairaFDN @vallhebron @EuropeanCharcot @CEspejoRuiz @CarmenTur1 @cobo_calvo @Villacieros_J â€œ We are committed to making further progress in treatment and cure for multiple sclerosis. Every patient countsâ€, Prof. @MarTintore says farewell to all #MSMilan2023 participants.

This is a wrap! 

Looking forward to meeting you next year! Many thanks ðŸ‘ðŸ‘ https://t.co/k6FNYIslww",twitter,ESP,cemcat_em,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@martintore @ectrims @xmontalban @j_sastregarriga @geoarrambide @thesumairafdn @vallhebron @europeancharcot @cespejoruiz @carmentur1 @cobo_calvo @villacieros_j â€œ we are committed to making further progress in treatment and cure for multiple sclerosis. every patient countsâ€, prof. @martintore says farewell to all #msmilan2023 participants. this is a wrap! looking forward to meeting you next year! many thanks ðŸ‘ðŸ‘ https://t.co/k6fnyislww",unknown,#msmilan2023,,,6000000000,1197805298,,3157,490,1,http://twitter.com/cemcat_em/statuses/1712860823381504370,,7,18,2934,False,"we are committed to making further progress in treatment and cure for multiple sclerosis. every patient counts, prof. says farewell to all ms milan participants. this is a wrap! looking forward to meeting you next year! many thanks","['treatment', 'cure', 'multiple sclerosis', 'patient', 'progress', 'commitment', 'farewell', 'wrap', 'meeting', 'thanks']","treatment,cure,multiple sclerosis,patient,progress,commitment,farewell,wrap,meeting,thanks",cure progress commitment farewell wrap meeting thanks,cure progress commitment farewell wrap meeting thanks,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9385562591888197,False
47,51,2023-10-13 16:00:01.0,Thank you for joining us at #MSMilan2023 as we pave the way for advancements in #multiplesclerosis research & patient care. We were excited to share our latest findings & deliver on our commitment to bridging science and clinical practice to drive better health outcomes for all. https://t.co/hCXze6I4eC,twitter,USA,GenentechMed,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thank you for joining us at #msmilan2023 as we pave the way for advancements in #multiplesclerosis research & patient care. we were excited to share our latest findings & deliver on our commitment to bridging science and clinical practice to drive better health outcomes for all. https://t.co/hcxze6i4ec,,"#msmilan2023, #multiplesclerosis",Beauty/Health & Fitness,,6000000000,1405237666677891073,,157,0,1,,,0,5,59,False,thank you for joining us at ms milan as we pave the way for advancements in multiple sclerosis research & patient care. we were excited to share our latest findings & deliver on our commitment to bridging science and clinical practice to drive better health outcomes for all.,"['MS', 'Milan', 'research', 'advancements', 'multiple sclerosis', 'patient care', 'findings', 'commitment', 'science', 'clinical practice', 'health outcomes']","ms,milan,research,advancements,multiple sclerosis,patient care,findings,commitment,science,clinical practice,health outcomes",advancements patient care findings commitment science clinical practice health outcomes,advancements patient care findings commitment science clinical practice health outcomes,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,0.8984744734175522,True
48,52,2023-10-13 15:55:06.0,"Data from #DanishMSRegistry reveal patterns and predictors of conversion from #RRMS to #SPMS #MultipleSclerosis, in study from #MSMilan2023 @ECTRIMS @ACTRIMS.https://t.co/YEYReXyrHx",twitter,,TheNeurologyHub,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","data from #danishmsregistry reveal patterns and predictors of conversion from #rrms to #spms #multiplesclerosis, in study from #msmilan2023 @ectrims @actrims.https://t.co/yeyrexyrhx",,"#danishmsregistry, #rrms, #spms, #multiplesclerosis, #msmilan2023",Beauty/Health & Fitness,,6000000000,1367549821612130307,,43,18,0,,,0,0,24,False,"data from #danishmsregistry reveal patterns and predictors of conversion from #rrms to #spms multiple sclerosis, in study from ms milan .","['DanishMSRegistry', 'RRMS', 'SPMS', 'Multiple Sclerosis', 'MS Milan']","danishmsregistry,rrms,spms,multiple sclerosis,ms milan",danishmsregistry rrms spms,danishmsregistry rrms spms,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
49,53,2023-10-13 15:45:00.0,"P764: We provide rationale for #CHIT1 as #biomarker for early microglial activation & future #disability progression in #MS, aiding clinicians in patient stratification & therapy selection. #MSMilan2023 @Neuro_KULeuven",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","p764: we provide rationale for #chit1 as #biomarker for early microglial activation & future #disability progression in #ms, aiding clinicians in patient stratification & therapy selection. #msmilan2023 @neuro_kuleuven",,"#chit1, #biomarker, #disability, #ms, #msmilan2023",,,6000000000,1054320667,,899,624,0,,,0,0,4214,False,"p764: we provide rationale for #chit1 as #biomarker for early microglial activation & future #disability progression in ms, aiding clinicians in patient stratification & therapy selection. ms milan","['#chit1', '#biomarker', 'disability progression', 'MS', 'patient stratification', 'therapy selection']","#chit1,#biomarker,disability progression,ms,patient stratification,therapy selection",#chit1 #biomarker disability progression patient stratification therapy selection,#chit1 #biomarker disability progression patient stratification therapy selection,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.317997679597817,False
50,54,2023-10-13 15:13:32.0,ECTRIMS 2023: New under-the-skin Ocrevus found effective in MS | New formulation seen to suppress MS activity in Phase 3 trial | #MultipleSclerosis News Today https://t.co/xwKlC7grA6,twitter,GBR,AbiBuddComms,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: new under-the-skin ocrevus found effective in ms | new formulation seen to suppress ms activity in phase 3 trial | #multiplesclerosis news today https://t.co/xwklc7gra6,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4065,2558,0,,,0,1,25538,False,ectrims 2023: new under-the-skin ocrevus found effective in ms | new formulation seen to suppress ms activity in phase 3 trial | multiple sclerosis news today,"['ectrims', 'Ocrevus', 'MS', 'multiple sclerosis', 'phase 3 trial']","ectrims,ocrevus,ms,multiple sclerosis,phase 3 trial",ocrevus phase 3 trial,ocrevus phase 3 trial,5,5_ocrevus_ocrelizumab_trial_chimes,Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.,"['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['ocrevus', 'ocrelizumab', 'ocarina', 'treatment', 'patients', 'msmilan', 'neurology', 'sclerosis', 'trial', 'neurologist']","['Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.', '', '', '', '', '', '', '', '', '']","['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan', 'ocrevus phase 3 trial', 'interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients']",ocrevus - ocrelizumab - trial - chimes - phase - patients - relapsing - decisions - noninferiority - brumvi,1.0,True
51,55,2023-10-13 15:12:04.0,New long-term data from #MSMilan2023 @ECTRIMS @ACTRIMS compares time to onset of #NMOSD attack for #Uplizna (@HorizonNews @Amgen) vs azathioprine + immunosuppressives vs placebo. https://t.co/gehM5RncUA,twitter,,TheNeurologyHub,"{id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",new long-term data from #msmilan2023 @ectrims @actrims compares time to onset of #nmosd attack for #uplizna (@horizonnews @amgen) vs azathioprine + immunosuppressives vs placebo. https://t.co/gehm5rncua,,"#msmilan2023, #nmosd, #uplizna",Beauty/Health & Fitness,,6000000000,1367549821612130307,,43,18,0,,,1,0,23,False,new long-term data from ms milan compares time to onset of #nmosd attack for #uplizna ( ) vs azathioprine + immunosuppressives vs placebo.,"['MS', 'Milan', 'NMOSD', 'uplizna', 'Azathioprine', 'immunosuppressives', 'placebo']","ms,milan,nmosd,uplizna,azathioprine,immunosuppressives,placebo",uplizna azathioprine immunosuppressives placebo,uplizna azathioprine immunosuppressives placebo,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,1.0,False
52,56,2023-10-13 15:03:42.0,Roche touts brain penetration shown by BTK inhibitor fenebrutinib in MS study $RHHBY #MSMilan2023 #ECTRIMS https://t.co/6s5MWLHZjo,twitter,,fwpharma,"{id=20767269, name=Fenebrutinib, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740628, name=Fenebrutinib, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711854, name=MS Drugs - BTKi, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",roche touts brain penetration shown by btk inhibitor fenebrutinib in ms study $rhhby #msmilan2023 #ectrims https://t.co/6s5mwlhzjo,,"#msmilan2023, #ectrims",,,6000000000,35789155,,54517,638,0,,,0,0,35407,True,roche touts brain penetration shown by btk inhibitor fenebrutinib in ms study $rhhby ms milan ec trims,"['Roche', 'brain', 'penetration', 'BTK', 'inhibitor', 'MS', 'study', 'rhHB-MS', 'Milan', 'EC', 'trims']","roche,brain,penetration,btk,inhibitor,ms,study,rhhb-ms,milan,ec,trims",roche brain penetration btk inhibitor study rhhb-ms,roche brain penetration btk inhibitor study rhhb-ms,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
53,57,2023-10-13 15:02:17.0,"How do B-cell levels influence #ocrelizumab's effectiveness in #neurology? The latest findings shed light on this critical connection. Delve into the science and its implications for patients with #MS! #MSMilan2023 @ECTRIMS @ACTRIMS @AnToSc

Read more: https://t.co/iKLkl5DqKG",twitter,USA,neurology_live,"{id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",how do b-cell levels influence #ocrelizumab's effectiveness in #neurology? the latest findings shed light on this critical connection. delve into the science and its implications for patients with #ms! #msmilan2023 @ectrims @actrims @antosc read more: https://t.co/iklkl5dqkg,,"#ocrelizumab's, #neurology, #ms, #msmilan2023",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8626,517,0,,,0,1,33754,False,how do b-cell levels influence #ocrelizumab's effectiveness in #neurology? the latest findings shed light on this critical connection. delve into the science and its implications for patients with ms! ms milan read more:,"['B-cell', 'Ocrelizumab', 'Neurology', 'MS', 'Milan']","b-cell,ocrelizumab,neurology,ms,milan",b-cell ocrelizumab neurology,b-cell ocrelizumab neurology,5,5_ocrevus_ocrelizumab_trial_chimes,Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.,"['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['ocrevus', 'ocrelizumab', 'ocarina', 'treatment', 'patients', 'msmilan', 'neurology', 'sclerosis', 'trial', 'neurologist']","['Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.', '', '', '', '', '', '', '', '', '']","['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan', 'ocrevus phase 3 trial', 'interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients']",ocrevus - ocrelizumab - trial - chimes - phase - patients - relapsing - decisions - noninferiority - brumvi,1.0,False
54,58,2023-10-13 15:00:24.0,"#MSMilan2023 | LIVE NOW!

Xavier Montaban @XMontalban, Director of @cemcat_em and former ECTRIMS President, delivers the Chariot Lecture, â€œA new look at diagnosing MSâ€.  

âž¡ï¸ https://t.co/9wFsejA2lp 

Every patient. Every pathway.",twitter,CHE,ECTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#msmilan2023 | live now! xavier montaban @xmontalban, director of @cemcat_em and former ectrims president, delivers the chariot lecture, â€œa new look at diagnosing msâ€. âž¡ï¸ https://t.co/9wfseja2lp every patient. every pathway.",,#msmilan2023,,,6000000000,714464982,,8020,65,0,,,1,3,7298,False,"ms milan | live now! xavier montaban , director of and former ectrims president, delivers the chariot lecture, a new look at diagnosing ms. every patient. every pathway.","['ms', 'milan', 'live', 'now', 'xavier', 'montaban', 'director', 'ectrims', 'president', 'chariot', 'lecture', 'diagnosing', 'ms', 'pathway']","ms,milan,live,now,xavier,montaban,director,ectrims,president,chariot,lecture,diagnosing,ms,pathway",live now xavier montaban director president chariot lecture diagnosing pathway,live now xavier montaban director president chariot lecture diagnosing pathway,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
55,59,2023-10-13 15:00:03.0,"ðŸ™ðŸŽ—ï¸Thank you, #MSMilan2023! The $IMUX team not only had a lot of excellent and enlightening discussions with colleagues from the #MS space, but also a lot of fun! See you next year in Copenhagen ðŸ‡©ðŸ‡°! 

@ECTRIMS #ECTRIMS #ACTRIMS #Immunic #MS #MultipleSclerosis #msresearch https://t.co/jqKGzyFPXY",twitter,USA,ImmunicInc,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸ™ðŸŽ—ï¸thank you, #msmilan2023! the $imux team not only had a lot of excellent and enlightening discussions with colleagues from the #ms space, but also a lot of fun! see you next year in copenhagen ðŸ‡©ðŸ‡°! @ectrims #ectrims #actrims #immunic #ms #multiplesclerosis #msresearch https://t.co/jqkgzyfpxy",,"#msmilan2023, #ms, #ectrims, #actrims, #immunic, #ms, #multiplesclerosis, #msresearch","Beauty/Health & Fitness, Business",,6000000000,951787758242226177,,592,756,0,,,3,4,1117,False,"thank you, ms milan! the $imux team not only had a lot of excellent and enlightening discussions with colleagues from the ms space, but also a lot of fun! see you next year in copenhagen ! ec trims #actrims #immunic ms multiple sclerosis msresearch","['ms', 'team', 'colleagues', 'discussions', 'fun', 'Copenhagen', 'ec', 'trim', 'actrims', 'immunic', 'ms', 'multiple sclerosis', 'research']","ms,team,colleagues,discussions,fun,copenhagen,ec,trim,actrims,immunic,ms,multiple sclerosis,research",team colleagues discussions fun copenhagen trim actrims immunic,team colleagues discussions fun copenhagen trim actrims immunic,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.37085596973029117,False
56,60,2023-10-13 14:32:52.0,"Scientific Session 22: Late Breaking Abstracts at #MSMilan2023. Varied and engaging presentations. Special congratulations to David Levitz, a med student who did a great job presenting alongside big MS specialists! #ECTRIMS #ACTRIMS https://t.co/2k4DndnWb5",twitter,ESP,GeoArrambide,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","scientific session 22: late breaking abstracts at #msmilan2023. varied and engaging presentations. special congratulations to david levitz, a med student who did a great job presenting alongside big ms specialists! #ectrims #actrims https://t.co/2k4dndnwb5",female,"#msmilan2023, #ectrims, #actrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1448356440108830725,,547,180,0,,,1,1,749,False,"scientific session 22: late breaking abstracts at ms milan. varied and engaging presentations. special congratulations to david levitz, a med student who did a great job presenting alongside big ms specialists! ec trims #actrims","['scientific', 'session', 'abstracts', 'MS Milan', 'varied', 'engaging', 'presentations', 'congratulations', 'David Levitz', 'med student', 'big MS specialists', 'ECTRIMS', 'ACTRIMS']","scientific,session,abstracts,ms milan,varied,engaging,presentations,congratulations,david levitz,med student,big ms specialists,ectrims,actrims",scientific session abstracts varied engaging presentations congratulations david levitz med student big ms specialists actrims,scientific session abstracts varied engaging presentations congratulations david levitz med student big ms specialists actrims,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
57,61,2023-10-13 14:25:41.0,Late breaking at #ECTRIMS fenebrutinib reduces MRI lesions by 69% & no serious adverse effects. #MSMilan2023 https://t.co/UIzFWPdoYE,twitter,GBR,RayDorsey7,"{id=20767269, name=Fenebrutinib, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740628, name=Fenebrutinib, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711854, name=MS Drugs - BTKi, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",late breaking at #ectrims fenebrutinib reduces mri lesions by 69% & no serious adverse effects. #msmilan2023 https://t.co/uizfwpdoye,male,"#ectrims, #msmilan2023","Beauty/Health & Fitness, Family & Parenting, Business, Sports","{profession=Health practitioner, jobTitle=Pharmacist}",6000000000,1277159750,,575,382,0,,,1,6,2148,False,late breaking at ec trims fenebrutinib reduces mri lesions by 69% & no serious adverse effects. ms milan,"['late', 'breaking', 'EC', 'trims', 'fenebrutinib', 'reduces', 'MRI', 'lesions', '69%', 'serious', 'adverse', 'effects', 'MS', 'Milan']","late,breaking,ec,trims,fenebrutinib,reduces,mri,lesions,69%,serious,adverse,effects,ms,milan",late breaking fenebrutinib reduces mri lesions 69% serious adverse effects,late breaking fenebrutinib reduces mri lesions 69% serious adverse effects,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
58,62,2023-10-13 14:04:38.0,"A personalized dosing schedule for Tysabri (natalizumab) seems to be just as effective as standard dosing for controlling MS disease activity https://t.co/3YmlD9BnZx 

#ectrims2023 #multiplesclerosis #msresearch #msdiagnosis #mssymptoms https://t.co/p66LhNkEt8",twitter,USA,MSNewsToday,"{id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",a personalized dosing schedule for tysabri (natalizumab) seems to be just as effective as standard dosing for controlling ms disease activity https://t.co/3ymld9bnzx #ectrims2023 #multiplesclerosis #msresearch #msdiagnosis #mssymptoms https://t.co/p66lhnket8,female,"#ectrims2023, #multiplesclerosis, #msresearch, #msdiagnosis, #mssymptoms",,,6000000000,2473350271,,10058,1542,0,,,2,7,28184,False,a personalized dosing schedule for tysabri (natalizumab) seems to be just as effective as standard dosing for controlling ms disease activity ec trims multiple sclerosis msresearch msdiagnosis mssymptoms,"['Tysabri', 'dosing schedule', 'MS disease activity', 'EC trims', 'multiple sclerosis', 'MS research', 'diagnosis', 'symptoms']","tysabri,dosing schedule,ms disease activity,ec trims,multiple sclerosis,ms research,diagnosis,symptoms",tysabri dosing schedule ms disease activity ms research diagnosis symptoms,tysabri dosing schedule ms disease activity ms research diagnosis symptoms,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
59,63,2023-10-13 13:37:11.0,"""#EBV may be necessaryâ€”but not sufficientâ€”to #cause #MS"" https://t.co/BAM3jXoZI7 @MSIntFederation @ECTRIMS @ACTRIMS #MSMilan2023",twitter,USA,SaligramaLab,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","""#ebv may be necessaryâ€”but not sufficientâ€”to #cause #ms"" https://t.co/bam3jxozi7 @msintfederation @ectrims @actrims #msmilan2023",unknown,"#ebv, #cause, #ms, #msmilan2023",Beauty/Health & Fitness,,6000000000,1424715908212199426,,1046,618,0,,,0,2,1295,False,"""#ebv may be necessarybut not sufficientto #cause ms"" ms milan","['#ebv', 'cause', 'ms', 'Milan']","#ebv,cause,ms,milan",#ebv cause,#ebv cause,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.5918695300597109,False
60,64,2023-10-13 13:06:06.0,"ðŸ§¡A big thanks to @ECTRIMS for enabling our team & our members to participate in #MSMilan2023 and striving to make people with #MultipleSclerosis an equal partner in all #MS relates discussions. See you @ ECTRIMS '24!
ðŸ‘‹Nothing about us without us!
@ACTRIMS https://t.co/4MYTCP69pE",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",ðŸ§¡a big thanks to @ectrims for enabling our team & our members to participate in #msmilan2023 and striving to make people with #multiplesclerosis an equal partner in all #ms relates discussions. see you @ ectrims '24! ðŸ‘‹nothing about us without us! @actrims https://t.co/4mytcp69pe,female,"#msmilan2023, #multiplesclerosis, #ms",,,6000000000,600110872,,4875,894,1,,,6,20,5948,False,a big thanks to for enabling our team & our members to participate in ms milan and striving to make people with multiple sclerosis an equal partner in all ms relates discussions. see you ectrims '24! nothing about us without us!,"['multiple sclerosis', 'team', 'discussion', 'participation', 'ECTRIMS']","multiple sclerosis,team,discussion,participation,ectrims",team discussion participation,team discussion participation,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
61,65,2023-10-13 12:52:03.0,"dreaMS collaborators putting their minds together in the context of an upcoming multi-center international validation study to develop digital biomarkers for #MS #MSMilan2023 
@ECTRIMS @ThINk_Basel https://t.co/eltRg2wuWf",twitter,ITA,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",dreams collaborators putting their minds together in the context of an upcoming multi-center international validation study to develop digital biomarkers for #ms #msmilan2023 @ectrims @think_basel https://t.co/eltrg2wuwf,,"#ms, #msmilan2023",Beauty/Health & Fitness,,6000000000,1493181686426779654,,91,65,0,,,4,6,22,False,dreams collaborators putting their minds together in the context of an upcoming multi-center international validation study to develop digital biomarkers for ms ms milan,"['Dreams', 'collaborators', 'minds', 'together', 'context', 'upcoming', 'multi-center', 'international', 'validation', 'study', 'develop', 'digital', 'biomarkers', 'MS', 'Milan']","dreams,collaborators,minds,together,context,upcoming,multi-center,international,validation,study,develop,digital,biomarkers,ms,milan",dreams collaborators minds together context upcoming multi-center international validation study develop digital biomarkers,dreams collaborators minds together context upcoming multi-center international validation study develop digital biomarkers,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,0.8941305501003577,False
62,66,2023-10-13 12:46:30.0,"Had a great in-person turnout @ECTRIMS Optimiz(s)ing ðŸ˜ƒ prognosis in MS session! Thanks also for tuning in! Engaged audience, interesting sometimes challenging questions such as smoldering vs smouldering ðŸ˜ƒ & a wonderful co-chair, it was such a pleasure! #ECTRIMS2023 @DrWBRO https://t.co/tn49q2FYKN",twitter,,burcuzeydanmd,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","had a great in-person turnout @ectrims optimiz(s)ing ðŸ˜ƒ prognosis in ms session! thanks also for tuning in! engaged audience, interesting sometimes challenging questions such as smoldering vs smouldering ðŸ˜ƒ & a wonderful co-chair, it was such a pleasure! #ectrims2023 @drwbro https://t.co/tn49q2fykn",female,#ectrims2023,Beauty/Health & Fitness,,6000000000,1221551673463705602,,547,444,0,http://twitter.com/burcuzeydanmd/statuses/1712571509686845640,,2,17,92,False,"had a great in-person turnout optimiz(s)ing prognosis in ms session! thanks also for tuning in! engaged audience, interesting sometimes challenging questions such as smoldering vs smouldering & a wonderful co-chair, it was such a pleasure! ec trims","['optimize', 'prognosis', 'MS', 'session', 'in-person', 'turnout', 'engage', 'audience', 'questions', 'smoldering', 'smouldering', 'EC', 'trims']","optimize,prognosis,ms,session,in-person,turnout,engage,audience,questions,smoldering,smouldering,ec,trims",optimize prognosis session in-person turnout engage audience questions smoldering smouldering,optimize prognosis session in-person turnout engage audience questions smoldering smouldering,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
63,67,2023-10-13 12:39:57.0,@DrAmyBSullivan provided more evidence for treating depression early after #multiplesclerosis diagnosis at #ECTRIMS2023. Progression independent of disease activity #PIRA was all the talk in #MSMilan2023 with @DrJNicholas breaking down the pathways and opportunities for early tx! https://t.co/qWZ23orX6t,twitter,USA,Heena_Manglani,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}",@dramybsullivan provided more evidence for treating depression early after #multiplesclerosis diagnosis at #ectrims2023. progression independent of disease activity #pira was all the talk in #msmilan2023 with @drjnicholas breaking down the pathways and opportunities for early tx! https://t.co/qwz23orx6t,female,"#multiplesclerosis, #ectrims2023, #pira, #msmilan2023",Beauty/Health & Fitness,,6000000000,3000485326,,406,671,0,,,1,2,179,False,provided more evidence for treating depression early after multiple sclerosis diagnosis at ec trims. progression independent of disease activity #pira was all the talk in ms milan with breaking down the pathways and opportunities for early tx!,"['depression', 'evidence', 'treatment', 'multiple sclerosis', 'EC Trims', 'progression', 'disease activity', 'PIRA', 'MS Milan', 'early treatment', 'pathways', 'opportunities.']","depression,evidence,treatment,multiple sclerosis,ec trims,progression,disease activity,pira,ms milan,early treatment,pathways,opportunities.",depression evidence progression disease activity pira early treatment pathways opportunities.,depression evidence progression disease activity pira early treatment pathways opportunities.,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,0.8469575188055247,False
64,68,2023-10-13 12:32:57.0,"@RachelHorne19 @ECTRIMS Everyone with MS needs a little hep for his mental health, not only because you have changes in your live. It is because the inflamation in our brain makes you feel depressed. It is because of the proper MS. I believe so, an I take medicines for it",twitter,ESP,LR_lolarivera,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@rachelhorne19 @ectrims everyone with ms needs a little hep for his mental health, not only because you have changes in your live. it is because the inflamation in our brain makes you feel depressed. it is because of the proper ms. i believe so, an i take medicines for it",female,,,,6000000000,58454283,,277,603,1,http://twitter.com/RachelHorne19/statuses/1712565686482985441,,0,0,5182,False,"everyone with ms needs a little hep for his mental health, not only because you have changes in your live. it is because the inflamation in our brain makes you feel depressed. it is because of the proper ms. i believe so, an i take medicines for it","['MS', 'mental health', 'inflammation', 'brain', 'depression', 'medication']","ms,mental health,inflammation,brain,depression,medication",mental health inflammation brain depression medication,mental health inflammation brain depression medication,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,0.9730934039454179,False
65,69,2023-10-13 12:32:22.0,"As the #MS community gathers at @ECTRIMS #MSMilan2023, we're inspired by scientific exchange & breakthroughs in MS. 

Co-founder Richard Ransohoff recently sat down with John Maraganore to discuss our new understanding of MS pathology & progression.
ICYMI: https://t.co/jQ2i5DmkDe",twitter,,AbataTx,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","as the #ms community gathers at @ectrims #msmilan2023, we're inspired by scientific exchange & breakthroughs in ms. co-founder richard ransohoff recently sat down with john maraganore to discuss our new understanding of ms pathology & progression. icymi: https://t.co/jq2i5dmkde",unknown,"#ms, #msmilan2023",Science,,6000000000,1367149082700087297,,208,78,0,,,0,0,137,False,"as the ms community gathers at ms milan, we're inspired by scientific exchange & breakthroughs in ms. co-founder richard ransohoff recently sat down with john maraganore to discuss our new understanding of ms pathology & progression. icymi:","['ms', 'community', 'gather', 'ms Milan', 'scientific exchange', 'breakthroughs', 'MS pathology', 'progression', 'co-founder', 'Richard Ransohoff', 'John Maraganore']","ms,community,gather,ms milan,scientific exchange,breakthroughs,ms pathology,progression,co-founder,richard ransohoff,john maraganore",gather scientific exchange breakthroughs ms pathology progression co-founder richard ransohoff john maraganore,gather scientific exchange breakthroughs ms pathology progression co-founder richard ransohoff john maraganore,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
66,70,2023-10-13 12:24:52.0,Breastfeeding recommendations in #ECTRIMS2023. We should encourage exclusive breastfeeding in MS patients. #iwims #MSmilan2023. https://t.co/sZfnJFXZQH,twitter,,GilPerotin,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",breastfeeding recommendations in #ectrims2023. we should encourage exclusive breastfeeding in ms patients. #iwims #msmilan2023. https://t.co/szfnjfxzqh,female,"#ectrims2023, #iwims, #msmilan2023","Books, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1490739116635561987,,92,275,0,,,2,5,42,False,breastfeeding recommendations in ec trims. we should encourage exclusive breastfeeding in ms patients. #iwims ms milan.,"['breastfeeding', 'recommendations', 'EC TRIsMs', 'encouragement', 'exclusive', 'MS', 'patients', 'IWIMs', 'Milan']","breastfeeding,recommendations,ec trisms,encouragement,exclusive,ms,patients,iwims,milan",breastfeeding recommendations ec trisms encouragement exclusive iwims,breastfeeding recommendations ec trisms encouragement exclusive iwims,3,3_pregnancy_breastfeeding_women_induction,"Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['breastfeeding', 'pregnancy', 'childbearing', 'trimester', 'nurses', 'pregs', 'medication', 'natalizumab', 'dmt', 'women']","['Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women', '', '', '', '', '', '', '', '', '']","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['women childbearing age pregnancy plan solution', 'pregnancy ms team dmt induction therapy pregs natalizumab glatiramer acetate second trimester', 'pregnancy breastfeeding women nurses experience understanding concerns']",pregnancy - breastfeeding - women - induction - trisms - trimester - solution - second - recommendations - pregs,1.0,False
67,71,2023-10-13 11:47:58.0,Participating in the most important #MSMilan2023Congress in the world on #MultipleSclerosis with great colleagues and friends. We continue working on research #msresearch @ECTRIMS https://t.co/9yyMDhsjaa,twitter,ESP,DrRafaelArroyo,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",participating in the most important #msmilan2023congress in the world on #multiplesclerosis with great colleagues and friends. we continue working on research #msresearch @ectrims https://t.co/9yymdhsjaa,male,"#msmilan2023congress, #multiplesclerosis, #msresearch",,,6000000000,2933988141,,1851,519,0,,,0,2,1096,False,participating in the most important ms milancongress in the world on multiple sclerosis with great colleagues and friends. we continue working on research msresearch,"['MS', 'MilanCongress', 'multiple sclerosis', 'research', 'colleagues', 'friends', 'work']","ms,milancongress,multiple sclerosis,research,colleagues,friends,work",milancongress colleagues friends work,milancongress colleagues friends work,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
68,72,2023-10-13 11:27:09.0,"Chiari Zecca: Nice talk on managing anti-B cel therapy to reduce infectious risks over time.
Most used is extended dosing intervals (or dose reductions) with fixed interval or by following B-cel reoccurrence.
Monitoring IgG levels is advised ðŸ˜Œ
#MSMilan2023 
#MultipleSclerosis https://t.co/k6ntGlb1Yb",twitter,BEL,bart_professor,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}",chiari zecca: nice talk on managing anti-b cel therapy to reduce infectious risks over time. most used is extended dosing intervals (or dose reductions) with fixed interval or by following b-cel reoccurrence. monitoring igg levels is advised ðŸ˜Œ #msmilan2023 #multiplesclerosis https://t.co/k6ntglb1yb,unknown,"#msmilan2023, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1109554254979743744,,1946,885,0,,,0,1,1885,False,chiari zecca: nice talk on managing anti-b cel therapy to reduce infectious risks over time. most used is extended dosing intervals (or dose reductions) with fixed interval or by following b-cel reoccurrence. monitoring igg levels is advised ms milan multiple sclerosis,"['Chiari', 'Zecca', 'anti-B cell therapy', 'infectious risks', 'extended dosing intervals', 'dose reductions', 'B-cell reoccurrence', 'IgG levels', 'Milan', 'multiple sclerosis.']","chiari,zecca,anti-b cell therapy,infectious risks,extended dosing intervals,dose reductions,b-cell reoccurrence,igg levels,milan,multiple sclerosis.",chiari zecca anti-b cell therapy infectious risks extended dosing intervals dose reductions b-cell reoccurrence igg levels multiple sclerosis.,chiari zecca anti-b cell therapy infectious risks extended dosing intervals dose reductions b-cell reoccurrence igg levels multiple sclerosis.,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
69,73,2023-10-13 11:01:21.0,"Exploring the intersection of hormones and #MS! Dive into this discussion on hormone replacement therapy during menopause with Rhonda Voskuhl, PhD. What could this mean for patients with MS? ðŸ¤” @UCLA @UCLAHealth @ECTRIMS @ACTRIMS #MSMilan

Watch: https://t.co/57RjlHnFuq https://t.co/bb8PXbibr7",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","exploring the intersection of hormones and #ms! dive into this discussion on hormone replacement therapy during menopause with rhonda voskuhl, phd. what could this mean for patients with ms? ðŸ¤” @ucla @uclahealth @ectrims @actrims #msmilan watch: https://t.co/57rjlhnfuq https://t.co/bb8pxbibr7",,"#ms, #msmilan",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8626,517,0,,,0,0,33752,False,"exploring the intersection of hormones and ms! dive into this discussion on hormone replacement therapy during menopause with rhonda voskuhl, phd. what could this mean for patients with ms? msmilan watch:","['hormones', 'MS', 'hormone replacement therapy', 'menopause', 'Rhonda Voskuhl', 'PhD', 'patients', 'MS Milan']","hormones,ms,hormone replacement therapy,menopause,rhonda voskuhl,phd,patients,ms milan",hormones hormone replacement therapy menopause rhonda voskuhl phd,hormones hormone replacement therapy menopause rhonda voskuhl phd,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
70,74,2023-10-13 11:01:00.0,"Great News Today: Tiziana Announces Positive Qualitative Six-Month PET Scan Results With Intranasal Foralumab Treating Multiple Sclerosis Patients Diagnosed With Non-Active Secondary Progressive MS #MSMilan2023 @ECTRIMS @ACTRIMS $TLSA #MultipleSclerosis
https://t.co/Bw3Vc7vCWY https://t.co/ESQyGU6jL9",twitter,,TizianaLS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}",great news today: tiziana announces positive qualitative six-month pet scan results with intranasal foralumab treating multiple sclerosis patients diagnosed with non-active secondary progressive ms #msmilan2023 @ectrims @actrims $tlsa #multiplesclerosis https://t.co/bw3vc7vcwy https://t.co/esqygu6jl9,unknown,"#msmilan2023, #multiplesclerosis",,,6000000000,847823456758575105,,1410,304,0,,,14,43,368,True,great news today: tiziana announces positive qualitative six-month pet scan results with intranasal foralumab treating multiple sclerosis patients diagnosed with non-active secondary progressive ms ms milan $tlsa multiple sclerosis,"['Tiziana', 'positive', 'qualitative', 'six-month', 'pet scan', 'results', 'intranasal', 'Foralumab', 'treating', 'multiple sclerosis', 'patients', 'diagnosed', 'non-active', 'secondary progressive MS', '']","tiziana,positive,qualitative,six-month,pet scan,results,intranasal,foralumab,treating,multiple sclerosis,patients,diagnosed,non-active,secondary progressive ms,",tiziana positive qualitative six-month pet scan results intranasal foralumab treating diagnosed non-active secondary progressive ms ,tiziana positive qualitative six-month pet scan results intranasal foralumab treating diagnosed non-active secondary progressive ms ,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,0.4467522455225372,False
71,75,2023-10-13 10:58:58.0,"So proud of Marloes! She presented on advanced ways of investigating how patterns of communication in the brain alternate, and how these are affected by MS. New insights on why the network becomes inefficient in some people with MS. Exciting times! #MSMilan2023 @MScentrum020",twitter,NLD,Mennoke,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","so proud of marloes! she presented on advanced ways of investigating how patterns of communication in the brain alternate, and how these are affected by ms. new insights on why the network becomes inefficient in some people with ms. exciting times! #msmilan2023 @mscentrum020",male,#msmilan2023,,"{profession=Scientist & Researcher, jobTitle=Neuroscientist}, {profession=Teacher & Lecturer, jobTitle=Associate Professor}",6000000000,83447713,,592,617,0,,,1,6,1085,False,"so proud of marloes! she presented on advanced ways of investigating how patterns of communication in the brain alternate, and how these are affected by ms. new insights on why the network becomes inefficient in some people with ms. exciting times! ms milan","['Marloes', 'communication', 'brain', 'investigation', 'patterns', 'MS', 'research', 'insights', 'efficiency', 'network', 'people', 'excitement', 'Milan']","marloes,communication,brain,investigation,patterns,ms,research,insights,efficiency,network,people,excitement,milan",marloes communication brain investigation patterns insights efficiency network people excitement,marloes communication brain investigation patterns insights efficiency network people excitement,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
72,76,2023-10-13 10:52:59.0,Grateful to have had the opportunity to present my work on functional brain dynamics yesterday at #ECTRIMS2023 in Milan. Special thanks to the co-authors and my supervisors @BroedersTommy  and @Mennoke  for their support! #MSMilan23 #MS https://t.co/zPw6mxBVPn,twitter,NLD,MarloesBet,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",grateful to have had the opportunity to present my work on functional brain dynamics yesterday at #ectrims2023 in milan. special thanks to the co-authors and my supervisors @broederstommy and @mennoke for their support! #msmilan23 #ms https://t.co/zpw6mxbvpn,female,"#ectrims2023, #msmilan23, #ms","Beauty/Health & Fitness, Science","{profession=Student, jobTitle=PhD Candidate}",6000000000,1364940824895750144,,17,123,0,,,4,6,1,False,grateful to have had the opportunity to present my work on functional brain dynamics yesterday at ec trims in milan. special thanks to the co-authors and my supervisors and for their support! msmilan23 ms,"['work', 'opportunity', 'presentation', 'brain', 'dynamics', 'EC', 'TRIms', 'Milan', 'support']","work,opportunity,presentation,brain,dynamics,ec,trims,milan,support",work opportunity presentation brain dynamics support,work opportunity presentation brain dynamics support,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
73,77,2023-10-13 10:47:45.0,"This morning @valegiunca presented during the #ECTRIMS2023 scientific session. Great to see @UKMSRegister data being used in some more brilliant research!

#MSMilan2023 #Research #MultipleSclerosis @imperialcollege https://t.co/AGDXRPvCbX",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",this morning @valegiunca presented during the #ectrims2023 scientific session. great to see @ukmsregister data being used in some more brilliant research! #msmilan2023 #research #multiplesclerosis @imperialcollege https://t.co/agdxrpvcbx,,"#ectrims2023, #msmilan2023, #research, #multiplesclerosis",,,6000000000,325527212,,2296,1835,1,,,2,7,1840,False,this morning presented during the ec trims scientific session. great to see data being used in some more brilliant research! ms milan #research multiple sclerosis,"['morning', 'ec trims', 'scientific', 'session', 'data', 'research', 'ms', 'milan', 'research', 'multiple sclerosis']","morning,ec trims,scientific,session,data,research,ms,milan,research,multiple sclerosis",morning scientific session,morning scientific session,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
74,78,2023-10-13 10:44:31.0,"There you go! A clear figure indicating higher prevalence of cerebrovascular comorbidity in MS compared to controls. Letâ€™s shift spotlight to how we can manage and better so, prevent -  Stella Sivertseva @ECTRIMS #MSMilan2023 Photo credit @KarenZoszak https://t.co/Momx0kxGhY",twitter,,OliviaWillsAPD,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","there you go! a clear figure indicating higher prevalence of cerebrovascular comorbidity in ms compared to controls. letâ€™s shift spotlight to how we can manage and better so, prevent - stella sivertseva @ectrims #msmilan2023 photo credit @karenzoszak https://t.co/momx0kxghy",female,#msmilan2023,"Beauty/Health & Fitness, Science","{profession=Student, jobTitle=PhD Candidate}",6000000000,1324106810597408769,,179,200,0,,,0,2,302,False,"there you go! a clear figure indicating higher prevalence of cerebrovascular comorbidity in ms compared to controls. lets shift spotlight to how we can manage and better so, prevent - stella sivertseva ms milan photo credit","['multiple sclerosis', 'cerebrovascular comorbidity', 'management', 'prevention', 'Stella Sivertseva', 'Milan']","multiple sclerosis,cerebrovascular comorbidity,management,prevention,stella sivertseva,milan",cerebrovascular comorbidity management prevention stella sivertseva,cerebrovascular comorbidity management prevention stella sivertseva,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
75,79,2023-10-13 10:23:41.0,"Family planning in women of  childbearing age with #MS should be included in standard clinical care, especially to choose the right treatment plans based on #pregnancy desire ðŸ¤°
â€¼ï¸MS treatment should not be compromised because there are solutions.
#MSMilan2023
@ECTRIMS @ACTRIMS https://t.co/STrJpOtrvF",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","family planning in women of childbearing age with #ms should be included in standard clinical care, especially to choose the right treatment plans based on #pregnancy desire ðŸ¤° â€¼ï¸ms treatment should not be compromised because there are solutions. #msmilan2023 @ectrims @actrims https://t.co/strjpotrvf",female,"#ms, #pregnancy, #msmilan2023",,,6000000000,600110872,,4874,893,0,,,1,7,5944,False,"family planning in women of childbearing age with ms should be included in standard clinical care, especially to choose the right treatment plans based on #pregnancy desire ms treatment should not be compromised because there are solutions. ms milan","['women', 'childbearing', 'age', 'pregnancy', 'treatment', 'plan', 'solution', 'ms', 'Milan']","women,childbearing,age,pregnancy,treatment,plan,solution,ms,milan",women childbearing age pregnancy plan solution,women childbearing age pregnancy plan solution,3,3_pregnancy_breastfeeding_women_induction,"Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['breastfeeding', 'pregnancy', 'childbearing', 'trimester', 'nurses', 'pregs', 'medication', 'natalizumab', 'dmt', 'women']","['Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women', '', '', '', '', '', '', '', '', '']","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['women childbearing age pregnancy plan solution', 'pregnancy ms team dmt induction therapy pregs natalizumab glatiramer acetate second trimester', 'pregnancy breastfeeding women nurses experience understanding concerns']",pregnancy - breastfeeding - women - induction - trisms - trimester - solution - second - recommendations - pregs,1.0,True
76,80,2023-10-13 10:19:12.0,"So far on Day 3 of #MSMilan2023, weâ€™ve had great chats on #MS with:

â€¢ @GeoArrambide, on differential diagnosis
â€¢ @drbarrysinger, on the latest in therapy & biomarkers
â€¢ @melindamagyari, on the role of hormones

Check out https://t.co/Ya6BOYo5VP for all our interview footage! https://t.co/eVxw6lUGo0",twitter,USA,byMattHoffman,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","so far on day 3 of #msmilan2023, weâ€™ve had great chats on #ms with: â€¢ @geoarrambide, on differential diagnosis â€¢ @drbarrysinger, on the latest in therapy & biomarkers â€¢ @melindamagyari, on the role of hormones check out https://t.co/ya6boyo5vp for all our interview footage! https://t.co/evxw6lugo0",male,"#msmilan2023, #ms",,"{profession=Journalist, jobTitle=Associate Editorial Director}, {profession=Artist, jobTitle=Producer}",6000000000,895689692271828992,,1067,989,0,,,2,5,10026,False,"so far on day 3 of ms milan, weve had great chats on ms with: , on differential diagnosis , on the latest in therapy & biomarkers , on the role of hormones check out for all our interview footage!","['ms', 'Milan', 'chat', 'diagnosis', 'therapy', 'biomarkers', 'hormones', 'interview']","ms,milan,chat,diagnosis,therapy,biomarkers,hormones,interview",chat diagnosis therapy biomarkers hormones interview,chat diagnosis therapy biomarkers hormones interview,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,0.6497498478979215,False
77,81,2023-10-13 09:01:31.0,Dr Anthony Feinstein presents the results of the CogEx clinical trial to improve cognition in people living with progressive MS @ECTRIMS #MSMilan2023 https://t.co/Xr3HtfRkG3,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr anthony feinstein presents the results of the cogex clinical trial to improve cognition in people living with progressive ms @ectrims #msmilan2023 https://t.co/xr3htfrkg3,female,#msmilan2023,,,6000000000,256679634,,1175,1912,0,,,3,5,6585,False,dr anthony feinstein presents the results of the cogex clinical trial to improve cognition in people living with progressive ms ms milan,"['Anthony Feinstein', 'CogEx', 'cognition', 'MS', 'Milan']","anthony feinstein,cogex,cognition,ms,milan",anthony feinstein cogex cognition,anthony feinstein cogex cognition,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
78,82,2023-10-13 08:57:37.0,"Dr Owain Howells discussing pathology and immunology at #ECTRIMS2023 yesterday, using data from @UKMSRegister ðŸ’»

#MSMilan2023 #MultipleSclerosis #Research https://t.co/AA94ddbWBH",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","dr owain howells discussing pathology and immunology at #ectrims2023 yesterday, using data from @ukmsregister ðŸ’» #msmilan2023 #multiplesclerosis #research https://t.co/aa94ddbwbh",,"#ectrims2023, #msmilan2023, #multiplesclerosis, #research",,,6000000000,325527212,,2296,1833,0,,,2,5,1839,False,"dr owain howells discussing pathology and immunology at ec trims yesterday, using data from ms milan multiple sclerosis #research","['Dr', 'Owain Howells', 'Pathology', 'Immunology', 'EC Trims', 'MS Milan', 'Multiple Sclerosis', 'Research']","dr,owain howells,pathology,immunology,ec trims,ms milan,multiple sclerosis,research",dr owain howells pathology immunology,dr owain howells pathology immunology,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
79,83,2023-10-13 08:56:14.0,Proud and honored to contribute to this @ectrims @MAGNIMS teaching course representing @cemcat,twitter,ESP,J_SastreGarriga,,proud and honored to contribute to this @ectrims @magnims teaching course representing @cemcat,male,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,829744742,,3220,868,0,,,7,24,6885,False,proud and honored to contribute to this teaching course representing,"['contribute', 'teaching', 'course', 'represent']","contribute,teaching,course,represent",contribute teaching course represent,contribute teaching course represent,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
80,84,2023-10-13 08:53:53.0,"MS new tratments: BTK inhibitors
#MSMilan2023 #ectrims2023 https://t.co/bTLQQwrdGZ",twitter,BRA,vcneri,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ms new tratments: btk inhibitors #msmilan2023 #ectrims2023 https://t.co/btlqqwrdgz,unknown,"#msmilan2023, #ectrims2023","Beauty/Health & Fitness, Science",,6000000000,53810006,,111,679,0,,,0,0,102,False,ms new tratments: btk inhibitors ms milan ec trims,"['BTK inhibitors', 'MS', 'Milan', 'EC', 'trims']","btk inhibitors,ms,milan,ec,trims",btk inhibitors,btk inhibitors,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
81,85,2023-10-13 08:51:33.0,"Progression in MS..,
#ectrims #MSMilan2023 https://t.co/RGLoaJJdXk",twitter,BRA,vcneri,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","progression in ms.., #ectrims #msmilan2023 https://t.co/rgloajjdxk",unknown,"#ectrims, #msmilan2023","Beauty/Health & Fitness, Science",,6000000000,53810006,,111,679,0,,,1,0,101,False,"progression in ms.., ec trims ms milan","['progression', 'MS', 'EC', 'trim', 'Milan']","progression,ms,ec,trim,milan",progression trim,progression trim,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,0.7184764713804549,False
82,86,2023-10-13 08:49:26.0,Our editorial board member @Duttalab2017 presenting on microglial miRNA in remyelination in #MultipleSclerosis at #MSMilam2023 @ECTRIMS https://t.co/TgOIJVeFS9,twitter,GBR,MSJ_Research,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",our editorial board member @duttalab2017 presenting on microglial mirna in remyelination in #multiplesclerosis at #msmilam2023 @ectrims https://t.co/tgoijvefs9,,"#multiplesclerosis, #msmilam2023",Beauty/Health & Fitness,,6000000000,764125362422972416,,3487,199,0,,,1,4,2607,False,our editorial board member presenting on microglial mirna in remyelination in multiple sclerosis at msmilam2023,"['microglial', 'miRNA', 'remyelination', 'multiple sclerosis', 'MSMILam2023']","microglial,mirna,remyelination,multiple sclerosis,msmilam2023",microglial mirna remyelination msmilam2023,microglial mirna remyelination msmilam2023,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.8665542320121206,False
83,87,2023-10-13 08:47:22.0,"Patient reported outcomes #PROMS- person with #MS capturing their own changes is a crucial topic at @ECTRIMS 
âœ”ï¸Reflect daily life
âœ”ï¸Patient experience
âœ”ï¸Practical
âœ”ï¸Low cost
ðŸ™ŒHigh potential to track progression and efficacy of intervention
#MSMilan2023 https://t.co/XLodG00LEc",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",patient reported outcomes #proms- person with #ms capturing their own changes is a crucial topic at @ectrims âœ”ï¸reflect daily life âœ”ï¸patient experience âœ”ï¸practical âœ”ï¸low cost ðŸ™Œhigh potential to track progression and efficacy of intervention #msmilan2023 https://t.co/xlodg00lec,female,"#proms, #ms, #msmilan2023",,,6000000000,600110872,,4874,893,0,,,5,13,5941,False,patient reported outcomes #proms- person with ms capturing their own changes is a crucial topic at reflect daily life patient experience practical low cost high potential to track progression and efficacy of intervention ms milan,"['patient', 'outcomes', 'PROMs', 'MS', 'multiple sclerosis', 'reflect', 'daily life', 'patient experience', 'practical', 'low cost', 'high potential', 'track', 'progression', 'efficacy', 'intervention', 'Milan']","patient,outcomes,proms,ms,multiple sclerosis,reflect,daily life,patient experience,practical,low cost,high potential,track,progression,efficacy,intervention,milan",outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention,outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,1.0,True
84,88,2023-10-13 08:46:17.0,"Great to breakfast with @danielsaloreich @ectrims @ACTRIMS #Milan2023 and discuss #MS #Biomarker research. Subdued & concerned about exposure of friends, family in #Israel to #HamasTerrorism https://t.co/TtWMFQwQ1h",twitter,ITA,KlausSchmierer,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","great to breakfast with @danielsaloreich @ectrims @actrims #milan2023 and discuss #ms #biomarker research. subdued & concerned about exposure of friends, family in #israel to #hamasterrorism https://t.co/ttwmfqwq1h",male,"#milan2023, #ms, #biomarker, #israel, #hamasterrorism",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,1618555326,,4090,1329,1,,,0,16,8360,False,"great to breakfast with milan2023 and discuss ms #biomarker research. subdued & concerned about exposure of friends, family in #israel to #hamasterrorism","['breakfast', 'Milan', 'biomarker', 'research', 'Hamas', 'terrorism', 'Israel', 'friends', 'family']","breakfast,milan,biomarker,research,hamas,terrorism,israel,friends,family",breakfast biomarker hamas terrorism israel friends family,breakfast biomarker hamas terrorism israel friends family,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
85,89,2023-10-13 08:37:07.0,It has been an honour to present our work at #MSMilan2023 #ECTRIMS #MultipleSclerosis #MS #UCL #QSMSC https://t.co/K0GtzjVP20,twitter,GBR,saalaraji,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",it has been an honour to present our work at #msmilan2023 #ectrims #multiplesclerosis #ms #ucl #qsmsc https://t.co/k0gtzjvp20,male,"#msmilan2023, #ectrims, #multiplesclerosis, #ms, #ucl, #qsmsc","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Research Fellow}",6000000000,1059537299535511552,,182,220,1,,,3,22,261,False,it has been an honour to present our work at ms milan ec trims multiple sclerosis ms #ucl #qsmsc,"['MS', 'Milan', 'honor', 'presentation', 'UCL', 'QSMSC']","ms,milan,honor,presentation,ucl,qsmsc",honor presentation ucl qsmsc,honor presentation ucl qsmsc,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
86,90,2023-10-13 08:25:50.0,"Starting Pediatric MS session this AM at #MSMilan2023 #ECTRIMS with Tanuja Chitnis discussing disability accrual, potential predictive value of sNFL, and treatment pathways https://t.co/Cng65PVEpV",twitter,USA,KSFisher,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","starting pediatric ms session this am at #msmilan2023 #ectrims with tanuja chitnis discussing disability accrual, potential predictive value of snfl, and treatment pathways https://t.co/cng65pvepv",female,"#msmilan2023, #ectrims",Family & Parenting,,6000000000,790055143433576448,,426,446,1,,,1,6,208,False,"starting pediatric ms session this am at ms milan ec trims with tanuja chitnis discussing disability accrual, potential predictive value of snfl, and treatment pathways","['ms', 'Milan', 'EC', 'trims', 'Tanuja Chitnis', 'disability', 'accrual', 'SNFL', 'treatment pathways']","ms,milan,ec,trims,tanuja chitnis,disability,accrual,snfl,treatment pathways",tanuja chitnis disability accrual snfl treatment pathways,tanuja chitnis disability accrual snfl treatment pathways,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.17460067460841183,False
87,91,2023-10-13 08:17:07.0,The 2nd of two @MAGNIMS educational activities at #MSMilan2023 @ECTRIMS was held this morning on â€œClinical relevance of spinal cord and optic nerve imaging in multiple sclerosisâ€ with @rocca_mara @DrWBRO & @J_SastreGarriga - We hope you found them informative! Thanks for coming! https://t.co/ehpt8C6qXr,twitter,,MAGNIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",the 2nd of two @magnims educational activities at #msmilan2023 @ectrims was held this morning on â€œclinical relevance of spinal cord and optic nerve imaging in multiple sclerosisâ€ with @rocca_mara @drwbro & @j_sastregarriga - we hope you found them informative! thanks for coming! https://t.co/ehpt8c6qxr,unknown,#msmilan2023,,,6000000000,2194426992,,1611,43,0,,,5,30,376,False,the 2nd of two educational activities at ms milan was held this morning on clinical relevance of spinal cord and optic nerve imaging in multiple sclerosis with & - we hope you found them informative! thanks for coming!,"['spinal cord', 'optic nerve', 'multiple sclerosis', 'education', 'activity', 'clinical relevance', 'hope', 'informative', 'thanks']","spinal cord,optic nerve,multiple sclerosis,education,activity,clinical relevance,hope,informative,thanks",spinal cord optic nerve education activity clinical relevance hope informative thanks,spinal cord optic nerve education activity clinical relevance hope informative thanks,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.964370140742404,False
88,92,2023-10-13 08:08:44.0,"Great to have the opportunity to present on the development of #biosimilar medications. With decrease costs, biosimilar DMTs will allow more #MS patients ðŸŒŽ have access to early high efficacy treatment.  ðŸ‘ #MSMilan2023 https://t.co/MIXQdVW2Mz",twitter,USA,drbarrysinger,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15960147, name=Zynteglo/ Pricing, displayName=null, parentId=15960144, parentName=Hemgenix SML}","great to have the opportunity to present on the development of #biosimilar medications. with decrease costs, biosimilar dmts will allow more #ms patients ðŸŒŽ have access to early high efficacy treatment. ðŸ‘ #msmilan2023 https://t.co/mixqdvw2mz",male,"#biosimilar, #ms, #msmilan2023",Science,,6000000000,1430793013,,7231,393,0,,,1,4,3167,False,"great to have the opportunity to present on the development of #biosimilar medications. with decrease costs, biosimilar dmts will allow more ms patients have access to early high efficacy treatment. ms milan","['biosimilar', 'medication', 'opportunity', 'development', 'cost', 'decrease', 'access', 'treatment', 'multiple sclerosis', 'Milan']","biosimilar,medication,opportunity,development,cost,decrease,access,treatment,multiple sclerosis,milan",biosimilar medication opportunity development cost decrease access,biosimilar medication opportunity development cost decrease access,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
89,93,2023-10-13 07:47:38.0,"Check out Poster 1183 
@ECTRIMS
 #MSMilan2023 by @YasmineProbst

Tools use in the lifestyle management studies for #MS and researcher checklist for best practice https://t.co/ejUtfiUZ8o",twitter,SAU,Aloufi_loqmani,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",check out poster 1183 @ectrims #msmilan2023 by @yasmineprobst tools use in the lifestyle management studies for #ms and researcher checklist for best practice https://t.co/ejutfiuz8o,unknown,"#msmilan2023, #ms","Beauty/Health & Fitness, Science","{profession=Health practitioner, jobTitle=Clinical Dietitian}, {profession=Student, jobTitle=PhD Candidate}",6000000000,1943651450,,244,1379,0,,,1,3,13440,False,check out poster 1183 ms milan by tools use in the lifestyle management studies for ms and researcher checklist for best practice,"['Multiple Sclerosis (MS)', 'poster', 'tools', 'lifestyle management', 'researcher', 'checklist', 'best practices']","multiple sclerosis (ms),poster,tools,lifestyle management,researcher,checklist,best practices",multiple sclerosis (ms) poster tools lifestyle management researcher checklist best practices,multiple sclerosis (ms) poster tools lifestyle management researcher checklist best practices,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
90,94,2023-10-13 04:37:46.0,"Our Day 2 #MSMilan2023 insights are live. Our team explores topics incl. the gut microbiome, biomarkers, potential future therapeutic targets, environmental, genetic & epigenetic risk factors, AHSCT & EBV, & more! #MultipleSclerosis #MS @ECTRIMS @ACTRIMS  https://t.co/3oXgh6WTb2",twitter,AUS,MStranslate,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","our day 2 #msmilan2023 insights are live. our team explores topics incl. the gut microbiome, biomarkers, potential future therapeutic targets, environmental, genetic & epigenetic risk factors, ahsct & ebv, & more! #multiplesclerosis #ms @ectrims @actrims https://t.co/3oxgh6wtb2",,"#msmilan2023, #multiplesclerosis, #ms",,,6000000000,833579503,,4906,4077,0,,,0,4,3601,False,"our day 2 ms milan insights are live. our team explores topics incl. the gut microbiome, biomarkers, potential future therapeutic targets, environmental, genetic & epigenetic risk factors, ahsct & ebv, & more! multiple sclerosis ms","['gut microbiome', 'biomarkers', 'potential future therapeutic targets', 'environmental', 'genetic', 'epigenetic risk factors', 'ahsct', 'ebv', 'multiple sclerosis']","gut microbiome,biomarkers,potential future therapeutic targets,environmental,genetic,epigenetic risk factors,ahsct,ebv,multiple sclerosis",gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv,gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.9945721725350324,True
91,95,2023-10-13 03:47:51.0,"@ECTRIMS @mssocietyuk @MStranslate THERE ARE SEVERAL CURES FOR #MS
https://t.co/xjl0NKz8rA",twitter,USA,MsStacyEllis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@ectrims @mssocietyuk @mstranslate there are several cures for #ms https://t.co/xjl0nkz8ra,female,#ms,Beauty/Health & Fitness,"{profession=Health practitioner, jobTitle=Psychotherapist}",6000000000,1179505063150182400,,984,560,0,http://twitter.com/ECTRIMS/statuses/1712525613184004099,,0,0,31765,False,there are several cures for ms,"['cure', 'MS', 'multiple sclerosis']","cure,ms,multiple sclerosis",cure,cure,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,0.8199389277082654,False
92,96,2023-10-13 03:47:21.0,"@mssocietyHCP @mssociety @ECTRIMS @ACTRIMS THERE ARE SO MANY CURES FOR #MSâ€¦
https://t.co/xjl0NKz8rA",twitter,USA,MsStacyEllis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@mssocietyhcp @mssociety @ectrims @actrims there are so many cures for #msâ€¦ https://t.co/xjl0nkz8ra,female,#ms,Beauty/Health & Fitness,"{profession=Health practitioner, jobTitle=Psychotherapist}",6000000000,1179505063150182400,,984,560,1,http://twitter.com/mssocietyHCP/statuses/1712426407232680248,,0,0,31764,False,there are so many cures for ms,"['cure', 'MS', 'multiple sclerosis']","cure,ms,multiple sclerosis",cure,cure,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,0.8173761245031234,False
93,97,2023-10-13 03:16:08.0,"My @ECTRIMS Poster 1675- Redefining brain health in MS to recognise the influence of biological, psychological, social, interpersonal and contextual factors. Consistency in behaviour change messaging to maximise lifelong brain health for people with MS is also needed #MSMilan2023 https://t.co/Hzi34EgOTy",twitter,,OliviaWillsAPD,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","my @ectrims poster 1675- redefining brain health in ms to recognise the influence of biological, psychological, social, interpersonal and contextual factors. consistency in behaviour change messaging to maximise lifelong brain health for people with ms is also needed #msmilan2023 https://t.co/hzi34egoty",female,#msmilan2023,"Beauty/Health & Fitness, Science","{profession=Student, jobTitle=PhD Candidate}",6000000000,1324106810597408769,,179,200,0,,,0,11,300,False,"my poster 1675- redefining brain health in ms to recognise the influence of biological, psychological, social, interpersonal and contextual factors. consistency in behaviour change messaging to maximise lifelong brain health for people with ms is also needed ms milan","['brain health', 'MS', 'biological', 'psychological', 'social', 'interpersonal', 'contextual', 'behaviour change', 'consistency', 'messaging', 'lifelong', 'Milan']","brain health,ms,biological,psychological,social,interpersonal,contextual,behaviour change,consistency,messaging,lifelong,milan",brain health biological psychological social interpersonal contextual behaviour change consistency messaging lifelong,brain health biological psychological social interpersonal contextual behaviour change consistency messaging lifelong,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
94,98,2023-10-13 00:58:48.0,"Great to see Comorbidities in MS receiving much more attention in #ECTRIMS #MSMilan2023 this year

Known that most comorbidities are modifiable diseases, this highlights the importance of Dietary Management to delay the onset + manage already present comorbidities",twitter,SAU,Aloufi_loqmani,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","great to see comorbidities in ms receiving much more attention in #ectrims #msmilan2023 this year known that most comorbidities are modifiable diseases, this highlights the importance of dietary management to delay the onset + manage already present comorbidities",unknown,"#ectrims, #msmilan2023","Beauty/Health & Fitness, Science","{profession=Health practitioner, jobTitle=Clinical Dietitian}, {profession=Student, jobTitle=PhD Candidate}",6000000000,1943651450,,244,1379,0,,,0,3,13438,False,"great to see comorbidities in ms receiving much more attention in ec trims ms milan this year known that most comorbidities are modifiable diseases, this highlights the importance of dietary management to delay the onset + manage already present comorbidities","['comorbidities', 'MS', 'EC', 'dietary management', 'delay', 'onset', 'manage']","comorbidities,ms,ec,dietary management,delay,onset,manage",comorbidities dietary management delay onset manage,comorbidities dietary management delay onset manage,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,0.7988701669446999,False
95,99,2023-10-13 00:29:59.0,"ECTRIMS 2023: Medical Gaslighting in People with Multiple Sclerosis, by @GavinGiovannoni https://t.co/Ir0he34LFI",twitter,,ButterflyCr8ion,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ectrims 2023: medical gaslighting in people with multiple sclerosis, by @gavingiovannoni https://t.co/ir0he34lfi",unknown,,Fashion,,6000000000,1565808354366218242,,4,51,0,,,0,0,60,False,"ectrims 2023: medical gaslighting in people with multiple sclerosis, by","['ectrims', 'medical', 'gaslighting', 'people', 'multiple', 'sclerosis']","ectrims,medical,gaslighting,people,multiple,sclerosis",medical gaslighting people multiple sclerosis,medical gaslighting people multiple sclerosis,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
96,100,2023-10-13 00:18:27.0,In line with the priority topics of @MSIntFederation and @mssociety we set out to investigate the access to health services in the LGBTQ+ population with #multiplesclerosis in Argentina.  A collaborative with @EMA_Argentina presented at #MSMilan2023 congress @ECTRIMS,twitter,ITA,bereniceanabel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15960147, name=Zynteglo/ Pricing, displayName=null, parentId=15960144, parentName=Hemgenix SML}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",in line with the priority topics of @msintfederation and @mssociety we set out to investigate the access to health services in the lgbtq+ population with #multiplesclerosis in argentina. a collaborative with @ema_argentina presented at #msmilan2023 congress @ectrims,female,"#multiplesclerosis, #msmilan2023",Science,"{profession=Scientist & Researcher, jobTitle=Research Fellow}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,946033424296501249,,198,339,2,,,0,5,587,False,in line with the priority topics of and we set out to investigate the access to health services in the lgbtq+ population with multiple sclerosis in argentina. a collaborative with presented at ms milan congress,"['health services', 'LGBTQ+', 'Argentina', 'access', 'multiple sclerosis', 'MS Milan Congress']","health services,lgbtq+,argentina,access,multiple sclerosis,ms milan congress",health services lgbtq+ argentina access ms milan congress,health services lgbtq+ argentina access ms milan congress,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
97,101,2023-10-13 00:18:08.0,"Thanks for your work, what is your poster number? #globalislocal in #MS @ECTRIMS #milan2023 https://t.co/Z8T7iMKekk",twitter,USA,DrJim4MS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","thanks for your work, what is your poster number? #globalislocal in #ms @ectrims #milan2023 https://t.co/z8t7imkekk",male,"#globalislocal, #ms, #milan2023",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1777,622,0,,,0,0,7996,False,"thanks for your work, what is your poster number? #globalislocal in ms milan2023","['work', 'thanks', 'global', 'local', 'poster', 'number', 'Milan', '2023']","work,thanks,global,local,poster,number,milan,2023",work thanks global local poster number 2023,work thanks global local poster number 2023,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9811496837946364,False
98,102,2023-10-13 00:01:01.0,"Infection with the Epstein-Barr virus may prime the immune system to accidentally attack a brain protein called ANO2, research shows.Â  https://t.co/s7R8TQz248 #ectrims2023 #news https://t.co/c00HYYGT6Q",twitter,USA,MSNewsToday,"{id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}","infection with the epstein-barr virus may prime the immune system to accidentally attack a brain protein called ano2, research shows. https://t.co/s7r8tqz248 #ectrims2023 #news https://t.co/c00hyygt6q",female,"#ectrims2023, #news",,,6000000000,2473350271,,10058,1542,0,,,4,9,28180,False,"infection with the epstein-barr virus may prime the immune system to accidentally attack a brain protein called ano2, research shows. ec trims #news","['Epstein-Barr virus', 'immune system', 'accidentally attack', 'brain protein', 'Ano2', 'research shows', 'EC trims', 'news']","epstein-barr virus,immune system,accidentally attack,brain protein,ano2,research shows,ec trims,news",epstein-barr virus immune system accidentally attack brain protein ano2 research shows news,epstein-barr virus immune system accidentally attack brain protein ano2 research shows news,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,1.0,True
99,104,2023-10-12 21:20:41.0,Learn about the MS research funding landscape in this poster  #msmilan2023 â¦@ECTRIMSâ© https://t.co/PrIrue4Hdb,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",learn about the ms research funding landscape in this poster #msmilan2023 â¦@ectrimsâ© https://t.co/prirue4hdb,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,0,4,6584,False,learn about the ms research funding landscape in this poster ms milan,"['research', 'funding', 'landscape', 'poster', 'MS', 'Milan']","research,funding,landscape,poster,ms,milan",funding landscape poster,funding landscape poster,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
100,105,2023-10-12 21:11:02.0,@MyelinIcm @BenedettaBodin1 Wonderful talk! And thank you for the shout-out ðŸ˜€! Please check out the poster by @ericklawiter on [18F]3F4AP in people with MS @ECTRIMS,twitter,USA,P_Brugarolas,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@myelinicm @benedettabodin1 wonderful talk! and thank you for the shout-out ðŸ˜€! please check out the poster by @ericklawiter on [18f]3f4ap in people with ms @ectrims,male,,"Technology, Animals & Pets, Family & Parenting","{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Software developer & IT, jobTitle=Developer}",6000000000,952251187952316417,,628,744,0,http://twitter.com/MyelinIcm/statuses/1712089991784935779,,0,2,554,False,wonderful talk! and thank you for the shout-out ! please check out the poster by on [18f]3f4ap in people with ms,"['talk', 'shout-out', 'poster', 'MS', 'people']","talk,shout-out,poster,ms,people",talk shout-out poster people,talk shout-out poster people,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
101,106,2023-10-12 21:04:05.0,Honoured to be invited to talk on optic nerve imaging (MS Pathophysiology and Disease Evolution) today @ECTRIMS #MSMilan2023 https://t.co/ZSd5fOAi8Q,twitter,,ahmedtoosy,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",honoured to be invited to talk on optic nerve imaging (ms pathophysiology and disease evolution) today @ectrims #msmilan2023 https://t.co/zsd5foai8q,unknown,#msmilan2023,,,6000000000,18452647,,122,246,0,,,2,16,229,False,honoured to be invited to talk on optic nerve imaging (ms pathophysiology and disease evolution) today ms milan,"['Optic nerve', 'imaging', 'MS', 'pathophysiology', 'disease evolution']","optic nerve,imaging,ms,pathophysiology,disease evolution",optic nerve imaging pathophysiology disease evolution,optic nerve imaging pathophysiology disease evolution,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,1.0,False
102,107,2023-10-12 20:50:40.0,Another session is coming up tomorrow on the third and last day of #ECTRIMS2023 Weâ€™ll be talking about optimizing (or optimising ðŸ˜ƒ) prognosis in MS. Come join us and letâ€™s discuss together @ECTRIMS @DrWBRO https://t.co/I1WIob6vXr,twitter,,burcuzeydanmd,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20279310, name=Ofev, displayName=null, parentId=20279181, parentName=ERS 2023 categories}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=15147375, name=Ofev, displayName=null, parentId=15147295, parentName=ESR 2022 Conference categories}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",another session is coming up tomorrow on the third and last day of #ectrims2023 weâ€™ll be talking about optimizing (or optimising ðŸ˜ƒ) prognosis in ms. come join us and letâ€™s discuss together @ectrims @drwbro https://t.co/i1wiob6vxr,female,#ectrims2023,Beauty/Health & Fitness,,6000000000,1221551673463705602,,544,444,2,,,3,19,89,False,another session is coming up tomorrow on the third and last day of ec trims well be talking about optimizing (or optimising ) prognosis in ms. come join us and lets discuss together,"['session', 'tomorrow', 'third', 'day', 'ec trims', 'optimizing', 'optimising', 'prognosis', 'ms', 'discuss', 'together']","session,tomorrow,third,day,ec trims,optimizing,optimising,prognosis,ms,discuss,together",session tomorrow third day optimizing optimising prognosis discuss together,session tomorrow third day optimizing optimising prognosis discuss together,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
103,108,2023-10-12 19:45:16.0,@J_SastreGarriga @clmguio @Neus_Mongay @CEMCAT @MAGNIMS @ECTRIMS @XMontalban @alexrovirarayos @MarTintore @rocca_mara @AVidalJordana @FBarkhof @CiccarelliOlga @segroppa Great! @Neus_Mongay,twitter,ITA,Vogrig_Alberto,,@j_sastregarriga @clmguio @neus_mongay @cemcat @magnims @ectrims @xmontalban @alexrovirarayos @martintore @rocca_mara @avidaljordana @fbarkhof @ciccarelliolga @segroppa great! @neus_mongay,male,,,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Research Fellow}",6000000000,1188448559886229507,,1021,650,0,http://twitter.com/J_SastreGarriga/statuses/1712472004786585621,,0,1,653,False,great!,['- great!'],- great!,- great!,- great!,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9654988754955731,False
104,110,2023-10-12 18:02:00.0,O064 Ana Beatriz Ayrosa Galvao Ribeiro Gomes: Isolated MOG-IgA in indivs w/distinct spectrum of clinical features: suggests MOG-IgA as potential diagnostic #biomarker in indivs w/ AQP4-/MOG-IgG double-seronegative CNS demyelination. @DepBiomedicine #MSMilan2023 #MS #MOGAD #NMOSD,twitter,,IJMSCtweets,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",o064 ana beatriz ayrosa galvao ribeiro gomes: isolated mog-iga in indivs w/distinct spectrum of clinical features: suggests mog-iga as potential diagnostic #biomarker in indivs w/ aqp4-/mog-igg double-seronegative cns demyelination. @depbiomedicine #msmilan2023 #ms #mogad #nmosd,,"#biomarker, #msmilan2023, #ms, #mogad, #nmosd",,,6000000000,1054320667,,896,623,0,,,0,0,4199,False,o064 ana beatriz ayrosa galvao ribeiro gomes: isolated mog-iga in indivs w/distinct spectrum of clinical features: suggests mog-iga as potential diagnostic #biomarker in indivs w/ aqp4-/mog-igg double-seronegative cns demyelination. ms milan ms #mogad #nmosd,"['Ana Beatriz Ayrosa Galvao Ribeiro Gomes', 'Mog-IGG', 'AQP4', 'MOG-IgG', 'CNS Demyelization', 'MS Milan', 'MOGAD', 'NM']","ana beatriz ayrosa galvao ribeiro gomes,mog-igg,aqp4,mog-igg,cns demyelization,ms milan,mogad,nm",ana beatriz ayrosa galvao ribeiro gomes mog-igg aqp4 mog-igg cns demyelization mogad nm,ana beatriz ayrosa galvao ribeiro gomes mog-igg aqp4 mog-igg cns demyelization mogad nm,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,0.9335706791278056,False
105,111,2023-10-12 18:01:07.0,"@MerckHealthcare @ECTRIMS @TawakkolKarman Why promote islam ideology, Merck?",twitter,,gtratwar,"{id=16441708, name=Merck, displayName=null, parentId=16441705, parentName=CI Updates'22}","@merckhealthcare @ectrims @tawakkolkarman why promote islam ideology, merck?",unknown,,,,6000000000,49117120,,495,165,0,http://twitter.com/MerckHealthcare/statuses/1712037892141322651,,0,1,101649,False,"why promote islam ideology, merck?","['Islam', 'ideology', 'Merck']","islam,ideology,merck",islam ideology merck,islam ideology merck,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
106,112,2023-10-12 18:00:43.0,Great to see this topic being addressed in the collab between @UniMelb Neuroepidemiliogy Unit @UKMSRegister @SwanseaUni on diet and #MS at#ECTRIMS2023,twitter,GBR,drrachhunter,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",great to see this topic being addressed in the collab between @unimelb neuroepidemiliogy unit @ukmsregister @swanseauni on diet and #ms at#ectrims2023,female,"#ms, #ectrims2023","Beauty/Health & Fitness, Science, Family & Parenting","{profession=Teacher & Lecturer, jobTitle=Senior Lecturer}, {profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Health practitioner, jobTitle=Clinical Psychologist}",6000000000,775366410,,877,1057,0,,,0,3,3029,False,great to see this topic being addressed in the collab between neuroepidemiliogy unit on diet and ms atec trims,"['neuroepidemiology', 'diet', 'MS', 'atet']","neuroepidemiology,diet,ms,atet",neuroepidemiology diet atet,neuroepidemiology diet atet,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,1.0,False
107,113,2023-10-12 17:45:00.0,"O130 @HCL_research: Immune checkpoint inhibitors & CAR-T cell therapy have dramatically improved #malignancy prognosis. Due to mechanism, both can trigger immune-related AEs. Neurological irAE are relatively rare but potentially serious. #MSMilan2023 #cancer #MultipleSclerosis",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","o130 @hcl_research: immune checkpoint inhibitors & car-t cell therapy have dramatically improved #malignancy prognosis. due to mechanism, both can trigger immune-related aes. neurological irae are relatively rare but potentially serious. #msmilan2023 #cancer #multiplesclerosis",,"#malignancy, #msmilan2023, #cancer, #multiplesclerosis",,,6000000000,1054320667,,896,623,0,,,0,0,4198,False,"o130 : immune checkpoint inhibitors & car-t cell therapy have dramatically improved #malignancy prognosis. due to mechanism, both can trigger immune-related aes. neurological irae are relatively rare but potentially serious. ms milan #cancer multiple sclerosis","['immune checkpoint inhibitors', 'car-t cell therapy', 'malignancy', 'prognosis', 'AEs', 'immune-related adverse events', 'neurological IRAE', 'MS', 'cancer', 'multiple scleros']","immune checkpoint inhibitors,car-t cell therapy,malignancy,prognosis,aes,immune-related adverse events,neurological irae,ms,cancer,multiple scleros",immune checkpoint inhibitors car-t cell therapy malignancy prognosis aes immune-related adverse events neurological irae cancer multiple scleros,immune checkpoint inhibitors car-t cell therapy malignancy prognosis aes immune-related adverse events neurological irae cancer multiple scleros,15,15_womenshealth_multiple_sclerosis_exposome,Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors,"['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['sclerosis', 'neuroimmunology', 'womenshealth', 'autoimmune', 'spondylitis', 'arthritis', 'immune', 'immunology', 'rheumatoid', 'malignancy']","[""Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors"", '', '', '', '', '', '', '', '', '']","['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb', 'womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut', 'multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ']",womenshealth - multiple - sclerosis - exposome - cancer - publichealth - primarycare - prescriptions - sunlight - neurological,1.0,False
108,114,2023-10-12 17:40:09.0,A stolen selfie from today #MultipleSclerosis Journal Editorial Board Meeting at #MSMilan2023 @ECTRIMS https://t.co/TlkY5RHGN1,twitter,GBR,MSJ_Research,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",a stolen selfie from today #multiplesclerosis journal editorial board meeting at #msmilan2023 @ectrims https://t.co/tlky5rhgn1,,"#multiplesclerosis, #msmilan2023",Beauty/Health & Fitness,,6000000000,764125362422972416,,3484,199,0,,,3,12,2604,False,a stolen selfie from today multiple sclerosis journal editorial board meeting at ms milan,"['selfie', 'multiple sclerosis', 'journal', 'editorial', 'board', 'meeting', 'MS', 'Milan']","selfie,multiple sclerosis,journal,editorial,board,meeting,ms,milan",selfie journal editorial board meeting,selfie journal editorial board meeting,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
109,115,2023-10-12 17:26:45.0,@RealTalkMS_jon our @DigiVidBio team had the honor to work with Jon to capture the latest MS research coming out of #ectrims #MSMilan2023 #ACTRIMS to help the MS community https://t.co/no6Qwlmi1F,twitter,USA,jfairdigital,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@realtalkms_jon our @digividbio team had the honor to work with jon to capture the latest ms research coming out of #ectrims #msmilan2023 #actrims to help the ms community https://t.co/no6qwlmi1f,male,"#ectrims, #msmilan2023, #actrims","Food & Drinks, Family & Parenting",,6000000000,66810011,,1022,2474,0,,,2,1,9389,False,our team had the honor to work with jon to capture the latest ms research coming out of ec trims ms milan #actrims to help the ms community,"['Jon', 'EC Trims', 'MS Research', 'MS Milan', 'Actrims', 'MS Community']","jon,ec trims,ms research,ms milan,actrims,ms community",jon ms research actrims ms community,jon ms research actrims ms community,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
110,116,2023-10-12 17:04:55.0,"Long-lasting friendship and many hours together dedicated to clinical care, research and teaching in #multiplesclerosis. Congratulations to  @MarTintore ,  President of @ECTRIMS, for the 2023 meeting in #Milano that is already an absolute success. @cemcat_em @vallhebron @VHIR_ https://t.co/OFDIAnAL4Y",twitter,ESP,XMontalban,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","long-lasting friendship and many hours together dedicated to clinical care, research and teaching in #multiplesclerosis. congratulations to @martintore , president of @ectrims, for the 2023 meeting in #milano that is already an absolute success. @cemcat_em @vallhebron @vhir_ https://t.co/ofdianal4y",male,"#multiplesclerosis, #milano",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,757774178,,5565,1117,2,,,15,153,2627,False,"long-lasting friendship and many hours together dedicated to clinical care, research and teaching in multiple sclerosis. congratulations to , president of , for the 2023 meeting in milano that is already an absolute success.","['friendship', 'clinical care', 'research', 'teaching', 'multiple sclerosis', 'congratulations', 'president', 'meeting', 'milano', 'success']","friendship,clinical care,research,teaching,multiple sclerosis,congratulations,president,meeting,milano,success",friendship clinical care teaching congratulations president meeting milano success,friendship clinical care teaching congratulations president meeting milano success,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
111,117,2023-10-12 16:31:14.0,ViewMind Inc.Â will be exhibiting atÂ #msmilan2023 and presenting posters based on studies supported by Biogen and Hospital Ramos MejÃ­a. (Booth D30)#MS Â #healthcareÂ #MSresearch ECTRIMS Congress ACTRIMS Â® Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS) https://t.co/XafKDY2l41,twitter,USA,ViewMind_,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=16441714, name=Biogen, displayName=null, parentId=16441705, parentName=CI Updates'22}",viewmind inc. will be exhibiting at #msmilan2023 and presenting posters based on studies supported by biogen and hospital ramos mejÃ­a. (booth d30)#ms #healthcare #msresearch ectrims congress actrims Â® americas committee for treatment & research in multiple sclerosis (actrims) https://t.co/xafkdy2l41,unknown,"#msmilan2023, #ms, #healthcare, #msresearch",Beauty/Health & Fitness,,6000000000,986583802154799104,,215,776,0,,,0,0,393,False,viewmind inc. will be exhibiting at ms milan and presenting posters based on studies supported by biogen and hospital ramos meja. (booth d30)ms #healthcare msresearch ectrims congress actrims americas committee for treatment & research in multiple sclerosis (actrims),"['ViewMind', 'Inc.', 'MS Milan', 'Biogen', 'Hospital Ramos Meja', 'booth D30', 'Healthcare', 'MS Research', 'ECTRIMS Congress', 'ACTRIMS Americas Committee for Treatment & Research in']","viewmind,inc.,ms milan,biogen,hospital ramos meja,booth d30,healthcare,ms research,ectrims congress,actrims americas committee for treatment & research in",viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in,viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,True
112,118,2023-10-12 16:22:02.0,"Exciting insights from @drbarrysinger into biosimilar natalizumab! Thanks a lot! ðŸ§¬ðŸ’¡

#MS #MultipleSclerosis #natalizumab #MSMilan2023 #ECTRIMS #sandoz https://t.co/3flJ7WiGJ7",twitter,,MSguncel,"{id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=16441706, name=Novartis, displayName=null, parentId=16441705, parentName=CI Updates'22}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",exciting insights from @drbarrysinger into biosimilar natalizumab! thanks a lot! ðŸ§¬ðŸ’¡ #ms #multiplesclerosis #natalizumab #msmilan2023 #ectrims #sandoz https://t.co/3flj7wigj7,female,"#ms, #multiplesclerosis, #natalizumab, #msmilan2023, #ectrims, #sandoz",,,6000000000,1338606356346048512,,1448,61,2,,,1,14,821,False,exciting insights from into biosimilar natalizumab! thanks a lot! ms multiple sclerosis #natalizumab ms milan ec trims #sandoz,"['Natalizumab', 'MS', 'multiple sclerosis', 'Milan', 'EC', 'Sandoz']","natalizumab,ms,multiple sclerosis,milan,ec,sandoz",natalizumab sandoz,natalizumab sandoz,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,0.5626960125930666,False
113,119,2023-10-12 15:37:44.0,"Slightly biased but this might possibly be the most iconic photo of #MSMilan2023 ðŸ©·ðŸ’•ðŸ’— 

#NMOSD #MOGAD #ECTRIMS #NeuroTwitter #girlpower https://t.co/AWdbnbP1Et",twitter,ITA,SumairaFlower,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",slightly biased but this might possibly be the most iconic photo of #msmilan2023 ðŸ©·ðŸ’•ðŸ’— #nmosd #mogad #ectrims #neurotwitter #girlpower https://t.co/awdbnbp1et,unknown,"#msmilan2023, #nmosd, #mogad, #ectrims, #neurotwitter, #girlpower",,"{profession=Executive, jobTitle=Founder}",6000000000,118800058,,1194,246,4,,,7,49,2985,False,slightly biased but this might possibly be the most iconic photo of ms milan #nmosd #mogad ec trims #neurotwitter #girlpower,"['ms Milan', 'photo', 'iconic', 'NMOSD', 'Mogat', 'NeuroTwitter', 'girlpower']","ms milan,photo,iconic,nmosd,mogat,neurotwitter,girlpower",photo iconic mogat neurotwitter girlpower,photo iconic mogat neurotwitter girlpower,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.7400921016174018,False
114,120,2023-10-12 15:31:22.0,"Treatment with immediate release tablets of a non-covalent Brutonâ€™s #tyrosine kinase inhibitor for relapsing forms of #MS met pharmacokinetic and pharmacodynamic goals, data from @ECTRIMS show #ECTRIMS2023. https://t.co/LuBWlJhS3E",twitter,,healioneurology,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","treatment with immediate release tablets of a non-covalent brutonâ€™s #tyrosine kinase inhibitor for relapsing forms of #ms met pharmacokinetic and pharmacodynamic goals, data from @ectrims show #ectrims2023. https://t.co/lubwljhs3e",unknown,"#tyrosine, #ms, #ectrims2023",,,6000000000,1288887610371452928,,56,211,0,,,0,0,1601,False,"treatment with immediate release tablets of a non-covalent brutons #tyrosine kinase inhibitor for relapsing forms of ms met pharmacokinetic and pharmacodynamic goals, data from show ec trims.","['treatment', 'immediate release', 'tablets', 'non-covalent', 'brutons', 'tyrosine kinase inhibitor', 'relapsing forms', 'MS', 'met', 'pharmacokinetic', 'pharmacodynamic', '']","treatment,immediate release,tablets,non-covalent,brutons,tyrosine kinase inhibitor,relapsing forms,ms,met,pharmacokinetic,pharmacodynamic,",immediate release tablets non-covalent brutons tyrosine kinase inhibitor relapsing forms met pharmacokinetic pharmacodynamic ,immediate release tablets non-covalent brutons tyrosine kinase inhibitor relapsing forms met pharmacokinetic pharmacodynamic ,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
115,121,2023-10-12 15:05:00.0,"Findings showed that the use of anti-CD20 therapies after natalizumab (Tysabri; @biogenms) were effective in treating MS, with most disease progression related being PIRA. #MSMilan2023 

https://t.co/hD8zrpBk3b",twitter,USA,neurology_live,"{id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","findings showed that the use of anti-cd20 therapies after natalizumab (tysabri; @biogenms) were effective in treating ms, with most disease progression related being pira. #msmilan2023 https://t.co/hd8zrpbk3b",,#msmilan2023,Beauty/Health & Fitness,,6000000000,1016356467073585152,,8626,517,0,,,0,0,33750,False,"findings showed that the use of anti-cd20 therapies after natalizumab (tysabri; ) were effective in treating ms, with most disease progression related being pira. ms milan","['Anti-CD20', 'therapies', 'Natalizumab', 'MS', 'disease progression', 'PIRA', 'MS Milan']","anti-cd20,therapies,natalizumab,ms,disease progression,pira,ms milan",anti-cd20 therapies natalizumab disease progression pira,anti-cd20 therapies natalizumab disease progression pira,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,0.7757028817772749,False
116,122,2023-10-12 15:04:31.0,#ECTRIMS2023 $TGTX presents data from the Ph3 ULTIMATE I & II trials of #ublituximab in #MS this week at #MSMILAN2023. Check out our 3 presentations at https://t.co/SvwvfB54pZ - Visit our Booth - C15. Details: https://t.co/q0aDGKS7fY #FearlessForPatients https://t.co/U9prJ7JgDu,twitter,USA,TGTherapeutics,"{id=20740625, name=Briumvi / ublituximab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20767266, name=Briumvi, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",#ectrims2023 $tgtx presents data from the ph3 ultimate i & ii trials of #ublituximab in #ms this week at #msmilan2023. check out our 3 presentations at https://t.co/svwvfb54pz - visit our booth - c15. details: https://t.co/q0adgks7fy #fearlessforpatients https://t.co/u9prj7jgdu,,"#ectrims2023, #ublituximab, #ms, #msmilan2023, #fearlessforpatients","Beauty/Health & Fitness, Business",,6000000000,439362597,,2813,60,0,,,0,7,581,False,ec trims $tgtx presents data from the ph3 ultimate i & ii trials of #ublituximab in ms this week at ms milan. check out our 3 presentations at - visit our booth - c15. details: #fearlessforpatients,"['ec', 'tgtx', 'ph3', 'ultimate', 'i & ii', 'trials', 'ubliximab', 'ms', 'fearlessforpatients']","ec,tgtx,ph3,ultimate,i & ii,trials,ubliximab,ms,fearlessforpatients",tgtx ph3 ultimate i & ii trials ubliximab fearlessforpatients,tgtx ph3 ultimate i & ii trials ubliximab fearlessforpatients,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,0.8492618515372913,False
117,123,2023-10-12 14:33:53.0,"Ready (and happy) to Poster Session 2 where we will present our data about the relationship between MDSCs and relapse recovery (P642; @leticalahorra et al) and disease severity in PPMS (@MCrisOrtega14 et al) at #ECTRIMS2023.
@HNParaplejicos
@CIBER_ISCIII @ciberned @SanidadCLM https://t.co/uQYnIPkki0",twitter,ESP,DrDiegoClemente,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",ready (and happy) to poster session 2 where we will present our data about the relationship between mdscs and relapse recovery (p642; @leticalahorra et al) and disease severity in ppms (@mcrisortega14 et al) at #ectrims2023. @hnparaplejicos @ciber_isciii @ciberned @sanidadclm https://t.co/uqynipkki0,male,#ectrims2023,Beauty/Health & Fitness,,6000000000,761582912223514624,,1941,1217,0,,,3,16,8744,False,ready (and happy) to poster session 2 where we will present our data about the relationship between mdscs and relapse recovery (p642; et al) and disease severity in ppms ( et al) at ec trims.,"['MDSCs', 'relapse recovery', 'disease severity', 'PPMS', 'EC Trims']","mdscs,relapse recovery,disease severity,ppms,ec trims",mdscs relapse recovery disease severity ppms,mdscs relapse recovery disease severity ppms,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,0.6538778202003472,False
118,124,2023-10-12 14:09:30.0,"Imaging the optic nerve and the spinal cord to understand MS pathophysiology and monitor disease evolution, #MSMilan2023. Great talks mostly focused on spinal cord lesions, volume and the spinal cord reserve. With @alexrovirarayos, @Neus_Mongay. @J_SastreGarriga #ECTRIMS #ACTRIMS https://t.co/sEw8GhLtfP",twitter,ESP,GeoArrambide,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}","imaging the optic nerve and the spinal cord to understand ms pathophysiology and monitor disease evolution, #msmilan2023. great talks mostly focused on spinal cord lesions, volume and the spinal cord reserve. with @alexrovirarayos, @neus_mongay. @j_sastregarriga #ectrims #actrims https://t.co/sew8ghltfp",female,"#msmilan2023, #ectrims, #actrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1448356440108830725,,537,175,0,,,5,27,734,False,"imaging the optic nerve and the spinal cord to understand ms pathophysiology and monitor disease evolution, ms milan. great talks mostly focused on spinal cord lesions, volume and the spinal cord reserve. with , . ec trims #actrims","['imaging', 'optic nerve', 'spinal cord', 'ms pathophysiology', 'disease evolution', 'MS Milan', 'talks', 'spinal cord lesions', 'volume', 'spinal cord reserve', 'EC', 'ACTRIMS']","imaging,optic nerve,spinal cord,ms pathophysiology,disease evolution,ms milan,talks,spinal cord lesions,volume,spinal cord reserve,ec,actrims",imaging optic nerve spinal cord ms pathophysiology disease evolution talks spinal cord lesions volume spinal cord reserve actrims,imaging optic nerve spinal cord ms pathophysiology disease evolution talks spinal cord lesions volume spinal cord reserve actrims,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,1.0,False
119,125,2023-10-12 14:06:45.0,"Greetings from the second day of #MSMilan2023!

If you haven't had the chance yet, make sure to visit our booth (E23) to get to know our team and learn more about the RIMS Initiatives.

We're looking forward to meeting you!

#RIMS #MS #MSMilan2023 #Booth #Networking https://t.co/1mc732yjfP",twitter,BEL,eurims,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","greetings from the second day of #msmilan2023! if you haven't had the chance yet, make sure to visit our booth (e23) to get to know our team and learn more about the rims initiatives. we're looking forward to meeting you! #rims #ms #msmilan2023 #booth #networking https://t.co/1mc732yjfp",,"#msmilan2023, #rims, #ms, #msmilan2023, #booth, #networking",,,6000000000,421874295,,843,88,1,,,1,15,457,False,"greetings from the second day of ms milan! if you haven't had the chance yet, make sure to visit our booth (e23) to get to know our team and learn more about the rims initiatives. we're looking forward to meeting you! #rims ms ms milan #booth #networking","['Greetings', 'MS Milan', 'rims initiatives', 'booth', 'networking']","greetings,ms milan,rims initiatives,booth,networking",greetings rims initiatives booth networking,greetings rims initiatives booth networking,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
120,126,2023-10-12 14:05:00.0,"P003: #Neurogenetic diseases may be #misdiagnosed as MS or overlap with #MS. Careful interpretation of clinical, CSF & MRI features can facilitate timely & accurate diagnosis & prevent unnecessary exposure to MS therapies. #MSMilan2023",twitter,,IJMSCtweets,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}","p003: #neurogenetic diseases may be #misdiagnosed as ms or overlap with #ms. careful interpretation of clinical, csf & mri features can facilitate timely & accurate diagnosis & prevent unnecessary exposure to ms therapies. #msmilan2023",,"#neurogenetic, #misdiagnosed, #ms, #msmilan2023",,,6000000000,1054320667,,896,623,0,,,1,2,4180,False,"p003: #neurogenetic diseases may be #misdiagnosed as ms or overlap with ms. careful interpretation of clinical, csf & mri features can facilitate timely & accurate diagnosis & prevent unnecessary exposure to ms therapies. ms milan","['neurogenetic', 'misdiagnosed', 'ms', 'overlap', 'careful', 'interpretation', 'clinical', 'CSF', 'MRI', 'features', 'timely', 'accurate', 'diagnosis', 'prevent', 'unnecessary', 'exposure', 'MS', 'therapies', '']","neurogenetic,misdiagnosed,ms,overlap,careful,interpretation,clinical,csf,mri,features,timely,accurate,diagnosis,prevent,unnecessary,exposure,ms,therapies,",neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ,neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.8235722471782502,True
121,127,2023-10-12 14:04:25.0,"Most MS patients treated with a new under-the-skin formulation of Ocrevus had no relapses or new MRI activity over six months, data show. https://t.co/ghHLF6n5Gz #ectrims2023 #news https://t.co/dHZpJ7Uc3r",twitter,USA,MSNewsToday,"{id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","most ms patients treated with a new under-the-skin formulation of ocrevus had no relapses or new mri activity over six months, data show. https://t.co/ghhlf6n5gz #ectrims2023 #news https://t.co/dhzpj7uc3r",female,"#ectrims2023, #news",,,6000000000,2473350271,,10056,1542,0,,,4,19,28175,False,"most ms patients treated with a new under-the-skin formulation of ocrevus had no relapses or new mri activity over six months, data show. ec trims #news","['MS', 'Ocrevus', 'treatment', 'relapses', 'MRI', 'data', 'news']","ms,ocrevus,treatment,relapses,mri,data,news",ocrevus relapses mri news,ocrevus relapses mri news,5,5_ocrevus_ocrelizumab_trial_chimes,Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.,"['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['ocrevus', 'ocrelizumab', 'ocarina', 'treatment', 'patients', 'msmilan', 'neurology', 'sclerosis', 'trial', 'neurologist']","['Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.', '', '', '', '', '', '', '', '', '']","['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan', 'ocrevus phase 3 trial', 'interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients']",ocrevus - ocrelizumab - trial - chimes - phase - patients - relapsing - decisions - noninferiority - brumvi,1.0,False
122,128,2023-10-12 13:59:35.0,"My favorite slide from Dr. Ilana Katz Sand's excellent presentation on diet and MS at #MSMilan2023 showing chemical compositions of foods. Just as we may pay attention to medications we take, the same care can be taken with what we eat ðŸ¥‘ðŸ‡ðŸ¥¬ 

@ECTRIMS #ECTRIMS https://t.co/xv0XBqzuhR",twitter,USA,SarahLevyPhD,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","my favorite slide from dr. ilana katz sand's excellent presentation on diet and ms at #msmilan2023 showing chemical compositions of foods. just as we may pay attention to medications we take, the same care can be taken with what we eat ðŸ¥‘ðŸ‡ðŸ¥¬ @ectrims #ectrims https://t.co/xv0xbqzuhr",female,"#msmilan2023, #ectrims",Beauty/Health & Fitness,,6000000000,1266888615394770944,,110,169,0,,,1,4,39,False,"my favorite slide from dr. ilana katz sand's excellent presentation on diet and ms at ms milan showing chemical compositions of foods. just as we may pay attention to medications we take, the same care can be taken with what we eat ec trims","['Ilana Katz Sand', 'diet', 'MS Milan', 'food', 'chemical compositions', 'medications', 'care', 'trim']","ilana katz sand,diet,ms milan,food,chemical compositions,medications,care,trim",ilana katz sand diet food chemical compositions medications care trim,ilana katz sand diet food chemical compositions medications care trim,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,0.827219703200709,False
123,129,2023-10-12 13:55:56.0,Very thrilled to have had the opportunity to present my PhD work in the @PratLab about the use of single-cell immune profiling for prediction of MS activity today at @ECTRIMS #MSMilan2023 ðŸ§  https://t.co/g9m6Aggfpf,twitter,,KarineThai_,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",very thrilled to have had the opportunity to present my phd work in the @pratlab about the use of single-cell immune profiling for prediction of ms activity today at @ectrims #msmilan2023 ðŸ§  https://t.co/g9m6aggfpf,female,#msmilan2023,,,6000000000,1338821204195602436,,43,87,1,,,3,21,13,False,very thrilled to have had the opportunity to present my phd work in the about the use of single-cell immune profiling for prediction of ms activity today at ms milan,"['PhD', 'presentation', 'immune profiling', 'MS', 'Milan']","phd,presentation,immune profiling,ms,milan",phd presentation immune profiling,phd presentation immune profiling,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
124,130,2023-10-12 13:50:47.0,"Salter: Interesting look at comorbidities in 17 clinical trials with ~18,000 #MS patients. The trial with the most comorbidities was FREEDOMS II, predominantly in the USA (101 of 117 centers). We need to work on overall health of our MS patients, especially in ðŸ‡ºðŸ‡¸! #MSMilan2023 https://t.co/TL4jNd5OHg",twitter,USA,drbarrysinger,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","salter: interesting look at comorbidities in 17 clinical trials with ~18,000 #ms patients. the trial with the most comorbidities was freedoms ii, predominantly in the usa (101 of 117 centers). we need to work on overall health of our ms patients, especially in ðŸ‡ºðŸ‡¸! #msmilan2023 https://t.co/tl4jnd5ohg",male,"#ms, #msmilan2023",Science,,6000000000,1430793013,,7222,393,0,,,1,8,3164,False,"salter: interesting look at comorbidities in 17 clinical trials with ~18,000 ms patients. the trial with the most comorbidities was freedoms ii, predominantly in the usa (101 of 117 centers). we need to work on overall health of our ms patients, especially in ! ms milan","['Salter', 'comorbidities', 'clinical trials', 'multiple sclerosis', 'MS', 'Freedom II', 'USA', 'health', 'overall health', 'MS Milan']","salter,comorbidities,clinical trials,multiple sclerosis,ms,freedom ii,usa,health,overall health,ms milan",salter comorbidities clinical trials freedom ii usa health overall health,salter comorbidities clinical trials freedom ii usa health overall health,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
125,131,2023-10-12 13:40:39.0,Almost half of participants in MS clinical trials have a comorbidity and this may be underrepresented compared to general MS population @ECTRIMS #MSMilan2023 https://t.co/wIgIKRxFoZ,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",almost half of participants in ms clinical trials have a comorbidity and this may be underrepresented compared to general ms population @ectrims #msmilan2023 https://t.co/wigikrxfoz,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,0,1,6582,False,almost half of participants in ms clinical trials have a comorbidity and this may be underrepresented compared to general ms population ms milan,"['Multiple Sclerosis (MS)', 'Clinical Trials', 'Comorbidities', 'Participants', 'Underrepresentation', 'General Population', 'MS Milan']","multiple sclerosis (ms),clinical trials,comorbidities,participants,underrepresentation,general population,ms milan",multiple sclerosis (ms) clinical trials comorbidities participants underrepresentation general population,multiple sclerosis (ms) clinical trials comorbidities participants underrepresentation general population,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
126,132,2023-10-12 13:37:03.0,ECTRIMS 2023: RRMS nerve damage reduced with vidofludimus calcium | #MultipleSclerosis News Today https://t.co/aEGT48e0Oe,twitter,GBR,AbiBuddComms,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: rrms nerve damage reduced with vidofludimus calcium | #multiplesclerosis news today https://t.co/aegt48e0oe,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4066,2558,0,,,0,0,25528,False,ectrims 2023: rrms nerve damage reduced with vidofludimus calcium | multiple sclerosis news today,"['ectrims', 'vidofludimus', 'calcium', 'rrms', 'nerve damage', 'multiple sclerosis']","ectrims,vidofludimus,calcium,rrms,nerve damage,multiple sclerosis",vidofludimus calcium rrms nerve damage,vidofludimus calcium rrms nerve damage,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.5823872023957681,False
127,133,2023-10-12 13:34:15.0,"Encouraging news from @ECTRIMS: ICI inhibitors appear safe in MS. Among 18 patients, only 3 relapsedâ€”they had stoped DMT (2 with Natalizumab), and were younger. 
If an MS patient faces cancer, a comprehensive approach to both conditions is crucial. #MSMilan2023 #MultipleSclerosis https://t.co/o5O0sTkaoA",twitter,ESP,andreuvilaseca7,"{id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","encouraging news from @ectrims: ici inhibitors appear safe in ms. among 18 patients, only 3 relapsedâ€”they had stoped dmt (2 with natalizumab), and were younger. if an ms patient faces cancer, a comprehensive approach to both conditions is crucial. #msmilan2023 #multiplesclerosis https://t.co/o5o0stkaoa",male,"#msmilan2023, #multiplesclerosis",,,6000000000,226254369,,515,794,0,,,2,8,2199,False,"encouraging news from : ici inhibitors appear safe in ms. among 18 patients, only 3 relapsedthey had stoped dmt (2 with natalizumab), and were younger. if an ms patient faces cancer, a comprehensive approach to both conditions is crucial. ms milan multiple sclerosis","['ms', 'multiple sclerosis', 'cancer', 'safety', 'relapses', 'dmt', 'natalizumab', 'comprehensive approach']","ms,multiple sclerosis,cancer,safety,relapses,dmt,natalizumab,comprehensive approach",cancer safety relapses dmt natalizumab comprehensive approach,cancer safety relapses dmt natalizumab comprehensive approach,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
128,134,2023-10-12 13:27:32.0,"Learning a lot in ""#MultipleSclerosis and comorbidities"".
#MSMilan2023
@ECTRIMS
@ACTRIMS https://t.co/igzFGovIkA",twitter,ESP,Laz1988L,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","learning a lot in ""#multiplesclerosis and comorbidities"". #msmilan2023 @ectrims @actrims https://t.co/igzfgovika",unknown,"#multiplesclerosis, #msmilan2023",,,6000000000,1363063831,,1584,4995,0,,,0,1,10274,False,"learning a lot in ""multiple sclerosis and comorbidities"". ms milan","['learning', 'multiple sclerosis', 'comorbidities', 'MS Milan']","learning,multiple sclerosis,comorbidities,ms milan",learning comorbidities,learning comorbidities,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,0.8227934335538462,False
129,135,2023-10-12 13:21:00.0,"P064: 78.8% discussed pregnancy in advance w/ at least 1 member of their MS team. 68.6% pregs were exposed to DMT or had recd previous induction therps; 41.6% still on DMT at 2nd trimester start. Most common DMT during preg: natalizumab, glatiramer acetate. #MSMilan2023",twitter,,IJMSCtweets,"{id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","p064: 78.8% discussed pregnancy in advance w/ at least 1 member of their ms team. 68.6% pregs were exposed to dmt or had recd previous induction therps; 41.6% still on dmt at 2nd trimester start. most common dmt during preg: natalizumab, glatiramer acetate. #msmilan2023",,#msmilan2023,,,6000000000,1054320667,,895,622,0,,,1,3,4176,False,"p064: 78.8% discussed pregnancy in advance w/ at least 1 member of their ms team. 68.6% pregs were exposed to dmt or had recd previous induction therps; 41.6% still on dmt at 2nd trimester start. most common dmt during preg: natalizumab, glatiramer acetate. ms milan","['pregnancy', 'ms team', 'dmt', 'induction therapy', 'pregs', 'natalizumab', 'glatiramer acetate', 'second trimester', 'ms Milan']","pregnancy,ms team,dmt,induction therapy,pregs,natalizumab,glatiramer acetate,second trimester,ms milan",pregnancy ms team dmt induction therapy pregs natalizumab glatiramer acetate second trimester,pregnancy ms team dmt induction therapy pregs natalizumab glatiramer acetate second trimester,3,3_pregnancy_breastfeeding_women_induction,"Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['breastfeeding', 'pregnancy', 'childbearing', 'trimester', 'nurses', 'pregs', 'medication', 'natalizumab', 'dmt', 'women']","['Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women', '', '', '', '', '', '', '', '', '']","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['women childbearing age pregnancy plan solution', 'pregnancy ms team dmt induction therapy pregs natalizumab glatiramer acetate second trimester', 'pregnancy breastfeeding women nurses experience understanding concerns']",pregnancy - breastfeeding - women - induction - trisms - trimester - solution - second - recommendations - pregs,1.0,True
130,136,2023-10-12 13:16:06.0,Dr. Ruth Ann Marrie shares comorbidity is common in ppl with MS and attention is needed for treatment and prevention @ECTRIMS #MSMilan2023 https://t.co/KPA7mckQaJ,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. ruth ann marrie shares comorbidity is common in ppl with ms and attention is needed for treatment and prevention @ectrims #msmilan2023 https://t.co/kpa7mckqaj,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,4,6,6581,False,dr. ruth ann marrie shares comorbidity is common in ppl with ms and attention is needed for treatment and prevention ms milan,"['Dr.', 'Ruth Ann Marrie', 'comorbidity', 'MS', 'attention', 'treatment', 'prevention', 'Milan']","dr.,ruth ann marrie,comorbidity,ms,attention,treatment,prevention,milan",dr. ruth ann marrie comorbidity attention prevention,dr. ruth ann marrie comorbidity attention prevention,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,1.0,True
131,137,2023-10-12 13:15:22.0,All influential MS conference in the world such include a session about #global perspectives  and pressing issues in #MS. Eradicating global disparities are critical for a world without MS @mssociety @MarTintore @Pluchinolab @Boaz_Spermon @XMontalban @AANmember  @ACTRIMS https://t.co/EkefKL8PMv,twitter,USA,DrJim4MS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",all influential ms conference in the world such include a session about #global perspectives and pressing issues in #ms. eradicating global disparities are critical for a world without ms @mssociety @martintore @pluchinolab @boaz_spermon @xmontalban @aanmember @actrims https://t.co/ekefkl8pmv,male,"#global, #ms",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1771,621,1,http://twitter.com/DrJim4MS/statuses/1712456927005815056,,1,7,7983,False,all influential ms conference in the world such include a session about #global perspectives and pressing issues in ms. eradicating global disparities are critical for a world without ms,"['ms', 'conference', 'global', 'disparities', 'eradicate', 'world']","ms,conference,global,disparities,eradicate,world",conference global disparities eradicate world,conference global disparities eradicate world,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
132,138,2023-10-12 13:15:21.0,"Suggestion for @ECTRIMS #Global #disparities in MS missing at #Milan2023:  According to the MS atlas, 1.1 million, 38% of MS pts live in the developing world, so ""pressing issues"" of almost half of the MS pts are not  represented in the most influential MS conference in the world",twitter,USA,DrJim4MS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","suggestion for @ectrims #global #disparities in ms missing at #milan2023: according to the ms atlas, 1.1 million, 38% of ms pts live in the developing world, so ""pressing issues"" of almost half of the ms pts are not represented in the most influential ms conference in the world",male,"#global, #disparities, #milan2023",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1771,621,2,,,2,9,7981,False,"suggestion for #global #disparities in ms missing at milan2023: according to the ms atlas, 1.1 million, 38% of ms pts live in the developing world, so ""pressing issues"" of almost half of the ms pts are not represented in the most influential ms conference in the world","['Global', 'disparities', 'MS', 'Milan2023', 'atlas', 'patients', 'pressing issues', 'conference', 'representation.']","global,disparities,ms,milan2023,atlas,patients,pressing issues,conference,representation.",global disparities milan2023 atlas pressing issues conference representation.,global disparities milan2023 atlas pressing issues conference representation.,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
133,139,2023-10-12 13:05:40.0,De Ruth Ann Marrie discusses the latest on comorbidities in MS @ECTRIMS #MSMilan2023 https://t.co/m1ZynldMQa,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",de ruth ann marrie discusses the latest on comorbidities in ms @ectrims #msmilan2023 https://t.co/m1zynldmqa,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,0,0,6580,False,de ruth ann marrie discusses the latest on comorbidities in ms ms milan,"['ruth', 'ann', 'marie', 'discusses', 'latest', 'comorbidities', 'ms', 'milan']","ruth,ann,marie,discusses,latest,comorbidities,ms,milan",ruth ann marie discusses latest comorbidities,ruth ann marie discusses latest comorbidities,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,1.0,True
134,140,2023-10-12 13:00:17.0,"Weâ€™re at MSMilan2023 with global experts who are committed to advancing care for neuromyelitis optica spectrum disorder (NMOSD), a rare and debilitating autoimmune disease that affects the central nervous system. Learn more about the science behind NMOSD below. https://t.co/vhspaq8RXe",twitter,USA,AlexionPharma,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","weâ€™re at msmilan2023 with global experts who are committed to advancing care for neuromyelitis optica spectrum disorder (nmosd), a rare and debilitating autoimmune disease that affects the central nervous system. learn more about the science behind nmosd below. https://t.co/vhspaq8rxe",unknown,,Beauty/Health & Fitness,,6000000000,246664765,,12811,332,1,,,0,0,1497,False,"were at msmilan2023 with global experts who are committed to advancing care for neuromyelitis optica spectrum disorder (nmosd), a rare and debilitating autoimmune disease that affects the central nervous system. learn more about the science behind nmosd below.","['msmilan2023', 'neuromyelitis optica spectrum disorder', 'autoimmune disease', 'central nervous system', 'science']","msmilan2023,neuromyelitis optica spectrum disorder,autoimmune disease,central nervous system,science",msmilan2023 neuromyelitis optica spectrum disorder autoimmune disease central nervous system science,msmilan2023 neuromyelitis optica spectrum disorder autoimmune disease central nervous system science,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.8665542320121206,False
135,141,2023-10-12 12:55:15.0,Future Progressive MS trials #ectrims2023 https://t.co/AWGx14j4E5,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",future progressive ms trials #ectrims2023 https://t.co/awgx14j4e5,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,471,2044,0,,,0,0,1828,False,future progressive ms trials ec trims,"['future', 'progressive', 'ms', 'trials', 'ec', 'trims']","future,progressive,ms,trials,ec,trims",future progressive trials,future progressive trials,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,1.0,False
136,142,2023-10-12 12:35:04.0,"Looking for a way to educate and empower your #MS patients?  ðŸ˜Ž Global experts & patient advocates enlighten listeners with the latest advances and tips on living well with MS ðŸŽ§
Check out MS Living Well #podcast! #MSMilan2023 https://t.co/V1KclLKTTp 5 years of episodes!",twitter,USA,drbarrysinger,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",looking for a way to educate and empower your #ms patients? ðŸ˜Ž global experts & patient advocates enlighten listeners with the latest advances and tips on living well with ms ðŸŽ§ check out ms living well #podcast! #msmilan2023 https://t.co/v1kcllkttp 5 years of episodes!,male,"#ms, #podcast, #msmilan2023",Science,,6000000000,1430793013,,7220,393,0,,,0,6,3162,False,looking for a way to educate and empower your ms patients? global experts & patient advocates enlighten listeners with the latest advances and tips on living well with ms check out ms living well #podcast! ms milan 5 years of episodes!,"['educate', 'empower', 'MS', 'patients', 'global experts', 'patient advocates', 'latest advances', 'living well', 'MS Living Well', 'podcast', 'MS Milan', '5 years', 'episodes']","educate,empower,ms,patients,global experts,patient advocates,latest advances,living well,ms living well,podcast,ms milan,5 years,episodes",educate empower global experts patient advocates latest advances living well ms living well podcast 5 years episodes,educate empower global experts patient advocates latest advances living well ms living well podcast 5 years episodes,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
137,143,2023-10-12 12:27:11.0,"What are your hopes for the future of #MS? Add your thread to the screen at our #ECTRIMS2023 booth. 
#AsOneForPatients #Neurology @ECTRIMS https://t.co/3Tz0DZO5dP",twitter,DEU,MerckHealthcare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",what are your hopes for the future of #ms? add your thread to the screen at our #ectrims2023 booth. #asoneforpatients #neurology @ectrims https://t.co/3tz0dzo5dp,unknown,"#ms, #ectrims2023, #asoneforpatients, #neurology",,,6000000000,857893749959086080,,7571,623,0,,,2,3,4083,False,what are your hopes for the future of ms? add your thread to the screen at our ec trims booth. #asoneforpatients #neurology,"['Hopes', 'future', 'MS', 'hopes for the future', 'Ms', 'neurology', 'EC trims booth', 'AS ONE for patients']","hopes,future,ms,hopes for the future,ms,neurology,ec trims booth,as one for patients",hopes future hopes for the future neurology ec trims booth as one for patients,hopes future hopes for the future neurology ec trims booth as one for patients,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.8056253663470111,True
138,144,2023-10-12 12:04:56.0,"ðŸŒ“#MSMilan2023 is half-way through. 9,000 researchers, clinicians, experts from more than 108 countries are here. 
ðŸ—£ï¸What are they talking about, what we are the learnings so far?
ðŸ”Watch our @PatriciaMghms highlighting  main themesðŸ‘‡ 
@ECTRIMS @ACTRIMS #MultipleSclerosis https://t.co/R9uHD9tCBz",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","ðŸŒ“#msmilan2023 is half-way through. 9,000 researchers, clinicians, experts from more than 108 countries are here. ðŸ—£ï¸what are they talking about, what we are the learnings so far? ðŸ”watch our @patriciamghms highlighting main themesðŸ‘‡ @ectrims @actrims #multiplesclerosis https://t.co/r9uhd9tcbz",female,"#msmilan2023, #multiplesclerosis",,,6000000000,600110872,,4870,893,1,,,4,12,5938,False,"ms milan is half-way through. 9,000 researchers, clinicians, experts from more than 108 countries are here. what are they talking about, what we are the learnings so far? watch our highlighting main themes multiple sclerosis","['ms', 'Milan', 'researchers', 'clinicians', 'experts', 'countries', 'talking', 'learnings', 'themes', 'multiple sclerosis']","ms,milan,researchers,clinicians,experts,countries,talking,learnings,themes,multiple sclerosis",researchers clinicians experts countries talking learnings themes,researchers clinicians experts countries talking learnings themes,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.8340803156897852,False
139,145,2023-10-12 11:57:01.0,"Another important abstract using @PregnancyMs @UKMSRegister data. Looking at medication exposure in MS pregnancies.

@ECTRIMS #ECTRIMS2023 #MSMilan2023 https://t.co/VSItUbWAVq",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",another important abstract using @pregnancyms @ukmsregister data. looking at medication exposure in ms pregnancies. @ectrims #ectrims2023 #msmilan2023 https://t.co/vsitubwavq,,"#ectrims2023, #msmilan2023",,,6000000000,325527212,,2295,1830,0,,,6,14,1833,False,another important abstract using data. looking at medication exposure in ms pregnancies. ec trims ms milan,"['Medication', 'exposure', 'MS', 'pregnancy', 'ECTRIMS', 'Milan']","medication,exposure,ms,pregnancy,ectrims,milan",medication exposure pregnancy,medication exposure pregnancy,3,3_pregnancy_breastfeeding_women_induction,"Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['breastfeeding', 'pregnancy', 'childbearing', 'trimester', 'nurses', 'pregs', 'medication', 'natalizumab', 'dmt', 'women']","['Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women', '', '', '', '', '', '', '', '', '']","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['women childbearing age pregnancy plan solution', 'pregnancy ms team dmt induction therapy pregs natalizumab glatiramer acetate second trimester', 'pregnancy breastfeeding women nurses experience understanding concerns']",pregnancy - breastfeeding - women - induction - trisms - trimester - solution - second - recommendations - pregs,1.0,False
140,146,2023-10-12 11:56:43.0,Thanks #ECTRIMS for giving  @VinzFleischer the opportunity to share this exciting work with the #MSMilan2023 community! #msresearch @MAGNIMS https://t.co/BzgIrdrjK9,twitter,DEU,NeurologyMainz,,thanks #ectrims for giving @vinzfleischer the opportunity to share this exciting work with the #msmilan2023 community! #msresearch @magnims https://t.co/bzgirdrjk9,,"#ectrims, #msmilan2023, #msresearch",,,6000000000,1369995180108087298,,131,138,0,,,3,8,135,False,thanks ec trims for giving the opportunity to share this exciting work with the ms milan community! msresearch,"['MS', 'research', 'opportunity', 'sharing', 'community', 'Milan']","ms,research,opportunity,sharing,community,milan",opportunity sharing,opportunity sharing,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
141,147,2023-10-12 10:54:18.0,@MarkusMatilain1 Markus Matilainen from #airasgroup at #ECTRIMS : #microglia activation in #MS brain increases with longer disease duration. #MSMilan2023 Well done Markus ðŸ‘ðŸ»#PET #SmolderingMS https://t.co/mYaWnwE3fG,twitter,,LauraAiras1,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@markusmatilain1 markus matilainen from #airasgroup at #ectrims : #microglia activation in #ms brain increases with longer disease duration. #msmilan2023 well done markus ðŸ‘ðŸ»#pet #smolderingms https://t.co/myawnwe3fg,female,"#airasgroup, #ectrims, #microglia, #ms, #msmilan2023, #pet, #smolderingms",,,6000000000,2539611216,,359,108,0,,,0,0,202,False,markus matilainen from #airasgroup at ec trims : #microglia activation in ms brain increases with longer disease duration. ms milan well done markus #pet #smolderingms,"['Markus Matilainen', 'AirasGroup', 'EC', 'microglia', 'MS', 'brain', 'disease', 'duration', 'Milan', 'PET', 'smolderingMS']","markus matilainen,airasgroup,ec,microglia,ms,brain,disease,duration,milan,pet,smolderingms",markus matilainen airasgroup microglia brain disease duration pet smolderingms,markus matilainen airasgroup microglia brain disease duration pet smolderingms,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.6353632671844214,False
142,148,2023-10-12 10:50:09.0,Very happy to listen to Dr Calvi @EmImagin presenting our work â€œEvolution of diffusivity measures within slowly expanding lesions (SELs) in multiple sclerosisâ€ at @ECTRIMS https://t.co/KwMR2wuh3t,twitter,ESP,SaraLlufriu,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",very happy to listen to dr calvi @emimagin presenting our work â€œevolution of diffusivity measures within slowly expanding lesions (sels) in multiple sclerosisâ€ at @ectrims https://t.co/kwmr2wuh3t,female,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,923878828111532032,,548,180,0,,,7,29,221,False,very happy to listen to dr calvi presenting our work evolution of diffusivity measures within slowly expanding lesions (sels) in multiple sclerosis at,"['Dr. Calvi', 'work', 'evolution', 'diffusivity', 'lesions', 'multiple sclerosis']","dr. calvi,work,evolution,diffusivity,lesions,multiple sclerosis",dr. calvi work evolution diffusivity lesions,dr. calvi work evolution diffusivity lesions,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,0.9049994717610924,False
143,149,2023-10-12 10:45:47.0,The poster numero uno from #airasgroup was presented yesterday at #ECTRIMS #MSMilan2023 Looking at impact of #MS susceptibility risk genes and astrocyte activation on lesion expansion.  P 193. Saraste et al. #smolderingMS https://t.co/IrZnv73JqE,twitter,ITA,LauraAiras1,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",the poster numero uno from #airasgroup was presented yesterday at #ectrims #msmilan2023 looking at impact of #ms susceptibility risk genes and astrocyte activation on lesion expansion. p 193. saraste et al. #smolderingms https://t.co/irznv73jqe,female,"#airasgroup, #ectrims, #msmilan2023, #ms, #smolderingms",,,6000000000,2539611216,,359,108,0,,,1,5,201,False,the poster numero uno from #airasgroup was presented yesterday at ec trims ms milan looking at impact of ms susceptibility risk genes and astrocyte activation on lesion expansion. p 193. saraste et al. #smolderingms,"['AirAsGroup', 'EC Trims MS', 'MS susceptibility risk genes', 'astrocyte activation', 'lesion expansion', 'Saraste et al.', 'smolderingMS']","airasgroup,ec trims ms,ms susceptibility risk genes,astrocyte activation,lesion expansion,saraste et al.,smolderingms",airasgroup ec trims ms ms susceptibility risk genes astrocyte activation lesion expansion saraste et al. smolderingms,airasgroup ec trims ms ms susceptibility risk genes astrocyte activation lesion expansion saraste et al. smolderingms,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
144,150,2023-10-12 10:34:23.0,"I'm not sure if it was a point of emphasis for the @ECTRIMS or @ACTRIMS organizing teams, but so far the spotlight on young investigators has been obvious and an overwhelming success. 
#YoungInvestigators #MSMilan",twitter,USA,titostiles,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","i'm not sure if it was a point of emphasis for the @ectrims or @actrims organizing teams, but so far the spotlight on young investigators has been obvious and an overwhelming success. #younginvestigators #msmilan",male,"#younginvestigators, #msmilan","Business, Science, Politics","{profession=Executive, jobTitle=CEO}, {profession=Executive, jobTitle=Entrepreneur}, {profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Neuroscientist}",6000000000,213397655,,1051,1708,0,http://twitter.com/titostiles/statuses/1712405505333948668,,1,4,28177,False,"i'm not sure if it was a point of emphasis for the or organizing teams, but so far the spotlight on young investigators has been obvious and an overwhelming success. #younginvestigators msmilan","['Young Investigators', 'Spotlight', 'Success']","young investigators,spotlight,success",young investigators spotlight success,young investigators spotlight success,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,1.0,False
145,151,2023-10-12 10:26:31.0,"The quality of life for people with #MS is strongly affected by depression, fatigue, pain, muscle weakness, and memory problems!
âž¡ï¸âž¡ï¸ This only highlights how important #symptomatic management â€¼ï¸ of #MultipleSclerosis #symptoms to improve the quality of life!

@ECTRIMS @ACTRIMS https://t.co/8wWPjRxj3k",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","the quality of life for people with #ms is strongly affected by depression, fatigue, pain, muscle weakness, and memory problems! âž¡ï¸âž¡ï¸ this only highlights how important #symptomatic management â€¼ï¸ of #multiplesclerosis #symptoms to improve the quality of life! @ectrims @actrims https://t.co/8wwpjrxj3k",female,"#ms, #symptomatic, #multiplesclerosis, #symptoms",,,6000000000,600110872,,4869,893,0,,,5,9,5938,False,"the quality of life for people with ms is strongly affected by depression, fatigue, pain, muscle weakness, and memory problems! this only highlights how important #symptomatic management of multiple sclerosis #symptoms to improve the quality of life!","['depression', 'fatigue', 'pain', 'muscle weakness', 'memory problems', 'symptomatic management', 'multiple sclerosis', 'quality of life']","depression,fatigue,pain,muscle weakness,memory problems,symptomatic management,multiple sclerosis,quality of life",depression fatigue pain muscle weakness memory problems symptomatic management quality of life,depression fatigue pain muscle weakness memory problems symptomatic management quality of life,6,6_fatigue_nourbakhsh_bardia_symptoms,"Fatigue management strategies and its effects on quality of life, cognitive function, and depression.","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['fatigue', 'depression', 'symptomatic', 'symptoms', 'weakness', 'disorders', 'anxiety', 'sleep', 'bardia', 'sclerosis']","['Fatigue management strategies and its effects on quality of life, cognitive function, and depression.', '', '', '', '', '', '', '', '', '']","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['bardia nourbakhsh fatigue', 'hello cognitive reserve outcomes symptoms fatigue depression anxiety eposter systematic review cognitive multiple sclerosis', 'dr. bardia nourbakhsh united states fatigue directions addressing']",fatigue - nourbakhsh - bardia - symptoms - cognitive - depression - united - directions - gold - eposter,1.0,False
146,152,2023-10-12 10:19:35.0,"Bennett (Swi):  sGFAP (corrected for age, BMI and sex) is a promising biomarker for disease progression independently from relapse or sNFL in #MS patients on highly active treatment!
#MSMilan2023 https://t.co/xGHbiNtZVI",twitter,BEL,bart_professor,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}","bennett (swi): sgfap (corrected for age, bmi and sex) is a promising biomarker for disease progression independently from relapse or snfl in #ms patients on highly active treatment! #msmilan2023 https://t.co/xghbintzvi",unknown,"#ms, #msmilan2023",,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1109554254979743744,,1943,884,1,,,0,1,1868,False,"bennett (swi): sgfap (corrected for age, bmi and sex) is a promising biomarker for disease progression independently from relapse or snfl in ms patients on highly active treatment! ms milan","['Bennett', 'SGFAP', 'MS', 'Milan']","bennett,sgfap,ms,milan",bennett sgfap,bennett sgfap,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
147,153,2023-10-12 10:16:03.0,"Prof Olga Ciccarelli @olgacicc (@UCLIoN) presenting at @ECTRIMS - the world's largest organisation dedicated to treatment and research in #MultipleSclerosis. 

#MS #MSMilan2023 https://t.co/FEExImC7Xe",twitter,GBR,UCLBrainScience,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",prof olga ciccarelli @olgacicc (@uclion) presenting at @ectrims - the world's largest organisation dedicated to treatment and research in #multiplesclerosis. #ms #msmilan2023 https://t.co/feeximc7xe,,"#multiplesclerosis, #ms, #msmilan2023",,,6000000000,440719416,,22346,1266,0,,,1,5,9275,False,prof olga ciccarelli () presenting at - the world's largest organisation dedicated to treatment and research in multiple sclerosis. ms ms milan,"['prof', 'olga', 'ciccarelli', 'ms', 'treatment', 'research', 'multiple sclerosis']","prof,olga,ciccarelli,ms,treatment,research,multiple sclerosis",prof olga ciccarelli,prof olga ciccarelli,12,12_massimo_filippi_freedman_ciccarelli,"Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['massimo', 'zeposia', 'ciccarelli', 'olga', 'sastregarriga', 'filippi', 'prize', 'rachel', 'horne', 'french']","['Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.', '', '', '', '', '', '', '', '', '']","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['prof olga ciccarelli', 'massimo filippi mark freedman who mogad actrims', 'rachel horne prize massimo filippi']",massimo - filippi - freedman - ciccarelli - career - zeposia - olga - rms - sastregarriga - who,1.0,True
148,154,2023-10-12 10:14:45.0,"Dr. Jens Kuhle presenting in the Auditorium @ECTRIMS exciting data on promising biomarkers in #MultipleSclerosis 
@JensKuhle @UniSpitalBasel @DKFBasel https://t.co/XrFOFLd26H",twitter,ITA,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. jens kuhle presenting in the auditorium @ectrims exciting data on promising biomarkers in #multiplesclerosis @jenskuhle @unispitalbasel @dkfbasel https://t.co/xrfofld26h,,#multiplesclerosis,Beauty/Health & Fitness,,6000000000,1493181686426779654,,90,65,0,,,3,12,20,False,dr. jens kuhle presenting in the auditorium exciting data on promising biomarkers in multiple sclerosis,"['Jens Kuhle', 'auditorium', 'data', 'biomarkers', 'multiple sclerosis']","jens kuhle,auditorium,data,biomarkers,multiple sclerosis",jens kuhle auditorium biomarkers,jens kuhle auditorium biomarkers,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
149,155,2023-10-12 10:12:09.0,Dr. Bardia Nourbakhsh (United States) identifies key future directions for addressing fatigue in #MS @ECTRIMS #MSMilan2023 https://t.co/noiuGXZSu1,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}",dr. bardia nourbakhsh (united states) identifies key future directions for addressing fatigue in #ms @ectrims #msmilan2023 https://t.co/noiugxzsu1,female,"#ms, #msmilan2023",,,6000000000,256679634,,1174,1912,0,,,0,0,6576,False,dr. bardia nourbakhsh (united states) identifies key future directions for addressing fatigue in ms ms milan,"['Dr. Bardia Nourbakhsh', 'MS', 'United States', 'fatigue', 'multiple sclerosis', 'directions', 'addressing']","dr. bardia nourbakhsh,ms,united states,fatigue,multiple sclerosis,directions,addressing",dr. bardia nourbakhsh united states fatigue directions addressing,dr. bardia nourbakhsh united states fatigue directions addressing,6,6_fatigue_nourbakhsh_bardia_symptoms,"Fatigue management strategies and its effects on quality of life, cognitive function, and depression.","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['fatigue', 'depression', 'symptomatic', 'symptoms', 'weakness', 'disorders', 'anxiety', 'sleep', 'bardia', 'sclerosis']","['Fatigue management strategies and its effects on quality of life, cognitive function, and depression.', '', '', '', '', '', '', '', '', '']","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['bardia nourbakhsh fatigue', 'hello cognitive reserve outcomes symptoms fatigue depression anxiety eposter systematic review cognitive multiple sclerosis', 'dr. bardia nourbakhsh united states fatigue directions addressing']",fatigue - nourbakhsh - bardia - symptoms - cognitive - depression - united - directions - gold - eposter,1.0,True
150,156,2023-10-12 10:08:42.0,"ðŸŒŸðŸŒŸðŸŒŸ14 abstracts from our Nottingham MS Research Group at #MSMilan2023! Well done us!!! 

@researchneuro1 @nikosevangelou3 @researchNuh @RaduTanasescu1 @MegiClarke @BlancaDios @LaurenATaylor26 @NEuRoMSproject",twitter,GBR,GogemTopcu,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",ðŸŒŸðŸŒŸðŸŒŸ14 abstracts from our nottingham ms research group at #msmilan2023! well done us!!! @researchneuro1 @nikosevangelou3 @researchnuh @radutanasescu1 @megiclarke @blancadios @laurenataylor26 @neuromsproject,unknown,#msmilan2023,"Beauty/Health & Fitness, Science, Animals & Pets, Travel","{profession=Scientist & Researcher, jobTitle=Researcher}",6000000000,942062432,,226,502,1,,,3,11,449,False,14 abstracts from our nottingham ms research group at ms milan! well done us!!!,"['Nottingham', 'MS', 'Milan', 'research', 'group']","nottingham,ms,milan,research,group",nottingham group,nottingham group,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
151,157,2023-10-12 10:04:28.0,"#Fatigue in #MS is a crucial topic!
â“ï¸How to measure it?
ðŸ‘¤ It's subjective: ""the goldest standard is what the person with MS tells you""
ðŸ‘‚listen to the patient - There is no better measure than patient reported
#PROMS #MultipleSclerosis
@ECTRIMS @ACTRIMS 
#MSMilan2023 https://t.co/P2BsZX7SmG",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","#fatigue in #ms is a crucial topic! â“ï¸how to measure it? ðŸ‘¤ it's subjective: ""the goldest standard is what the person with ms tells you"" ðŸ‘‚listen to the patient - there is no better measure than patient reported #proms #multiplesclerosis @ectrims @actrims #msmilan2023 https://t.co/p2bszx7smg",female,"#fatigue, #ms, #proms, #multiplesclerosis, #msmilan2023",,,6000000000,600110872,,4869,893,0,,,8,18,5935,False,"#fatigue in ms is a crucial topic! how to measure it? it's subjective: ""the goldest standard is what the person with ms tells you"" listen to the patient - there is no better measure than patient reported #proms multiple sclerosis ms milan","['fatigue', 'MS', 'measure', 'subjective', 'patient', 'report', 'gold standard', 'Proms', 'Multiple Sclerosis', 'Milan']","fatigue,ms,measure,subjective,patient,report,gold standard,proms,multiple sclerosis,milan",fatigue measure subjective report gold standard proms,fatigue measure subjective report gold standard proms,6,6_fatigue_nourbakhsh_bardia_symptoms,"Fatigue management strategies and its effects on quality of life, cognitive function, and depression.","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['fatigue', 'depression', 'symptomatic', 'symptoms', 'weakness', 'disorders', 'anxiety', 'sleep', 'bardia', 'sclerosis']","['Fatigue management strategies and its effects on quality of life, cognitive function, and depression.', '', '', '', '', '', '', '', '', '']","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['bardia nourbakhsh fatigue', 'hello cognitive reserve outcomes symptoms fatigue depression anxiety eposter systematic review cognitive multiple sclerosis', 'dr. bardia nourbakhsh united states fatigue directions addressing']",fatigue - nourbakhsh - bardia - symptoms - cognitive - depression - united - directions - gold - eposter,1.0,False
152,158,2023-10-12 10:04:15.0,We finally present the results of or multinational (7 centers) study on adult-onset leukodystrophies misdiagnosed or occurring with #MultipleSclerosis at @ECTRIMS #MSMilan2023 - paper coming up soon @ClevelandClinic @HopPitieSalpe @ChumNeuro @TheNeuro_MNI https://t.co/8y6R7OeE9C,twitter,CAN,GMacaronMD,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",we finally present the results of or multinational (7 centers) study on adult-onset leukodystrophies misdiagnosed or occurring with #multiplesclerosis at @ectrims #msmilan2023 - paper coming up soon @clevelandclinic @hoppitiesalpe @chumneuro @theneuro_mni https://t.co/8y6r7oee9c,female,"#multiplesclerosis, #msmilan2023",,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}",6000000000,1177957381566808069,,982,445,1,,,2,32,393,False,we finally present the results of or multinational (7 centers) study on adult-onset leukodystrophies misdiagnosed or occurring with multiple sclerosis at ms milan - paper coming up soon,"['leukodystrophies', 'adult-onset', 'multinational', 'study', 'results', 'presentation', 'centers', 'adults', 'misdiagnosed', 'multiple sclerosis', 'MS Milan', 'paper']","leukodystrophies,adult-onset,multinational,study,results,presentation,centers,adults,misdiagnosed,multiple sclerosis,ms milan,paper",leukodystrophies adult-onset multinational study results presentation centers adults misdiagnosed paper,leukodystrophies adult-onset multinational study results presentation centers adults misdiagnosed paper,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,0.7558712214677434,False
153,159,2023-10-12 10:02:32.0,"ðŸŸ Our members came to #MSMilan2023 from all around Europe to bring #MS community voice & perspective to ultimately make life better for people with #MultipleSclerosis. 
ðŸ“¹Watch the President of @SPEMportugal, our member organisation in Portugal ðŸ‡µðŸ‡¹.
 @ECTRIMS @ACTRIMS #ECTRIMS4me https://t.co/W8ZgQh7Gms",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","ðŸŸ our members came to #msmilan2023 from all around europe to bring #ms community voice & perspective to ultimately make life better for people with #multiplesclerosis. ðŸ“¹watch the president of @spemportugal, our member organisation in portugal ðŸ‡µðŸ‡¹. @ectrims @actrims #ectrims4me https://t.co/w8zgqh7gms",female,"#msmilan2023, #ms, #multiplesclerosis, #ectrims4me",,,6000000000,600110872,,4869,893,0,,,2,9,5934,False,"our members came to ms milan from all around europe to bring ms community voice & perspective to ultimately make life better for people with multiple sclerosis. watch the president of , our member organisation in portugal . ec trims4me","['MS', 'Europe', 'community', 'voice', 'perspective', 'better', 'life', 'people', 'multiple sclerosis', 'Portugal', 'president', 'member organization', 'EC', 'trim4me']","ms,europe,community,voice,perspective,better,life,people,multiple sclerosis,portugal,president,member organization,ec,trim4me",europe voice perspective better life people portugal president member organization trim4me,europe voice perspective better life people portugal president member organization trim4me,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
154,160,2023-10-12 10:01:13.0,More posters from Nottingham MS Research Group! Come check out! #MSMilan2023 https://t.co/5eQvgAsrbE,twitter,GBR,NEuRoMSproject,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",more posters from nottingham ms research group! come check out! #msmilan2023 https://t.co/5eqvgasrbe,unknown,#msmilan2023,Beauty/Health & Fitness,,6000000000,1134060973789237249,,506,234,0,,,3,11,561,False,more posters from nottingham ms research group! come check out! ms milan,"['posters', 'Nottingham', 'MS', 'research', 'group', 'check', 'Milan']","posters,nottingham,ms,research,group,check,milan",posters nottingham group check,posters nottingham group check,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
155,161,2023-10-12 09:59:16.0,"Brilliant opportunity for @ECTRIMS  attendees to ask the experts - @GeoArrambide and Andrew Solomon discuss complex #MultipleSclerosis differential diagnoses.

#MSMilan2023 https://t.co/lZ1Imtmugo",twitter,GBR,AnneHelme,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",brilliant opportunity for @ectrims attendees to ask the experts - @geoarrambide and andrew solomon discuss complex #multiplesclerosis differential diagnoses. #msmilan2023 https://t.co/lz1imtmugo,female,"#multiplesclerosis, #msmilan2023",Beauty/Health & Fitness,,6000000000,46126120,,1055,1041,1,,,2,7,3296,False,brilliant opportunity for attendees to ask the experts - and andrew solomon discuss complex multiple sclerosis differential diagnoses. ms milan,"['Andrew Solomon', 'opportunity', 'attendees', 'experts', 'complex', 'multiple sclerosis', 'differential diagnoses', 'MS Milan']","andrew solomon,opportunity,attendees,experts,complex,multiple sclerosis,differential diagnoses,ms milan",andrew solomon opportunity attendees experts complex differential diagnoses,andrew solomon opportunity attendees experts complex differential diagnoses,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,1.0,False
156,162,2023-10-12 09:57:12.0,Dr. Bardia Nourbakhsh shares the impact and importance of fatigue in MS #MSMilan2023 @ECTRIMS https://t.co/F8glvHTXoY,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}",dr. bardia nourbakhsh shares the impact and importance of fatigue in ms #msmilan2023 @ectrims https://t.co/f8glvhtxoy,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,0,0,6575,False,dr. bardia nourbakhsh shares the impact and importance of fatigue in ms ms milan,"['Bardia', 'Nourbakhsh', 'MS', 'Milan', 'fatigue']","bardia,nourbakhsh,ms,milan,fatigue",bardia nourbakhsh fatigue,bardia nourbakhsh fatigue,6,6_fatigue_nourbakhsh_bardia_symptoms,"Fatigue management strategies and its effects on quality of life, cognitive function, and depression.","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['fatigue', 'depression', 'symptomatic', 'symptoms', 'weakness', 'disorders', 'anxiety', 'sleep', 'bardia', 'sclerosis']","['Fatigue management strategies and its effects on quality of life, cognitive function, and depression.', '', '', '', '', '', '', '', '', '']","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['bardia nourbakhsh fatigue', 'hello cognitive reserve outcomes symptoms fatigue depression anxiety eposter systematic review cognitive multiple sclerosis', 'dr. bardia nourbakhsh united states fatigue directions addressing']",fatigue - nourbakhsh - bardia - symptoms - cognitive - depression - united - directions - gold - eposter,1.0,True
157,163,2023-10-12 09:40:48.0,Alexion to Present Data Reinforcing Effectiveness of Ultomiris and Soliris in Treating Rare Neurological Disorder at ECTRIMS-ACTRIMS Meeting https://t.co/YE2ZPrSBwL https://t.co/mKwioo6Po8,twitter,,europawire,"{id=20740635, name=Ultomiris / ravulizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740634, name=Soliris / eculizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=16441711, name=AstraZeneca, displayName=null, parentId=16441705, parentName=CI Updates'22}",alexion to present data reinforcing effectiveness of ultomiris and soliris in treating rare neurological disorder at ectrims-actrims meeting https://t.co/ye2zprsbwl https://t.co/mkwioo6po8,,,Business,,6000000000,712663225,,1553,1987,0,,,0,0,56542,True,alexion to present data reinforcing effectiveness of ultomiris and soliris in treating rare neurological disorder at ectrims-actrims meeting,"['Alexion', 'data', 'effectiveness', 'Ultomiris', 'Soliris', 'treating', 'rare', 'neurological', 'disorder', 'ECTRIMS-ACTRIMS', 'meeting']","alexion,data,effectiveness,ultomiris,soliris,treating,rare,neurological,disorder,ectrims-actrims,meeting",alexion effectiveness ultomiris soliris treating rare neurological disorder ectrims-actrims meeting,alexion effectiveness ultomiris soliris treating rare neurological disorder ectrims-actrims meeting,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,1.0,False
158,164,2023-10-12 09:00:26.0,â€œImproving MRI implementation in the clinical settingâ€ Are we ready to implement the central vein sign in the clinic? I think the two prospective studies of the CVS (CAVS-MS and DECISIVE) presented this year at #ECTRIMS will help us answer this important question! #MSMilan2023 https://t.co/9gZqMTvs5R,twitter,GBR,MegiClarke,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",â€œimproving mri implementation in the clinical settingâ€ are we ready to implement the central vein sign in the clinic? i think the two prospective studies of the cvs (cavs-ms and decisive) presented this year at #ectrims will help us answer this important question! #msmilan2023 https://t.co/9gzqmtvs5r,female,"#ectrims, #msmilan2023",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neuroscientist}",6000000000,855537687662604288,,236,178,2,,,1,14,146,False,improving mri implementation in the clinical setting are we ready to implement the central vein sign in the clinic? i think the two prospective studies of the cvs (cavs-ms and decisive) presented this year at ec trims will help us answer this important question! ms milan,"['MRI', 'implementation', 'clinical', 'setting', 'central', 'vein', 'sign', 'clinic', 'ready', 'improve', 'prospective', 'studies', 'CAVS-MS', 'Decisive', 'EC TRIs', 'Milan']","mri,implementation,clinical,setting,central,vein,sign,clinic,ready,improve,prospective,studies,cavs-ms,decisive,ec tris,milan",mri implementation clinical setting central vein sign clinic ready improve prospective studies cavs-ms decisive ec tris,mri implementation clinical setting central vein sign clinic ready improve prospective studies cavs-ms decisive ec tris,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
159,165,2023-10-12 08:38:27.0,"Three speakers, including me, at our session @ECTRIMS session today condemned Hamas terrorists clear and loud.",twitter,,jonykipnis,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","three speakers, including me, at our session @ectrims session today condemned hamas terrorists clear and loud.",male,,,,6000000000,60739511,,23661,608,4,,,2,47,12656,False,"three speakers, including me, at our session session today condemned hamas terrorists clear and loud.","['speakers', 'session', 'condemned', 'hamas', 'terrorists']","speakers,session,condemned,hamas,terrorists",speakers session condemned hamas terrorists,speakers session condemned hamas terrorists,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
160,166,2023-10-12 08:34:01.0,"Are you at #MSMilan2023 and would like to meet us? Pass by the @EuropeanCharcot booth E.02 & letâ€™s have a chat! 

You can also grab one of our brochures to learn more about our work towards meaningful PROsâ€™ use in MS research & care

Stay tuned for more PROMS news from @ECTRIMS! https://t.co/Ud3JHHbaaC",twitter,,PromsInitiative,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",are you at #msmilan2023 and would like to meet us? pass by the @europeancharcot booth e.02 & letâ€™s have a chat! you can also grab one of our brochures to learn more about our work towards meaningful prosâ€™ use in ms research & care stay tuned for more proms news from @ectrims! https://t.co/ud3jhhbaac,unknown,#msmilan2023,,,6000000000,1579794712323624962,,86,96,0,,,2,14,59,False,are you at ms milan and would like to meet us? pass by the booth e.02 & lets have a chat! you can also grab one of our brochures to learn more about our work towards meaningful pros use in ms research & care stay tuned for more proms news from !,"['meet', 'MS', 'Milan', 'brochure', 'research', 'care', 'proms']","meet,ms,milan,brochure,research,care,proms",meet brochure care proms,meet brochure care proms,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
161,167,2023-10-12 08:30:46.0,"50% of women with #ms have sleep disorders. I am one of them, itâ€™s a â€žtypical problemâ€œ of women in my age, doctor said. My question: And why donâ€™t we do something? Nothing happened. Not acceptable. Because sleeping disorders have a lot of impact on other ms symptoms. #MSMilan2023 https://t.co/l0UY3dddSq",twitter,DEU,Birgitpower,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","50% of women with #ms have sleep disorders. i am one of them, itâ€™s a â€žtypical problemâ€œ of women in my age, doctor said. my question: and why donâ€™t we do something? nothing happened. not acceptable. because sleeping disorders have a lot of impact on other ms symptoms. #msmilan2023 https://t.co/l0uy3dddsq",female,"#ms, #msmilan2023",,,6000000000,22899395,,3334,1989,2,,,2,21,31846,False,"50% of women with ms have sleep disorders. i am one of them, its a typical problem of women in my age, doctor said. my question: and why dont we do something? nothing happened. not acceptable. because sleeping disorders have a lot of impact on other ms symptoms. ms milan","['MS', 'women', 'sleep disorders', 'doctor', 'impact', 'symptoms']","ms,women,sleep disorders,doctor,impact,symptoms",women sleep disorders doctor impact symptoms,women sleep disorders doctor impact symptoms,6,6_fatigue_nourbakhsh_bardia_symptoms,"Fatigue management strategies and its effects on quality of life, cognitive function, and depression.","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['fatigue', 'depression', 'symptomatic', 'symptoms', 'weakness', 'disorders', 'anxiety', 'sleep', 'bardia', 'sclerosis']","['Fatigue management strategies and its effects on quality of life, cognitive function, and depression.', '', '', '', '', '', '', '', '', '']","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['bardia nourbakhsh fatigue', 'hello cognitive reserve outcomes symptoms fatigue depression anxiety eposter systematic review cognitive multiple sclerosis', 'dr. bardia nourbakhsh united states fatigue directions addressing']",fatigue - nourbakhsh - bardia - symptoms - cognitive - depression - united - directions - gold - eposter,1.0,False
162,168,2023-10-12 08:28:46.0,"Day 2 is underway at #MSMilan2023! Many exciting sessions planned for today on #MultipleSclerosis research topics such as EBV, environmental & genetic risk factors, biomarkers, lifestyle modifications, the gut microbiome & much more. What are you most looking forward to? @ECTRIMS https://t.co/Jm5pVD9k15",twitter,AUS,MStranslate,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","day 2 is underway at #msmilan2023! many exciting sessions planned for today on #multiplesclerosis research topics such as ebv, environmental & genetic risk factors, biomarkers, lifestyle modifications, the gut microbiome & much more. what are you most looking forward to? @ectrims https://t.co/jm5pvd9k15",,"#msmilan2023, #multiplesclerosis",,,6000000000,833579503,,4899,4075,0,,,2,13,3595,False,"day 2 is underway at ms milan! many exciting sessions planned for today on multiple sclerosis research topics such as ebv, environmental & genetic risk factors, biomarkers, lifestyle modifications, the gut microbiome & much more. what are you most looking forward to?","['day', 'two', 'MS Milan', 'multiple sclerosis', 'research', 'EBV', 'environment', 'genetics', 'risk factors', 'biomarkers', 'lifestyle', 'modifications', 'gut microbiome']","day,two,ms milan,multiple sclerosis,research,ebv,environment,genetics,risk factors,biomarkers,lifestyle,modifications,gut microbiome",day two ebv environment genetics risk factors biomarkers lifestyle modifications gut microbiome,day two ebv environment genetics risk factors biomarkers lifestyle modifications gut microbiome,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.9945721725350324,False
163,169,2023-10-12 08:22:48.0,"#PIRA stands for progression independent of relapse activity .

â€œIt is the main mechanism of accumulation of disability and can predict multiple sclerosis progressionâ€ insightful talk by @CarmenTur1 at #MSMilan2023 Hot Topic 6 Session. https://t.co/mF6T8bt9Ky",twitter,ESP,cemcat_em,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",#pira stands for progression independent of relapse activity . â€œit is the main mechanism of accumulation of disability and can predict multiple sclerosis progressionâ€ insightful talk by @carmentur1 at #msmilan2023 hot topic 6 session. https://t.co/mf6t8bt9ky,unknown,"#pira, #msmilan2023",,,6000000000,1197805298,,3146,487,1,http://twitter.com/cemcat_em/statuses/1712354426172719132,,5,14,2908,False,#pira stands for progression independent of relapse activity . it is the main mechanism of accumulation of disability and can predict multiple sclerosis progression insightful talk by at ms milan hot topic 6 session.,"['pira', 'progression', 'independent', 'relapse activity', 'accumulation', 'disability', 'prediction', 'multiple sclerosis', 'progression', 'insightful', 'talk', 'MS', 'Milan', 'hot topic', 'session']","pira,progression,independent,relapse activity,accumulation,disability,prediction,multiple sclerosis,progression,insightful,talk,ms,milan,hot topic,session",pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session,pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,True
164,170,2023-10-12 08:21:58.0,"#MSMilan2023: analysis of the PREVENT and CHAMPION-NMOSD found no significant differences in safety outcomes for patients with AQP4+ #NMOSD who were treated with rituximab prior to starting C5 complement inhibitors in specific timeframes.
https://t.co/auQ5IPLBDM",twitter,USA,byMattHoffman,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#msmilan2023: analysis of the prevent and champion-nmosd found no significant differences in safety outcomes for patients with aqp4+ #nmosd who were treated with rituximab prior to starting c5 complement inhibitors in specific timeframes. https://t.co/auq5iplbdm,male,"#msmilan2023, #nmosd",,"{profession=Journalist, jobTitle=Associate Editorial Director}, {profession=Artist, jobTitle=Producer}",6000000000,895689692271828992,,1067,989,0,,,0,0,10021,False,ms milan: analysis of the prevent and champion-nmosd found no significant differences in safety outcomes for patients with aqp4+ #nmosd who were treated with rituximab prior to starting c5 complement inhibitors in specific timeframes.,"['ms', 'Milan', 'analysis', 'prevent', 'champion', 'NMOSD', 'AQP4', 'rituximab', 'c5', 'complement inhibitors', 'timeframes']","ms,milan,analysis,prevent,champion,nmosd,aqp4,rituximab,c5,complement inhibitors,timeframes",analysis prevent champion aqp4 rituximab c5 complement inhibitors timeframes,analysis prevent champion aqp4 rituximab c5 complement inhibitors timeframes,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,0.6971548338601621,False
165,171,2023-10-12 08:00:13.0,"Donâ€™t forget to book your Braindate at #MSMilan2023. Topic meetings are filling up. Connect & network with your colleagues via this customised service, available onsite and online. 
âž¡ï¸ https://t.co/gr5X58BSBi https://t.co/aU1BE7mwMO",twitter,CHE,ECTRIMS,,"donâ€™t forget to book your braindate at #msmilan2023. topic meetings are filling up. connect & network with your colleagues via this customised service, available onsite and online. âž¡ï¸ https://t.co/gr5x58bsbi https://t.co/au1be7mwmo",,#msmilan2023,,,6000000000,714464982,,7978,65,0,,,0,1,7206,False,"dont forget to book your braindate at ms milan. topic meetings are filling up. connect & network with your colleagues via this customised service, available onsite and online.","['brain', 'date', 'Milan', 'meeting', 'colleagues', 'service', 'site', 'online']","brain,date,milan,meeting,colleagues,service,site,online",brain date meeting colleagues service site online,brain date meeting colleagues service site online,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
166,172,2023-10-12 07:56:43.0,"After an inspiring first day, I am proud to present our latest work on immune response to SARS-CoV-2 in people with Multiple Sclerosis at todayâ€˜s poster session at #MSMilan2023  #ECTRIMS @NeurologyMainz https://t.co/EZ37HvHGHl",twitter,,Muriel85354596,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","after an inspiring first day, i am proud to present our latest work on immune response to sars-cov-2 in people with multiple sclerosis at todayâ€˜s poster session at #msmilan2023 #ectrims @neurologymainz https://t.co/ez37hvhghl",female,"#msmilan2023, #ectrims","Beauty/Health & Fitness, Science","{profession=Health practitioner, jobTitle=Medical Doctor}",6000000000,1407283003257151490,,22,72,0,,,0,4,16,False,"after an inspiring first day, i am proud to present our latest work on immune response to sars-cov-2 in people with multiple sclerosis at todays poster session at ms milan ec trims","['SARS-CoV-2', 'immune response', 'multiple sclerosis', 'MS Milan ECTRIMS']","sars-cov-2,immune response,multiple sclerosis,ms milan ectrims",sars-cov-2 immune response ms milan ectrims,sars-cov-2 immune response ms milan ectrims,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,1.0,False
167,173,2023-10-12 07:42:15.0,"Not sure if Ocrevus side effects were discussed at #MSMilan2023 #NS #MultipleSclerosis meeting. 

Neurologist now starting her on #briumvi

$TGTX @TGTherapeutics https://t.co/ekLg0pNEq7",twitter,,Biotech2050,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20740625, name=Briumvi / ublituximab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20767266, name=Briumvi, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",not sure if ocrevus side effects were discussed at #msmilan2023 #ns #multiplesclerosis meeting. neurologist now starting her on #briumvi $tgtx @tgtherapeutics https://t.co/eklg0pneq7,male,"#msmilan2023, #ns, #multiplesclerosis, #briumvi",Business,,6000000000,2494896473,,6157,1535,0,,,2,8,66138,False,not sure if ocrevus side effects were discussed at ms milan #ns multiple sclerosis meeting. neurologist now starting her on #briumvi $tgtx,"['Ocrevus', 'MS', 'Milan', 'side effects', 'discussion', 'neurologist', 'Brumvi', 'STGTX']","ocrevus,ms,milan,side effects,discussion,neurologist,brumvi,stgtx",ocrevus side effects discussion neurologist brumvi stgtx,ocrevus side effects discussion neurologist brumvi stgtx,5,5_ocrevus_ocrelizumab_trial_chimes,Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.,"['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['ocrevus', 'ocrelizumab', 'ocarina', 'treatment', 'patients', 'msmilan', 'neurology', 'sclerosis', 'trial', 'neurologist']","['Ocrevus clinical trials and their outcomes for relapsing multiple sclerosis patients.', '', '', '', '', '', '', '', '', '']","['ocrevus', 'ocrelizumab', 'trial', 'chimes', 'phase', 'patients', 'relapsing', 'decisions', 'noninferiority', 'brumvi']","['care versatile noninferiority subcutaneous ocrelizumab iv relapsing primary progressive treatment decisions msmilan', 'ocrevus phase 3 trial', 'interim results chimes trial ocrevus relapsing multiple sclerosis black patients hispanic patients']",ocrevus - ocrelizumab - trial - chimes - phase - patients - relapsing - decisions - noninferiority - brumvi,1.0,False
168,174,2023-10-12 07:27:48.0,"Day 2 of #ECTRIMS2023 starts soon! We are looking forward to meeting many of you at our booth today. 
#HCPsOnly #MultipleSclerosis #Neurology @ECTRIMS https://t.co/jMvQRwnC1B",twitter,DEU,MerckHealthcare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",day 2 of #ectrims2023 starts soon! we are looking forward to meeting many of you at our booth today. #hcpsonly #multiplesclerosis #neurology @ectrims https://t.co/jmvqrwnc1b,unknown,"#ectrims2023, #hcpsonly, #multiplesclerosis, #neurology",,,6000000000,857893749959086080,,7569,623,0,,,0,9,4081,False,day 2 of ec trims starts soon! we are looking forward to meeting many of you at our booth today. #hcpsonly multiple sclerosis #neurology,"['day', 'ec trims', 'meeting', 'booth', 'hcps', 'multiple sclerosis', 'neurology']","day,ec trims,meeting,booth,hcps,multiple sclerosis,neurology",day meeting booth hcps neurology,day meeting booth hcps neurology,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.529966723073457,False
169,175,2023-10-12 07:05:40.0,Thrilled to learn that AI can aid in early identification of disease progression[PIRA] in MS. Early interventions in MS are now more possible than ever! ðŸ™Œ Kudos to Llucia Coll for presenting her groundbreaking work. #MultipleSclerosis #AIinHealthcare #AI #MSawarness #ectrims2023 https://t.co/Fsoxvpmed1,twitter,GBR,AgneStraukiene,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thrilled to learn that ai can aid in early identification of disease progression[pira] in ms. early interventions in ms are now more possible than ever! ðŸ™Œ kudos to llucia coll for presenting her groundbreaking work. #multiplesclerosis #aiinhealthcare #ai #msawarness #ectrims2023 https://t.co/fsoxvpmed1,unknown,"#multiplesclerosis, #aiinhealthcare, #ai, #msawarness, #ectrims2023",Beauty/Health & Fitness,"{profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1246352834897076224,,1074,920,1,,,5,40,620,True,thrilled to learn that ai can aid in early identification of disease progression[pira] in ms. early interventions in ms are now more possible than ever! kudos to llucia coll for presenting her groundbreaking work. multiple sclerosis #aiinhealthcare #ai msawarness ec trims,"['AI', 'identification', 'disease progression', 'MS', 'intervention', 'Lucia Coll', 'multiple sclerosis', 'AI in healthcare', 'awareness', 'trim']","ai,identification,disease progression,ms,intervention,lucia coll,multiple sclerosis,ai in healthcare,awareness,trim",ai identification disease progression intervention lucia coll ai in healthcare awareness trim,ai identification disease progression intervention lucia coll ai in healthcare awareness trim,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
170,176,2023-10-12 06:47:31.0,@GavinGiovannoni on the stage ðŸ˜ #ms #MSMilan2023 #ectrims https://t.co/c9Qb0muRhE,twitter,,MSguncel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}",@gavingiovannoni on the stage ðŸ˜ #ms #msmilan2023 #ectrims https://t.co/c9qb0murhe,female,"#ms, #msmilan2023, #ectrims",,,6000000000,1338606356346048512,,1448,61,0,,,0,0,820,False,on the stage ms ms milan ec trims,"['stage', 'ms', 'Milan', 'EC', 'trims']","stage,ms,milan,ec,trims",stage,stage,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
171,177,2023-10-12 06:39:30.0,@MSIRELAND for anyone living with MS this information day is being run by @ECTRIMS and is free to attend. Registration here: https://t.co/F7vmKfg3R5,twitter,IRL,hugh_kearney,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@msireland for anyone living with ms this information day is being run by @ectrims and is free to attend. registration here: https://t.co/f7vmkfg3r5,male,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,619101398,,513,815,0,,,5,4,563,False,for anyone living with ms this information day is being run by and is free to attend. registration here:,"['MS', 'information', 'attend', 'registration']","ms,information,attend,registration",information attend registration,information attend registration,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
172,178,2023-10-12 06:17:14.0,"Don't miss Scientific Session 6: Imaging MS progression, today at #MSMilan2023. @VinzFleischer will be discussing the prognostic value of single-subject grey matter networks in early #MultipleSclerosis ðŸ§ ",twitter,DEU,NeurologyMainz,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","don't miss scientific session 6: imaging ms progression, today at #msmilan2023. @vinzfleischer will be discussing the prognostic value of single-subject grey matter networks in early #multiplesclerosis ðŸ§ ",,"#msmilan2023, #multiplesclerosis",,,6000000000,1369995180108087298,,129,137,0,,,0,2,131,False,"don't miss scientific session 6: imaging ms progression, today at ms milan. will be discussing the prognostic value of single-subject grey matter networks in early multiple sclerosis","['scientific', 'session', 'imaging', 'MS', 'progression', 'Milan', 'discussion', 'prognostic', 'value', 'single-subject', 'grey matter', 'networks', 'early', 'multiple sclerosis']","scientific,session,imaging,ms,progression,milan,discussion,prognostic,value,single-subject,grey matter,networks,early,multiple sclerosis",scientific session imaging progression discussion prognostic value single-subject grey matter networks early,scientific session imaging progression discussion prognostic value single-subject grey matter networks early,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.5399732642283928,False
173,179,2023-10-12 05:03:11.0,"Our presence at ECTRIMS demonstrates our commitment to staying at the forefront of MS research and ensuring that our community benefits from the latest development.

#MSMilan2023 #MultipleStoriesUnitedAsOne #MSSocietyUAE #MultipleSclerosis #MSawareness #LivingwithMS",twitter,,nmssocietyuae,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",our presence at ectrims demonstrates our commitment to staying at the forefront of ms research and ensuring that our community benefits from the latest development. #msmilan2023 #multiplestoriesunitedasone #mssocietyuae #multiplesclerosis #msawareness #livingwithms,female,"#msmilan2023, #multiplestoriesunitedasone, #mssocietyuae, #multiplesclerosis, #msawareness, #livingwithms",,,6000000000,1514928447931494403,,178,28,0,http://twitter.com/nmssocietyuae/statuses/1712333063814865045,,0,0,392,True,our presence at ectrims demonstrates our commitment to staying at the forefront of ms research and ensuring that our community benefits from the latest development. ms milan #multiplestoriesunitedasone mssocietyuae multiple sclerosis msawareness #livingwithms,"['ectrims', 'commitment', 'staying', 'forefront', 'ms research', 'community', 'benefits', 'latest developments', 'ms milan', 'multiplesclerosis', 'awareness', 'livingwithms']","ectrims,commitment,staying,forefront,ms research,community,benefits,latest developments,ms milan,multiplesclerosis,awareness,livingwithms",commitment staying forefront ms research benefits latest developments multiplesclerosis awareness livingwithms,commitment staying forefront ms research benefits latest developments multiplesclerosis awareness livingwithms,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
174,180,2023-10-12 05:01:24.0,#Breaking: New 10-year data at #MSMilan2023 show the effect of our aCD20 antibody on slowing disease progression in a number of endpoints for people with #MultipleSclerosis. Learn more: https://t.co/3Rag3gUFAO,twitter,USA,genentech,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",#breaking: new 10-year data at #msmilan2023 show the effect of our acd20 antibody on slowing disease progression in a number of endpoints for people with #multiplesclerosis. learn more: https://t.co/3rag3gufao,,"#breaking, #msmilan2023, #multiplesclerosis",,,6000000000,16150688,,128312,236,0,,,0,0,7668,False,#breaking: new 10-year data at ms milan show the effect of our acd20 antibody on slowing disease progression in a number of endpoints for people with multiple sclerosis. learn more:,"['Breaking', 'ACD20', 'Antibody', 'Multiple Sclerosis', 'Disease Progression', 'Endpoints.']","breaking,acd20,antibody,multiple sclerosis,disease progression,endpoints.",breaking acd20 antibody disease progression endpoints.,breaking acd20 antibody disease progression endpoints.,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,1.0,False
175,181,2023-10-12 05:01:02.0,"Learn more about the evolving mindset in detection and treatment of MS, involving biomarkers & anti-CD20 therapies during this yearâ€™s #ECTRIMS #MSMilan2023

https://t.co/VZoH0mSn4V https://t.co/xMcPa5lXNN",twitter,,NovartisMedical,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","learn more about the evolving mindset in detection and treatment of ms, involving biomarkers & anti-cd20 therapies during this yearâ€™s #ectrims #msmilan2023 https://t.co/vzoh0msn4v https://t.co/xmcpa5lxnn",,"#ectrims, #msmilan2023",Beauty/Health & Fitness,,6000000000,1529472917397970946,,7798,4,0,,,0,0,111,True,"learn more about the evolving mindset in detection and treatment of ms, involving biomarkers & anti-cd20 therapies during this years ec trims ms milan","['ms', 'detection', 'treatment', 'biomarkers', 'anti-cd20', 'therapy', 'EC TRiMS MS Milan']","ms,detection,treatment,biomarkers,anti-cd20,therapy,ec trims ms milan",detection biomarkers anti-cd20 therapy ec trims ms milan,detection biomarkers anti-cd20 therapy ec trims ms milan,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,1.0,False
176,182,2023-10-11 23:30:45.0,Are we ready for biosimilar natalizumab? #MSMilan2023 #ectrims,twitter,GBR,UKCPANeuro,"{id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",are we ready for biosimilar natalizumab? #msmilan2023 #ectrims,,"#msmilan2023, #ectrims",,,6000000000,3184780972,,438,79,0,,,0,0,1065,False,are we ready for biosimilar natalizumab? ms milan ec trims,"['natalizumab', 'MS', 'Milan', 'EC', 'trim']","natalizumab,ms,milan,ec,trim",natalizumab trim,natalizumab trim,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,0.5726894252413142,False
177,183,2023-10-11 20:44:29.0,"Hello #ECTRIMS! Interested in cognitive reserve/ outcomes & 'invisible' symptoms (fatigue, depression, anxiety) in #MS? 

Check out ePoster P1059 ""Systematic review of cognitive reserve in multiple sclerosis: Accounting for methods used and disease-related aspects"" #MSMilan2023",twitter,,ClaraMStein,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}","hello #ectrims! interested in cognitive reserve/ outcomes & 'invisible' symptoms (fatigue, depression, anxiety) in #ms? check out eposter p1059 ""systematic review of cognitive reserve in multiple sclerosis: accounting for methods used and disease-related aspects"" #msmilan2023",female,"#ectrims, #ms, #msmilan2023",,"{profession=Scientist & Researcher, jobTitle=Scholar}",6000000000,1405202918916169728,,807,836,0,,,3,20,390,False,"hello ec trims! interested in cognitive reserve/ outcomes & 'invisible' symptoms (fatigue, depression, anxiety) in ms? check out eposter p1059 ""systematic review of cognitive reserve in multiple sclerosis: accounting for methods used and disease-related aspects"" ms milan","['hello', 'ec', 'trims', 'cognitive', 'reserve', 'outcomes', 'symptoms', 'fatigue', 'depression', 'anxiety', 'eposter', 'systematic', 'review', 'cognitive', 'multiple', 'sclerosis', 'ms', 'milan']","hello,ec,trims,cognitive,reserve,outcomes,symptoms,fatigue,depression,anxiety,eposter,systematic,review,cognitive,multiple,sclerosis,ms,milan",hello cognitive reserve outcomes symptoms fatigue depression anxiety eposter systematic review cognitive multiple sclerosis,hello cognitive reserve outcomes symptoms fatigue depression anxiety eposter systematic review cognitive multiple sclerosis,6,6_fatigue_nourbakhsh_bardia_symptoms,"Fatigue management strategies and its effects on quality of life, cognitive function, and depression.","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['fatigue', 'depression', 'symptomatic', 'symptoms', 'weakness', 'disorders', 'anxiety', 'sleep', 'bardia', 'sclerosis']","['Fatigue management strategies and its effects on quality of life, cognitive function, and depression.', '', '', '', '', '', '', '', '', '']","['fatigue', 'nourbakhsh', 'bardia', 'symptoms', 'cognitive', 'depression', 'united', 'directions', 'gold', 'eposter']","['bardia nourbakhsh fatigue', 'hello cognitive reserve outcomes symptoms fatigue depression anxiety eposter systematic review cognitive multiple sclerosis', 'dr. bardia nourbakhsh united states fatigue directions addressing']",fatigue - nourbakhsh - bardia - symptoms - cognitive - depression - united - directions - gold - eposter,1.0,True
178,184,2023-10-11 20:00:01.0,"P344: Switching Btwn #DMT for #RRMS, Retrospective Review of Practice: There was mean of 1 #switch every 3 ys & mean time on any particular DMT was 1-2 ys. Post2015 1st-line: dimethyl #fumarate 51%. Post2019 2nd-line: #ocrelizumab 52%. @DebzClark @jonessa1980 #MSMilan2023",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","p344: switching btwn #dmt for #rrms, retrospective review of practice: there was mean of 1 #switch every 3 ys & mean time on any particular dmt was 1-2 ys. post2015 1st-line: dimethyl #fumarate 51%. post2019 2nd-line: #ocrelizumab 52%. @debzclark @jonessa1980 #msmilan2023",,"#dmt, #rrms, #switch, #fumarate, #ocrelizumab, #msmilan2023",,,6000000000,1054320667,,894,622,0,,,0,3,4168,False,"p344: switching btwn #dmt for #rrms, retrospective review of practice: there was mean of 1 #switch every 3 ys & mean time on any particular dmt was 1-2 ys. post2015 1st-line: dimethyl #fumarate 51%. post2019 2nd-line: #ocrelizumab 52%. ms milan","['#dmt', '#rrms', 'practice', 'switch', 'mean', 'year', '#switch', 'mean time', 'particular', 'dmt', 'post2015', '1st-line', 'dimethyl', 'fumarate', 'post20']","#dmt,#rrms,practice,switch,mean,year,#switch,mean time,particular,dmt,post2015,1st-line,dimethyl,fumarate,post20",#dmt #rrms practice switch mean year #switch mean time particular dmt post2015 1st-line dimethyl fumarate post20,#dmt #rrms practice switch mean year #switch mean time particular dmt post2015 1st-line dimethyl fumarate post20,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
179,185,2023-10-11 19:11:39.0,ðŸ§  Delighted to have shared today our research on MS lesions from white matter at #ECTRIMS2023 in Milan! I've talked about how our single-nuc and spatial atlas sheds light on disease progression. Grateful for the opportunity to present and happy to see that the room was packed ðŸ˜Š https://t.co/BPyX8mjvVj,twitter,DEU,Cels121,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",ðŸ§  delighted to have shared today our research on ms lesions from white matter at #ectrims2023 in milan! i've talked about how our single-nuc and spatial atlas sheds light on disease progression. grateful for the opportunity to present and happy to see that the room was packed ðŸ˜Š https://t.co/bpyx8mjvvj,unknown,#ectrims2023,Science,"{profession=Student, jobTitle=Student}",6000000000,819895202353737729,,68,85,1,,,5,21,14,False,delighted to have shared today our research on ms lesions from white matter at ec trims in milan! i've talked about how our single-nuc and spatial atlas sheds light on disease progression. grateful for the opportunity to present and happy to see that the room was packed,"['research', 'MS', 'lesions', 'white matter', 'EC', 'trims', 'Milan', 'single-nuc', 'spatial atlas', 'disease progression', 'presentation', 'room', 'packed']","research,ms,lesions,white matter,ec,trims,milan,single-nuc,spatial atlas,disease progression,presentation,room,packed",lesions white matter single-nuc spatial atlas disease progression presentation room packed,lesions white matter single-nuc spatial atlas disease progression presentation room packed,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,0.8499597911429837,False
180,186,2023-10-11 19:10:15.0,"Day 1 of ECTRIMS 2023 with MS and neuroimmune diseases team of University of Antwerp and Antwerp University Hospital. ðŸ‡§ðŸ‡ª
Ready ðŸ’ªfor  #MSMilan2023 #girlpower https://t.co/vRYQvRjocr",twitter,BEL,drBWillekens,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",day 1 of ectrims 2023 with ms and neuroimmune diseases team of university of antwerp and antwerp university hospital. ðŸ‡§ðŸ‡ª ready ðŸ’ªfor #msmilan2023 #girlpower https://t.co/vryqvrjocr,female,"#msmilan2023, #girlpower",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1172127267222360064,,364,313,2,,,2,14,181,False,day 1 of ectrims 2023 with ms and neuroimmune diseases team of university of antwerp and antwerp university hospital. ready for ms milan #girlpower,"['ectrims', '2023', 'ms', 'neuroimmune', 'diseases', 'university', 'antwerp', 'hospital', 'Milan', 'girlpower']","ectrims,2023,ms,neuroimmune,diseases,university,antwerp,hospital,milan,girlpower",2023 neuroimmune diseases university antwerp hospital girlpower,2023 neuroimmune diseases university antwerp hospital girlpower,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
181,187,2023-10-11 18:41:28.0,"@PamelaKanellis @ECTRIMS Are you talking about people with progressive MS, who live for 20 years and have breath problems, dependence and low quality of life? Why patients with severe dependency and disability due to the progression of MS are  abandoned by the neurologist?",twitter,,mptg1971,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@pamelakanellis @ectrims are you talking about people with progressive ms, who live for 20 years and have breath problems, dependence and low quality of life? why patients with severe dependency and disability due to the progression of ms are abandoned by the neurologist?",unknown,,,,6000000000,193848740,,926,1240,0,http://twitter.com/PamelaKanellis/statuses/1712048324730089585,,0,1,7992,False,"are you talking about people with progressive ms, who live for 20 years and have breath problems, dependence and low quality of life? why patients with severe dependency and disability due to the progression of ms are abandoned by the neurologist?","['MS', 'people', 'progressive', '20 years', 'breath', 'problems', 'dependence', 'low quality of life', 'patients', 'severe', 'dependency', 'disability', 'progression', 'neurologist', 'abandoned']","ms,people,progressive,20 years,breath,problems,dependence,low quality of life,patients,severe,dependency,disability,progression,neurologist,abandoned",people progressive 20 years breath problems dependence low quality of life severe dependency disability progression neurologist abandoned,people progressive 20 years breath problems dependence low quality of life severe dependency disability progression neurologist abandoned,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
182,189,2023-10-11 17:45:09.0,"This year, #MSMilan2023 is bringing Braindate by @e180 back to the congress. Connect, learn, and share your insights with fellow MS researchers and experts. Don't miss this fantastic networking opportunity! 
Book now: https://t.co/gr5X58BSBi https://t.co/sYYNu0BE0x",twitter,CHE,ECTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","this year, #msmilan2023 is bringing braindate by @e180 back to the congress. connect, learn, and share your insights with fellow ms researchers and experts. don't miss this fantastic networking opportunity! book now: https://t.co/gr5x58bsbi https://t.co/syynu0be0x",,#msmilan2023,,,6000000000,714464982,,7970,65,0,,,0,0,7195,False,"this year, ms milan is bringing braindate by back to the congress. connect, learn, and share your insights with fellow ms researchers and experts. don't miss this fantastic networking opportunity! book now:","['this', 'year', 'ms', 'milan', 'bringing', 'brain', 'date', 'congress', 'connect', 'learn', 'share', 'insights', 'fellow', 'researchers', 'experts', 'networking', 'opportunity', 'book']","this,year,ms,milan,bringing,brain,date,congress,connect,learn,share,insights,fellow,researchers,experts,networking,opportunity,book",this year bringing brain date congress connect learn share insights fellow researchers experts networking opportunity book,this year bringing brain date congress connect learn share insights fellow researchers experts networking opportunity book,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
183,190,2023-10-11 17:44:53.0,We are at #ECTRIMS2023 and we are ready for the patient community day on 14th October. ðŸ™        #advocacy #ms #NMOSD #MOGAD #neurotwitter  #MSMilan2023 https://t.co/HYCzXAZb3l,twitter,,FranceNmo,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",we are at #ectrims2023 and we are ready for the patient community day on 14th october. ðŸ™ #advocacy #ms #nmosd #mogad #neurotwitter #msmilan2023 https://t.co/hyczxazb3l,unknown,"#ectrims2023, #advocacy, #ms, #nmosd, #mogad, #neurotwitter, #msmilan2023",,,6000000000,1344962861882355712,,299,670,0,,,1,5,448,False,we are at ec trims and we are ready for the patient community day on 14th october. #advocacy ms #nmosd #mogad #neurotwitter ms milan,"['EC', 'Trims', 'patient', 'community', 'October', 'advocacy', 'MS', 'NMOSD', 'Mogad', 'NeuroTwitter', 'Milan']","ec,trims,patient,community,october,advocacy,ms,nmosd,mogad,neurotwitter,milan",october advocacy mogad neurotwitter,october advocacy mogad neurotwitter,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.9253085451957483,False
184,191,2023-10-11 17:44:29.0,"On #ECTRIMS day 1, Matthias, #NMOSD patient & TSF Ambassador of Germany ðŸ‡©ðŸ‡ª, presented his perspective on the #raredisease journey after symptoms begin & how to reinvent oneâ€™s life without letting disease define, limit or consume you. 

Thank you Roche for this platform https://t.co/SsUdRNYRdg",twitter,USA,TheSumairaFDN,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","on #ectrims day 1, matthias, #nmosd patient & tsf ambassador of germany ðŸ‡©ðŸ‡ª, presented his perspective on the #raredisease journey after symptoms begin & how to reinvent oneâ€™s life without letting disease define, limit or consume you. thank you roche for this platform https://t.co/ssudrnyrdg",,"#ectrims, #nmosd, #raredisease",Beauty/Health & Fitness,,6000000000,2871642269,,945,404,0,,,1,6,2164,False,"on ec trims day 1, matthias, #nmosd patient & tsf ambassador of germany , presented his perspective on the #raredisease journey after symptoms begin & how to reinvent ones life without letting disease define, limit or consume you. thank you roche for this platform","['ec', 'trims', 'Matthias', 'NMOSD', 'TSF', 'Germany', 'raredisease', 'journey', 'symptoms', 'disease', 'life', 'Roche', 'platform']","ec,trims,matthias,nmosd,tsf,germany,raredisease,journey,symptoms,disease,life,roche,platform",matthias tsf germany raredisease journey symptoms disease life roche platform,matthias tsf germany raredisease journey symptoms disease life roche platform,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.20918004596122036,False
185,192,2023-10-11 17:40:09.0,"@TizianaLS will present SPMS safety data @ the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS) in Milan, October 11-13.
$TLSA PR: https://t.co/jBeWLGvF8Q",twitter,USA,vanjohn10,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@tizianals will present spms safety data @ the european committee for treatment and research of multiple sclerosis (ectrims) in milan, october 11-13. $tlsa pr: https://t.co/jbewlgvf8q",male,,Beauty/Health & Fitness,,6000000000,28637628,,1393,719,1,,,0,2,6561,False,"will present spms safety data the european committee for treatment and research of multiple sclerosis (ectrims) in milan, october 11-13. $tlsa pr:","['Multiple sclerosis', 'ECTRIMS', 'Milan', 'October', 'TSLA']","multiple sclerosis,ectrims,milan,october,tsla",october tsla,october tsla,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
186,193,2023-10-11 17:24:47.0,"This week members of the MSIF team are in Milan for the #MSMilan2023. Today's presentations included reference to the @WHO decision to add MS treatments to their Essential Medicines List, which was made possible through global collaboration. 

@ECTRIMS  @ACTRIMS",twitter,,MSIntFederation,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","this week members of the msif team are in milan for the #msmilan2023. today's presentations included reference to the @who decision to add ms treatments to their essential medicines list, which was made possible through global collaboration. @ectrims @actrims",female,#msmilan2023,,,6000000000,390672087,,6657,380,0,,,2,12,3461,False,"this week members of the msif team are in milan for the ms milan. today's presentations included reference to the decision to add ms treatments to their essential medicines list, which was made possible through global collaboration.","['MS', 'MSF', 'Milan', 'presentation', 'decision', 'treatment', 'medication', 'collaboration']","ms,msf,milan,presentation,decision,treatment,medication,collaboration",msf presentation decision medication collaboration,msf presentation decision medication collaboration,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
187,194,2023-10-11 17:03:29.0,Six months of vidofludimus calcium led to reductions in a marker of nerve damage among people withÂ RRMS in a Phase 2 clinical trial.Â  https://t.co/7FhKRf9k5x #ectrims2023 #news https://t.co/MR0bpkNGcT,twitter,USA,MSNewsToday,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",six months of vidofludimus calcium led to reductions in a marker of nerve damage among people with rrms in a phase 2 clinical trial. https://t.co/7fhkrf9k5x #ectrims2023 #news https://t.co/mr0bpkngct,female,"#ectrims2023, #news",,,6000000000,2473350271,,10052,1541,0,,,0,4,28170,False,six months of vidofludimus calcium led to reductions in a marker of nerve damage among people with rrms in a phase 2 clinical trial. ec trims #news,"['vidofludimus', 'calcium', 'marker', 'nerve damage', 'RRMS', 'clinical trial', 'EC']","vidofludimus,calcium,marker,nerve damage,rrms,clinical trial,ec",vidofludimus calcium marker nerve damage rrms clinical trial,vidofludimus calcium marker nerve damage rrms clinical trial,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.5823872023957681,False
188,195,2023-10-11 16:00:33.0,"#ECTRIMS is he world's largest meeting on #MultipleSclerosis. This year's meeting is in Milan. 

The first day at #MSMilan2023 was packed with some great talks.  The morning ""Hot Topic"" session on #EBV and #MultipleSclerosis was was particularly interesting. https://t.co/I36TtSDhK9",twitter,,Dr_Gulfaraz,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","#ectrims is he world's largest meeting on #multiplesclerosis. this year's meeting is in milan. the first day at #msmilan2023 was packed with some great talks. the morning ""hot topic"" session on #ebv and #multiplesclerosis was was particularly interesting. https://t.co/i36ttsdhk9",unknown,"#ectrims, #multiplesclerosis, #msmilan2023, #ebv, #multiplesclerosis",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,1227269111966785536,,602,615,2,,,4,14,1324,False,"ec trims is he world's largest meeting on multiple sclerosis. this year's meeting is in milan. the first day at ms milan was packed with some great talks. the morning ""hot topic"" session on #ebv and multiple sclerosis was was particularly interesting.","['ec', 'trims', 'multiple sclerosis', 'Milan', 'hot topic', 'EBV']","ec,trims,multiple sclerosis,milan,hot topic,ebv",hot topic ebv,hot topic ebv,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
189,196,2023-10-11 15:58:05.0,"Very happy to present the most recent advances of #MRI application in multiple sclerosis research and clinical setting at #ECTRIMS meeting in Milan.
@ECTRIMS 
#MS #ECTRIMS2023 #MSMilan2023 https://t.co/6ENEfNhObq",twitter,ITA,paolopreziosa,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",very happy to present the most recent advances of #mri application in multiple sclerosis research and clinical setting at #ectrims meeting in milan. @ectrims #ms #ectrims2023 #msmilan2023 https://t.co/6enefnhobq,male,"#mri, #ectrims, #ms, #ectrims2023, #msmilan2023",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1058541278,,398,563,0,,,0,4,720,False,very happy to present the most recent advances of #mri application in multiple sclerosis research and clinical setting at ec trims meeting in milan. ms ec trims ms milan,"['MRI', 'application', 'multiple sclerosis', 'research', 'clinical', 'setting', 'EC TRiMS', 'meeting', 'Milan']","mri,application,multiple sclerosis,research,clinical,setting,ec trims,meeting,milan",mri application clinical setting meeting,mri application clinical setting meeting,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.5449776291920935,False
190,197,2023-10-11 15:26:17.0,Check out my poster P287. #MSMilan2023 Lymphopenia vs. normal lymphocyte counts on diroximel fumarate #DRF did not impact overall efficacy.  But quartile with lowest ALC over 96 weeks had best Gd+ & NEDA results. https://t.co/WTMkANNMRk https://t.co/Nm90qJYKCt,twitter,USA,drbarrysinger,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",check out my poster p287. #msmilan2023 lymphopenia vs. normal lymphocyte counts on diroximel fumarate #drf did not impact overall efficacy. but quartile with lowest alc over 96 weeks had best gd+ & neda results. https://t.co/wtmkannmrk https://t.co/nm90qjykct,male,"#msmilan2023, #drf",Science,,6000000000,1430793013,,7201,393,3,,,6,28,3156,False,check out my poster p287. ms milan lymphopenia vs. normal lymphocyte counts on diroximel fumarate #drf did not impact overall efficacy. but quartile with lowest alc over 96 weeks had best gd+ & neda results.,"['poster', 'p287', 'lymphopenia', 'normal', 'lymphocyte', 'diroximel', 'fumarate', 'drf', 'efficacy', 'quartile', 'alc', 'weeks', 'gd', 'neda', '']","poster,p287,lymphopenia,normal,lymphocyte,diroximel,fumarate,drf,efficacy,quartile,alc,weeks,gd,neda,",poster p287 lymphopenia normal lymphocyte diroximel fumarate drf efficacy quartile alc weeks gd neda ,poster p287 lymphopenia normal lymphocyte diroximel fumarate drf efficacy quartile alc weeks gd neda ,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
191,198,2023-10-11 15:25:05.0,"@ECTRIMS the buzzwords are PIRA, smoldering MS and pre-disease markers. Neurodegeneration begins early but in MS we seem to specialize in treating it late.ðŸ˜±",twitter,ITA,Jagan1234,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@ectrims the buzzwords are pira, smoldering ms and pre-disease markers. neurodegeneration begins early but in ms we seem to specialize in treating it late.ðŸ˜±",unknown,,,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,106094125,,138,95,0,,,1,3,1373,False,"the buzzwords are pira, smoldering ms and pre-disease markers. neurodegeneration begins early but in ms we seem to specialize in treating it late.","['pira', 'smoldering MS', 'pre-disease markers', 'neurodegeneration', 'MS', 'treating']","pira,smoldering ms,pre-disease markers,neurodegeneration,ms,treating",pira smoldering ms pre-disease markers neurodegeneration treating,pira smoldering ms pre-disease markers neurodegeneration treating,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
192,199,2023-10-11 15:20:55.0,"Kicking off our coverage of #ECTRIMS2023...
For those with #RRMS, treatment with #vidofludimuscalcium led to reductions in #NfL biomarkers as early as week 6 compared with placebo, according to a presentation at @ECTRIMS. https://t.co/FLSZTFf5hF",twitter,,healioneurology,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","kicking off our coverage of #ectrims2023... for those with #rrms, treatment with #vidofludimuscalcium led to reductions in #nfl biomarkers as early as week 6 compared with placebo, according to a presentation at @ectrims. https://t.co/flsztff5hf",unknown,"#ectrims2023, #rrms, #vidofludimuscalcium, #nfl",,,6000000000,1288887610371452928,,56,211,0,,,0,0,1600,False,"kicking off our coverage of ec trims... for those with #rrms, treatment with #vidofludimuscalcium led to reductions in #nfl biomarkers as early as week 6 compared with placebo, according to a presentation at .","['ec trims', 'rrms', 'vidofludimuscalcium', 'nfl biomarkers', 'presentation']","ec trims,rrms,vidofludimuscalcium,nfl biomarkers,presentation",rrms vidofludimuscalcium nfl biomarkers presentation,rrms vidofludimuscalcium nfl biomarkers presentation,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
193,200,2023-10-11 15:11:29.0,Strong patient advocate Ellen @ECTRIMS : Discussion with the neurologist means not just talking. Itâ€™s about listening and understanding. Thank you! Couldnâ€™t! #MSMilan2023 #ms,twitter,DEU,Birgitpower,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",strong patient advocate ellen @ectrims : discussion with the neurologist means not just talking. itâ€™s about listening and understanding. thank you! couldnâ€™t! #msmilan2023 #ms,female,"#msmilan2023, #ms",,,6000000000,22899395,,3334,1989,0,,,1,3,31842,False,strong patient advocate ellen : discussion with the neurologist means not just talking. its about listening and understanding. thank you! couldnt! ms milan ms,"['advocate', 'Ellen', 'discussion', 'listening', 'understanding', 'neurologist', 'thank you', 'MS', 'Milan']","advocate,ellen,discussion,listening,understanding,neurologist,thank you,ms,milan",advocate ellen discussion listening understanding neurologist thank you,advocate ellen discussion listening understanding neurologist thank you,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.8824906050672969,False
194,201,2023-10-11 15:08:59.0,"Tiziana (Nasdaq:Â TLSA) Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress

#TizianaLifeSciences #TLSA #ALS 

https://t.co/0f6vFSFThO",twitter,USA,Tradigital__IR,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",tiziana (nasdaq: tlsa) announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress #tizianalifesciences #tlsa #als https://t.co/0f6vfsftho,,"#tizianalifesciences, #tlsa, #als",Business,,6000000000,1095001232450691072,,29,177,0,,,0,0,1142,False,tiziana (nasdaq: tlsa) announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress #tizianalifesciences tls a #als,"['Tiziana', 'Nasdaq', 'TLSA', 'safety', 'biomarker', 'data', 'patients', 'non-active', 'secondary progressive', 'multiple sclerosis', 'na-SPMS', 'ECTRIMS', 'annual congress']","tiziana,nasdaq,tlsa,safety,biomarker,data,patients,non-active,secondary progressive,multiple sclerosis,na-spms,ectrims,annual congress",tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress,tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,1.0,True
195,202,2023-10-11 15:08:10.0,"Happy to share in #MSMilan2023 congress our collaborative work on COVID-19 vaccines in #MultipleSclerosis: 9 MS centres from Argentina, 3 Labs of @fundacionleloir and @gabyrabi groups working together !! @ECTRIMS https://t.co/rnitbmRKeS",twitter,ITA,bereniceanabel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","happy to share in #msmilan2023 congress our collaborative work on covid-19 vaccines in #multiplesclerosis: 9 ms centres from argentina, 3 labs of @fundacionleloir and @gabyrabi groups working together !! @ectrims https://t.co/rnitbmrkes",female,"#msmilan2023, #multiplesclerosis",Science,"{profession=Scientist & Researcher, jobTitle=Research Fellow}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,946033424296501249,,196,337,5,,,3,26,581,False,"happy to share in ms milan congress our collaborative work on covid-19 vaccines in multiple sclerosis: 9 ms centres from argentina, 3 labs of and groups working together !!","['Covid-19', 'vaccines', 'multiple sclerosis', 'Argentina', 'labs', 'collaboration']","covid-19,vaccines,multiple sclerosis,argentina,labs,collaboration",covid-19 vaccines argentina labs collaboration,covid-19 vaccines argentina labs collaboration,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.5567205978250886,False
196,203,2023-10-11 14:52:47.0,"More from #ECTRIMS2023 ðŸ‘‡

Good Q&A from @HeajerKaroui at the end of the 'Effects of MS on Cognition and Beyond' session #MSMilan2023 https://t.co/FZIBqcZPmI",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",more from #ectrims2023 ðŸ‘‡ good q&a from @heajerkaroui at the end of the 'effects of ms on cognition and beyond' session #msmilan2023 https://t.co/fzibqczpmi,,"#ectrims2023, #msmilan2023",,,6000000000,325527212,,2292,1830,0,,,3,11,1830,False,more from ec trims good q&a from at the end of the 'effects of ms on cognition and beyond' session ms milan,"['MS', 'Milan', 'cognition', 'effects', 'Q&A', 'trim']","ms,milan,cognition,effects,q&a,trim",cognition effects q&a trim,cognition effects q&a trim,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
197,204,2023-10-11 14:49:50.0,"$TLSA
Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress https://t.co/e7QPOm4Z1c",twitter,,MarcJacksonLA,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$tlsa tiziana announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress https://t.co/e7qpom4z1c,unknown,,Technology,,6000000000,4058194633,,3660,385,0,,,0,1,92166,False,$tlsa tiziana announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress,"['$tlsa', 'tiziana', 'presentation', 'six-month', 'safety', 'biomarker', 'data', 'patients', 'non-active', 'secondary progressive', 'multiple sclerosis', 'na-spms', 'ectrims', '']","$tlsa,tiziana,presentation,six-month,safety,biomarker,data,patients,non-active,secondary progressive,multiple sclerosis,na-spms,ectrims,",$tlsa tiziana presentation six-month safety biomarker non-active secondary progressive na-spms ,$tlsa tiziana presentation six-month safety biomarker non-active secondary progressive na-spms ,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,1.0,False
198,205,2023-10-11 14:38:53.0,#Kickoff #ECTRIMS2023 $TGTX will be presenting data from the Ph3 ULTIMATE I & II trials of #ublituximab in #MS this Wed&Thurs at #MSMILAN2023. Check out our first 2 of 3 presentations: https://t.co/SvwvfB4wAr - Visit Booth C15 Details: https://t.co/1xbZfvcv9J #FearlessForPatients https://t.co/zGYAiPWXKV,twitter,USA,TGTherapeutics,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20740625, name=Briumvi / ublituximab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767266, name=Briumvi, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",#kickoff #ectrims2023 $tgtx will be presenting data from the ph3 ultimate i & ii trials of #ublituximab in #ms this wed&thurs at #msmilan2023. check out our first 2 of 3 presentations: https://t.co/svwvfb4war - visit booth c15 details: https://t.co/1xbzfvcv9j #fearlessforpatients https://t.co/zgyaipwxkv,,"#kickoff, #ectrims2023, #ublituximab, #ms, #msmilan2023, #fearlessforpatients","Beauty/Health & Fitness, Business",,6000000000,439362597,,2814,60,0,,,1,8,580,False,#kickoff ec trims $tgtx will be presenting data from the ph3 ultimate i & ii trials of #ublituximab in ms this wed&thurs at ms milan. check out our first 2 of 3 presentations: - visit booth c15 details: #fearlessforpatients,"['#kickoff', 'ec', 'trims', '$tgtx', 'ubli', 'tuximab', 'ms', 'ph3', 'i', 'ii', 'trials', 'fearlessforpatients']","#kickoff,ec,trims,$tgtx,ubli,tuximab,ms,ph3,i,ii,trials,fearlessforpatients",#kickoff $tgtx ubli tuximab ph3 i ii trials fearlessforpatients,#kickoff $tgtx ubli tuximab ph3 i ii trials fearlessforpatients,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
199,206,2023-10-11 14:21:25.0,"Very glad I got the opportunity to present some cool work I've been working on looking into cognitive impairment in #MultipleSclerosis, and get some feedback and interest from the scientific community #ectrims2023 @ECTRIMS",twitter,GBR,HeajerKaroui,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","very glad i got the opportunity to present some cool work i've been working on looking into cognitive impairment in #multiplesclerosis, and get some feedback and interest from the scientific community #ectrims2023 @ectrims",unknown,"#multiplesclerosis, #ectrims2023",Fine arts,"{profession=Scientist & Researcher, jobTitle=Researcher}",6000000000,1403270777688965121,,130,311,1,,,4,18,101,False,"very glad i got the opportunity to present some cool work i've been working on looking into cognitive impairment in multiple sclerosis, and get some feedback and interest from the scientific community ec trims","['work', 'opportunity', 'presentation', 'cognitive impairment', 'multiple sclerosis', 'scientific community', 'feedback']","work,opportunity,presentation,cognitive impairment,multiple sclerosis,scientific community,feedback",work opportunity presentation cognitive impairment scientific community feedback,work opportunity presentation cognitive impairment scientific community feedback,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
200,207,2023-10-11 14:13:32.0,"It is extremely inspiring to virtually participate in the first day of #MSMilan2023, despite of waking up early,  two monitors cannot keep up!, will review @ECTRIMS on demand #MS @ACTRIMS @mssociety https://t.co/nkmaaIQKAd",twitter,USA,DrJim4MS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","it is extremely inspiring to virtually participate in the first day of #msmilan2023, despite of waking up early, two monitors cannot keep up!, will review @ectrims on demand #ms @actrims @mssociety https://t.co/nkmaaiqkad",male,"#msmilan2023, #ms",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1770,621,1,,,1,9,7972,False,"it is extremely inspiring to virtually participate in the first day of ms milan, despite of waking up early, two monitors cannot keep up!, will review on demand ms","['MS Milan', 'virtual', 'participate', 'early', 'monitors', 'demand', 'review']","ms milan,virtual,participate,early,monitors,demand,review",virtual participate early monitors demand review,virtual participate early monitors demand review,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9563198702024277,False
201,208,2023-10-11 14:06:58.0,"""Cognitive dysfunction in indivs w/RRMS may respond to cognitive rehab or exercise; similar data are lacking in progressive MS: Processing speed can improve in substantial number of individuals with #progressive #MS but #interventions may need rethinking."" #MSMilan2023 @ECTRIMS",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","""cognitive dysfunction in indivs w/rrms may respond to cognitive rehab or exercise; similar data are lacking in progressive ms: processing speed can improve in substantial number of individuals with #progressive #ms but #interventions may need rethinking."" #msmilan2023 @ectrims",,"#progressive, #ms, #interventions, #msmilan2023",,,6000000000,1054320667,,893,620,0,,,0,0,4148,False,"""cognitive dysfunction in indivs w/rrms may respond to cognitive rehab or exercise; similar data are lacking in progressive ms: processing speed can improve in substantial number of individuals with #progressive ms but #interventions may need rethinking."" ms milan","['individuals', 'cognitive', 'rehabilitation', 'exercise', 'progressive', 'multiple sclerosis', 'interventions', 'processing speed', 'response']","individuals,cognitive,rehabilitation,exercise,progressive,multiple sclerosis,interventions,processing speed,response",individuals cognitive rehabilitation exercise progressive interventions processing speed response,individuals cognitive rehabilitation exercise progressive interventions processing speed response,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
202,209,2023-10-11 14:01:29.0,"Learn more about FSD Pharma's therapeutic pipeline ""Lucid-MS"" candidate for targeting Multiple Sclerosis, in the link below.

https://t.co/et3kWlIbWf

#Multiplesclerosis #MSMilan2023 #Biotech #Nasdaq #Neurodegenerative #Remyelination #Healthcare https://t.co/M8Y1V0S91U",twitter,,FsdPharma,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","learn more about fsd pharma's therapeutic pipeline ""lucid-ms"" candidate for targeting multiple sclerosis, in the link below. https://t.co/et3kwlibwf #multiplesclerosis #msmilan2023 #biotech #nasdaq #neurodegenerative #remyelination #healthcare https://t.co/m8y1v0s91u",unknown,"#multiplesclerosis, #msmilan2023, #biotech, #nasdaq, #neurodegenerative, #remyelination, #healthcare","Beauty/Health & Fitness, Books",,6000000000,1012892543925850113,,5260,272,0,,,2,6,591,True,"learn more about fsd pharma's therapeutic pipeline ""lucid-ms"" candidate for targeting multiple sclerosis, in the link below. multiple sclerosis ms milan #biotech #nasdaq #neurodegenerative #remyelination #healthcare","['fsd pharma', 'therapeutic pipeline', 'lucid-ms', 'multiple sclerosis', 'MS Milan', 'biotech', 'NASDAQ', 'neurodegenerative', 'remyelination', 'healthcare']","fsd pharma,therapeutic pipeline,lucid-ms,multiple sclerosis,ms milan,biotech,nasdaq,neurodegenerative,remyelination,healthcare",fsd pharma therapeutic pipeline lucid-ms biotech nasdaq neurodegenerative remyelination healthcare,fsd pharma therapeutic pipeline lucid-ms biotech nasdaq neurodegenerative remyelination healthcare,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.7977384623741508,False
203,211,2023-10-11 13:50:06.0,$TLSA Tiziana Life Sciences to present MS treatment at ECTRIMS Annual Congress  https://t.co/izjG7pnhU2 @tizianals #TLSA,twitter,USA,proactive_NA,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$tlsa tiziana life sciences to present ms treatment at ectrims annual congress https://t.co/izjg7pnhu2 @tizianals #tlsa,,#tlsa,,,6000000000,198835982,,9691,4446,1,,,1,9,71228,False,$tlsa tiziana life sciences to present ms treatment at ectrims annual congress tls a,"['TLSa', 'Tiziana Life Sciences', 'MS', 'treatment', 'ECTRIMS', 'annual congress']","tlsa,tiziana life sciences,ms,treatment,ectrims,annual congress",tlsa tiziana life sciences annual congress,tlsa tiziana life sciences annual congress,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,0.6838787058413855,False
204,212,2023-10-11 13:48:07.0,Thatâ€™s my PI!!!! So proud of our lab for developing a potential treatment for progressive multiple sclerosis #ECTRIMS2023 #ECTRIMS @francesca_gilli @NeuronswithNora https://t.co/YofOK4xkBI,twitter,USA,SeqWithSteve,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thatâ€™s my pi!!!! so proud of our lab for developing a potential treatment for progressive multiple sclerosis #ectrims2023 #ectrims @francesca_gilli @neuronswithnora https://t.co/yofok4xkbi,male,"#ectrims2023, #ectrims",Science,"{profession=Student, jobTitle=Student}",6000000000,1384961019999571968,,79,135,1,,,0,15,17,False,thats my pi!!!! so proud of our lab for developing a potential treatment for progressive multiple sclerosis ec trims ec trims,"['pi', 'treatment', 'multiple sclerosis', 'lab', 'progressive', 'ec trims']","pi,treatment,multiple sclerosis,lab,progressive,ec trims",pi lab progressive,pi lab progressive,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
205,213,2023-10-11 13:25:39.0,"""Many women will not have completed their family by the time of diagnosis"" 
âž¡ï¸ MS nurses share their experience on how important it is to have an in-depth understanding of the concerns that women have about #pregnancy and #breastfeeding in #MS

@ECTRIMS @ACTRIMS 
#MSMilan2023 https://t.co/pA5xRPdBFf",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","""many women will not have completed their family by the time of diagnosis"" âž¡ï¸ ms nurses share their experience on how important it is to have an in-depth understanding of the concerns that women have about #pregnancy and #breastfeeding in #ms @ectrims @actrims #msmilan2023 https://t.co/pa5xrpdbff",female,"#pregnancy, #breastfeeding, #ms, #msmilan2023",,,6000000000,600110872,,4867,891,0,,,3,6,5926,False,"""many women will not have completed their family by the time of diagnosis"" ms nurses share their experience on how important it is to have an in-depth understanding of the concerns that women have about #pregnancy and #breastfeeding in ms ms milan","['pregnancy', 'breastfeeding', 'MS', 'women', 'nurses', 'experience', 'understanding', 'concerns']","pregnancy,breastfeeding,ms,women,nurses,experience,understanding,concerns",pregnancy breastfeeding women nurses experience understanding concerns,pregnancy breastfeeding women nurses experience understanding concerns,3,3_pregnancy_breastfeeding_women_induction,"Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['breastfeeding', 'pregnancy', 'childbearing', 'trimester', 'nurses', 'pregs', 'medication', 'natalizumab', 'dmt', 'women']","['Pregnancy, Breastfeeding, and Induction Therapy Recommendations for Women', '', '', '', '', '', '', '', '', '']","['pregnancy', 'breastfeeding', 'women', 'induction', 'trisms', 'trimester', 'solution', 'second', 'recommendations', 'pregs']","['women childbearing age pregnancy plan solution', 'pregnancy ms team dmt induction therapy pregs natalizumab glatiramer acetate second trimester', 'pregnancy breastfeeding women nurses experience understanding concerns']",pregnancy - breastfeeding - women - induction - trisms - trimester - solution - second - recommendations - pregs,1.0,True
206,214,2023-10-11 13:24:34.0,"ðŸ“¢Fantastic talk from @Cels121 
ðŸŽ¯demonstrating tools for examining spatial transcriptomics âœ…delineate which cells, what are they doing and where are they in #MS
#ECTRIMS2023 #MSMilan2023 @ECTRIMS https://t.co/LHtn7vGINM",twitter,CAN,DrHArmstrong,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","ðŸ“¢fantastic talk from @cels121 ðŸŽ¯demonstrating tools for examining spatial transcriptomics âœ…delineate which cells, what are they doing and where are they in #ms #ectrims2023 #msmilan2023 @ectrims https://t.co/lhtn7vginm",female,"#ms, #ectrims2023, #msmilan2023",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",6000000000,2340290918,,1798,1037,0,,,4,5,2224,False,"fantastic talk from demonstrating tools for examining spatial transcriptomics delineate which cells, what are they doing and where are they in ms ec trims ms milan","['Spatial transcriptomics', 'cells', 'examining', 'tools', 'demonstrating', 'MS', 'Milan']","spatial transcriptomics,cells,examining,tools,demonstrating,ms,milan",spatial transcriptomics cells examining tools demonstrating,spatial transcriptomics cells examining tools demonstrating,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
207,215,2023-10-11 13:22:54.0,"Stephen Hauser's ECTRIMS lecture: #MultipleSclerosis: a path to a #cure
This work identifies longitudinally stable #autoantibody profile that is present before, during & after first symptom onset for a subset of individuals with #MS. 
https://t.co/M2WNq4rYCi
#ECTRIMS2023",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","stephen hauser's ectrims lecture: #multiplesclerosis: a path to a #cure this work identifies longitudinally stable #autoantibody profile that is present before, during & after first symptom onset for a subset of individuals with #ms. https://t.co/m2wnq4ryci #ectrims2023",,"#multiplesclerosis, #cure, #autoantibody, #ms, #ectrims2023",,,6000000000,1054320667,,893,620,0,,,1,7,4145,False,"stephen hauser's ectrims lecture: multiple sclerosis: a path to a #cure this work identifies longitudinally stable #autoantibody profile that is present before, during & after first symptom onset for a subset of individuals with ms. ec trims","['Stephen Hauser', 'ECTRIMS', 'Multiple Sclerosis', 'Autoantibody', 'Cure', 'Subset', 'Individuals', 'Symptom onset', 'EC Trims']","stephen hauser,ectrims,multiple sclerosis,autoantibody,cure,subset,individuals,symptom onset,ec trims",stephen hauser autoantibody cure subset individuals symptom onset,stephen hauser autoantibody cure subset individuals symptom onset,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,1.0,False
208,216,2023-10-11 13:09:15.0,"$IMUX Data from Immunic's Phase 2 EMPhASIS trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis presented at MSMilan2023. 

More Info: https://t.co/1qfECJzD4j $XBI $IBB $XPH $PPH https://t.co/4k87IiQOKk",twitter,USA,OzmosiHealth,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$imux data from immunic's phase 2 emphasis trial of vidofludimus calcium in relapsing-remitting multiple sclerosis presented at msmilan2023. more info: https://t.co/1qfecjzd4j $xbi $ibb $xph $pph https://t.co/4k87iiqokk,unknown,,"Beauty/Health & Fitness, Business, Technology",,6000000000,1055982930,,1373,790,0,,,0,0,7250,True,$imux data from immunic's phase 2 emphasis trial of vidofludimus calcium in relapsing-remitting multiple sclerosis presented at msmilan2023. more info: $xbi $ibb $xph $pph,"['vidofludimus', 'calcium', 'immun', 'phase 2', 'emphasis trial', 'relapsing-remitting', 'multiple sclerosis', 'MSMilan2023', '$IMUX', '$IBB']","vidofludimus,calcium,immun,phase 2,emphasis trial,relapsing-remitting,multiple sclerosis,msmilan2023,$imux,$ibb",vidofludimus calcium immun phase 2 emphasis trial relapsing-remitting msmilan2023 $imux $ibb,vidofludimus calcium immun phase 2 emphasis trial relapsing-remitting msmilan2023 $imux $ibb,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
209,217,2023-10-11 13:09:08.0,"Tiziana to share 6-month safety and biomarker info for Intranasal Foralumab in na-SPMS patients at ECTRIMS Annual Congress.  

More Info: https://t.co/BGegqDYQ0o $XBI $IBB $XPH $PPH https://t.co/4Pr2Ct0nrA",twitter,USA,OzmosiHealth,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",tiziana to share 6-month safety and biomarker info for intranasal foralumab in na-spms patients at ectrims annual congress. more info: https://t.co/bgegqdyq0o $xbi $ibb $xph $pph https://t.co/4pr2ct0nra,unknown,,"Beauty/Health & Fitness, Business, Technology",,6000000000,1055982930,,1373,790,0,,,0,0,7246,True,tiziana to share 6-month safety and biomarker info for intranasal foralumab in na-spms patients at ectrims annual congress. more info: $xbi $ibb $xph $pph,"['Tiziana', 'safety', 'biomarker', 'info', 'intranasal', 'NA-SPMS', 'ECTRIMS', 'annual', 'Congress', 'XBI', 'IBD', 'PPH', 'XPH']","tiziana,safety,biomarker,info,intranasal,na-spms,ectrims,annual,congress,xbi,ibd,pph,xph",tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph,tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,1.0,True
210,218,2023-10-11 13:04:57.0,"ðŸ“¢Dr V. wee Yong @UCalgary
âœ…microglia and monocyte-derived MÎ¸ in lesions of #MS - how can we target these?
ðŸŽ¯BTK highly expressed on these cells in MS lesions
ðŸ¤”hydroxychloroquine for PPMS
#ECTRIMS2023 #MSMILAN2023 https://t.co/wrucXuTJFz",twitter,CAN,DrHArmstrong,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",ðŸ“¢dr v. wee yong @ucalgary âœ…microglia and monocyte-derived mÎ¸ in lesions of #ms - how can we target these? ðŸŽ¯btk highly expressed on these cells in ms lesions ðŸ¤”hydroxychloroquine for ppms #ectrims2023 #msmilan2023 https://t.co/wrucxutjfz,female,"#ms, #ectrims2023, #msmilan2023",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",6000000000,2340290918,,1797,1036,2,,,0,0,2223,False,dr v. wee yong microglia and monocyte-derived m in lesions of ms - how can we target these? btk highly expressed on these cells in ms lesions hydroxychloroquine for ppms ec trims ms milan,"['Wee Yong', 'Microglia', 'Monocyte', 'Lesions', 'MS', 'BTK', 'Hydroxychloroquine', 'PPMS', 'EC', 'Milan']","wee yong,microglia,monocyte,lesions,ms,btk,hydroxychloroquine,ppms,ec,milan",wee yong microglia monocyte lesions btk hydroxychloroquine ppms,wee yong microglia monocyte lesions btk hydroxychloroquine ppms,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.7116201739145475,False
211,219,2023-10-11 13:02:45.0,Depression and MS conclusions .. CBT helps depression and anxiety #ectrims2023 https://t.co/xnTL64bMwo,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",depression and ms conclusions .. cbt helps depression and anxiety #ectrims2023 https://t.co/xntl64bmwo,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,469,2043,0,,,0,0,1815,False,depression and ms conclusions .. cbt helps depression and anxiety ec trims,"['depression', 'ms', 'conclusions', 'cbt', 'helps', 'anxiety', 'ec', 'trims']","depression,ms,conclusions,cbt,helps,anxiety,ec,trims",depression conclusions cbt helps anxiety,depression conclusions cbt helps anxiety,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,1.0,False
212,220,2023-10-11 13:01:31.0,@gianmarcoabba reveals a key issue: Epstein Barr Virus-specific CD8+ T cells decrease post-Ocrelizumab treatment. How close are we to fully grasping MS's origin and its relationship with EBV? @ECTRIMS #MSMilan2023,twitter,ESP,andreuvilaseca7,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",@gianmarcoabba reveals a key issue: epstein barr virus-specific cd8+ t cells decrease post-ocrelizumab treatment. how close are we to fully grasping ms's origin and its relationship with ebv? @ectrims #msmilan2023,male,#msmilan2023,,,6000000000,226254369,,504,793,0,,,1,4,2193,False,reveals a key issue: epstein barr virus-specific cd8+ t cells decrease post-ocrelizumab treatment. how close are we to fully grasping ms's origin and its relationship with ebv? ms milan,"['Epstein Barr virus', 'CD8+ T cells', 'Ocrelizumab', 'MS', 'origin', 'relationship', 'Milan']","epstein barr virus,cd8+ t cells,ocrelizumab,ms,origin,relationship,milan",epstein barr virus cd8+ t cells ocrelizumab origin relationship,epstein barr virus cd8+ t cells ocrelizumab origin relationship,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,1.0,False
213,221,2023-10-11 13:00:27.0,"Have you heard of MSMilan Patient Community Day? Connect with the MS community online: share your questions, voice your needs and spark conversations.

ðŸ“…Saturday 14 October 2023
âž¡ï¸Register to the event: https://t.co/IKRU9Eg19J

#ECTRIMS4me https://t.co/iaFwrdmuxk",twitter,GBR,mssocietyuk,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","have you heard of msmilan patient community day? connect with the ms community online: share your questions, voice your needs and spark conversations. ðŸ“…saturday 14 october 2023 âž¡ï¸register to the event: https://t.co/ikru9eg19j #ectrims4me https://t.co/iafwrdmuxk",female,#ectrims4me,,,6000000000,10869022,,55540,4343,0,,,3,9,54548,False,"have you heard of msmilan patient community day? connect with the ms community online: share your questions, voice your needs and spark conversations. saturday 14 october 2023 register to the event: ec trims4me","['MSmilan', 'patient', 'community', 'day', 'MS', 'multiple sclerosis', 'connect', 'online', 'share', 'questions', 'voice', 'needs', 'conversation', 'Saturday', 'October', '2023', 'register', 'event', 'EC', 'trims']","msmilan,patient,community,day,ms,multiple sclerosis,connect,online,share,questions,voice,needs,conversation,saturday,october,2023,register,event,ec,trims",msmilan day connect online share questions voice needs conversation saturday october 2023 register event,msmilan day connect online share questions voice needs conversation saturday october 2023 register event,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,True
214,222,2023-10-11 13:00:01.0,"ðŸ“¢ #News: Weâ€™re presenting data at #ECTRIMS2023 on our investigational BTK inhibitor for people with relapsing multiple sclerosis. Find out more here: https://t.co/bD6oPKqssW 

#MS #Neurology #HCPsOnly https://t.co/oagzdgNrBi",twitter,USA,EMDSerono,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",ðŸ“¢ #news: weâ€™re presenting data at #ectrims2023 on our investigational btk inhibitor for people with relapsing multiple sclerosis. find out more here: https://t.co/bd6opkqssw #ms #neurology #hcpsonly https://t.co/oagzdgnrbi,unknown,"#news, #ectrims2023, #ms, #neurology, #hcpsonly",Business,,6000000000,574524931,,9119,781,0,,,0,0,4469,False,#news: were presenting data at ec trims on our investigational btk inhibitor for people with relapsing multiple sclerosis. find out more here: ms #neurology #hcpsonly,"['data', 'ec', 'investigational', 'btk', 'inhibitor', 'people', 'relapsing', 'multiple', 'sclerosis', 'news', 'neurology', 'hcpsonly']","data,ec,investigational,btk,inhibitor,people,relapsing,multiple,sclerosis,news,neurology,hcpsonly",investigational btk inhibitor people relapsing multiple sclerosis news neurology hcpsonly,investigational btk inhibitor people relapsing multiple sclerosis news neurology hcpsonly,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
215,223,2023-10-11 12:57:17.0,GREAT speech by @BenedettaBodin1 at #MSMilan2023 about PET imaging and advances in MS! https://t.co/k7SENOJQcp,twitter,FRA,MyelinIcm,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",great speech by @benedettabodin1 at #msmilan2023 about pet imaging and advances in ms! https://t.co/k7senojqcp,female,#msmilan2023,"Beauty/Health & Fitness, Science, Animals & Pets",,6000000000,1451160878309679104,,247,190,1,,,7,28,66,False,great speech by at ms milan about pet imaging and advances in ms!,"['MS', 'Milan', 'pet imaging', 'speech']","ms,milan,pet imaging,speech",pet imaging speech,pet imaging speech,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.5400182173666698,False
216,224,2023-10-11 12:56:37.0,Dr Feinstein shares 16-weeks of cognitive behavioural therapy show benefits for depression in people with MS @ECTRIMS #MSMilan2023 https://t.co/QqlpvcwN7R,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr feinstein shares 16-weeks of cognitive behavioural therapy show benefits for depression in people with ms @ectrims #msmilan2023 https://t.co/qqlpvcwn7r,female,#msmilan2023,,,6000000000,256679634,,1172,1912,0,,,0,2,6570,False,dr feinstein shares 16-weeks of cognitive behavioural therapy show benefits for depression in people with ms ms milan,"['Dr Feinstein', 'Cognitive Behavioural Therapy', 'Depression', 'MS', 'Milan']","dr feinstein,cognitive behavioural therapy,depression,ms,milan",dr feinstein cognitive behavioural therapy depression,dr feinstein cognitive behavioural therapy depression,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,1.0,False
217,225,2023-10-11 12:50:22.0,Atrophy in hippocampus and elevated cortisol can increase depression in MS #ectrims2023 https://t.co/xu1uQip6HW,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",atrophy in hippocampus and elevated cortisol can increase depression in ms #ectrims2023 https://t.co/xu1uqip6hw,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,469,2043,0,,,0,0,1812,False,atrophy in hippocampus and elevated cortisol can increase depression in ms ec trims,"['atrophy', 'hippocampus', 'cortisol', 'depression', 'MS', 'ec', 'trims']","atrophy,hippocampus,cortisol,depression,ms,ec,trims",atrophy hippocampus cortisol depression,atrophy hippocampus cortisol depression,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,0.9364971239582229,False
218,226,2023-10-11 12:48:56.0,Dr Anthony Feinstein discusses psychiatric comorbidity in MS @ECTRIMS #MSMilan2023 https://t.co/0TQk5NDTWB,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr anthony feinstein discusses psychiatric comorbidity in ms @ectrims #msmilan2023 https://t.co/0tqk5ndtwb,female,#msmilan2023,,,6000000000,256679634,,1172,1912,0,,,0,1,6569,False,dr anthony feinstein discusses psychiatric comorbidity in ms ms milan,"['Anthony Feinstein', 'MS', 'Milan']","anthony feinstein,ms,milan",anthony feinstein,anthony feinstein,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
219,227,2023-10-11 12:47:20.0,Cognition and MS Summary .. John Deluca . #ectrims2023 https://t.co/e3DMYXNfr5,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",cognition and ms summary .. john deluca . #ectrims2023 https://t.co/e3dmyxnfr5,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,469,2043,0,,,0,0,1810,False,cognition and ms summary .. john deluca . ec trims,"['cognition', 'MS', 'summary', 'John DeLuca', 'EC trims']","cognition,ms,summary,john deluca,ec trims",cognition summary john deluca,cognition summary john deluca,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
220,228,2023-10-11 12:35:17.0,"@ThINk_Basel wholistic intro to AI and its application to MS detection by Prof. Cristina Granziera @ECTRIMS 
#MSMilan2023 https://t.co/1l0NGfeOHv",twitter,ITA,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@think_basel wholistic intro to ai and its application to ms detection by prof. cristina granziera @ectrims #msmilan2023 https://t.co/1l0ngfeohv,,#msmilan2023,Beauty/Health & Fitness,,6000000000,1493181686426779654,,88,64,0,,,2,3,16,False,wholistic intro to ai and its application to ms detection by prof. cristina granziera ms milan,"['Artificial Intelligence', 'Multiple Sclerosis', 'Cristina Granziera', 'Milan']","artificial intelligence,multiple sclerosis,cristina granziera,milan",artificial intelligence cristina granziera,artificial intelligence cristina granziera,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
221,229,2023-10-11 12:15:00.0,Stay up to date on findings from the Phase III OCARINA II trial at #MSMilan2023. View late-breaking Poster P370 to see the data comparing an investigational subcutaneous injection formulation of an anti-CD20 monoclonal antibody vs an IV infusion in patients with MS. #NeuroTwitter,twitter,USA,GenentechMed,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=19587268, name=SC, displayName=null, parentId=19587266, parentName=Crova generative AI_SML}",stay up to date on findings from the phase iii ocarina ii trial at #msmilan2023. view late-breaking poster p370 to see the data comparing an investigational subcutaneous injection formulation of an anti-cd20 monoclonal antibody vs an iv infusion in patients with ms. #neurotwitter,,"#msmilan2023, #neurotwitter",Beauty/Health & Fitness,,6000000000,1405237666677891073,,153,0,0,,,1,0,56,False,stay up to date on findings from the phase iii ocarina ii trial at ms milan. view late-breaking poster p370 to see the data comparing an investigational subcutaneous injection formulation of an anti-cd20 monoclonal antibody vs an iv infusion in patients with ms. #neurotwitter,"['Ocarina II trial', 'MS Milan', 'anti-CD20 monoclonal antibody', 'IV infusion', 'neuroTwitter']","ocarina ii trial,ms milan,anti-cd20 monoclonal antibody,iv infusion,neurotwitter",ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter,ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,0.9952723660760542,True
222,230,2023-10-11 11:45:28.0,Ozanimod Data in preservation of brain volume in early MS #ectrims2023 https://t.co/9nokNryLcq,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ozanimod data in preservation of brain volume in early ms #ectrims2023 https://t.co/9noknrylcq,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,468,2043,0,,,0,1,1802,False,ozanimod data in preservation of brain volume in early ms ec trims,"['ozanimod', 'brain', 'volume', 'early', 'MS', 'EC', 'trims']","ozanimod,brain,volume,early,ms,ec,trims",ozanimod brain volume early,ozanimod brain volume early,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
223,231,2023-10-11 11:44:08.0,"Wonderful to see our members at #MSMilan2023! Many friends within #MultipleSclerosis community already visited our booth to say helloðŸ¤—
If you have not done that yet, we are eagerly awaiting to see you at our booth Nr. 1âƒ£4âƒ£ ðŸ™Œ
@ECTRIMS @ACTRIMS #ECTRIMS2023 https://t.co/9lsry19Gpa",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","wonderful to see our members at #msmilan2023! many friends within #multiplesclerosis community already visited our booth to say helloðŸ¤— if you have not done that yet, we are eagerly awaiting to see you at our booth nr. 1âƒ£4âƒ£ ðŸ™Œ @ectrims @actrims #ectrims2023 https://t.co/9lsry19gpa",female,"#msmilan2023, #multiplesclerosis, #ectrims2023",,,6000000000,600110872,,4865,891,0,,,2,14,5924,False,"wonderful to see our members at ms milan! many friends within multiple sclerosis community already visited our booth to say hello if you have not done that yet, we are eagerly awaiting to see you at our booth nr. 14 ec trims","['ms', 'members', 'Milan', 'visit', 'booth', 'hello', 'eagerly', 'awaiting', 'EC', 'trims']","ms,members,milan,visit,booth,hello,eagerly,awaiting,ec,trims",members visit booth hello eagerly awaiting,members visit booth hello eagerly awaiting,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
224,232,2023-10-11 11:33:37.0,Thalamus as relay station and thalamic atrophy in MS #ectrims2023 https://t.co/p0YyQ7oqsR,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",thalamus as relay station and thalamic atrophy in ms #ectrims2023 https://t.co/p0yyq7oqsr,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,468,2043,0,,,0,0,1799,False,thalamus as relay station and thalamic atrophy in ms ec trims,"['Thalamus', 'relay station', 'atrophy', 'MS', 'EC', 'trim']","thalamus,relay station,atrophy,ms,ec,trim",thalamus relay station atrophy trim,thalamus relay station atrophy trim,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
225,233,2023-10-11 11:33:32.0,"@ThINk_Basel Prof. Granziera now discussing smoldering MS @ECTRIMS 
#MSMilan2023 https://t.co/WLVhHFfVMb",twitter,ITA,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@think_basel prof. granziera now discussing smoldering ms @ectrims #msmilan2023 https://t.co/wlvhhffvmb,,#msmilan2023,Beauty/Health & Fitness,,6000000000,1493181686426779654,,88,64,0,,,0,5,13,False,prof. granziera now discussing smoldering ms ms milan,"['Granziera', 'Milan', 'MS', 'smoldering']","granziera,milan,ms,smoldering",granziera smoldering,granziera smoldering,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
226,234,2023-10-11 11:30:00.0,We're pleased to share the latest results from a real-world analysis of the largest available database for pregnancy and infant outcomes in women receiving an anti-CD20 monoclonal antibody for #multiplesclerosis. See Poster P061 at #MSMilan2023 to learn more. #NeuroTwitter,twitter,USA,GenentechMed,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",we're pleased to share the latest results from a real-world analysis of the largest available database for pregnancy and infant outcomes in women receiving an anti-cd20 monoclonal antibody for #multiplesclerosis. see poster p061 at #msmilan2023 to learn more. #neurotwitter,,"#multiplesclerosis, #msmilan2023, #neurotwitter",Beauty/Health & Fitness,,6000000000,1405237666677891073,,152,0,0,,,0,0,53,False,we're pleased to share the latest results from a real-world analysis of the largest available database for pregnancy and infant outcomes in women receiving an anti-cd20 monoclonal antibody for multiple sclerosis. see poster p061 at ms milan to learn more. #neurotwitter,"['pregnancy', 'infant', 'outcomes', 'anti-cd20', 'monoclonal antibody', 'multiple sclerosis', 'poster', 'neurotwitter']","pregnancy,infant,outcomes,anti-cd20,monoclonal antibody,multiple sclerosis,poster,neurotwitter",pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter,pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,1.0,True
227,235,2023-10-11 11:24:28.0,We're ready for day 1 of #ECTRIMS2023 in #Milan and can't wait to get started! #MS #AsOneForPatients @ECTRIMS https://t.co/qEtjoaR4jP,twitter,DEU,MerckHealthcare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",we're ready for day 1 of #ectrims2023 in #milan and can't wait to get started! #ms #asoneforpatients @ectrims https://t.co/qetjoar4jp,unknown,"#ectrims2023, #milan, #ms, #asoneforpatients",,,6000000000,857893749959086080,,7565,623,0,,,1,15,4080,False,we're ready for day 1 of ec trims in milan and can't wait to get started! ms #asoneforpatients,"['day', 'ready', 'Milan', 'start', 'excited', 'patients', 'AS ONE']","day,ready,milan,start,excited,patients,as one",day ready start excited as one,day ready start excited as one,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9384031113344851,False
228,236,2023-10-11 11:22:04.0,Today we announced Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress. $TLSA #multiplesclerosis #SPMS #MS #MSMilan2023 #ECTRIMS #ACTRIMSâ€¦,twitter,,TizianaLS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",today we announced presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress. $tlsa #multiplesclerosis #spms #ms #msmilan2023 #ectrims #actrimsâ€¦,unknown,"#multiplesclerosis, #spms, #ms, #msmilan2023, #ectrims, #actrims",,,6000000000,847823456758575105,,1410,304,0,,,1,28,366,True,today we announced presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress. $tlsa multiple sclerosis #spms ms ms milan ec trims #actrims,"['TLSa', 'SPMS', 'MS', 'Milan', 'EC', 'ECTRIMS', 'announcement', 'safety', 'biomarker', 'data', 'patients', 'non-active secondary progressive multiple sclerosis', 'presentation.']","tlsa,spms,ms,milan,ec,ectrims,announcement,safety,biomarker,data,patients,non-active secondary progressive multiple sclerosis,presentation.",tlsa spms announcement safety biomarker non-active secondary progressive multiple sclerosis presentation.,tlsa spms announcement safety biomarker non-active secondary progressive multiple sclerosis presentation.,15,15_womenshealth_multiple_sclerosis_exposome,Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors,"['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['sclerosis', 'neuroimmunology', 'womenshealth', 'autoimmune', 'spondylitis', 'arthritis', 'immune', 'immunology', 'rheumatoid', 'malignancy']","[""Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors"", '', '', '', '', '', '', '', '', '']","['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb', 'womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut', 'multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ']",womenshealth - multiple - sclerosis - exposome - cancer - publichealth - primarycare - prescriptions - sunlight - neurological,0.7651426778569614,False
229,237,2023-10-11 11:21:42.0,Brilliant opening lecture at #MSMilan2023 by Prof Steven Hauser on the Path to Cure for MS. So much progress and incredible opportunities to create a world free of #MS. https://t.co/kLUs6kcnCK,twitter,USA,tim_coetzee,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",brilliant opening lecture at #msmilan2023 by prof steven hauser on the path to cure for ms. so much progress and incredible opportunities to create a world free of #ms. https://t.co/klus6kcnck,male,"#msmilan2023, #ms",Science,,6000000000,29843656,,556,229,0,,,4,19,611,True,brilliant opening lecture at ms milan by prof steven hauser on the path to cure for ms. so much progress and incredible opportunities to create a world free of ms.,"['brilliant', 'opening', 'lecture', 'MS', 'Milan', 'Prof', 'Steven Hauser', 'path', 'cure', 'multiple sclerosis', 'progress', 'opportunities', 'world', 'free', 'disease']","brilliant,opening,lecture,ms,milan,prof,steven hauser,path,cure,multiple sclerosis,progress,opportunities,world,free,disease",brilliant opening lecture prof steven hauser path cure progress opportunities world free disease,brilliant opening lecture prof steven hauser path cure progress opportunities world free disease,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,1.0,False
230,238,2023-10-11 11:12:04.0,Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress $TLSA https://t.co/NeZK4H0M34,twitter,USA,health_stocks,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",tiziana announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress $tlsa https://t.co/nezk4h0m34,unknown,,"Business, Science",,6000000000,1090012514820280324,,690,157,0,,,0,0,14832,True,tiziana announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress $tlsa,"['Tiziana', 'presentation', 'safety', 'biomarker', 'data', 'patients', 'non-active', 'secondary', 'progressive', 'multiple sclerosis', 'na-spms', 'ECTRIMS', 'annual congress', 'TLS']","tiziana,presentation,safety,biomarker,data,patients,non-active,secondary,progressive,multiple sclerosis,na-spms,ectrims,annual congress,tls",tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls,tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,0.9975085335410669,True
231,239,2023-10-11 10:57:23.0,"Incredible plenary session by Dr Hauser (UCSF) about multiple phases of autoimmunity, and multiple mechanisms of inflammation in MS #msmilan2023 https://t.co/9IJN8kPlHi",twitter,ITA,samjcohn,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","incredible plenary session by dr hauser (ucsf) about multiple phases of autoimmunity, and multiple mechanisms of inflammation in ms #msmilan2023 https://t.co/9ijn8kplhi",male,#msmilan2023,Games,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,8294442,,13261,3177,0,,,0,3,13007,False,"incredible plenary session by dr hauser (ucsf) about multiple phases of autoimmunity, and multiple mechanisms of inflammation in ms ms milan","['Dr. Hauser', 'UCSF', 'autoimmunity', 'multiple sclerosis', 'MS', 'Milan', 'inflammation']","dr. hauser,ucsf,autoimmunity,multiple sclerosis,ms,milan,inflammation",dr. hauser ucsf autoimmunity inflammation,dr. hauser ucsf autoimmunity inflammation,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
232,240,2023-10-11 10:40:34.0,"Thought-provoking, superb talk by Stephen Hauser: the path to prevent and cure MS. #MSMilan2023. #ECTRIMS #ACTRIMS https://t.co/JVyADCyeUh",twitter,ESP,GeoArrambide,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","thought-provoking, superb talk by stephen hauser: the path to prevent and cure ms. #msmilan2023. #ectrims #actrims https://t.co/jvyadcyeuh",female,"#msmilan2023, #ectrims, #actrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1448356440108830725,,532,171,0,,,5,22,719,False,"thought-provoking, superb talk by stephen hauser: the path to prevent and cure ms. ms milan. ec trims #actrims","['Stephen Hauser', 'MS', 'talk', 'prevent', 'cure', 'trim']","stephen hauser,ms,talk,prevent,cure,trim",stephen hauser talk prevent cure trim,stephen hauser talk prevent cure trim,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,1.0,True
233,241,2023-10-11 10:37:29.0,"Day 1 of #MSMilan2023, surrounded by thousands of colleagues in the pursuit of progress for every person with MS. Every Person. Every Pathway. The energy here is brilliant! #ECTRIMS #ACTRIMS #multiplesclerosis https://t.co/UOeF7EwEmy",twitter,,mssocietyHCP,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","day 1 of #msmilan2023, surrounded by thousands of colleagues in the pursuit of progress for every person with ms. every person. every pathway. the energy here is brilliant! #ectrims #actrims #multiplesclerosis https://t.co/uoef7ewemy",female,"#msmilan2023, #ectrims, #actrims, #multiplesclerosis",Beauty/Health & Fitness,,6000000000,1321452751818207232,,394,146,0,,,2,10,396,False,"day 1 of ms milan, surrounded by thousands of colleagues in the pursuit of progress for every person with ms. every person. every pathway. the energy here is brilliant! ec trims #actrims multiple sclerosis","['ms', 'Milan', 'colleagues', 'progress', 'person', 'pathway', 'energy', 'brilliant', 'actrims', 'multiple sclerosis']","ms,milan,colleagues,progress,person,pathway,energy,brilliant,actrims,multiple sclerosis",colleagues progress person pathway energy brilliant actrims,colleagues progress person pathway energy brilliant actrims,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.37059605716975375,False
234,242,2023-10-11 10:28:20.0,"Prof Stephen Hauser giving opening @ECTRIMS lecture, discussing patterns of autoimmunity in different conditions. As someone living with #RheumatoidArthritis I had no idea autoantibodies could be present 20 years before clinical signs! What could it mean for #MS?
 
#MSMilan2023 https://t.co/YkT0ajqIFs",twitter,GBR,AnneHelme,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","prof stephen hauser giving opening @ectrims lecture, discussing patterns of autoimmunity in different conditions. as someone living with #rheumatoidarthritis i had no idea autoantibodies could be present 20 years before clinical signs! what could it mean for #ms? #msmilan2023 https://t.co/ykt0ajqifs",female,"#rheumatoidarthritis, #ms, #msmilan2023",Beauty/Health & Fitness,,6000000000,46126120,,1054,1040,0,,,1,5,3293,False,"prof stephen hauser giving opening lecture, discussing patterns of autoimmunity in different conditions. as someone living with #rheumatoidarthritis i had no idea autoantibodies could be present 20 years before clinical signs! what could it mean for ms? ms milan","['Stephen Hauser', 'rheumatoid arthritis', 'autoimmunity', 'autoantibodies', 'MS', 'Milan']","stephen hauser,rheumatoid arthritis,autoimmunity,autoantibodies,ms,milan",stephen hauser rheumatoid arthritis autoimmunity autoantibodies,stephen hauser rheumatoid arthritis autoimmunity autoantibodies,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
235,243,2023-10-11 10:22:26.0,"#MSMilan2023 Patient Community Day is ðŸ”œ this Saturday! Prof @MarTintore highlighted during the opening:
ðŸ‘ @ECTRIMS @ACTRIMS are focusing more on patient engagement and this patient day is bringing in people with #MS together with researchers
#ECTRIMS4me
Link for registration ðŸ‘‡",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#msmilan2023 patient community day is ðŸ”œ this saturday! prof @martintore highlighted during the opening: ðŸ‘ @ectrims @actrims are focusing more on patient engagement and this patient day is bringing in people with #ms together with researchers #ectrims4me link for registration ðŸ‘‡,female,"#msmilan2023, #ms, #ectrims4me",,,6000000000,600110872,,4863,891,0,,,4,9,5921,False,ms milan patient community day is this saturday! prof highlighted during the opening: are focusing more on patient engagement and this patient day is bringing in people with ms together with researchers ec trims4me link for registration,"['ms', 'Milan', 'patient', 'community', 'Saturday', 'highlighted', 'opening', 'focusing', 'patient engagement', 'people', 'MS', 'researchers', 'registration']","ms,milan,patient,community,saturday,highlighted,opening,focusing,patient engagement,people,ms,researchers,registration",saturday highlighted opening focusing patient engagement people researchers registration,saturday highlighted opening focusing patient engagement people researchers registration,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
236,244,2023-10-11 10:19:45.0,"We're at @ECTRIMS the worldâ€™s largest research conference for MS. We're here to find out the latest advancements and discoveries in MS research and treatment.

Weâ€™ll be sharing some of the hot topics over the coming days, on things like EBV and the gut brain axis.

#MSMilan2023 https://t.co/VBx3QzeDSm",twitter,GBR,mssocietyuk,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","we're at @ectrims the worldâ€™s largest research conference for ms. we're here to find out the latest advancements and discoveries in ms research and treatment. weâ€™ll be sharing some of the hot topics over the coming days, on things like ebv and the gut brain axis. #msmilan2023 https://t.co/vbx3qzedsm",female,#msmilan2023,,,6000000000,10869022,,55539,4343,0,,,3,44,54547,False,"we're at the worlds largest research conference for ms. we're here to find out the latest advancements and discoveries in ms research and treatment. well be sharing some of the hot topics over the coming days, on things like ebv and the gut brain axis. ms milan","['ms', 'research', 'conference', 'advancements', 'discoveries', 'ms research', 'treatment', 'ebv', 'gut brain axis']","ms,research,conference,advancements,discoveries,ms research,treatment,ebv,gut brain axis",conference advancements discoveries ms research ebv gut brain axis,conference advancements discoveries ms research ebv gut brain axis,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.9945721725350324,False
237,245,2023-10-11 10:19:01.0,"RC2NB @ECTRIMS and excited to learn about the newest developments in MS therapy towards a cure

#MSMilan2023 https://t.co/0QcBltJ4wH",twitter,CHE,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",rc2nb @ectrims and excited to learn about the newest developments in ms therapy towards a cure #msmilan2023 https://t.co/0qcbltj4wh,,#msmilan2023,Beauty/Health & Fitness,,6000000000,1493181686426779654,,88,64,0,,,0,4,12,False,rc2nb and excited to learn about the newest developments in ms therapy towards a cure ms milan,"['Multiple Sclerosis (MS)', 'Therapy', 'Cure', 'Milan']","multiple sclerosis (ms),therapy,cure,milan",multiple sclerosis (ms) therapy cure,multiple sclerosis (ms) therapy cure,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,True
238,246,2023-10-11 10:14:15.0,Dr. Stephen Hauser shares there are more than 230 genetic loci for MS susceptibility and more recent loci in severity @ECTRIMS #msmilan2023 https://t.co/El2WZBP5zL,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. stephen hauser shares there are more than 230 genetic loci for ms susceptibility and more recent loci in severity @ectrims #msmilan2023 https://t.co/el2wzbp5zl,female,#msmilan2023,,,6000000000,256679634,,1171,1912,1,,,0,0,6566,False,dr. stephen hauser shares there are more than 230 genetic loci for ms susceptibility and more recent loci in severity ms milan,"['Stephen Hauser', 'genetic', 'loci', 'multiple sclerosis', 'susceptibility', 'severity', 'Milan']","stephen hauser,genetic,loci,multiple sclerosis,susceptibility,severity,milan",stephen hauser genetic loci susceptibility severity,stephen hauser genetic loci susceptibility severity,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,0.923884977895375,False
239,247,2023-10-11 10:08:45.0,Dr. Stephen Hauser describes #MS as one of the greatest advances in molecular medicine @ECTRIMS #msmilan2023,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. stephen hauser describes #ms as one of the greatest advances in molecular medicine @ectrims #msmilan2023,female,"#ms, #msmilan2023",,,6000000000,256679634,,1171,1912,0,,,1,1,6564,False,dr. stephen hauser describes ms as one of the greatest advances in molecular medicine ms milan,"['Dr.', 'Stephen Hauser', 'MS', 'molecular medicine', 'Milan']","dr.,stephen hauser,ms,molecular medicine,milan",dr. stephen hauser molecular medicine,dr. stephen hauser molecular medicine,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,1.0,False
240,248,2023-10-11 10:07:30.0,"@MarTintore, Massimo Filippi and Mark Freedman welcome us to #MSMilan2023. The most important MS highlight this year was mentioned: inclusion of certain DMTs in the WHO's essential medicines list. NMOSD and MOGAD also earning their place. #ECTRIMS #ACTRIMS @cemcat_em https://t.co/WURiFL39UO",twitter,ESP,GeoArrambide,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@martintore, massimo filippi and mark freedman welcome us to #msmilan2023. the most important ms highlight this year was mentioned: inclusion of certain dmts in the who's essential medicines list. nmosd and mogad also earning their place. #ectrims #actrims @cemcat_em https://t.co/wurifl39uo",female,"#msmilan2023, #ectrims, #actrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1448356440108830725,,532,171,0,,,3,22,717,False,", massimo filippi and mark freedman welcome us to ms milan. the most important ms highlight this year was mentioned: inclusion of certain dmts in the who's essential medicines list. nmosd and mogad also earning their place. ec trims #actrims","['Massimo Filippi', 'Mark Freedman', 'MS Milan', 'WHO', 'NMOsD', 'MOGAD', 'EC', 'ACTRIMS']","massimo filippi,mark freedman,ms milan,who,nmosd,mogad,ec,actrims",massimo filippi mark freedman who mogad actrims,massimo filippi mark freedman who mogad actrims,12,12_massimo_filippi_freedman_ciccarelli,"Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['massimo', 'zeposia', 'ciccarelli', 'olga', 'sastregarriga', 'filippi', 'prize', 'rachel', 'horne', 'french']","['Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.', '', '', '', '', '', '', '', '', '']","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['prof olga ciccarelli', 'massimo filippi mark freedman who mogad actrims', 'rachel horne prize massimo filippi']",massimo - filippi - freedman - ciccarelli - career - zeposia - olga - rms - sastregarriga - who,1.0,True
241,249,2023-10-11 10:07:03.0,Dr. Stephen Hauser : MS Path to a Cure  #ectrims2023 https://t.co/hfpXGdpLuB,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. stephen hauser : ms path to a cure #ectrims2023 https://t.co/hfpxgdplub,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,467,2043,0,,,1,6,1794,False,dr. stephen hauser : ms path to a cure ec trims,"['Dr.', 'Stephen', 'Hauser', 'MS', 'Path', 'Cure', 'ECTRMS', 'Trims']","dr.,stephen,hauser,ms,path,cure,ectrms,trims",dr. stephen hauser path cure ectrms,dr. stephen hauser path cure ectrms,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,1.0,True
242,250,2023-10-11 09:54:22.0,"âœ¨ So excited to attend #MSMilan2023! Check out our poster on healthcare utilization in MS teleneurology today ðŸ“žðŸ“º@MarisaMcginley 

See you all there! #MS #msresearch https://t.co/4vuSdOuQk9",twitter,,kaitlyn_palmer1,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",âœ¨ so excited to attend #msmilan2023! check out our poster on healthcare utilization in ms teleneurology today ðŸ“žðŸ“º@marisamcginley see you all there! #ms #msresearch https://t.co/4vusdouqk9,female,"#msmilan2023, #ms, #msresearch",,,6000000000,1288660763104743429,,89,87,1,,,0,9,12,False,so excited to attend ms milan! check out our poster on healthcare utilization in ms teleneurology today see you all there! ms msresearch,"['MS', 'Milan', 'poster', 'healthcare', 'utilization', 'MS research']","ms,milan,poster,healthcare,utilization,ms research",poster healthcare utilization ms research,poster healthcare utilization ms research,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
243,251,2023-10-11 09:53:49.0,"ðŸ“£ We are ready to greet all of you at the RIMS booth during #MSMilan2023!

Make sure to swing by booth E23 in the Exhibition Area to meet our team and discover more about RIMS, its initiatives, projects, and more. Join us for an enriching conversation.

#RIMS #MS #MSMilan202 https://t.co/ERc41FQNm5",twitter,BEL,eurims,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","ðŸ“£ we are ready to greet all of you at the rims booth during #msmilan2023! make sure to swing by booth e23 in the exhibition area to meet our team and discover more about rims, its initiatives, projects, and more. join us for an enriching conversation. #rims #ms #msmilan202 https://t.co/erc41fqnm5",,"#msmilan2023, #rims, #ms, #msmilan202",,,6000000000,421874295,,843,88,0,,,1,7,456,False,"we are ready to greet all of you at the rims booth during ms milan! make sure to swing by booth e23 in the exhibition area to meet our team and discover more about rims, its initiatives, projects, and more. join us for an enriching conversation. #rims ms msmilan202","['Greet', 'RIMS', 'MS Milan', 'booth', 'team', 'conversation', 'initiatives', 'projects.']","greet,rims,ms milan,booth,team,conversation,initiatives,projects.",greet rims booth team conversation initiatives projects.,greet rims booth team conversation initiatives projects.,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
244,252,2023-10-11 09:53:09.0,"The new era of MS treatment, WHO @ECTRIMS : â€œthe WHO emphasises the critical need to make MS treatments available in all health systems at all times.â€ https://t.co/sE728BiD0s",twitter,MEX,irenetrefrenk,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","the new era of ms treatment, who @ectrims : â€œthe who emphasises the critical need to make ms treatments available in all health systems at all times.â€ https://t.co/se728bid0s",female,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,196023048,,6427,1061,0,,,2,8,7019,False,"the new era of ms treatment, who : the who emphasises the critical need to make ms treatments available in all health systems at all times.","['Multiple Sclerosis (MS)', 'treatment', 'health systems', 'availability']","multiple sclerosis (ms),treatment,health systems,availability",multiple sclerosis (ms) health systems availability,multiple sclerosis (ms) health systems availability,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
245,253,2023-10-11 09:52:57.0,"The team are here in Milan at #ECTRIMS2023 come and say hello ðŸ‘‹ at Stand E.21

Looking forward to a day of talks and networking ðŸ¤

#MSMILAN2023 #MultipleSclerosis https://t.co/A7pX6xYGfH",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",the team are here in milan at #ectrims2023 come and say hello ðŸ‘‹ at stand e.21 looking forward to a day of talks and networking ðŸ¤ #msmilan2023 #multiplesclerosis https://t.co/a7px6xygfh,,"#ectrims2023, #msmilan2023, #multiplesclerosis",,,6000000000,325527212,,2289,1817,0,,,4,22,1820,False,the team are here in milan at ec trims come and say hello at stand e.21 looking forward to a day of talks and networking ms milan multiple sclerosis,"['Milan', 'EC Trims', 'MS Milan Multiple Sclerosis', 'team', 'talks', 'networking']","milan,ec trims,ms milan multiple sclerosis,team,talks,networking",ms milan multiple sclerosis team talks networking,ms milan multiple sclerosis team talks networking,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
246,254,2023-10-11 09:50:41.0,"@MarTintore, President @ECTRIMS launching #MSMilan2023 
ðŸ’¡""How we think of #MultipleSclerosis is changing! Every person and every pathway is our theme - we aim to be #inclusive not only in research and trials, but importantly with our community engagement"" https://t.co/BiNf02JQXZ",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@martintore, president @ectrims launching #msmilan2023 ðŸ’¡""how we think of #multiplesclerosis is changing! every person and every pathway is our theme - we aim to be #inclusive not only in research and trials, but importantly with our community engagement"" https://t.co/binf02jqxz",female,"#msmilan2023, #multiplesclerosis, #inclusive",,,6000000000,600110872,,4863,891,0,,,8,20,5919,False,", president launching ms milan ""how we think of multiple sclerosis is changing! every person and every pathway is our theme - we aim to be #inclusive not only in research and trials, but importantly with our community engagement""","['multiple sclerosis', 'inclusive', 'research', 'trials', 'community engagement']","multiple sclerosis,inclusive,research,trials,community engagement",inclusive trials community engagement,inclusive trials community engagement,11,11_trials_patient_clinical_outcomes,Advancements in Clinical Practice for Improved Health Outcomes,"['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['clinical', 'efficacy', 'fearlessforpatients', 'outcomes', 'trials', 'patient', 'trial', 'advancements', 'health', 'success']","['Advancements in Clinical Practice for Improved Health Outcomes', '', '', '', '', '', '', '', '', '']","['trials', 'patient', 'clinical', 'outcomes', 'health', 'advancements', 'science', 'practice', 'care', 'investigators']","['outcomes proms reflect daily life patient experience practical low cost high potential track progression efficacy intervention', 'dedication advancements patient care health outcomes science clinical practice', 'advancements patient care findings commitment science clinical practice health outcomes']",trials - patient - clinical - outcomes - health - advancements - science - practice - care - investigators,1.0,False
247,255,2023-10-11 09:45:26.0,"Live in 15 minutes! Stephen Hauser, Prof of Neurology at @UCSF is giving this yearâ€™s ECTRIMS Lecture, â€œMultiple sclerosis: Path to a cureâ€
 
ðŸ“… Wednesday 12.00â€“12.30 CEST 
âž¡ï¸ https://t.co/Mv3Q85yPdP
 
#MSMilan2023 @ACTRIMS https://t.co/CAu5wlOa9V",twitter,CHE,ECTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","live in 15 minutes! stephen hauser, prof of neurology at @ucsf is giving this yearâ€™s ectrims lecture, â€œmultiple sclerosis: path to a cureâ€ ðŸ“… wednesday 12.00â€“12.30 cest âž¡ï¸ https://t.co/mv3q85ypdp #msmilan2023 @actrims https://t.co/cau5wloa9v",,#msmilan2023,,,6000000000,714464982,,7948,65,0,,,4,15,7119,False,"live in 15 minutes! stephen hauser, prof of neurology at is giving this years ectrims lecture, multiple sclerosis: path to a cure wednesday 12.0012.30 cest ms milan","['Stephen Hauser', 'Neurology', 'ECTRIMS', 'Lecture', 'Multiple Sclerosis', 'Path to a Cure', 'Milan']","stephen hauser,neurology,ectrims,lecture,multiple sclerosis,path to a cure,milan",stephen hauser neurology lecture path to a cure,stephen hauser neurology lecture path to a cure,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,0.9554639039804703,True
248,256,2023-10-11 09:43:25.0,The first of two @MAGNIMS educational activities at #MSMilan23 @ECTRIMS was held this morning on â€œImaging features of MOGAD and differential diagnosis with MSâ€ with @alexrovirarayos @FBarkhof M. Filippi & J. Palace - Do not miss our second course on Friday! https://t.co/L5fMN0ar9Z,twitter,,MAGNIMS,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",the first of two @magnims educational activities at #msmilan23 @ectrims was held this morning on â€œimaging features of mogad and differential diagnosis with msâ€ with @alexrovirarayos @fbarkhof m. filippi & j. palace - do not miss our second course on friday! https://t.co/l5fmn0ar9z,unknown,#msmilan23,,,6000000000,2194426992,,1603,43,0,,,7,37,374,False,the first of two educational activities at msmilan23 was held this morning on imaging features of mogad and differential diagnosis with ms with m. filippi & j. palace - do not miss our second course on friday!,"['educational', 'activities', 'imaging', 'features', 'Mogad', 'differential', 'diagnosis', 'MS', 'msmilan23', 'Friday', 'course']","educational,activities,imaging,features,mogad,differential,diagnosis,ms,msmilan23,friday,course",educational activities imaging features mogad differential diagnosis msmilan23 friday course,educational activities imaging features mogad differential diagnosis msmilan23 friday course,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,1.0,True
249,257,2023-10-11 09:43:20.0,"Prof. @mtintore has opened the #MSMilan2023 , the biggest international congress about #multiplesclerosis  
@ECTRIMS @cemcat_em https://t.co/2VQeGanM0w",twitter,ESP,C_OrejaGuevara,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","prof. @mtintore has opened the #msmilan2023 , the biggest international congress about #multiplesclerosis @ectrims @cemcat_em https://t.co/2vqeganm0w",female,"#msmilan2023, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1221603110,,4142,1105,1,,,11,53,23709,False,"prof. has opened the ms milan , the biggest international congress about multiple sclerosis","['professor', 'Milan', 'multiple sclerosis', 'congress']","professor,milan,multiple sclerosis,congress",professor congress,professor congress,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
250,258,2023-10-11 09:41:49.0,2023 also brought consensus for a need for a new classification system for #MS #msmilan2023 @ECTRIMS https://t.co/wRxuKO1CxX,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",2023 also brought consensus for a need for a new classification system for #ms #msmilan2023 @ectrims https://t.co/wrxuko1cxx,female,"#ms, #msmilan2023",,,6000000000,256679634,,1171,1912,0,,,0,2,6560,False,2023 also brought consensus for a need for a new classification system for ms ms milan,"['ms', 'Milan', 'classification', 'system', '2023']","ms,milan,classification,system,2023",classification system 2023,classification system 2023,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
251,259,2023-10-11 09:40:13.0,"In 2023, WHO essential medicines list included disease-modifying therapies for #MS @ECTRIMS #MSMilan2023 https://t.co/FMUQVWIkpX",twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","in 2023, who essential medicines list included disease-modifying therapies for #ms @ectrims #msmilan2023 https://t.co/fmuqvwikpx",female,"#ms, #msmilan2023",,,6000000000,256679634,,1171,1912,0,,,1,7,6559,False,"in 2023, who essential medicines list included disease-modifying therapies for ms ms milan","['2023', 'essential', 'medicines', 'list', 'disease-modifying', 'therapies', 'MS', 'Milan']","2023,essential,medicines,list,disease-modifying,therapies,ms,milan",2023 essential medicines list disease-modifying therapies,2023 essential medicines list disease-modifying therapies,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,0.4962340442274282,False
252,260,2023-10-11 09:30:16.0,"ðŸ“… Join us today at our â€œIâ€™M INâ€ event, â€œUnleashing Potential: Transformational Leadership and Neuro Resilienceâ€ @ECTRIMS. Featuring Nobel Peace Prize Laureate @TawakkolKarman and #MultipleSclerosis specialists Dr. LÃ©orah Freeman and Dr. Augusto Miravalle #HCPsOnly #ECTRIMS2023 https://t.co/86TX8bVbzc",twitter,DEU,MerckHealthcare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","ðŸ“… join us today at our â€œiâ€™m inâ€ event, â€œunleashing potential: transformational leadership and neuro resilienceâ€ @ectrims. featuring nobel peace prize laureate @tawakkolkarman and #multiplesclerosis specialists dr. lÃ©orah freeman and dr. augusto miravalle #hcpsonly #ectrims2023 https://t.co/86tx8bvbzc",unknown,"#multiplesclerosis, #hcpsonly, #ectrims2023",,,6000000000,857893749959086080,,7566,623,14,,,4,28,4078,False,"join us today at our im in event, unleashing potential: transformational leadership and neuro resilience . featuring nobel peace prize laureate and multiple sclerosis specialists dr. lorah freeman and dr. augusto miravalle #hcpsonly ec trims","['join', 'today', 'event', 'unleashing', 'potential', 'transformational', 'leadership', 'neuro', 'resilience', 'Nobel', 'Peace', 'Prize', 'laureate', 'Dr.', 'Lorah', 'Freeman', 'Augusto', 'Miravalle', '']","join,today,event,unleashing,potential,transformational,leadership,neuro,resilience,nobel,peace,prize,laureate,dr.,lorah,freeman,augusto,miravalle,",join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ,join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.7303845421685964,True
253,261,2023-10-11 09:14:04.0,"#mentalhealth in people with #MS @#MSMilan2023 #ECTRIMS 

Adjustment to diagnosis &/or fnx change can feel like being hit by a tornado.

Prev rates #mentalhealth conditions in #MultipleSclerosis r 3-4x higher than the general population 

MS steals so much, donâ€™t let it steal Joy https://t.co/uL5ew0c0rT",twitter,ITA,DrAmyBSullivan,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","#mentalhealth in people with #ms @#msmilan2023 #ectrims adjustment to diagnosis &/or fnx change can feel like being hit by a tornado. prev rates #mentalhealth conditions in #multiplesclerosis r 3-4x higher than the general population ms steals so much, donâ€™t let it steal joy https://t.co/ul5ew0c0rt",female,"#mentalhealth, #ms, #msmilan2023, #ectrims, #mentalhealth, #multiplesclerosis",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Associate Professor}",6000000000,861179188430204928,,1967,1297,0,,,1,7,5644,False,"#mentalhealth in people with ms ms milan ec trims adjustment to diagnosis &/or fnx change can feel like being hit by a tornado. prev rates #mentalhealth conditions in multiple sclerosis r 3-4x higher than the general population ms steals so much, dont let it steal joy","['mentalhealth', 'MS', 'Milan', 'EC', 'trims', 'adjustment', 'diagnosis', 'FNX', 'change', 'tornado', 'rates', 'conditions', 'multiple sclerosis', 'steals', 'joy']","mentalhealth,ms,milan,ec,trims,adjustment,diagnosis,fnx,change,tornado,rates,conditions,multiple sclerosis,steals,joy",mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy,mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy,9,9_depression_comorbidities_ann_ruth,Comorbidities and Depression: Understanding the Progression and Treatment Pathways,"['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['comorbidities', 'comorbidity', 'depression', 'mentalhealth', 'anxiety', 'therapy', 'cortisol', 'treatment', 'health', 'cbt']","['Comorbidities and Depression: Understanding the Progression and Treatment Pathways', '', '', '', '', '', '', '', '', '']","['depression', 'comorbidities', 'ann', 'ruth', 'dr', 'delay', 'behavioural', 'conclusions', 'cortisol', 'cbt']","['mentalhealth adjustment diagnosis fnx change tornado rates conditions steals joy', 'ruth ann marie discusses latest comorbidities', 'dr. ruth ann marrie comorbidity attention prevention']",depression - comorbidities - ann - ruth - dr - delay - behavioural - conclusions - cortisol - cbt,1.0,True
254,262,2023-10-11 09:00:31.0,"Pathology continually sparks curiosity,answering questions while raising new ones
@LucchinettiMD's captivating talk at @ECTRIMS highlighted distinctive pathology in MS,MOGAD,and AQP4+NMOSD
Unique meningeal lymphoid follicles in MS underscore CNS compartmentalization? #MSMilan2023 https://t.co/VFKK2Grx5p",twitter,ESP,andreuvilaseca7,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","pathology continually sparks curiosity,answering questions while raising new ones @lucchinettimd's captivating talk at @ectrims highlighted distinctive pathology in ms,mogad,and aqp4+nmosd unique meningeal lymphoid follicles in ms underscore cns compartmentalization? #msmilan2023 https://t.co/vfkk2grx5p",male,#msmilan2023,,,6000000000,226254369,,504,791,0,,,0,2,2190,False,"pathology continually sparks curiosity,answering questions while raising new ones 's captivating talk at highlighted distinctive pathology in ms,mogad,and aqp4+nmosd unique meningeal lymphoid follicles in ms underscore cns compartmentalization? ms milan","['pathology', 'curiosity', 'questions', 'captivating talk', 'distinctive pathology', 'MS', 'Mogad', 'AQP4+NMOsD', 'unique meningeal lymphoid follicles', 'CNS compartmental']","pathology,curiosity,questions,captivating talk,distinctive pathology,ms,mogad,aqp4+nmosd,unique meningeal lymphoid follicles,cns compartmental",pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental,pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,0.6976638256224954,True
255,263,2023-10-11 08:56:03.0,"@J_SastreGarriga @ECTRIMS @cemcat_em @MAGNIMS @rocca_mara @DrWBRO @XMontalban @MarTintore @MSIntFederation @ACTRIMS @eumsplatform @FundacioEM @esclerosiseme @mssociety @MSJ_Research @EMdeMallorca Congratulations Pr Sastre-Garriga !! 25th Ectrims !!
Thank you for your career and your work for us !!
Thank you so much...
Nicolas, a French guy impacted by Multiple Sclerosis",twitter,FRA,D53Nicolas,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@j_sastregarriga @ectrims @cemcat_em @magnims @rocca_mara @drwbro @xmontalban @martintore @msintfederation @actrims @eumsplatform @fundacioem @esclerosiseme @mssociety @msj_research @emdemallorca congratulations pr sastre-garriga !! 25th ectrims !! thank you for your career and your work for us !! thank you so much... nicolas, a french guy impacted by multiple sclerosis",unknown,,Sports,,6000000000,1269759847035293700,,257,527,0,http://twitter.com/J_SastreGarriga/statuses/1711974035934826871,,0,7,24296,False,"congratulations pr sastre-garriga !! 25th ectrims !! thank you for your career and your work for us !! thank you so much... nicolas, a french guy impacted by multiple sclerosis","['Congratulations', 'Sastre-Garriga', 'ECTRIMS', 'career', 'work', 'French', 'multiple sclerosis']","congratulations,sastre-garriga,ectrims,career,work,french,multiple sclerosis",congratulations sastre-garriga career work french,congratulations sastre-garriga career work french,12,12_massimo_filippi_freedman_ciccarelli,"Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['massimo', 'zeposia', 'ciccarelli', 'olga', 'sastregarriga', 'filippi', 'prize', 'rachel', 'horne', 'french']","['Career achievements and notable individuals in the field of Massimo Filippi, including Olga Ciccarelli and Zeposia.', '', '', '', '', '', '', '', '', '']","['massimo', 'filippi', 'freedman', 'ciccarelli', 'career', 'zeposia', 'olga', 'rms', 'sastregarriga', 'who']","['prof olga ciccarelli', 'massimo filippi mark freedman who mogad actrims', 'rachel horne prize massimo filippi']",massimo - filippi - freedman - ciccarelli - career - zeposia - olga - rms - sastregarriga - who,1.0,False
256,264,2023-10-11 08:54:26.0,"ðŸ§ For #MentalHealthAwarenessDay I am fortunate to be in Milan @#MSMilan2023 #ECTRIMS presenting: Minding the Gap: #mentalhealth in #MS ðŸ§  ðŸ’š

So grateful for this opportunity ðŸ™ŒðŸ™ðŸ½ https://t.co/64piWDZYcp",twitter,USA,DrAmyBSullivan,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",ðŸ§ for #mentalhealthawarenessday i am fortunate to be in milan @#msmilan2023 #ectrims presenting: minding the gap: #mentalhealth in #ms ðŸ§  ðŸ’š so grateful for this opportunity ðŸ™ŒðŸ™ðŸ½ https://t.co/64piwdzycp,female,"#mentalhealthawarenessday, #msmilan2023, #ectrims, #mentalhealth, #ms",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Associate Professor}",6000000000,861179188430204928,,1967,1297,0,,,1,12,5643,False,for #mentalhealthawarenessday i am fortunate to be in milan ms milan ec trims presenting: minding the gap: #mentalhealth in ms so grateful for this opportunity,"['mental health', 'awareness day', 'Milan', 'MS', 'mental health awareness', 'Milan Ec Trims', 'Minding the Gap', 'opportunity']","mental health,awareness day,milan,ms,mental health awareness,milan ec trims,minding the gap,opportunity",mental health awareness day mental health awareness milan ec trims minding the gap opportunity,mental health awareness day mental health awareness milan ec trims minding the gap opportunity,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
257,265,2023-10-11 08:44:00.0,"Ultimate goal for #nurses is to â€œprovide a better standard of care for people with #MultipleSclerosis using #research, #evidencebased practice to ensure #qualityimprovement in MS services #role #value @iamIOMSN #UKMSSNA @ECTRIMS @amyharbour7 @MSTrustCEO @TheNeuroAcademy https://t.co/cxhELRJBxG",twitter,ITA,ruthstross,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ultimate goal for #nurses is to â€œprovide a better standard of care for people with #multiplesclerosis using #research, #evidencebased practice to ensure #qualityimprovement in ms services #role #value @iamiomsn #ukmssna @ectrims @amyharbour7 @mstrustceo @theneuroacademy https://t.co/cxhelrjbxg",female,"#nurses, #multiplesclerosis, #research, #evidencebased, #qualityimprovement, #role, #value, #ukmssna","Travel, Family & Parenting","{profession=Health practitioner, jobTitle=Nurse}",6000000000,264140472,,154,597,0,,,0,10,323,False,"ultimate goal for #nurses is to provide a better standard of care for people with multiple sclerosis using #research, #evidencebased practice to ensure #qualityimprovement in ms services #role #value #ukmssna","['nurses', 'research', 'evidence-based practice', 'quality improvement', 'MS services', 'role', 'value', 'UKMSNA']","nurses,research,evidence-based practice,quality improvement,ms services,role,value,ukmsna",nurses evidence-based practice quality improvement ms services role value ukmsna,nurses evidence-based practice quality improvement ms services role value ukmsna,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,0.8935048879583944,False
258,266,2023-10-11 08:40:12.0,"If at first you donâ€™t succeed, use more tape. Lessons learned at #ECTRIMS 2023â€¦

Stop by poster 203 this afternoon for a look at MS topography and our new Lesion Parenchymal Fraction concept! 
@ECTRIMS @icometrix https://t.co/aIHhKWMYXY",twitter,USA,SKriegerMD,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","if at first you donâ€™t succeed, use more tape. lessons learned at #ectrims 2023â€¦ stop by poster 203 this afternoon for a look at ms topography and our new lesion parenchymal fraction concept! @ectrims @icometrix https://t.co/aihhkwmyxy",male,#ectrims,Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,3028542540,,3103,493,0,,,3,26,757,False,"if at first you dont succeed, use more tape. lessons learned at ec trims 2023 stop by poster 203 this afternoon for a look at ms topography and our new lesion parenchymal fraction concept!","['succeed', 'tape', 'learn', 'lesson', 'topography', 'parenchymal', 'concept']","succeed,tape,learn,lesson,topography,parenchymal,concept",succeed tape learn lesson topography parenchymal concept,succeed tape learn lesson topography parenchymal concept,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.8812148038253063,False
259,267,2023-10-11 08:38:06.0,Dr. Deborah Pareto @idi_cat @VHIR_ @cemcat_em is now presenting in #MSMilan2023 a @MAGNIMS multicentre study exploring Inter- and Intrahemispheric connectivity and their clinical impact in #multiplesclerosis - Many thanks to all centres involved! https://t.co/gOSEue1pWj,twitter,ESP,J_SastreGarriga,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",dr. deborah pareto @idi_cat @vhir_ @cemcat_em is now presenting in #msmilan2023 a @magnims multicentre study exploring inter- and intrahemispheric connectivity and their clinical impact in #multiplesclerosis - many thanks to all centres involved! https://t.co/goseue1pwj,male,"#msmilan2023, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,829744742,,3211,866,1,,,9,25,6868,False,dr. deborah pareto is now presenting in ms milan a multicentre study exploring inter- and intrahemispheric connectivity and their clinical impact in multiple sclerosis - many thanks to all centres involved!,"['Deborah Pareto', 'MS', 'Milan', 'multicenter study', 'inter-hemispheric connectivity', 'intrahemispheric connectivity', 'clinical impact', 'multiple sclerosis']","deborah pareto,ms,milan,multicenter study,inter-hemispheric connectivity,intrahemispheric connectivity,clinical impact,multiple sclerosis",deborah pareto multicenter study inter-hemispheric connectivity intrahemispheric connectivity clinical impact,deborah pareto multicenter study inter-hemispheric connectivity intrahemispheric connectivity clinical impact,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
260,268,2023-10-11 08:31:35.0,"@DrHArmstrong @ECTRIMS Thank you for your work in MS and for your work for us, Dr Armstrong !!
Nicolas, a French guy impacted by Multiple Sclerosis",twitter,FRA,D53Nicolas,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@drharmstrong @ectrims thank you for your work in ms and for your work for us, dr armstrong !! nicolas, a french guy impacted by multiple sclerosis",unknown,,Sports,,6000000000,1269759847035293700,,257,526,0,http://twitter.com/DrHArmstrong/statuses/1711998683359629787,,0,1,24290,False,"thank you for your work in ms and for your work for us, dr armstrong !! nicolas, a french guy impacted by multiple sclerosis","['work', 'MS', 'French', 'impacted', 'multiple sclerosis']","work,ms,french,impacted,multiple sclerosis",work french impacted,work french impacted,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.797774618157768,False
261,269,2023-10-11 08:25:44.0,"ðŸ“¢ Dr Paolo Preziosa
âœ… lesions/atrophy linked to worsened outcomes accumulative disability (EDSS) 
âœ… No single biomarker likely
âœ… Relapse onset MS vs PPMS
ðŸ”‘In early disease conventional MRI
ðŸŽ¯chronic inflammation + GM/spinal cord involvement in dx MS
#ECTRIMS2023 #MSMILAN2023 https://t.co/SfMtLN26c4",twitter,CAN,DrHArmstrong,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}",ðŸ“¢ dr paolo preziosa âœ… lesions/atrophy linked to worsened outcomes accumulative disability (edss) âœ… no single biomarker likely âœ… relapse onset ms vs ppms ðŸ”‘in early disease conventional mri ðŸŽ¯chronic inflammation + gm/spinal cord involvement in dx ms #ectrims2023 #msmilan2023 https://t.co/sfmtln26c4,female,"#ectrims2023, #msmilan2023",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",6000000000,2340290918,,1795,1033,0,,,0,4,2212,False,dr paolo preziosa lesions/atrophy linked to worsened outcomes accumulative disability (edss) no single biomarker likely relapse onset ms vs ppms in early disease conventional mri chronic inflammation + gm/spinal cord involvement in dx ms ec trims ms milan,"['Dr', 'Paolo', 'Preziosa', 'Lesions', 'Atrophy', 'Worsened Outcomes', 'Accumulative Disability', 'EDSS', 'Biomarker', 'Relapse Onset', 'MS', 'PPMS', 'Early D']","dr,paolo,preziosa,lesions,atrophy,worsened outcomes,accumulative disability,edss,biomarker,relapse onset,ms,ppms,early d",dr paolo preziosa lesions atrophy worsened outcomes accumulative disability edss biomarker relapse onset ppms early d,dr paolo preziosa lesions atrophy worsened outcomes accumulative disability edss biomarker relapse onset ppms early d,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
262,270,2023-10-11 08:24:39.0,"@mcomabellalopez @ECTRIMS @XMontalban @GeoArrambide @MarTintore @SuOteroRomero talks on individualized vaccination strategy  as standard care in #MS.

Happening now at #MSMilan2023! https://t.co/hG8pDk5FN4",twitter,ESP,cemcat_em,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@mcomabellalopez @ectrims @xmontalban @geoarrambide @martintore @suoteroromero talks on individualized vaccination strategy as standard care in #ms. happening now at #msmilan2023! https://t.co/hg8pdk5fn4,unknown,"#ms, #msmilan2023",,,6000000000,1197805298,,3142,486,1,http://twitter.com/cemcat_em/statuses/1712017025340526638,,4,13,2888,False,talks on individualized vaccination strategy as standard care in ms. happening now at ms milan!,"['vaccination', 'strategy', 'individualized', 'MS', 'Milan']","vaccination,strategy,individualized,ms,milan",vaccination strategy individualized,vaccination strategy individualized,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.5404689303259682,False
263,271,2023-10-11 08:16:35.0,"ðŸ“¢ Dr Federica Esposito
âœ…Epigenetic factors, DNA methylation, and environment risk in MS (smoking/obesity)
âœ…MS display epigenetic age acceleration with immune links
#ECTRIMS2023 #MSMILAN2023 #MS https://t.co/1ABRg7Pxjl",twitter,CAN,DrHArmstrong,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸ“¢ dr federica esposito âœ…epigenetic factors, dna methylation, and environment risk in ms (smoking/obesity) âœ…ms display epigenetic age acceleration with immune links #ectrims2023 #msmilan2023 #ms https://t.co/1abrg7pxjl",female,"#ectrims2023, #msmilan2023, #ms",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",6000000000,2340290918,,1795,1033,0,,,0,0,2211,False,"dr federica esposito epigenetic factors, dna methylation, and environment risk in ms (smoking/obesity) ms display epigenetic age acceleration with immune links ec trims ms milan ms","['Federica Esposito', 'DNA methylation', 'MS', 'smoking', 'obesity', 'epigenetic age acceleration', 'immune system', 'Milan', 'EC.']","federica esposito,dna methylation,ms,smoking,obesity,epigenetic age acceleration,immune system,milan,ec.",federica esposito dna methylation smoking obesity epigenetic age acceleration immune system ec.,federica esposito dna methylation smoking obesity epigenetic age acceleration immune system ec.,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.9424133936304575,False
264,272,2023-10-11 08:16:02.0,Defining #multiplesclerosis #nursing @ECTRIMS the crucial role #nurses play within ALL parts of MS services from beginning onwards @alisonleary1 @amyharbour7 #UKMSSNA @Sue_NHiS @MSTrustCEO https://t.co/pcIHs0ePNh,twitter,ITA,ruthstross,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",defining #multiplesclerosis #nursing @ectrims the crucial role #nurses play within all parts of ms services from beginning onwards @alisonleary1 @amyharbour7 #ukmssna @sue_nhis @mstrustceo https://t.co/pcihs0epnh,female,"#multiplesclerosis, #nursing, #nurses, #ukmssna","Travel, Family & Parenting","{profession=Health practitioner, jobTitle=Nurse}",6000000000,264140472,,154,597,1,,,0,10,322,False,defining multiple sclerosis #nursing the crucial role #nurses play within all parts of ms services from beginning onwards #ukmssna,"['multiple sclerosis', 'nursing', 'crucial role', 'nurses', 'ms services', 'ukms']","multiple sclerosis,nursing,crucial role,nurses,ms services,ukms",nursing crucial role nurses ms services ukms,nursing crucial role nurses ms services ukms,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
265,273,2023-10-11 08:09:34.0,Let's go ðŸ˜ #MSmilan2023 #ms #multiplesclerosis #ectrims https://t.co/1cLzyDefGJ,twitter,,MSguncel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",let's go ðŸ˜ #msmilan2023 #ms #multiplesclerosis #ectrims https://t.co/1clzydefgj,female,"#msmilan2023, #ms, #multiplesclerosis, #ectrims",,,6000000000,1338606356346048512,,1448,61,0,,,1,21,819,False,let's go ms milan ms multiple sclerosis ec trims,"['MS', 'Milan', 'Multiple Sclerosis', 'EC', 'trims']","ms,milan,multiple sclerosis,ec,trims",,,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9856761948747765,False
266,274,2023-10-11 08:00:14.0,"Have you booked your Braindate at #MSMilan2023? Topic meetings are filling up. Connect & network with your colleagues via this customised service, available onsite and online
âž¡ï¸ https://t.co/CjiX1Vj4Qo 

@e180 https://t.co/JWTpHUEpek",twitter,CHE,ECTRIMS,,"have you booked your braindate at #msmilan2023? topic meetings are filling up. connect & network with your colleagues via this customised service, available onsite and online âž¡ï¸ https://t.co/cjix1vj4qo @e180 https://t.co/jwtphuepek",,#msmilan2023,,,6000000000,714464982,,7941,65,0,,,2,5,7099,False,"have you booked your braindate at ms milan? topic meetings are filling up. connect & network with your colleagues via this customised service, available onsite and online","['brain date', 'MS Milan', 'topic meetings', 'colleagues', 'customised service', 'onsite', 'online']","brain date,ms milan,topic meetings,colleagues,customised service,onsite,online",brain date topic meetings colleagues customised service onsite online,brain date topic meetings colleagues customised service onsite online,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
267,275,2023-10-11 07:58:35.0,Arrived at @ECTRIMS #MSMilan2023 ready to learn and share the latest research news on multiple sclerosis #MS! Goal is to improve the lives of those living with MS and hopefully preventing the disease! Iâ€™ll be live tweeting as usual. https://t.co/jHsKUxYFAl,twitter,USA,drbarrysinger,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",arrived at @ectrims #msmilan2023 ready to learn and share the latest research news on multiple sclerosis #ms! goal is to improve the lives of those living with ms and hopefully preventing the disease! iâ€™ll be live tweeting as usual. https://t.co/jhskuxyfal,male,"#msmilan2023, #ms",Science,,6000000000,1430793013,,7200,393,6,,,5,116,3149,False,arrived at ms milan ready to learn and share the latest research news on multiple sclerosis ms! goal is to improve the lives of those living with ms and hopefully preventing the disease! ill be live tweeting as usual.,"['ms', 'Milan', 'research', 'news', 'multiple sclerosis', 'improve', 'lives', 'prevent', 'disease', 'live', 'tweeting']","ms,milan,research,news,multiple sclerosis,improve,lives,prevent,disease,live,tweeting",news improve lives prevent disease live tweeting,news improve lives prevent disease live tweeting,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
268,276,2023-10-11 07:48:48.0,"ðŸš€And so #MSMilan2023 has begun! 
ðŸŽ¥Before the start, we asked our President @HerbertTemmes why this event is important, why we participate and what is our contribution? 
Watch the video ðŸ‘‡to find out the answers. 
@ECTRIMS @ACTRIMS #MultipleSclerosis https://t.co/yryZ51IZza",twitter,BEL,eumsplatform,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸš€and so #msmilan2023 has begun! ðŸŽ¥before the start, we asked our president @herberttemmes why this event is important, why we participate and what is our contribution? watch the video ðŸ‘‡to find out the answers. @ectrims @actrims #multiplesclerosis https://t.co/yryz51izza",female,"#msmilan2023, #multiplesclerosis",,,6000000000,600110872,,4862,891,0,,,7,20,5917,False,"and so ms milan has begun! before the start, we asked our president why this event is important, why we participate and what is our contribution? watch the video to find out the answers. multiple sclerosis","['MS Milan', 'event', 'start', 'president', 'answers', 'video', 'multiple sclerosis']","ms milan,event,start,president,answers,video,multiple sclerosis",event start president answers video,event start president answers video,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
269,277,2023-10-11 07:45:22.0,"Martina Absinta unveiled diverse mechanisms propelling the edge in chronic active MS lesions. Does this result from T lymphocytes or self-perpetuate via astrocytes nearby? A crucial query in understanding MS progression. #MultipleSclerosis 
#MSMilan2023 @ECTRIMS https://t.co/SR1CvheSYt",twitter,ESP,andreuvilaseca7,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",martina absinta unveiled diverse mechanisms propelling the edge in chronic active ms lesions. does this result from t lymphocytes or self-perpetuate via astrocytes nearby? a crucial query in understanding ms progression. #multiplesclerosis #msmilan2023 @ectrims https://t.co/sr1cvhesyt,male,"#multiplesclerosis, #msmilan2023",,,6000000000,226254369,,504,790,0,,,1,10,2189,False,martina absinta unveiled diverse mechanisms propelling the edge in chronic active ms lesions. does this result from t lymphocytes or self-perpetuate via astrocytes nearby? a crucial query in understanding ms progression. multiple sclerosis ms milan,"['Martina Absinta', 'mechanisms', 'chronic active MS lesions', 'T lymphocytes', 'astrocytes', 'progression', 'multiple sclerosis', 'MS Milan']","martina absinta,mechanisms,chronic active ms lesions,t lymphocytes,astrocytes,progression,multiple sclerosis,ms milan",martina absinta mechanisms chronic active ms lesions t lymphocytes astrocytes progression,martina absinta mechanisms chronic active ms lesions t lymphocytes astrocytes progression,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
270,278,2023-10-11 07:05:07.0,Aging in MS #ectrims2023 https://t.co/0Qi394kzST,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",aging in ms #ectrims2023 https://t.co/0qi394kzst,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,467,2043,0,,,0,0,1787,False,aging in ms ec trims,"['MS', 'EC', 'trim']","ms,ec,trim",trim,trim,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
271,279,2023-10-11 06:59:24.0,Who has it right? Smouldering vs smoldering MS #MSmilan2023 @Merck @sanofi  Excited to be at my first in-person @ECTRIMS conference https://t.co/wBlUMZpfi6,twitter,GBR,cawalton,"{id=16441708, name=Merck, displayName=null, parentId=16441705, parentName=CI Updates'22}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",who has it right? smouldering vs smoldering ms #msmilan2023 @merck @sanofi excited to be at my first in-person @ectrims conference https://t.co/wblumzpfi6,female,#msmilan2023,"Beauty/Health & Fitness, Sports, Animals & Pets",,6000000000,22329895,,1791,2178,1,,,1,14,3079,False,who has it right? smouldering vs smoldering ms ms milan excited to be at my first in-person conference,"['smouldering', 'smoldering', 'ms', 'Milan', 'in-person', 'conference']","smouldering,smoldering,ms,milan,in-person,conference",smouldering smoldering in-person conference,smouldering smoldering in-person conference,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
272,280,2023-10-11 06:53:59.0,"The NCNE Multiple Sclerosis Team is in Milan Italy for the largest gathering of MS specialists , researchers and industry leaders. We are here to learn of the newest updates in MS care! #patientsfirst#ectrims2023 https://t.co/YwrhqKH01M",twitter,,napolineuro,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","the ncne multiple sclerosis team is in milan italy for the largest gathering of ms specialists , researchers and industry leaders. we are here to learn of the newest updates in ms care! #patientsfirst#ectrims2023 https://t.co/ywrhqkh01m",male,"#patientsfirst, #ectrims2023",,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,467,2043,0,,,0,0,1786,False,"the ncne multiple sclerosis team is in milan italy for the largest gathering of ms specialists , researchers and industry leaders. we are here to learn of the newest updates in ms care! #patientsfirstec trims","['MS', 'Milan', 'Italy', 'specialists', 'researchers', 'industry leaders', 'updates', 'care', 'patients', '#patientsfirstec']","ms,milan,italy,specialists,researchers,industry leaders,updates,care,patients,#patientsfirstec",italy specialists researchers industry leaders updates care #patientsfirstec,italy specialists researchers industry leaders updates care #patientsfirstec,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
273,282,2023-10-11 06:10:45.0,"(Brain) Networks matter!
Honoured to be taking the stage at #MSMilan2023! Looking forward to to share our research findings and exchange knowledge with colleagues from all over the world. See you all in Milan! ðŸ‘‹
#MAGNIMS #ECTRIMS https://t.co/OnrkQUdWG0",twitter,,VinzFleischer,"{id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",(brain) networks matter! honoured to be taking the stage at #msmilan2023! looking forward to to share our research findings and exchange knowledge with colleagues from all over the world. see you all in milan! ðŸ‘‹ #magnims #ectrims https://t.co/onrkqudwg0,male,"#msmilan2023, #magnims, #ectrims",,,6000000000,735756919588065280,,57,111,0,,,1,18,22,False,(brain) networks matter! honoured to be taking the stage at ms milan! looking forward to to share our research findings and exchange knowledge with colleagues from all over the world. see you all in milan! #magnims ec trims,"['brain', 'networks', 'matter', 'stage', 'research', 'knowledge', 'colleagues', 'Milan', 'share', 'exchange', 'excited', 'looking forward', 'see you']","brain,networks,matter,stage,research,knowledge,colleagues,milan,share,exchange,excited,looking forward,see you",brain networks matter stage knowledge colleagues share exchange excited looking forward see you,brain networks matter stage knowledge colleagues share exchange excited looking forward see you,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
274,283,2023-10-11 05:01:01.0,"Shared decision-making can be an important factor in an MS patientâ€™s journey. Join our discussion with an MS nurse and a person living with MS about empowering patients and finding solutions together for MS management from diagnosis to care #MSMilan23

https://t.co/k8l8mONEc4 https://t.co/J0W5ataNYr",twitter,,NovartisMedical,"{id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",shared decision-making can be an important factor in an ms patientâ€™s journey. join our discussion with an ms nurse and a person living with ms about empowering patients and finding solutions together for ms management from diagnosis to care #msmilan23 https://t.co/k8l8monec4 https://t.co/j0w5atanyr,,#msmilan23,Beauty/Health & Fitness,,6000000000,1529472917397970946,,7797,4,0,,,0,0,110,True,shared decision-making can be an important factor in an ms patients journey. join our discussion with an ms nurse and a person living with ms about empowering patients and finding solutions together for ms management from diagnosis to care msmilan23,"['decision-making', 'MS', 'patient', 'journey', 'nurse', 'empowerment', 'solutions', 'management', 'diagnosis', 'care']","decision-making,ms,patient,journey,nurse,empowerment,solutions,management,diagnosis,care",decision-making journey nurse empowerment solutions management diagnosis care,decision-making journey nurse empowerment solutions management diagnosis care,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,0.909869247944441,False
275,284,2023-10-10 21:32:25.0,"#ECTRIMS2023 MS Patient Community Day on Saturday, Oct 14th. 3-5 pm CEST. Meet with the scientific community Learn about advancements in MS care.
Attend for FREE in-person or online. 

USA 6 am PDT, 7 am MDT, 8 am CDT, 9 am EST.
https://t.co/pYba8KNcKz",twitter,,SolvingMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#ectrims2023 ms patient community day on saturday, oct 14th. 3-5 pm cest. meet with the scientific community learn about advancements in ms care. attend for free in-person or online. usa 6 am pdt, 7 am mdt, 8 am cdt, 9 am est. https://t.co/pyba8knckz",female,#ectrims2023,,,6000000000,1633532750434119680,,742,2300,2,,,3,6,718,False,"ec trims ms patient community day on saturday, oct 14th. 3-5 pm cest. meet with the scientific community learn about advancements in ms care. attend for free in-person or online. usa 6 am pdt, 7 am mdt, 8 am cdt, 9 am est.","['ec', 'ms', 'patient', 'community', 'day', 'saturday', 'october', '14th', '3-5 pm', 'cest', 'meet', 'scientific', 'advancements', 'care', 'attend', 'free', 'in-person', 'online', '']","ec,ms,patient,community,day,saturday,october,14th,3-5 pm,cest,meet,scientific,advancements,care,attend,free,in-person,online,",day saturday october 14th 3-5 pm cest meet scientific advancements care attend free in-person online ,day saturday october 14th 3-5 pm cest meet scientific advancements care attend free in-person online ,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
276,285,2023-10-10 20:12:08.0,"Check out P344/1717 (Switching Between Disease Modifying Treatment for Relapsing Remitting Multiple Sclerosis, a Retrospective Review of Practice at a Regional Multiple Sclerosis Centre in England) by Dr Brex and colleagues #ECTRIMS2023",twitter,,KingsMScentre,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","check out p344/1717 (switching between disease modifying treatment for relapsing remitting multiple sclerosis, a retrospective review of practice at a regional multiple sclerosis centre in england) by dr brex and colleagues #ectrims2023",female,#ectrims2023,,,6000000000,1531038944766345217,,100,168,0,,,0,2,31,False,"check out p344/1717 (switching between disease modifying treatment for relapsing remitting multiple sclerosis, a retrospective review of practice at a regional multiple sclerosis centre in england) by dr brex and colleagues ec trims","['disease', 'modifying', 'treatment', 'relapsing', 'remitting', 'multiple', 'sclerosis', 'retrospective', 'review', 'practice', 'regional', 'centre', 'england', 'dr', 'brex', 'colleagues', 'ec', 'trims']","disease,modifying,treatment,relapsing,remitting,multiple,sclerosis,retrospective,review,practice,regional,centre,england,dr,brex,colleagues,ec,trims",disease modifying relapsing remitting multiple sclerosis retrospective review practice regional centre england dr brex colleagues,disease modifying relapsing remitting multiple sclerosis retrospective review practice regional centre england dr brex colleagues,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
277,286,2023-10-10 20:10:59.0,Delighted to see colleagues from all over the world dedicated to accelerating research in MS and canâ€™t wait to attend #MSmilan2023 @ECTRIMS tomorrow! https://t.co/OS0DPswE9c,twitter,CAN,PamelaKanellis,"{id=20279310, name=Ofev, displayName=null, parentId=20279181, parentName=ERS 2023 categories}, {id=15147375, name=Ofev, displayName=null, parentId=15147295, parentName=ESR 2022 Conference categories}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",delighted to see colleagues from all over the world dedicated to accelerating research in ms and canâ€™t wait to attend #msmilan2023 @ectrims tomorrow! https://t.co/os0dpswe9c,female,#msmilan2023,,,6000000000,256679634,,1171,1912,0,,,2,14,6555,False,delighted to see colleagues from all over the world dedicated to accelerating research in ms and cant wait to attend ms milan tomorrow!,"['MS', 'colleagues', 'research', 'world', 'accelerating', 'Milan']","ms,colleagues,research,world,accelerating,milan",colleagues world accelerating,colleagues world accelerating,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9241342887488248,False
278,287,2023-10-10 20:10:09.0,Check out poster P064/1261 (Increasing medication exposure in MS pregnancies: results from the UK MS Pregnancy Register) by Dr Brex and colleagues #ECTRIMS2023,twitter,,KingsMScentre,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",check out poster p064/1261 (increasing medication exposure in ms pregnancies: results from the uk ms pregnancy register) by dr brex and colleagues #ectrims2023,female,#ectrims2023,,,6000000000,1531038944766345217,,100,168,0,,,1,2,30,False,check out poster p064/1261 (increasing medication exposure in ms pregnancies: results from the uk ms pregnancy register) by dr brex and colleagues ec trims,"['Medication', 'Exposure', 'Multiple Sclerosis', 'Pregnancy', 'Register', 'Dr Brex', 'EC Trims']","medication,exposure,multiple sclerosis,pregnancy,register,dr brex,ec trims",medication exposure pregnancy register dr brex,medication exposure pregnancy register dr brex,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
279,288,2023-10-10 18:31:22.0,"Congrats @MarTintore and team for #MSMilan2023, I will follow virtually the exciting conferences and speakers, for a #world without #MS @ECTRIMS @ACTRIMS @mssociety @XMontalban @Pluchinolab @tim_coetzee @BeboBruce the countdown to end #progressive #MS is on. https://t.co/qpjdaPZeho",twitter,USA,DrJim4MS,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","congrats @martintore and team for #msmilan2023, i will follow virtually the exciting conferences and speakers, for a #world without #ms @ectrims @actrims @mssociety @xmontalban @pluchinolab @tim_coetzee @bebobruce the countdown to end #progressive #ms is on. https://t.co/qpjdapzeho",male,"#msmilan2023, #world, #ms, #progressive, #ms",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1769,619,0,,,3,7,7964,False,"congrats and team for ms milan, i will follow virtually the exciting conferences and speakers, for a #world without ms the countdown to end #progressive ms is on.","['congrats', 'team', 'ms Milan', 'conferences', 'speakers', 'world', 'progressive MS', 'countdown']","congrats,team,ms milan,conferences,speakers,world,progressive ms,countdown",congrats team conferences speakers world progressive ms countdown,congrats team conferences speakers world progressive ms countdown,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
280,289,2023-10-10 16:55:09.0,"This week we're headed to #MSMilan2023 - the world's largest #MultipleSclerosis research event! ðŸ‡®ðŸ‡¹ðŸ” Join this global community of #MS professionals and connect with our team of SimoaÂ® experts at the event by reserving time here: https://t.co/dBmA5S0B46
@ECTRIMS ðŸ§ª https://t.co/S8rEvFdFjg",twitter,USA,QuanterixSimoa,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",this week we're headed to #msmilan2023 - the world's largest #multiplesclerosis research event! ðŸ‡®ðŸ‡¹ðŸ” join this global community of #ms professionals and connect with our team of simoaÂ® experts at the event by reserving time here: https://t.co/dbma5s0b46 @ectrims ðŸ§ª https://t.co/s8revfdfjg,unknown,"#msmilan2023, #multiplesclerosis, #ms",,,6000000000,979206722,,1299,626,0,,,0,0,3651,False,this week we're headed to ms milan - the world's largest multiple sclerosis research event! join this global community of ms professionals and connect with our team of simoa experts at the event by reserving time here:,"['MS', 'Milan', 'research', 'event', 'community', 'professionals', 'SIOMOA', 'reserve', 'time.']","ms,milan,research,event,community,professionals,siomoa,reserve,time.",event professionals siomoa reserve time.,event professionals siomoa reserve time.,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
281,290,2023-10-10 14:00:02.0,"ðŸ“¢ #News: @ECTRIMS is almost here, and weâ€™re presenting key data from our treatment portfolio for people living with relapsing #MultipleSclerosis. Read more: https://t.co/3HavEgf1tZ 

#ECTRIMS2023 #MS #Neurology #HCPsOnly https://t.co/kwbkBvpE5R",twitter,USA,EMDSerono,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸ“¢ #news: @ectrims is almost here, and weâ€™re presenting key data from our treatment portfolio for people living with relapsing #multiplesclerosis. read more: https://t.co/3havegf1tz #ectrims2023 #ms #neurology #hcpsonly https://t.co/kwbkbvpe5r",unknown,"#news, #multiplesclerosis, #ectrims2023, #ms, #neurology, #hcpsonly",Business,,6000000000,574524931,,9118,781,0,,,0,1,4467,False,"#news: is almost here, and were presenting key data from our treatment portfolio for people living with relapsing multiple sclerosis. read more: ec trims ms #neurology #hcpsonly","['multiple sclerosis', 'news', 'treatment', 'portfolio', 'data', 'neurology', 'healthcare professionals', 'EC', 'trim']","multiple sclerosis,news,treatment,portfolio,data,neurology,healthcare professionals,ec,trim",news portfolio neurology healthcare professionals trim,news portfolio neurology healthcare professionals trim,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,1.0,False
282,291,2023-10-10 13:23:19.0,"This has become my life. 
The higher cancer lesion risk seen in MS patients on high-efficacy DMTs may be due to immunosuppression and exposure to HPV, scientists say. https://t.co/7VdNiQzpmi",twitter,GBR,JustMsChelseaM,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","this has become my life. the higher cancer lesion risk seen in ms patients on high-efficacy dmts may be due to immunosuppression and exposure to hpv, scientists say. https://t.co/7vdniqzpmi",female,,"Animals & Pets, Family & Parenting",,6000000000,613604052,,4715,2005,0,,,0,0,34629,False,"this has become my life. the higher cancer lesion risk seen in ms patients on high-efficacy dmts may be due to immunosuppression and exposure to hpv, scientists say.","['cancer', 'lesion', 'risk', 'MS', 'patients', 'DMTs', 'immunosuppression', 'HPV', 'scientists']","cancer,lesion,risk,ms,patients,dmts,immunosuppression,hpv,scientists",cancer lesion risk dmts immunosuppression hpv scientists,cancer lesion risk dmts immunosuppression hpv scientists,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
283,292,2023-10-10 13:15:44.0,"Proposed #diagnostic criteria may not accurately distinguish #MOGAD from #MS, contributing to diagnostic inconsistencies across centers. MOG-IgG testing & consideration of MOGAD diagnosis are recommended only in absence of better alternative causes, such as MS. #ECTRIMS2023",twitter,,IJMSCtweets,"{id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","proposed #diagnostic criteria may not accurately distinguish #mogad from #ms, contributing to diagnostic inconsistencies across centers. mog-igg testing & consideration of mogad diagnosis are recommended only in absence of better alternative causes, such as ms. #ectrims2023",,"#diagnostic, #mogad, #ms, #ectrims2023",,,6000000000,1054320667,,893,620,0,,,0,1,4135,False,"proposed #diagnostic criteria may not accurately distinguish #mogad from ms, contributing to diagnostic inconsistencies across centers. mog-igg testing & consideration of mogad diagnosis are recommended only in absence of better alternative causes, such as ms. ec trims","['Mogad', 'diagnostic', 'criteria', 'consistencies', 'centers', 'Mogad-IgG', 'testing', 'alternative causes', 'MS', 'ECTRIMS']","mogad,diagnostic,criteria,consistencies,centers,mogad-igg,testing,alternative causes,ms,ectrims",mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes,mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,1.0,True
284,293,2023-10-10 11:13:25.0,@samjcohn @ECTRIMS @ACTRIMS Safe travels! I hope for a cure for MS!,twitter,USA,GregoryAlexan10,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@samjcohn @ectrims @actrims safe travels! i hope for a cure for ms!,male,,"Politics, Family & Parenting, Sports, Travel","{profession=Teacher & Lecturer, jobTitle=Educator}",6000000000,420587078,,292,640,0,http://twitter.com/samjcohn/statuses/1711618047193014488,,0,0,10339,False,safe travels! i hope for a cure for ms!,"['travel', 'safety', 'hope', 'cure', 'MS']","travel,safety,hope,cure,ms",travel safety hope cure,travel safety hope cure,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
285,294,2023-10-10 09:00:41.0,"The #MS Special this week: âŒ› Counting down the days to #MSMilan2023! Canâ€™t wait to dive into the latest research and connect with experts in the field of #multiplesclerosis ðŸ”¬ðŸ’¡ðŸ¤ðŸ½. 
See you all there! 
#MS #msresearch https://t.co/M34joUyhLQ",twitter,,DSL_Deutschland,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",the #ms special this week: âŒ› counting down the days to #msmilan2023! canâ€™t wait to dive into the latest research and connect with experts in the field of #multiplesclerosis ðŸ”¬ðŸ’¡ðŸ¤ðŸ½. see you all there! #ms #msresearch https://t.co/m34jouyhlq,unknown,"#ms, #msmilan2023, #multiplesclerosis, #ms, #msresearch",,,6000000000,1587452051168034816,,177,348,0,,,0,0,593,False,the ms special this week: counting down the days to ms milan! cant wait to dive into the latest research and connect with experts in the field of multiple sclerosis . see you all there! ms msresearch,"['ms', 'Milan', 'research', 'connect', 'experts', 'multiple sclerosis']","ms,milan,research,connect,experts,multiple sclerosis",connect experts,connect experts,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.8812148038253063,False
286,295,2023-10-10 08:55:01.0,Hans Lassmann telling us how important brain resident CD8+ T-cells are in the MS brain #ECTRIMS2023 #ECF https://t.co/NSO0dSGJUY,twitter,GBR,GavinGiovannoni,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",hans lassmann telling us how important brain resident cd8+ t-cells are in the ms brain #ectrims2023 #ecf https://t.co/nso0dsgjuy,male,"#ectrims2023, #ecf",,,6000000000,55284565,,14268,11,1,,,4,39,19595,True,hans lassmann telling us how important brain resident cd8+ t-cells are in the ms brain ec trims #ecf,"['Hans Lassmann', 'brain', 'T-cells', 'MS', 'ECF']","hans lassmann,brain,t-cells,ms,ecf",hans lassmann brain t-cells ecf,hans lassmann brain t-cells ecf,1,1_virus_ebv_immune_gut,"Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['immune', 'microbiome', 'epigenetic', 'ebv', 'vaccines', 'autoimmune', 'biomarkers', 'disease', 'vaccinate', 'genetic']","['Impact of viruses like Epstein-Barr on the immune system and gut microbiome, exploring potential therapeutic targets.', '', '', '', '', '', '', '', '', '']","['virus', 'ebv', 'immune', 'gut', 'epsteinbarr', 'risk', 'system', 'brain', 'accidentally', 'ano2']","['gut microbiome biomarkers potential future therapeutic targets environmental genetic epigenetic risk factors ahsct ebv', 'epstein-barr virus immune system accidentally attack brain protein ano2', 'epstein-barr virus immune system accidentally attack brain protein ano2 research shows news']",virus - ebv - immune - gut - epsteinbarr - risk - system - brain - accidentally - ano2,0.9424133936304575,False
287,296,2023-10-10 08:28:08.0,On my way to Milan to go to @ECTRIMS to learn more about #ms and meet a lot of people. Follow #MSmilan2023 https://t.co/U2NU0vyI5x,twitter,DEU,Birgitpower,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",on my way to milan to go to @ectrims to learn more about #ms and meet a lot of people. follow #msmilan2023 https://t.co/u2nu0vyi5x,female,"#ms, #msmilan2023",,,6000000000,22899395,,3334,1990,1,,,0,10,31834,False,on my way to milan to go to to learn more about ms and meet a lot of people. follow ms milan,"['Milan', 'MS', 'people']","milan,ms,people",people,people,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
288,297,2023-10-10 08:18:39.0,"@jefflan58459713 Totally, agree. I've done 5 clinical trials on remyelination at my #MS center but still need a breakthrough for people living with multiple sclerosis.  Check out the latest research this week at ECTRIMS meeting in #MSMilan2023. I'll  be live posting.",twitter,USA,drbarrysinger,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@jefflan58459713 totally, agree. i've done 5 clinical trials on remyelination at my #ms center but still need a breakthrough for people living with multiple sclerosis. check out the latest research this week at ectrims meeting in #msmilan2023. i'll be live posting.",male,"#ms, #msmilan2023",Science,,6000000000,1430793013,,7199,393,0,http://twitter.com/jefflan58459713/statuses/1711503561937322295,,0,0,3147,False,"totally, agree. i've done 5 clinical trials on remyelination at my ms center but still need a breakthrough for people living with multiple sclerosis. check out the latest research this week at ectrims meeting in ms milan. i'll be live posting.","['Remyelination', 'MS', 'clinical trials', 'ECTRIMS', 'Milan', 'breakthrough', 'multiple sclerosis', 'research']","remyelination,ms,clinical trials,ectrims,milan,breakthrough,multiple sclerosis,research",remyelination clinical trials breakthrough,remyelination clinical trials breakthrough,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.712226625081397,False
289,298,2023-10-10 07:35:07.0,Biogen is gearing up for the #ECTRIMS2023 Congress in Milan this October!  Join us at booth A05 to explore the latest in #MultipleSclerosis and chat with our team about important topics in the field #MSMilan,twitter,USA,biogen,"{id=16441714, name=Biogen, displayName=null, parentId=16441705, parentName=CI Updates'22}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",biogen is gearing up for the #ectrims2023 congress in milan this october! join us at booth a05 to explore the latest in #multiplesclerosis and chat with our team about important topics in the field #msmilan,,"#ectrims2023, #multiplesclerosis, #msmilan","Beauty/Health & Fitness, Science",,6000000000,155650832,,45715,254,0,,,1,2,5857,False,biogen is gearing up for the ec trims congress in milan this october! join us at booth a05 to explore the latest in multiple sclerosis and chat with our team about important topics in the field msmilan,"['Biogen', 'EC Trims Congress', 'Milan', 'October', 'Multiple Sclerosis', 'Booth A05', 'Important Topics', 'Field MS']","biogen,ec trims congress,milan,october,multiple sclerosis,booth a05,important topics,field ms",biogen ec trims congress october booth a05 important topics field ms,biogen ec trims congress october booth a05 important topics field ms,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
290,299,2023-10-10 06:24:26.0,"ðŸ“¢ #News: Weâ€™re presenting key data on the efficacy of our portfolio for relapsing #MultipleSclerosis  treatments at #ECTRIMS2023, which is starting soon. Find out more here: https://t.co/AUcVLyW1hy

#MS #Neurology #HCPsOnly https://t.co/whJiyD7Elk",twitter,DEU,MerckHealthcare,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸ“¢ #news: weâ€™re presenting key data on the efficacy of our portfolio for relapsing #multiplesclerosis treatments at #ectrims2023, which is starting soon. find out more here: https://t.co/aucvlyw1hy #ms #neurology #hcpsonly https://t.co/whjiyd7elk",unknown,"#news, #multiplesclerosis, #ectrims2023, #ms, #neurology, #hcpsonly",,,6000000000,857893749959086080,,7566,623,0,,,2,6,4074,False,"#news: were presenting key data on the efficacy of our portfolio for relapsing multiple sclerosis treatments at ec trims, which is starting soon. find out more here: ms #neurology #hcpsonly","['ms', 'neurology', 'hcpsonly']","ms,neurology,hcpsonly",neurology hcpsonly,neurology hcpsonly,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,0.8669184474799955,False
291,300,2023-10-10 05:41:57.0,Heading to Milan for #MSMilan2023! Looking forward to connecting with colleagues and learning about the latest in Multiple Sclerosis research and treatment! @ECTRIMS @ACTRIMS https://t.co/8YmArxV39U,twitter,NLD,samjcohn,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",heading to milan for #msmilan2023! looking forward to connecting with colleagues and learning about the latest in multiple sclerosis research and treatment! @ectrims @actrims https://t.co/8ymarxv39u,male,#msmilan2023,Games,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,8294442,,13257,3175,3,,,2,65,13002,False,heading to milan for ms milan! looking forward to connecting with colleagues and learning about the latest in multiple sclerosis research and treatment!,"['Milan', 'colleagues', 'research', 'treatment', 'multiple sclerosis']","milan,colleagues,research,treatment,multiple sclerosis",colleagues,colleagues,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
292,301,2023-10-10 04:00:00.0,Our commitment to bridging science and clinical practice to drive better health outcomes for all continues. Thank you to the investigators who pave the way for advances in #multiplesclerosis research. Join us at #MSMilan2023 as we share 24 MS abstracts! #NeuroTwitter #ECTRIMS https://t.co/KgAHpU4l48,twitter,USA,GenentechMed,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",our commitment to bridging science and clinical practice to drive better health outcomes for all continues. thank you to the investigators who pave the way for advances in #multiplesclerosis research. join us at #msmilan2023 as we share 24 ms abstracts! #neurotwitter #ectrims https://t.co/kgahpu4l48,,"#multiplesclerosis, #msmilan2023, #neurotwitter, #ectrims",Beauty/Health & Fitness,,6000000000,1405237666677891073,,149,0,0,,,0,1,51,False,our commitment to bridging science and clinical practice to drive better health outcomes for all continues. thank you to the investigators who pave the way for advances in multiple sclerosis research. join us at ms milan as we share 24 ms abstracts! #neurotwitter ec trims,"['health', 'science', 'clinical practice', 'research', 'multiple sclerosis', 'MS', 'abstracts', 'neurotwitter', 'EC']","health,science,clinical practice,research,multiple sclerosis,ms,abstracts,neurotwitter,ec",health science clinical practice abstracts neurotwitter,health science clinical practice abstracts neurotwitter,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,1.0,False
293,302,2023-10-10 02:40:19.0,"Have you ever experienced Medical gaslighting?
@GavinGiovannoni  is presenting his #MS patient survey at the biggest #MultipleSclerosis conference of the year! #ECTRIMS2023",twitter,,SolvingMS,"{id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",have you ever experienced medical gaslighting? @gavingiovannoni is presenting his #ms patient survey at the biggest #multiplesclerosis conference of the year! #ectrims2023,female,"#ms, #multiplesclerosis, #ectrims2023",,,6000000000,1633532750434119680,,743,2300,2,,,3,6,717,False,have you ever experienced medical gaslighting? is presenting his ms patient survey at the biggest multiple sclerosis conference of the year! ec trims,"['medical', 'gaslighting', 'patient', 'survey', 'multiple sclerosis', 'conference', 'EC']","medical,gaslighting,patient,survey,multiple sclerosis,conference,ec",medical gaslighting survey conference,medical gaslighting survey conference,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
294,303,2023-10-10 02:20:29.0,"@GavinGiovannoni Dec 2021 my neuro refused to test for EBV.
""No chance you have EBV in your brain"". Gaslight!
Jan 2022 Harvard published proof #EBVcausesMS
Got EBV tests from GP.  Where do I go from here?
#ECTRIMS 2023 Hot Topic 1: MS and EBV > answers? https://t.co/JQHgb2vDFT",twitter,USA,SammyJoLDN,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@gavingiovannoni dec 2021 my neuro refused to test for ebv. ""no chance you have ebv in your brain"". gaslight! jan 2022 harvard published proof #ebvcausesms got ebv tests from gp. where do i go from here? #ectrims 2023 hot topic 1: ms and ebv > answers? https://t.co/jqhgb2vdft",unknown,"#ebvcausesms, #ectrims","Beauty/Health & Fitness, Books","{profession=Artist, jobTitle=Co-author}",6000000000,29497803,,1221,2114,1,http://twitter.com/GavinGiovannoni/statuses/1711286408571191336,,0,3,5583,False,"dec 2021 my neuro refused to test for ebv. ""no chance you have ebv in your brain"". gaslight! jan 2022 harvard published proof #ebvcausesms got ebv tests from gp. where do i go from here? ec trims 2023 hot topic 1: ms and ebv > answers?","['December', '2021', 'January', '2022', 'Harvard', 'proof', 'Ebv', 'tests', 'GP', 'Ec', 'trims', '2023', 'hot topic', 'Ms', 'Ebv', 'answers']","december,2021,january,2022,harvard,proof,ebv,tests,gp,ec,trims,2023,hot topic,ms,ebv,answers",december 2021 january 2022 harvard proof ebv tests gp 2023 hot topic ebv answers,december 2021 january 2022 harvard proof ebv tests gp 2023 hot topic ebv answers,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
295,304,2023-10-09 21:36:38.0,"Headed to Milan, Italy for MS conference. #MSMilan2023 #ECTRIMS https://t.co/Og21VCF4P6",twitter,USA,OdagoDr,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","headed to milan, italy for ms conference. #msmilan2023 #ectrims https://t.co/og21vcf4p6",male,"#msmilan2023, #ectrims","Beauty/Health & Fitness, Sports, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1449379917750284289,,410,648,1,,,0,8,367,False,"headed to milan, italy for ms conference. ms milan ec trims","['Milan', 'Italy', 'MS', 'conference', 'travel']","milan,italy,ms,conference,travel",italy conference travel,italy conference travel,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
296,305,2023-10-09 20:14:45.0,Great pleasure to finally meet Sumaira flower! Together we will contribute to make @ECTRIMS as the umbrella for #MS but also #nmosd #MOGAD,twitter,ESP,MarTintore,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",great pleasure to finally meet sumaira flower! together we will contribute to make @ectrims as the umbrella for #ms but also #nmosd #mogad,unknown,"#ms, #nmosd, #mogad",,,6000000000,486940610,,2278,416,2,,,4,33,4780,False,great pleasure to finally meet sumaira flower! together we will contribute to make as the umbrella for ms but also #nmosd #mogad,"['Sumaira', 'flower', 'meet', 'contribution', 'umbrella', 'MS', 'NMOSD', 'Mogad']","sumaira,flower,meet,contribution,umbrella,ms,nmosd,mogad",sumaira flower meet contribution umbrella mogad,sumaira flower meet contribution umbrella mogad,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
297,306,2023-10-09 16:40:07.0,"ðŸ§ ðŸš€ Braindates are in high demand at #MSMilan2023! Don't wait - seize the chance to connect with fellow attendees. Ready to lead a discussion? 

Jump on the platform and share your topic ðŸ‘‰ https://t.co/gr5X58BSBi
Let's make every conversation count!

#networking #collaboration https://t.co/jltnAOvCM6",twitter,CHE,ECTRIMS,,ðŸ§ ðŸš€ braindates are in high demand at #msmilan2023! don't wait - seize the chance to connect with fellow attendees. ready to lead a discussion? jump on the platform and share your topic ðŸ‘‰ https://t.co/gr5x58bsbi let's make every conversation count! #networking #collaboration https://t.co/jltnaovcm6,,"#msmilan2023, #networking, #collaboration",,,6000000000,714464982,,7921,65,0,,,1,1,7087,False,braindates are in high demand at ms milan! don't wait - seize the chance to connect with fellow attendees. ready to lead a discussion? jump on the platform and share your topic let's make every conversation count! #networking #collaboration,"['brain dates', 'networking', 'collaboration', 'discussion', 'attendees', 'opportunity', 'conference', 'share', 'conversation']","brain dates,networking,collaboration,discussion,attendees,opportunity,conference,share,conversation",brain dates networking collaboration discussion attendees opportunity conference share conversation,brain dates networking collaboration discussion attendees opportunity conference share conversation,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
298,307,2023-10-09 15:18:08.0,"We are eager to join with the MS community at @ECTRIMS #MSMilan2023.

We look forward to coming together with researchers, physicians, & advocates, who share in our dedication to improving quality of life for people living with #MS.

https://t.co/kEX5sZ1y2G https://t.co/dsdczfNpUc",twitter,,AbataTx,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","we are eager to join with the ms community at @ectrims #msmilan2023. we look forward to coming together with researchers, physicians, & advocates, who share in our dedication to improving quality of life for people living with #ms. https://t.co/kex5sz1y2g https://t.co/dsdczfnpuc",unknown,"#msmilan2023, #ms",Science,,6000000000,1367149082700087297,,209,78,0,,,0,0,136,False,"we are eager to join with the ms community at ms milan. we look forward to coming together with researchers, physicians, & advocates, who share in our dedication to improving quality of life for people living with ms.","['MS', 'community', 'researchers', 'physicians', 'advocates', 'quality of life', 'dedication']","ms,community,researchers,physicians,advocates,quality of life,dedication",researchers physicians advocates quality of life dedication,researchers physicians advocates quality of life dedication,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
299,308,2023-10-09 14:15:58.0,"ðŸŽ—ï¸The $IMUX team is looking forward to the #MSMilan2023 congress, taking place this week! It's going to be an exciting gathering of #MS researchers, healthcare professionals & industry leaders from all around the world.

#MultipleSclerosis #MSresearch #Immunic @ECTRIMS #ACTRIMS https://t.co/bqxebEbg8n",twitter,USA,ImmunicInc,"{id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸŽ—ï¸the $imux team is looking forward to the #msmilan2023 congress, taking place this week! it's going to be an exciting gathering of #ms researchers, healthcare professionals & industry leaders from all around the world. #multiplesclerosis #msresearch #immunic @ectrims #actrims https://t.co/bqxebebg8n",,"#msmilan2023, #ms, #multiplesclerosis, #msresearch, #immunic, #actrims","Beauty/Health & Fitness, Business",,6000000000,951787758242226177,,590,756,0,,,2,5,1103,False,"the $imux team is looking forward to the ms milan congress, taking place this week! it's going to be an exciting gathering of ms researchers, healthcare professionals & industry leaders from all around the world. multiple sclerosis msresearch #immunic #actrims","['$imux', 'team', 'MS Milan Congress', 'exciting', 'gathering', 'researchers', 'healthcare professionals', 'industry leaders', 'multiple sclerosis', 'MSResearch', 'immunic', 'Actrims']","$imux,team,ms milan congress,exciting,gathering,researchers,healthcare professionals,industry leaders,multiple sclerosis,msresearch,immunic,actrims",$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims,$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,True
300,309,2023-10-09 11:37:48.0,"Ever had ur MS symptoms waved away or told they were in ur head?
Was ur MS diagnosis delayed because u weren't believed?
So thrilled this poster raising the issue of medical gaslighting in MS - written with @GavinGiovannoni, @NerdyNeuroMD & SÃ¼leyman GÃ¼ler - debuts at @ECTRIMS.",twitter,GBR,RachelHorne19,"{id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ever had ur ms symptoms waved away or told they were in ur head? was ur ms diagnosis delayed because u weren't believed? so thrilled this poster raising the issue of medical gaslighting in ms - written with @gavingiovannoni, @nerdyneuromd & sÃ¼leyman gÃ¼ler - debuts at @ectrims.",female,,,"{profession=Journalist, jobTitle=Journalist}, {profession=Scientist & Researcher, jobTitle=Research Fellow}",6000000000,1284849469704540160,,6186,3465,21,,,22,96,5513,False,"ever had ur ms symptoms waved away or told they were in ur head? was ur ms diagnosis delayed because u weren't believed? so thrilled this poster raising the issue of medical gaslighting in ms - written with , & sleyman gler - debuts at .","['MS', 'symptoms', 'head', 'diagnosis', 'believed', 'issue', 'medical', 'gaslighting', 'poster', 'Sleiman Gler', 'debut']","ms,symptoms,head,diagnosis,believed,issue,medical,gaslighting,poster,sleiman gler,debut",symptoms head diagnosis believed issue medical gaslighting poster sleiman gler debut,symptoms head diagnosis believed issue medical gaslighting poster sleiman gler debut,10,10_mogad_diagnosis_centers_cns,"Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['diagnosis', 'diagnostic', 'diagnoses', 'misdiagnosed', 'mogad', 'mogadigg', 'pathology', 'lesions', 'mogigg', 'disease']","['Mogad syndrome: Diagnosis, CNS involvement, and distinctive pathological lesions.', '', '', '', '', '', '', '', '', '']","['mogad', 'diagnosis', 'centers', 'cns', 'mogigg', 'diagnostic', 'differential', 'pathology', 'lesions', 'presentation']","['mogad diagnostic criteria consistencies centers mogad-igg testing alternative causes', 'educational activities imaging features mogad differential diagnosis msmilan23 friday course', 'pathology curiosity questions captivating talk distinctive pathology mogad aqp4+nmosd unique meningeal lymphoid follicles cns compartmental']",mogad - diagnosis - centers - cns - mogigg - diagnostic - differential - pathology - lesions - presentation,1.0,False
301,310,2023-10-09 08:00:57.0,Weâ€™re presenting new data at #MSMilan2023 reflecting our long-standing commitment to advance the science in #multiplesclerosis and #NMOSD and improve the treatment experience for everyone living with this disease. Learn more: https://t.co/YLc9LIPVcD,twitter,IND,maheshpansare,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",weâ€™re presenting new data at #msmilan2023 reflecting our long-standing commitment to advance the science in #multiplesclerosis and #nmosd and improve the treatment experience for everyone living with this disease. learn more: https://t.co/ylc9lipvcd,male,"#msmilan2023, #multiplesclerosis, #nmosd",,,6000000000,150924846,,446,2886,1,,,0,0,52537,False,were presenting new data at ms milan reflecting our long-standing commitment to advance the science in multiple sclerosis and #nmosd and improve the treatment experience for everyone living with this disease. learn more:,"['multiple sclerosis', 'NMOSD', 'data', 'commitment', 'science', 'treatment', 'disease', 'learn']","multiple sclerosis,nmosd,data,commitment,science,treatment,disease,learn",commitment science disease learn,commitment science disease learn,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
302,312,2023-10-09 01:29:07.0,#immunology #neuroimmunology #publichealth #microbiome #ECTRIMS2023 #MS #multiple #sclerosis #COVID19 #SarsCov2 #T1DM #womenshealth #primarycare #prevention #autoimmune #autoimmunity #butyrate #heartfailure #microglia #neurology #cardiology #obstetrics #cytokines #Tregs #health https://t.co/Q2XIq3Wpdi,twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#immunology #neuroimmunology #publichealth #microbiome #ectrims2023 #ms #multiple #sclerosis #covid19 #sarscov2 #t1dm #womenshealth #primarycare #prevention #autoimmune #autoimmunity #butyrate #heartfailure #microglia #neurology #cardiology #obstetrics #cytokines #tregs #health https://t.co/q2xiq3wpdi,unknown,"#immunology, #neuroimmunology, #publichealth, #microbiome, #ectrims2023, #ms, #multiple, #sclerosis, #covid19, #sarscov2, #t1dm, #womenshealth, #primarycare, #prevention, #autoimmune, #autoimmunity, #butyrate, #heartfailure, #microglia, #neurology, #cardiology, #obstetrics, #cytokines, #tregs, #health",,,6000000000,569107992,,4658,5105,0,,,0,0,52391,False,#immunology #neuroimmunology #publichealth #microbiome ec trims ms #multiple #sclerosis #covid19 #sarscov2 #t1dm #womenshealth #primarycare #prevention #autoimmune #autoimmunity #butyrate #heartfailure #microglia #neurology #cardiology #obstetrics #cytokines #tregs #health,"['immunology', 'neuroimmunology', 'publichealth', 'microbiome', 'multiple', 'sclerosis', 'covid19', 'sarscov2', 't1dm', 'womenshealth', 'primarycare', 'prevention']","immunology,neuroimmunology,publichealth,microbiome,multiple,sclerosis,covid19,sarscov2,t1dm,womenshealth,primarycare,prevention",immunology neuroimmunology publichealth microbiome multiple sclerosis covid19 sarscov2 t1dm womenshealth primarycare prevention,immunology neuroimmunology publichealth microbiome multiple sclerosis covid19 sarscov2 t1dm womenshealth primarycare prevention,15,15_womenshealth_multiple_sclerosis_exposome,Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors,"['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['sclerosis', 'neuroimmunology', 'womenshealth', 'autoimmune', 'spondylitis', 'arthritis', 'immune', 'immunology', 'rheumatoid', 'malignancy']","[""Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors"", '', '', '', '', '', '', '', '', '']","['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb', 'womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut', 'multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ']",womenshealth - multiple - sclerosis - exposome - cancer - publichealth - primarycare - prescriptions - sunlight - neurological,0.9704201772747413,False
303,313,2023-10-09 01:01:25.0,#MS #multiple #sclerosis #ECTRIMS2023 #autoimmune #neuroimmunology #womenshealth #primarycare #ankylosing cancer under 50 #spondylitis #autoantibodies #exposome #environmental #health #rheumatoid #arthritis #psoriasis #microbiome #dietetics #OneHealth #AI #health #autoimmunity https://t.co/NiJej9eMD6,twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#ms #multiple #sclerosis #ectrims2023 #autoimmune #neuroimmunology #womenshealth #primarycare #ankylosing cancer under 50 #spondylitis #autoantibodies #exposome #environmental #health #rheumatoid #arthritis #psoriasis #microbiome #dietetics #onehealth #ai #health #autoimmunity https://t.co/nijej9emd6,unknown,"#ms, #multiple, #sclerosis, #ectrims2023, #autoimmune, #neuroimmunology, #womenshealth, #primarycare, #ankylosing, #spondylitis, #autoantibodies, #exposome, #environmental, #health, #rheumatoid, #arthritis, #psoriasis, #microbiome, #dietetics, #onehealth, #ai, #health, #autoimmunity",,,6000000000,569107992,,4658,5105,0,,,0,0,52390,False,ms #multiple #sclerosis ec trims #autoimmune #neuroimmunology #womenshealth #primarycare #ankylosing cancer under 50 #spondylitis #autoantibodies #exposome #environmental #health #rheumatoid #arthritis #psoriasis #microbiome #dietetics #onehealth #ai #health #autoimmunity,"['ms', 'multiple', 'sclerosis', 'ec', 'trims', 'autoimmune', 'neuroimmunology', 'womenshealth', 'primarycare', 'ankylosing', 'cancer', 'under 50', 'spondylitis', '']","ms,multiple,sclerosis,ec,trims,autoimmune,neuroimmunology,womenshealth,primarycare,ankylosing,cancer,under 50,spondylitis,",multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ,multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ,15,15_womenshealth_multiple_sclerosis_exposome,Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors,"['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['sclerosis', 'neuroimmunology', 'womenshealth', 'autoimmune', 'spondylitis', 'arthritis', 'immune', 'immunology', 'rheumatoid', 'malignancy']","[""Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors"", '', '', '', '', '', '', '', '', '']","['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb', 'womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut', 'multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ']",womenshealth - multiple - sclerosis - exposome - cancer - publichealth - primarycare - prescriptions - sunlight - neurological,1.0,True
304,314,2023-10-09 00:28:51.0,"#MS #multiple #sclerosis #ECTRIMS2023 #womenshealth #exposome 

Multi-generational exposure to pollution
and insufficient sunlight prescriptions
during preconception, prenatal development and throughout life
adversely affect
microbiome health, brain health and immune function. https://t.co/4CBLBbmHNT",twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#ms #multiple #sclerosis #ectrims2023 #womenshealth #exposome multi-generational exposure to pollution and insufficient sunlight prescriptions during preconception, prenatal development and throughout life adversely affect microbiome health, brain health and immune function. https://t.co/4cblbbmhnt",unknown,"#ms, #multiple, #sclerosis, #ectrims2023, #womenshealth, #exposome",,,6000000000,569107992,,4658,5105,0,,,0,0,52389,False,"ms #multiple #sclerosis ec trims #womenshealth #exposome multi-generational exposure to pollution and insufficient sunlight prescriptions during preconception, prenatal development and throughout life adversely affect microbiome health, brain health and immune function.","['ms', 'multiple', 'sclerosis', 'ec', 'trims', 'womenshealth', 'exposome', 'multi-generational', 'pollution', 'insufficient', 'sunlight', 'prescriptions', 'preconception', 'prenatal', '']","ms,multiple,sclerosis,ec,trims,womenshealth,exposome,multi-generational,pollution,insufficient,sunlight,prescriptions,preconception,prenatal,",multiple sclerosis womenshealth exposome multi-generational pollution insufficient sunlight prescriptions preconception prenatal ,multiple sclerosis womenshealth exposome multi-generational pollution insufficient sunlight prescriptions preconception prenatal ,15,15_womenshealth_multiple_sclerosis_exposome,Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors,"['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['sclerosis', 'neuroimmunology', 'womenshealth', 'autoimmune', 'spondylitis', 'arthritis', 'immune', 'immunology', 'rheumatoid', 'malignancy']","[""Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors"", '', '', '', '', '', '', '', '', '']","['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb', 'womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut', 'multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ']",womenshealth - multiple - sclerosis - exposome - cancer - publichealth - primarycare - prescriptions - sunlight - neurological,1.0,False
305,315,2023-10-09 00:25:07.0,"#ECTRIMS2023 #womenshealth #MS #multiple #sclerosis #ClimateActionNow #publichealth #exposome #OneHealth

Multi-generational exposure to environmental pollutants
and insufficient sunlight prescriptions
increases the risk of
autoimmune disorders,
neurological disorders
and cancer. https://t.co/5JQJWwo7w7",twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#ectrims2023 #womenshealth #ms #multiple #sclerosis #climateactionnow #publichealth #exposome #onehealth multi-generational exposure to environmental pollutants and insufficient sunlight prescriptions increases the risk of autoimmune disorders, neurological disorders and cancer. https://t.co/5jqjwwo7w7",unknown,"#ectrims2023, #womenshealth, #ms, #multiple, #sclerosis, #climateactionnow, #publichealth, #exposome, #onehealth",,,6000000000,569107992,,4658,5105,0,,,0,0,52395,False,"ec trims #womenshealth ms #multiple #sclerosis #climateactionnow #publichealth #exposome #onehealth multi-generational exposure to environmental pollutants and insufficient sunlight prescriptions increases the risk of autoimmune disorders, neurological disorders and cancer.","['ec', 'womenshealth', 'ms', 'multiple', 'sclerosis', 'climateactionnow', 'publichealth', 'exposome', 'onehealth', 'autoimmune', 'disorders', 'neurological', 'cancer', 'environmental', 'pollut']","ec,womenshealth,ms,multiple,sclerosis,climateactionnow,publichealth,exposome,onehealth,autoimmune,disorders,neurological,cancer,environmental,pollut",womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut,womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut,15,15_womenshealth_multiple_sclerosis_exposome,Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors,"['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['sclerosis', 'neuroimmunology', 'womenshealth', 'autoimmune', 'spondylitis', 'arthritis', 'immune', 'immunology', 'rheumatoid', 'malignancy']","[""Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors"", '', '', '', '', '', '', '', '', '']","['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb', 'womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut', 'multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ']",womenshealth - multiple - sclerosis - exposome - cancer - publichealth - primarycare - prescriptions - sunlight - neurological,1.0,True
306,316,2023-10-09 00:16:42.0,#neuroimmunology #digital #health #virtual #health #ehealth #AI #health #prevention #primarycare AI in healthcare #ECTRIMS2023 #MS #multiple #sclerosis #aging #longevity #healthspan #agedcare #demenz #microglia #microbiome #endometriosis #rheumatoid #arthritis #chronic #pain https://t.co/ofbD7jgVaT,twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#neuroimmunology #digital #health #virtual #health #ehealth #ai #health #prevention #primarycare ai in healthcare #ectrims2023 #ms #multiple #sclerosis #aging #longevity #healthspan #agedcare #demenz #microglia #microbiome #endometriosis #rheumatoid #arthritis #chronic #pain https://t.co/ofbd7jgvat,unknown,"#neuroimmunology, #digital, #health, #virtual, #health, #ehealth, #ai, #health, #prevention, #primarycare, #ectrims2023, #ms, #multiple, #sclerosis, #aging, #longevity, #healthspan, #agedcare, #demenz, #microglia, #microbiome, #endometriosis, #rheumatoid, #arthritis, #chronic, #pain",,,6000000000,569107992,,4658,5105,1,,,0,0,52386,False,#neuroimmunology #digital #health #virtual #health #ehealth #ai #health #prevention #primarycare ai in healthcare ec trims ms #multiple #sclerosis #aging #longevity #healthspan #agedcare #demenz #microglia #microbiome #endometriosis #rheumatoid #arthritis #chronic #pain,"['neuroimmunology', 'digital', 'health', 'virtual', 'ehealth', 'AI', 'prevention', 'primary care', 'MS', 'multiple sclerosis', 'aging', 'longevity', 'aged care', 'dementia', 'microglia']","neuroimmunology,digital,health,virtual,ehealth,ai,prevention,primary care,ms,multiple sclerosis,aging,longevity,aged care,dementia,microglia",neuroimmunology digital health virtual ehealth ai prevention primary care aging longevity aged care dementia microglia,neuroimmunology digital health virtual ehealth ai prevention primary care aging longevity aged care dementia microglia,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
307,317,2023-10-09 00:08:05.0,"#womenshealth #rheumatoid #arthritis #ECTRIMS2023 #MS #multiple #sclerosis #exposome 

Sunlight prescriptions (infrared, UVA, UVB)
need to be adequate for each genotype.

(nitro-)PAHs,
black carbon,
diesel compounds,
benzene metabolites
arsenic
and fluoride
need to be measured. https://t.co/OTxuaIlh9k",twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#womenshealth #rheumatoid #arthritis #ectrims2023 #ms #multiple #sclerosis #exposome sunlight prescriptions (infrared, uva, uvb) need to be adequate for each genotype. (nitro-)pahs, black carbon, diesel compounds, benzene metabolites arsenic and fluoride need to be measured. https://t.co/otxuailh9k",unknown,"#womenshealth, #rheumatoid, #arthritis, #ectrims2023, #ms, #multiple, #sclerosis, #exposome",,,6000000000,569107992,,4658,5105,0,,,0,0,52384,False,"#womenshealth #rheumatoid #arthritis ec trims ms #multiple #sclerosis #exposome sunlight prescriptions (infrared, uva, uvb) need to be adequate for each genotype. (nitro-)pahs, black carbon, diesel compounds, benzene metabolites arsenic and fluoride need to be measured.","['#womenshealth', 'rheumatoid', 'arthritis', 'ec trims', 'ms', 'multiple', 'sclerosis', 'exposome', 'sunlight', 'prescriptions', 'infrared', 'uva', 'uvb']","#womenshealth,rheumatoid,arthritis,ec trims,ms,multiple,sclerosis,exposome,sunlight,prescriptions,infrared,uva,uvb",#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb,#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb,15,15_womenshealth_multiple_sclerosis_exposome,Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors,"['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['sclerosis', 'neuroimmunology', 'womenshealth', 'autoimmune', 'spondylitis', 'arthritis', 'immune', 'immunology', 'rheumatoid', 'malignancy']","[""Women's Health and Multiple Sclerosis: Exploring the Impact of Environmental Factors"", '', '', '', '', '', '', '', '', '']","['womenshealth', 'multiple', 'sclerosis', 'exposome', 'cancer', 'publichealth', 'primarycare', 'prescriptions', 'sunlight', 'neurological']","['#womenshealth rheumatoid arthritis multiple sclerosis exposome sunlight prescriptions infrared uva uvb', 'womenshealth multiple sclerosis climateactionnow publichealth exposome onehealth autoimmune disorders neurological cancer environmental pollut', 'multiple sclerosis autoimmune neuroimmunology womenshealth primarycare ankylosing cancer under 50 spondylitis ']",womenshealth - multiple - sclerosis - exposome - cancer - publichealth - primarycare - prescriptions - sunlight - neurological,1.0,True
308,318,2023-10-07 14:48:52.0,"Just one week till #MSMilan2023 Patient Community Day! â° Don't miss this opportunity to connect with experts in the MS field and learn more about the latest #MSResearch. Will you be joining online? ðŸ‘‰ https://t.co/aUfYTUsO5a 
#ECTRIMS4me @ECTRIMS @ACTRIMS @aism_nazionale https://t.co/ZL9N6HXPKr",twitter,,MSIntFederation,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",just one week till #msmilan2023 patient community day! â° don't miss this opportunity to connect with experts in the ms field and learn more about the latest #msresearch. will you be joining online? ðŸ‘‰ https://t.co/aufytuso5a #ectrims4me @ectrims @actrims @aism_nazionale https://t.co/zl9n6hxpkr,female,"#msmilan2023, #msresearch, #ectrims4me",,,6000000000,390672087,,6652,380,1,,,3,13,3451,False,just one week till ms milan patient community day! don't miss this opportunity to connect with experts in the ms field and learn more about the latest msresearch. will you be joining online? ec trims4me,"['MS', 'Milan', 'patient', 'community', 'day', 'opportunity', 'experts', 'research', 'learning', 'online']","ms,milan,patient,community,day,opportunity,experts,research,learning,online",day opportunity experts learning online,day opportunity experts learning online,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,True
309,320,2023-10-07 09:00:13.0,"Just 1ï¸âƒ£ week till #MSMilan2023 Patient Community Day! 
Don't miss this opportunity to connect with experts in the #MS field and learn more about the latest #MSResearch. 
Will you be joining online? ðŸ‘‰ https://t.co/pHsSSRMhIq
#ECTRIMS4me @ECTRIMS @ACTRIMS @aism_nazionale https://t.co/aIdZh7fwND",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",just 1ï¸âƒ£ week till #msmilan2023 patient community day! don't miss this opportunity to connect with experts in the #ms field and learn more about the latest #msresearch. will you be joining online? ðŸ‘‰ https://t.co/phsssrmhiq #ectrims4me @ectrims @actrims @aism_nazionale https://t.co/aidzh7fwnd,female,"#msmilan2023, #ms, #msresearch, #ectrims4me",,,6000000000,600110872,,4857,890,0,,,0,6,5914,False,just 1 week till ms milan patient community day! don't miss this opportunity to connect with experts in the ms field and learn more about the latest msresearch. will you be joining online? ec trims4me,"['MS', 'Milan', 'patient', 'community', 'day', 'opportunity', 'experts', 'research', 'learning', 'online']","ms,milan,patient,community,day,opportunity,experts,research,learning,online",day opportunity experts learning online,day opportunity experts learning online,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,True
310,321,2023-10-06 13:14:04.0,"ðŸ“¢ Weâ€™re heading to Milan for #ECTRIMS2023 where we'll be sharing our latest data and research on #MS. 

ðŸ‘‹ See you soon @ECTRIMS #HCPsOnly https://t.co/qqIfiG1za6 https://t.co/RWCEiK5eRj",twitter,USA,EMDSerono,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ðŸ“¢ weâ€™re heading to milan for #ectrims2023 where we'll be sharing our latest data and research on #ms. ðŸ‘‹ see you soon @ectrims #hcpsonly https://t.co/qqifig1za6 https://t.co/rwceik5erj,unknown,"#ectrims2023, #ms, #hcpsonly",Business,,6000000000,574524931,,9120,781,0,,,0,6,4473,False,were heading to milan for ec trims where we'll be sharing our latest data and research on ms. see you soon #hcpsonly,"['Milan', 'EC trims', 'data', 'research', 'MS', 'HCPs (Healthcare Professionals)', 'hashtag']","milan,ec trims,data,research,ms,hcps (healthcare professionals),hashtag",hcps (healthcare professionals) hashtag,hcps (healthcare professionals) hashtag,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
311,322,2023-10-06 13:00:37.0,"I am excited to remotely attend #ECTRIMS - the worldâ€™s largest research meeting for Multiple Sclerosis. The MS Patient Comminty day is Saturday, October 14! Will anyone else be there?

#MultipleSclerosis #ECTRIMS4me #MSresearch #MSCommunity #innovation https://t.co/W66kk9L3aH",twitter,USA,JessicaBraggin,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","i am excited to remotely attend #ectrims - the worldâ€™s largest research meeting for multiple sclerosis. the ms patient comminty day is saturday, october 14! will anyone else be there? #multiplesclerosis #ectrims4me #msresearch #mscommunity #innovation https://t.co/w66kk9l3ah",female,"#ectrims, #multiplesclerosis, #ectrims4me, #msresearch, #mscommunity, #innovation",Beauty/Health & Fitness,,6000000000,709974061,,163,909,0,,,0,0,428,False,"i am excited to remotely attend ec trims - the worlds largest research meeting for multiple sclerosis. the ms patient comminty day is saturday, october 14! will anyone else be there? multiple sclerosis ec trims4me msresearch mscommunity #innovation","['excited', 'attend', 'research', 'meeting', 'multiple sclerosis', 'MS', 'community', 'innovation']","excited,attend,research,meeting,multiple sclerosis,ms,community,innovation",excited attend meeting innovation,excited attend meeting innovation,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
312,323,2023-10-06 08:47:09.0,"Join me in #Milan2023 #ECTRIMS for a #Braindate, we will discuss MS treatments for the less fortunate. The acceess of MS patients to new expensive treaments still poses a problem in developing countries. We need alternatives, off-label options, trials. https://t.co/0hwmkyLPTJ",twitter,EGY,MHegazyMD,"{id=15960147, name=Zynteglo/ Pricing, displayName=null, parentId=15960144, parentName=Hemgenix SML}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","join me in #milan2023 #ectrims for a #braindate, we will discuss ms treatments for the less fortunate. the acceess of ms patients to new expensive treaments still poses a problem in developing countries. we need alternatives, off-label options, trials. https://t.co/0hwmkylptj",male,"#milan2023, #ectrims, #braindate",Business,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,1455259296,,120,236,0,,,0,3,75,False,"join me in milan2023 ec trims for a #braindate, we will discuss ms treatments for the less fortunate. the acceess of ms patients to new expensive treaments still poses a problem in developing countries. we need alternatives, off-label options, trials.","['Milan', '2023', 'brain', 'date', 'MS', 'treatments', 'less fortunate', 'access', 'problem', 'developing countries', 'alternatives', 'off-label', 'options', 'trials.']","milan,2023,brain,date,ms,treatments,less fortunate,access,problem,developing countries,alternatives,off-label,options,trials.",2023 brain date treatments less fortunate access problem developing countries alternatives off-label options trials.,2023 brain date treatments less fortunate access problem developing countries alternatives off-label options trials.,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
313,324,2023-10-05 18:59:00.0,"ðŸ“¢Ferran Prados, researcher at the @ADaSLab from #eHealthUOC, will be taking the role of chair in the session on ""Artificial Intelligence in MS: from diagnosis to prediction and treatment monitoring"" at @ECTRIMS in Milan. ðŸ¤–ðŸ§ #ECTRIMS #MultipleSclerosis https://t.co/LVQ1d9337c https://t.co/V6jrnIhbV2",twitter,ESP,eHealthUOC,"{id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸ“¢ferran prados, researcher at the @adaslab from #ehealthuoc, will be taking the role of chair in the session on ""artificial intelligence in ms: from diagnosis to prediction and treatment monitoring"" at @ectrims in milan. ðŸ¤–ðŸ§ #ectrims #multiplesclerosis https://t.co/lvq1d9337c https://t.co/v6jrnihbv2",unknown,"#ehealthuoc, #ectrims, #multiplesclerosis",Beauty/Health & Fitness,,6000000000,843855847914704897,,2843,1259,0,,,0,2,8975,False,"ferran prados, researcher at the from #ehealthuoc, will be taking the role of chair in the session on ""artificial intelligence in ms: from diagnosis to prediction and treatment monitoring"" at in milan. ec trims multiple sclerosis","['Ferran Prados', 'researcher', 'eHealthUOC', 'chair', 'session', 'artificial intelligence', 'MS', 'diagnosis', 'prediction', 'treatment monitoring', 'Milan']","ferran prados,researcher,ehealthuoc,chair,session,artificial intelligence,ms,diagnosis,prediction,treatment monitoring,milan",ferran prados researcher ehealthuoc chair session artificial intelligence diagnosis prediction treatment monitoring,ferran prados researcher ehealthuoc chair session artificial intelligence diagnosis prediction treatment monitoring,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
314,325,2023-10-05 14:44:23.0,"ViewMind Inc.Â will be exhibiting atÂ #msmilan2023 and presenting posters based on studies supported by Biogen and Hospital Ramos MejÃ­a. (Booth D30)
#MS #multiplesclerosisÂ #healthcareÂ #MSresearch ECTRIMS Congress ACTRIMS Â®",twitter,USA,ViewMind_,"{id=16441714, name=Biogen, displayName=null, parentId=16441705, parentName=CI Updates'22}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",viewmind inc. will be exhibiting at #msmilan2023 and presenting posters based on studies supported by biogen and hospital ramos mejÃ­a. (booth d30) #ms #multiplesclerosis #healthcare #msresearch ectrims congress actrims Â®,unknown,"#msmilan2023, #ms, #multiplesclerosis, #healthcare, #msresearch",Beauty/Health & Fitness,,6000000000,986583802154799104,,213,778,0,,,0,1,389,False,viewmind inc. will be exhibiting at ms milan and presenting posters based on studies supported by biogen and hospital ramos meja. (booth d30) ms multiple sclerosis #healthcare msresearch ectrims congress actrims,"['viewmind', 'inc.', 'exhibiting', 'ms Milan', 'posters', 'studies', 'Biogen', 'Hospital Ramos Meja', 'booth D30', 'MS', 'multiple sclerosis', 'healthcare', 'MS research', 'ECTRIMS Congress']","viewmind,inc.,exhibiting,ms milan,posters,studies,biogen,hospital ramos meja,booth d30,ms,multiple sclerosis,healthcare,ms research,ectrims congress",viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress,viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,True
315,326,2023-10-05 14:22:21.0,"ðŸ§  Join us at #MSMilan2023 for discussions on key topics like #biomarkers, future therapies, new #MS technologies, and more. Don't miss our poster presentations exploring digital health tools and in-depth MS research insights! #BrainAI #MultipleSclerosis #ECTRIMS https://t.co/dptK91Ko7C",twitter,BEL,icometrix,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸ§  join us at #msmilan2023 for discussions on key topics like #biomarkers, future therapies, new #ms technologies, and more. don't miss our poster presentations exploring digital health tools and in-depth ms research insights! #brainai #multiplesclerosis #ectrims https://t.co/dptk91ko7c",unknown,"#msmilan2023, #biomarkers, #ms, #brainai, #multiplesclerosis, #ectrims",Beauty/Health & Fitness,,6000000000,434832427,,3318,2785,0,,,0,3,1335,False,"join us at ms milan for discussions on key topics like #biomarkers, future therapies, new ms technologies, and more. don't miss our poster presentations exploring digital health tools and in-depth ms research insights! #brainai multiple sclerosis ec trims","['Biomarkers', 'therapies', 'MS technologies', 'poster presentations', 'digital health tools', 'MS research insights', 'brainAI', 'multiple sclerosis', 'ECTRMS']","biomarkers,therapies,ms technologies,poster presentations,digital health tools,ms research insights,brainai,multiple sclerosis,ectrms",biomarkers therapies ms technologies poster presentations digital health tools ms research insights brainai ectrms,biomarkers therapies ms technologies poster presentations digital health tools ms research insights brainai ectrms,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
316,327,2023-10-05 14:05:09.0,"ðŸ“… We're looking forward to #ECTRIMS2023 in Milan, Oct 11-13. 
ðŸ“¢ Our team will be sharing the latest data and research that have the potential to improve outcomes for people living with #MS.
ðŸ”— Read our blog about our activities at @ECTRIMS: https://t.co/RQMzvIMtBW #HCPsOnly https://t.co/bOCsPZfUKk",twitter,DEU,MerckHealthcare,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ðŸ“… we're looking forward to #ectrims2023 in milan, oct 11-13. ðŸ“¢ our team will be sharing the latest data and research that have the potential to improve outcomes for people living with #ms. ðŸ”— read our blog about our activities at @ectrims: https://t.co/rqmzvimtbw #hcpsonly https://t.co/bocspzfukk",unknown,"#ectrims2023, #ms, #hcpsonly",,,6000000000,857893749959086080,,7549,622,0,,,2,39,4064,False,"we're looking forward to ec trims in milan, oct 11-13. our team will be sharing the latest data and research that have the potential to improve outcomes for people living with ms. read our blog about our activities at : #hcpsonly","['Multiple Sclerosis (MS)', 'Milan', 'research', 'data', 'outcomes', 'healthcare', 'blog', 'activities']","multiple sclerosis (ms),milan,research,data,outcomes,healthcare,blog,activities",multiple sclerosis (ms) outcomes healthcare blog activities,multiple sclerosis (ms) outcomes healthcare blog activities,16,16_ms_research_sclerosis_multiple,Multiple Sclerosis Research and Management Practices at ViewMind Inc.,"['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['ms', 'multiplesclerosis', 'sclerosis', 'med', 'nursing', 'healthcare', 'nurses', 'nurse', 'ukmsna', 'specialists']","['Multiple Sclerosis Research and Management Practices at ViewMind Inc.', '', '', '', '', '', '', '', '', '']","['ms', 'research', 'sclerosis', 'multiple', 'healthcare', 'management', 'practice', 'well', 'ramos', 'viewmind']","['multiple sclerosis (ms) therapy cure', 'viewmind inc. exhibiting posters studies biogen hospital ramos meja booth d30 healthcare ms research ectrims congress', 'viewmind inc. biogen hospital ramos meja booth d30 healthcare ms research ectrims congress actrims americas committee for treatment & research in']",ms - research - sclerosis - multiple - healthcare - management - practice - well - ramos - viewmind,1.0,False
317,328,2023-10-05 09:04:28.0,"This time next week we will be at #MSMilan2023 ðŸ‡®ðŸ‡¹ We can't wait to connect with researchers, clinicians, and industry professionals. 

Join us at our booth for networking opportunities and to explore potential collaborations ðŸ¤ðŸ½ðŸ“·

#MS #MultiplsSclerosis #MSResearch https://t.co/AzNfOuaMO6",twitter,GBR,UKMSRegister,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","this time next week we will be at #msmilan2023 ðŸ‡®ðŸ‡¹ we can't wait to connect with researchers, clinicians, and industry professionals. join us at our booth for networking opportunities and to explore potential collaborations ðŸ¤ðŸ½ðŸ“· #ms #multiplssclerosis #msresearch https://t.co/aznfouamo6",,"#msmilan2023, #ms, #multiplssclerosis, #msresearch",,,6000000000,325527212,,2283,1814,0,,,4,10,1815,False,"this time next week we will be at ms milan we can't wait to connect with researchers, clinicians, and industry professionals. join us at our booth for networking opportunities and to explore potential collaborations ms #multiplssclerosis msresearch","['MS', 'Milan', 'researchers', 'clinicians', 'industry professionals', 'networking', 'opportunities', 'collaborations']","ms,milan,researchers,clinicians,industry professionals,networking,opportunities,collaborations",researchers clinicians industry professionals networking opportunities collaborations,researchers clinicians industry professionals networking opportunities collaborations,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
318,330,2023-10-03 20:03:07.0,"Roche - Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD - Oct 02 2023

https://t.co/2S9cC9edkn",twitter,IND,lswonline,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",roche - roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd - oct 02 2023 https://t.co/2s9cc9edkn,,,,,6000000000,1032901399,,83,160,0,,,0,0,1503,False,roche - roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd - oct 02 2023,"['Roche', 'ECTRIMS-ACTRIMS', 'MS', 'NMOSD', 'clinical', 'data', 'outcomes', 'strength', 'long-term']","roche,ectrims-actrims,ms,nmosd,clinical,data,outcomes,strength,long-term",roche ectrims-actrims clinical outcomes strength long-term,roche ectrims-actrims clinical outcomes strength long-term,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,1.0,False
319,331,2023-10-03 15:20:11.0,"ForuMS: Highlights in MS Care. 

A 75-minute online video that reviews important information presented at the CMSC meeting and other meetings, such as ECTRIMS, as well as key updates in MS care that happened in 2022.

@CatMedEd

https://t.co/X2URcWkpmu https://t.co/DtF3YTU5TQ",twitter,USA,mscare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","forums: highlights in ms care. a 75-minute online video that reviews important information presented at the cmsc meeting and other meetings, such as ectrims, as well as key updates in ms care that happened in 2022. @catmeded https://t.co/x2urcwkpmu https://t.co/dtf3ytu5tq",unknown,,Beauty/Health & Fitness,,6000000000,47616454,,2614,370,0,,,0,0,2397,False,"forums: highlights in ms care. a 75-minute online video that reviews important information presented at the cmsc meeting and other meetings, such as ectrims, as well as key updates in ms care that happened in 2022.","['meetings', 'forum', 'video', 'information', 'multiple sclerosis', 'CMSC', 'ECTRIMS', 'updates', '2022']","meetings,forum,video,information,multiple sclerosis,cmsc,ectrims,updates,2022",meetings forum video information cmsc updates 2022,meetings forum video information cmsc updates 2022,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
320,332,2023-10-03 13:56:53.0,"Only a week to go ... So get ready to rub shoulders with esteemed figures in the field of MS!

Register nowðŸ“² https://t.co/h1uXXxEaFX #PreECTRIMS2023 #ECTRIMS #MSMILAN2023 #MedExLearning #EuropeanCharcotFoundation #ECF #fondazioneprada #MS #CME #MedicalEducation https://t.co/GEHxsItdqK",twitter,ITA,Medexlearning_,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",only a week to go ... so get ready to rub shoulders with esteemed figures in the field of ms! register nowðŸ“² https://t.co/h1uxxxeafx #preectrims2023 #ectrims #msmilan2023 #medexlearning #europeancharcotfoundation #ecf #fondazioneprada #ms #cme #medicaleducation https://t.co/gehxsitdqk,unknown,"#preectrims2023, #ectrims, #msmilan2023, #medexlearning, #europeancharcotfoundation, #ecf, #fondazioneprada, #ms, #cme, #medicaleducation",,,6000000000,199276285,,1302,819,0,,,0,0,2893,False,only a week to go ... so get ready to rub shoulders with esteemed figures in the field of ms! register now #preectrims2023 ec trims ms milan #medexlearning #europeancharcotfoundation #ecf #fondazioneprada ms #cme #medicaleducation,"['MS', 'Milan', 'medical education', 'CME', 'European Charcot Foundation', 'EC Trims MS Milan', 'PREECTRIMS 2023']","ms,milan,medical education,cme,european charcot foundation,ec trims ms milan,preectrims 2023",medical education cme european charcot foundation ec trims ms milan preectrims 2023,medical education cme european charcot foundation ec trims ms milan preectrims 2023,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
321,333,2023-10-03 02:36:26.0,Whoooo! Iâ€™m outta here next week! Iâ€™ll be at @ECTRIMS  in #Milan to keep fighting MS. https://t.co/pWARBkqYqr,twitter,USA,PruePlummer,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",whoooo! iâ€™m outta here next week! iâ€™ll be at @ectrims in #milan to keep fighting ms. https://t.co/pwarbkqyqr,unknown,#milan,"Science, Animals & Pets, Fashion","{profession=Scientist & Researcher, jobTitle=Scientist}, {profession=Health practitioner, jobTitle=Clinician}",6000000000,72426830,,484,849,1,,,0,4,2468,False,whoooo! im outta here next week! ill be at in milan to keep fighting ms.,"['out', 'Milan', 'fight', 'MS']","out,milan,fight,ms",out fight,out fight,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,0.9878916892921487,False
322,334,2023-10-02 20:30:33.0,"Pharma/Biotech Highlights:

$TRVN: Trevena presents respiratory monitoring study results.
$HZNP: Horizon presents UPLIZNA data at ECTRIMS.
$TGTX: TG Therapeutics highlights BRIUMVIG at European conference.
$SAVA: Cassava completes Alzheimer's trial enrollment successfully. https://t.co/eQRyd2oDRW",twitter,USA,OzmosiHealth,"{id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",pharma/biotech highlights: $trvn: trevena presents respiratory monitoring study results. $hznp: horizon presents uplizna data at ectrims. $tgtx: tg therapeutics highlights briumvig at european conference. $sava: cassava completes alzheimer's trial enrollment successfully. https://t.co/eqryd2odrw,unknown,,"Beauty/Health & Fitness, Business, Technology",,6000000000,1055982930,,1359,792,6,,,0,0,7046,True,pharma/biotech highlights: $trvn: trevena presents respiratory monitoring study results. $hznp: horizon presents uplizna data at ectrims. $tgtx: tg therapeutics highlights briumvig at european conference. $sava: cassava completes alzheimer's trial enrollment successfully.,"['pharma', 'biotech', 'trevena', 'respiratory', 'monitoring', 'study', 'results', '$trvn', 'horizon', 'uplizna', 'data', 'ectrims', 'tg', 'therapeutics', 'brium']","pharma,biotech,trevena,respiratory,monitoring,study,results,$trvn,horizon,uplizna,data,ectrims,tg,therapeutics,brium",pharma biotech trevena respiratory monitoring study results $trvn horizon uplizna tg therapeutics brium,pharma biotech trevena respiratory monitoring study results $trvn horizon uplizna tg therapeutics brium,0,0_tiziana_annual_naspms_secondary,Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses.,"['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana', 'biomarker', 'tlsa', 'tls', 'pharma', 'tg', 'immunosuppressives', 'foralumab', 'naspms', 'nasdaq']","[""Tiziana Pharmaceuticals' research on non-active secondary progressive multiple sclerosis at annual congresses."", '', '', '', '', '', '', '', '', '']","['tiziana', 'annual', 'naspms', 'secondary', 'nonactive', 'safety', 'biomarker', 'tlsa', 'progressive', 'congress']","['tiziana safety biomarker info intranasal na-spms annual congress xbi ibd pph xph', 'tiziana presentation safety biomarker non-active secondary progressive na-spms annual congress tls', 'tiziana nasdaq tlsa safety biomarker non-active secondary progressive na-spms annual congress']",tiziana - annual - naspms - secondary - nonactive - safety - biomarker - tlsa - progressive - congress,0.8218748294017912,False
323,335,2023-10-02 18:42:25.0,"$HZNP
Horizon Therapeutics plc Announces New UPLIZNAÂ® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 - https://t.co/hKnV1UhJuc",twitter,,MarcJacksonLA,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$hznp horizon therapeutics plc announces new upliznaÂ® (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 - https://t.co/hknv1uhjuc,unknown,,Technology,,6000000000,4058194633,,3645,386,1,,,0,0,91493,False,$hznp horizon therapeutics plc announces new uplizna (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 -,"['Horizon Therapeutics', 'Uplizna', 'NMO', 'ECTRIMS', 'Neuromyelitis Optica Spectrum Disorder']","horizon therapeutics,uplizna,nmo,ectrims,neuromyelitis optica spectrum disorder",horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder,horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,1.0,True
324,336,2023-10-02 18:41:05.0,Can anti-CD20 monoclonal antibodies be passed to breastmilk in postpartum women with #MS? A recent study found that the treatment is well-tolerated for mother and child. Read more MS research new in the #ECTRIMSBulletin: https://t.co/aDZJaOk7tj https://t.co/0nGsjDdZVG,twitter,CHE,ECTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",can anti-cd20 monoclonal antibodies be passed to breastmilk in postpartum women with #ms? a recent study found that the treatment is well-tolerated for mother and child. read more ms research new in the #ectrimsbulletin: https://t.co/adzjaok7tj https://t.co/0ngsjddzvg,,"#ms, #ectrimsbulletin",,,6000000000,714464982,,7886,65,0,,,2,3,7077,False,can anti-cd20 monoclonal antibodies be passed to breastmilk in postpartum women with ms? a recent study found that the treatment is well-tolerated for mother and child. read more ms research new in the ec trimsbulletin:,"['Anti-CD20', 'monoclonal antibodies', 'breastmilk', 'postpartum', 'MS', 'tolerated', 'mother', 'child', 'EC Trends Bulletin', 'MS research', 'new']","anti-cd20,monoclonal antibodies,breastmilk,postpartum,ms,tolerated,mother,child,ec trends bulletin,ms research,new",anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new,anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new,4,4_anticd20_monoclonal_antibody_natalizumab,"Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['antibody', 'antibodies', 'anticd20', 'natalizumab', 'ofatumumab', 'satralizumab', 'inhibitors', 'therapies', 'monoclonal', 'disease']","['Anti-CD20 Monoclonal Antibody Therapies in Neurology: Analysis, Pregnancy Outcomes, and Breastfeeding Considerations', '', '', '', '', '', '', '', '', '']","['anticd20', 'monoclonal', 'antibody', 'natalizumab', 'therapies', 'neurotwitter', 'ec', 'analysis', 'acd20', 'essential']","['pregnancy infant outcomes anti-cd20 monoclonal antibody poster neurotwitter', 'ocarina ii trial anti-cd20 monoclonal antibody iv infusion neurotwitter', 'anti-cd20 monoclonal antibodies breastmilk postpartum tolerated mother child ec trends bulletin ms research new']",anticd20 - monoclonal - antibody - natalizumab - therapies - neurotwitter - ec - analysis - acd20 - essential,1.0,True
325,337,2023-10-02 14:37:31.0,"$RHHBY
Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD  https://t.co/X1ECgg0AV9",twitter,,MarcJacksonLA,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$rhhby roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/x1ecgg0av9,unknown,,Technology,,6000000000,4058194633,,3644,386,1,,,0,0,91437,False,$rhhby roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd,"['Roche', 'ECTRIMS-ACTRIMS', 'multiple sclerosis', 'non-msod', 'clinical data', 'real-world data', 'long-term outcomes']","roche,ectrims-actrims,multiple sclerosis,non-msod,clinical data,real-world data,long-term outcomes",roche ectrims-actrims non-msod clinical data real-world data long-term outcomes,roche ectrims-actrims non-msod clinical data real-world data long-term outcomes,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.5760431335094492,True
326,338,2023-10-02 13:15:41.0,"$HZNP Horizon Therapeutics reveals updated UPLIZNAÂ® (inebilizumab-cdon) findings on Neuromyelitis Optica Spectrum Disorder (NMOSD) at ECTRIMS 2023.

More Info: https://t.co/uypS7Sflo0 $XBI $IBB $XPH $PPH https://t.co/t6qPKEsFrS",twitter,USA,OzmosiHealth,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$hznp horizon therapeutics reveals updated upliznaÂ® (inebilizumab-cdon) findings on neuromyelitis optica spectrum disorder (nmosd) at ectrims 2023. more info: https://t.co/uyps7sflo0 $xbi $ibb $xph $pph https://t.co/t6qpkesfrs,unknown,,"Beauty/Health & Fitness, Business, Technology",,6000000000,1055982930,,1358,791,0,,,0,0,7010,True,$hznp horizon therapeutics reveals updated uplizna (inebilizumab-cdon) findings on neuromyelitis optica spectrum disorder (nmosd) at ectrims 2023. more info: $xbi $ibb $xph $pph,"['Horizon Therapeutics', 'Uplizna', 'ECTRIMS', 'NMO', 'Neuromyelitis Optica Spectrum Disorder', '$hznp', '$shnp', '$IBB', '$XBI', '']","horizon therapeutics,uplizna,ectrims,nmo,neuromyelitis optica spectrum disorder,$hznp,$shnp,$ibb,$xbi,",horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ,horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,1.0,True
327,339,2023-10-02 12:08:45.0,Horizon Therapeutics plc Announces New UPLIZNAÂ® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 https://t.co/6Vb38SNfij https://t.co/gbxxpJF2Jo,twitter,,NewsFromBW,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",horizon therapeutics plc announces new upliznaÂ® (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 https://t.co/6vb38snfij https://t.co/gbxxpjf2jo,,,Business,,6000000000,976297820532518914,,3110,25,0,,,0,0,581486,False,horizon therapeutics plc announces new uplizna (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023,"['Horizon Therapeutics', 'Plc', 'Uplizna', 'NMO', 'ECTRIMS', '2023']","horizon therapeutics,plc,uplizna,nmo,ectrims,2023",horizon therapeutics plc uplizna nmo 2023,horizon therapeutics plc uplizna nmo 2023,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.778149090388855,False
328,340,2023-10-02 12:06:30.0,NEWS: Today we announced that new data for our neuromyelitis optica spectrum disorder (#NMOSD) medicine will be presented at the 39th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (@ECTRIMS). Learn more: https://t.co/oFd6oi0REP. #MSMilan2023 https://t.co/2JhfikXveH,twitter,IRL,HorizonNews,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",news: today we announced that new data for our neuromyelitis optica spectrum disorder (#nmosd) medicine will be presented at the 39th congress of the european committee for treatment and research in multiple sclerosis (@ectrims). learn more: https://t.co/ofd6oi0rep. #msmilan2023 https://t.co/2jhfikxveh,unknown,"#nmosd, #msmilan2023",Science,,6000000000,2880366354,,4657,1594,0,,,2,6,4942,False,news: today we announced that new data for our neuromyelitis optica spectrum disorder (#nmosd) medicine will be presented at the 39th congress of the european committee for treatment and research in multiple sclerosis (). learn more: . ms milan,"['Neuromyelitis Optica Spectrum Disorder', 'European Committee for Treatment and Research in Multiple Sclerosis', 'MS Milan']","neuromyelitis optica spectrum disorder,european committee for treatment and research in multiple sclerosis,ms milan",neuromyelitis optica spectrum disorder european committee for treatment and research in multiple sclerosis,neuromyelitis optica spectrum disorder european committee for treatment and research in multiple sclerosis,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,0.9391970537181575,False
329,342,2023-10-02 12:03:02.0,Horizon Therapeutics plc Announces New UPLIZNAÂ® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 $HZNP https://t.co/bHMtVx2aSZ,twitter,USA,health_stocks,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",horizon therapeutics plc announces new upliznaÂ® (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 $hznp https://t.co/bhmtvx2asz,unknown,,"Business, Science",,6000000000,1090012514820280324,,649,155,0,,,0,0,14294,True,horizon therapeutics plc announces new uplizna (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 $hznp,"['Horizon Therapeutics', 'Plc', 'Uplizna', 'Neuromyelitis Optica Spectrum Disorder', 'ECTRIMS 2023']","horizon therapeutics,plc,uplizna,neuromyelitis optica spectrum disorder,ectrims 2023",horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023,horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023,14,14_nerve_optica_neuromyelitis_spectrum,"Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna.","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['neuromyelitis', 'optica', 'neurodegeneration', 'optic', 'remyelination', 'microglial', 'microglia', 'neurovascular', 'neurodegenerative', 'disease']","[""Neuromyelitis Optica Spectrum Disorder (NMOSD) research and treatment options, including Horizon Therapeutics' Uplizna."", '', '', '', '', '', '', '', '', '']","['nerve', 'optica', 'neuromyelitis', 'spectrum', 'disorder', 'spinal', 'cord', 'remyelination', 'horizon', 'therapeutics']","['horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder $hznp $shnp $ibb $xbi ', 'horizon therapeutics plc uplizna neuromyelitis optica spectrum disorder ectrims 2023', 'horizon therapeutics uplizna nmo neuromyelitis optica spectrum disorder']",nerve - optica - neuromyelitis - spectrum - disorder - spinal - cord - remyelination - horizon - therapeutics,1.0,True
330,343,2023-10-02 11:55:15.0,"Excited to share groundbreaking #MS #GWAS findings on Time of Conversion to SPMS and Age at MS Progression at #ECTRIMS2023/#ACTRIMS2023! ðŸ§¬ Join me at Poster Session [2], Poster number P520 to explore the first ever study done on this MS severity!",twitter,,SoumeenJin,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","excited to share groundbreaking #ms #gwas findings on time of conversion to spms and age at ms progression at #ectrims2023/#actrims2023! ðŸ§¬ join me at poster session [2], poster number p520 to explore the first ever study done on this ms severity!",unknown,"#ms, #gwas, #ectrims2023, #actrims2023","Beauty/Health & Fitness, Science","{profession=Student, jobTitle=Student}",6000000000,1609553391180546048,,5,16,0,,,0,0,2,False,"excited to share groundbreaking ms #gwas findings on time of conversion to spms and age at ms progression at ec trims/#actrims2023! join me at poster session [2], poster number p520 to explore the first ever study done on this ms severity!","['GWAS', 'MS', 'SPMS', 'EC', 'ACTRIMS', 'poster', 'study', 'severity']","gwas,ms,spms,ec,actrims,poster,study,severity",gwas spms actrims poster study severity,gwas spms actrims poster study severity,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,1.0,False
331,344,2023-10-02 08:18:07.0,Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD #BusinessWire  https://t.co/LgzPz3QYXY,twitter,,Stock_Market_Pr,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd #businesswire https://t.co/lgzpz3qyxy,,#businesswire,Business,,6000000000,1089978712685273090,,30284,61,0,,,0,0,393467,False,genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd businesswire,"['Genentech', 'ECTRIMS-ACTRIMS', 'MS', 'NMOSD', 'clinical', 'data', 'outcomes', 'strength', 'long-term']","genentech,ectrims-actrims,ms,nmosd,clinical,data,outcomes,strength,long-term",genentech ectrims-actrims clinical outcomes strength long-term,genentech ectrims-actrims clinical outcomes strength long-term,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,1.0,False
332,345,2023-10-02 05:26:06.0,"$RO.SW | $ROG.SW | $RHHBY
ðŸ‡¨ðŸ‡­
Roche 

To present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD 

https://t.co/VQnibja2gq https://t.co/06IySOjP7R",twitter,FIN,BullBearBres,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$ro.sw | $rog.sw | $rhhby ðŸ‡¨ðŸ‡­ roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/vqnibja2gq https://t.co/06iysojp7r,unknown,,,,6000000000,1384738758587817986,,289,1,0,,,1,4,3846,False,$ro.sw | $rog.sw | $rhhby roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd,"['$ro.sw', '$rog.sw', '$rhhby', 'Roche', 'ECTRIMS-ACTRIMS', 'MS', 'NMOSD']","$ro.sw,$rog.sw,$rhhby,roche,ectrims-actrims,ms,nmosd",$ro.sw $rog.sw $rhhby roche ectrims-actrims,$ro.sw $rog.sw $rhhby roche ectrims-actrims,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.8601091796808971,False
333,346,2023-10-02 05:08:44.0,"$RHHBY [15s. delayed]: Issued Press Release on October 02, 01:00:00: Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD https://t.co/pxZCYpv0tH",twitter,USA,FlashAlert_me,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","$rhhby [15s. delayed]: issued press release on october 02, 01:00:00: genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/pxzcypv0th",,,,,6000000000,1069693680066420736,,4641,0,0,,,0,0,1410768,False,"$rhhby [15s. delayed]: issued press release on october 02, 01:00:00: genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd","['Genentech', 'ECTRIMS-ACTRIMS', 'MS', 'NMOSD', 'clinical data', 'real-world data', 'long-term outcomes']","genentech,ectrims-actrims,ms,nmosd,clinical data,real-world data,long-term outcomes",genentech ectrims-actrims clinical data real-world data long-term outcomes,genentech ectrims-actrims clinical data real-world data long-term outcomes,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,1.0,True
334,347,2023-10-02 05:06:03.0,Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD $RHHBY https://t.co/KF6sAmi1OI,twitter,USA,health_stocks,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd $rhhby https://t.co/kf6sami1oi,unknown,,"Business, Science",,6000000000,1090012514820280324,,648,155,0,,,0,0,14265,True,genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd $rhhby,"['Genentech', 'ECTRIMS-ACTRIMS', 'MS', 'NMOSD', 'rhHBy']","genentech,ectrims-actrims,ms,nmosd,rhhby",genentech ectrims-actrims rhhby,genentech ectrims-actrims rhhby,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.7398196692344682,False
335,348,2023-10-02 05:03:23.0,"$RHHBY [15s. delayed]: Issued Press Release on October 02, 01:00:00: Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD https://t.co/lUr5jsTxpx",twitter,USA,FlashAlert_me,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","$rhhby [15s. delayed]: issued press release on october 02, 01:00:00: roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/lur5jstxpx",,,,,6000000000,1069693680066420736,,4641,0,0,,,0,0,1410764,False,"$rhhby [15s. delayed]: issued press release on october 02, 01:00:00: roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd","['Roche', 'ECTRIMS-ACTRIMS', 'MS', 'NMOSD', 'clinical data', 'real-world data', 'press release', 'October', 'strength', 'long-term outcomes']","roche,ectrims-actrims,ms,nmosd,clinical data,real-world data,press release,october,strength,long-term outcomes",roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes,roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,0.5208878453599152,True
336,349,2023-10-02 05:02:35.0,Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD https://t.co/feiwDux815 https://t.co/MBBQQJOPgL,twitter,,NewsFromBW,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/feiwdux815 https://t.co/mbbqqjopgl,,,Business,,6000000000,976297820532518914,,3109,25,0,,,0,0,581322,False,genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd,"['Genentech', 'ECTRIMS-ACTRIMS', 'MS', 'NMOSD', 'clinical', 'data', 'outcomes']","genentech,ectrims-actrims,ms,nmosd,clinical,data,outcomes",genentech ectrims-actrims clinical outcomes,genentech ectrims-actrims clinical outcomes,2,2_ectrimsactrims_data_longterm_roche,Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings.,"['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['ectrimsactrims', 'actrims', 'clinical', 'biomarker', 'roche', 'severity', 'outcomes', 'strength', 'treatments', 'treatment']","[""Long-term efficacy and strength of Roche and Genentech's ECTRIMS-ACTRIMS clinical trials data compared in real-world settings."", '', '', '', '', '', '', '', '', '']","['ectrimsactrims', 'data', 'longterm', 'roche', 'outcomes', 'genentech', 'clinical', 'strength', 'realworld', 'chitnis']","['genentech ectrims-actrims clinical data real-world data long-term outcomes', 'roche ectrims-actrims non-msod clinical data real-world data long-term outcomes', 'roche ectrims-actrims clinical data real-world data press release october strength long-term outcomes']",ectrimsactrims - data - longterm - roche - outcomes - genentech - clinical - strength - realworld - chitnis,1.0,False
337,350,2023-10-02 05:01:54.0,#Breaking: Weâ€™re presenting new data at #MSMilan2023 reflecting our long-standing commitment to advance the science in #multiplesclerosis and #NMOSD and improve the treatment experience for everyone living with this disease. Learn more: https://t.co/tvJ7mvfLNX,twitter,USA,genentech,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#breaking: weâ€™re presenting new data at #msmilan2023 reflecting our long-standing commitment to advance the science in #multiplesclerosis and #nmosd and improve the treatment experience for everyone living with this disease. learn more: https://t.co/tvj7mvflnx,,"#breaking, #msmilan2023, #multiplesclerosis, #nmosd",,,6000000000,16150688,,128328,237,0,,,2,9,7658,False,#breaking: were presenting new data at ms milan reflecting our long-standing commitment to advance the science in multiple sclerosis and #nmosd and improve the treatment experience for everyone living with this disease. learn more:,"['Breaking', 'MS Milan', 'multiple sclerosis', 'NMOSD', 'treatment experience']","breaking,ms milan,multiple sclerosis,nmosd,treatment experience",breaking treatment experience,breaking treatment experience,8,8_hauser_stephen_cure_path,Stephen Hauser's lectures on potential cures for diseases through innovative paths.,"['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['cure', 'treatment', 'hauser', 'disease', 'medicine', 'dr', 'neurology', 'symptom', 'stephen', 'onset']","[""Stephen Hauser's lectures on potential cures for diseases through innovative paths."", '', '', '', '', '', '', '', '', '']","['hauser', 'stephen', 'cure', 'path', 'trim', 'lecture', 'dr', 'medications', 'loci', 'katz']","['stephen hauser talk prevent cure trim', 'stephen hauser neurology lecture path to a cure', 'dr. stephen hauser path cure ectrms']",hauser - stephen - cure - path - trim - lecture - dr - medications - loci - katz,0.7307879003822395,False
338,351,2023-10-01 08:25:14.0,"T-minus 10 days until #MSMilan2023 â°

Milan is set to be the epicenter of MS breakthroughs and discussions.! While we connect virtually, our commitment to bringing you the latest is unwavering. Stay tuned to âœ¨https://t.co/FB5htuqt0qâœ¨

@ECTRIMS https://t.co/edadj8uxa2",twitter,,VJNeurology,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","t-minus 10 days until #msmilan2023 â° milan is set to be the epicenter of ms breakthroughs and discussions.! while we connect virtually, our commitment to bringing you the latest is unwavering. stay tuned to âœ¨https://t.co/fb5htuqt0qâœ¨ @ectrims https://t.co/edadj8uxa2",,#msmilan2023,Photo & Video,,6000000000,751336894068355072,,22530,582,0,,,0,0,3270,True,"t-minus 10 days until ms milan milan is set to be the epicenter of ms breakthroughs and discussions.! while we connect virtually, our commitment to bringing you the latest is unwavering. stay tuned to","['T-minus', 'days', 'Milan', 'breakthroughs', 'discussions', 'virtually', 'commitment', 'latest']","t-minus,days,milan,breakthroughs,discussions,virtually,commitment,latest",t-minus days breakthroughs discussions virtually commitment latest,t-minus days breakthroughs discussions virtually commitment latest,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
339,352,2023-10-01 06:24:14.0,/ @OxMEDiscovery  I noticed in NP today that in Milan there's going to be a meeting for European Committee for Treatment and Research in MS (ECTRIMS). Will you be presenting your Raman Spectroscopy and AI there- that it can differentiate between ME/CFS /MS/ HC's would be helpful?,twitter,,MECFSNanoneedle,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",/ @oxmediscovery i noticed in np today that in milan there's going to be a meeting for european committee for treatment and research in ms (ectrims). will you be presenting your raman spectroscopy and ai there- that it can differentiate between me/cfs /ms/ hc's would be helpful?,unknown,,,,6000000000,1548186101403172866,,482,1946,1,,,0,4,3253,False,/ i noticed in np today that in milan there's going to be a meeting for european committee for treatment and research in ms (ectrims). will you be presenting your raman spectroscopy and ai there- that it can differentiate between me/cfs /ms/ hc's would be helpful?,"['meeting', 'Milan', 'European Committee', 'MS', 'ECTRIMS', 'Raman spectroscopy', 'AI', 'ME/CFS', 'HCs']","meeting,milan,european committee,ms,ectrims,raman spectroscopy,ai,me/cfs,hcs",meeting european committee raman spectroscopy ai me/cfs hcs,meeting european committee raman spectroscopy ai me/cfs hcs,-1,-1_researchers_session_smoldering_ms,Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.,"['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['disability', 'clinical', 'medical', 'dmts', 'dmt', 'health', 'healthcare', 'prognosis', 'clinic', 'disease']","['Advances in MS research and AI technology for predicting disease progression at the European Charcot Foundation Congress in 2023.', '', '', '', '', '', '', '', '', '']","['researchers', 'session', 'smoldering', 'ms', '2023', 'ai', 'progression', 'rrms', 'disability', 'care']","['2023 dmts disability progression rrms', '$imux team ms milan congress exciting gathering researchers healthcare professionals industry leaders msresearch immunic actrims', 'pira progression independent relapse activity accumulation disability prediction progression insightful talk hot topic session']",researchers - session - smoldering - ms - 2023 - ai - progression - rrms - disability - care,0.0,False
340,353,2023-09-30 22:46:12.0,Prof Sokhi and colleagues published their data from Kenyans with MS (https://t.co/Kg5a5lVUeT) which has set the stage for other studies in the continent. We will be presenting our data from @MayoClinicNeuro on Somalis with MS living in Minnesota @ECTRIMS next month. (2/2),twitter,USA,neuronathoo,"{id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",prof sokhi and colleagues published their data from kenyans with ms (https://t.co/kg5a5lvuet) which has set the stage for other studies in the continent. we will be presenting our data from @mayoclinicneuro on somalis with ms living in minnesota @ectrims next month. (2/2),female,,,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,231585347,,733,736,0,,,6,19,2251,False,prof sokhi and colleagues published their data from kenyans with ms () which has set the stage for other studies in the continent. we will be presenting our data from on somalis with ms living in minnesota next month. (2/2),"['Kenyans', 'MS', 'data', 'stage', 'studies', 'continent', 'Somalis', 'MS', 'Minnesota', 'data', 'presentation.']","kenyans,ms,data,stage,studies,continent,somalis,ms,minnesota,data,presentation.",kenyans stage studies continent somalis minnesota presentation.,kenyans stage studies continent somalis minnesota presentation.,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
341,354,2023-10-12 18:39:45.0,"Rhonda Voskuhl, MD, neurologist, research scientist and clinician at the University of California (UCLA) is the first winner of the Rachel Horne Prize for Womenâ€™s Research in MS. Dr. Voskuhl serves on the ACTRIMS Program Committee. https://t.co/YeL8XhgIeZ 
#ACTRIMS #MSMilan23",twitter,USA,ACTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","rhonda voskuhl, md, neurologist, research scientist and clinician at the university of california (ucla) is the first winner of the rachel horne prize for womenâ€™s research in ms. dr. voskuhl serves on the actrims program committee. https://t.co/yel8xhgiez #actrims #msmilan23",,"#actrims, #msmilan23",,,6000000000,556155283,,4384,330,0,,,0,2,656,False,"rhonda voskuhl, md, neurologist, research scientist and clinician at the university of california (ucla) is the first winner of the rachel horne prize for womens research in ms. dr. voskuhl serves on the actrims program committee. #actrims msmilan23","['Rhonda Voskuhl', 'UCLA', 'neurologist', 'research scientist', 'clinician', 'Rachel Horne Prize', 'MS', 'ACTRIMS', 'program committee.']","rhonda voskuhl,ucla,neurologist,research scientist,clinician,rachel horne prize,ms,actrims,program committee.",rhonda voskuhl ucla neurologist research scientist clinician rachel horne prize actrims program committee.,rhonda voskuhl ucla neurologist research scientist clinician rachel horne prize actrims program committee.,7,7_neurology_neurotwitter_neurologist_hopes,UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.,"['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurologist', 'neurology', 'neuroepidemiology', 'neurogenetic', 'neuro', 'neurotwitter', 'neurologically', 'neuromodulation', 'misdiagnosed', 'mri']","['UCLA Neurologist Rhonda Voskuhl discusses future hopes in neurology and the importance of accurate diagnosis.', '', '', '', '', '', '', '', '', '']","['neurology', 'neurotwitter', 'neurologist', 'hopes', 'clinical', 'prize', 'future', 'for', 'imaging', 'mri']","['neurogenetic misdiagnosed overlap careful interpretation clinical csf mri features timely accurate diagnosis prevent unnecessary exposure therapies ', 'hopes future hopes for the future neurology ec trims booth as one for patients', 'join today event unleashing potential transformational leadership neuro resilience nobel peace prize laureate dr. lorah freeman augusto miravalle ']",neurology - neurotwitter - neurologist - hopes - clinical - prize - future - for - imaging - mri,1.0,False
342,355,2023-10-03 15:11:14.0,"#ACTRIMSForum 2024 theme is ""Breaking Barriers in MS."" Register now and join us February 29 - March 2 in West Palm Beach, Florida. Visit our website for details. https://t.co/zYJOCLzIWS https://t.co/ISx6nkBUWh",twitter,USA,ACTRIMS,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#actrimsforum 2024 theme is ""breaking barriers in ms."" register now and join us february 29 - march 2 in west palm beach, florida. visit our website for details. https://t.co/zyjoclziws https://t.co/isx6nkbuwh",,#actrimsforum,,,6000000000,556155283,,4349,330,0,,,0,0,654,False,"act rims forum 2024 theme is ""breaking barriers in ms."" register now and join us february 29 - march 2 in west palm beach, florida. visit our website for details.","['act', 'rims', 'forum', '2024', 'theme', 'breaking', 'barriers', 'ms', 'register', 'now', 'join', 'february', '29', 'march', '2', 'west', 'palm', 'beach', 'florida', '']","act,rims,forum,2024,theme,breaking,barriers,ms,register,now,join,february,29,march,2,west,palm,beach,florida,",act rims forum 2024 theme breaking barriers register now join february 29 march 2 west palm beach florida ,act rims forum 2024 theme breaking barriers register now join february 29 march 2 west palm beach florida ,13,13_online_opportunity_colleagues_day,Online Brain Conversation Opportunities with Experts,"['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day', 'participate', 'meetings', 'meeting', 'discussions', 'attend', 'opportunity', 'saturday', 'learning', 'learn']","['Online Brain Conversation Opportunities with Experts', '', '', '', '', '', '', '', '', '']","['online', 'opportunity', 'colleagues', 'day', 'brain', 'experts', 'connect', 'conversation', 'event', 'share']","['day opportunity experts learning online', 'day connect questions needs conversation saturday october register event trims4me', 'msmilan day connect online share questions voice needs conversation saturday october 2023 register event']",online - opportunity - colleagues - day - brain - experts - connect - conversation - event - share,1.0,False
